NZ742971B2 - Trisubstitutedsilylphenoxyheterocycles and analogues - Google Patents
Trisubstitutedsilylphenoxyheterocycles and analogues Download PDFInfo
- Publication number
- NZ742971B2 NZ742971B2 NZ742971A NZ74297116A NZ742971B2 NZ 742971 B2 NZ742971 B2 NZ 742971B2 NZ 742971 A NZ742971 A NZ 742971A NZ 74297116 A NZ74297116 A NZ 74297116A NZ 742971 B2 NZ742971 B2 NZ 742971B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- unsubstituted
- substituted
- alkyl
- group
- formula
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims abstract description 313
- 238000000034 method Methods 0.000 claims abstract description 199
- 239000000203 mixture Substances 0.000 claims abstract description 123
- 230000008569 process Effects 0.000 claims abstract description 91
- 230000003032 phytopathogenic effect Effects 0.000 claims abstract description 17
- -1 hydroxyimino Chemical group 0.000 claims description 235
- 125000005843 halogen group Chemical group 0.000 claims description 178
- 150000003839 salts Chemical class 0.000 claims description 124
- 125000000623 heterocyclic group Chemical group 0.000 claims description 82
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 75
- 125000003107 substituted aryl group Chemical group 0.000 claims description 58
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims description 49
- 229910052727 yttrium Inorganic materials 0.000 claims description 43
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 41
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 37
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 34
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 claims description 33
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 30
- 229910052801 chlorine Inorganic materials 0.000 claims description 28
- 244000005700 microbiome Species 0.000 claims description 28
- 229910052717 sulfur Inorganic materials 0.000 claims description 25
- 229910052760 oxygen Inorganic materials 0.000 claims description 24
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 23
- 125000004649 C2-C8 alkynyl group Chemical group 0.000 claims description 23
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 21
- 229910052740 iodine Inorganic materials 0.000 claims description 21
- 239000003446 ligand Substances 0.000 claims description 21
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 20
- 125000000217 alkyl group Chemical group 0.000 claims description 19
- 229910052757 nitrogen Inorganic materials 0.000 claims description 17
- 125000001889 triflyl group Chemical group FC(F)(F)S(*)(=O)=O 0.000 claims description 16
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims description 15
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 claims description 15
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 14
- 229910052799 carbon Inorganic materials 0.000 claims description 13
- 229910052731 fluorine Inorganic materials 0.000 claims description 13
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 13
- 229920006395 saturated elastomer Polymers 0.000 claims description 13
- 150000002148 esters Chemical class 0.000 claims description 12
- 125000001153 fluoro group Chemical group F* 0.000 claims description 12
- 239000002184 metal Chemical class 0.000 claims description 12
- 229910052751 metal Inorganic materials 0.000 claims description 12
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 12
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 11
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 10
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 10
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 claims description 10
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 9
- 239000000969 carrier Substances 0.000 claims description 9
- 229910052710 silicon Inorganic materials 0.000 claims description 9
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 9
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 8
- 125000001188 haloalkyl group Chemical group 0.000 claims description 8
- 150000001340 alkali metals Chemical class 0.000 claims description 7
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 claims description 7
- COERJHDMQUPDCV-UHFFFAOYSA-N [K].FB(F)F Chemical compound [K].FB(F)F COERJHDMQUPDCV-UHFFFAOYSA-N 0.000 claims description 6
- 229910052783 alkali metal Inorganic materials 0.000 claims description 6
- 125000005842 heteroatom Chemical group 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 125000000304 alkynyl group Chemical group 0.000 claims description 4
- 125000002619 bicyclic group Chemical group 0.000 claims description 4
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 4
- 150000001204 N-oxides Chemical class 0.000 claims description 3
- 229910052752 metalloid Inorganic materials 0.000 claims description 3
- 150000002738 metalloids Chemical class 0.000 claims description 3
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 claims description 3
- 239000010703 silicon Substances 0.000 claims description 3
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 48
- 241000233866 Fungi Species 0.000 abstract description 21
- 239000000417 fungicide Substances 0.000 abstract description 15
- 230000000855 fungicidal effect Effects 0.000 abstract description 10
- 239000000543 intermediate Substances 0.000 abstract description 4
- 241000196324 Embryophyta Species 0.000 description 171
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 72
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 56
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 48
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 42
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 39
- 239000011541 reaction mixture Substances 0.000 description 37
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 35
- 238000005160 1H NMR spectroscopy Methods 0.000 description 32
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 31
- 239000004480 active ingredient Substances 0.000 description 30
- 239000002904 solvent Substances 0.000 description 29
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 28
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 28
- 238000012360 testing method Methods 0.000 description 28
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 27
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 25
- 238000006243 chemical reaction Methods 0.000 description 24
- 201000010099 disease Diseases 0.000 description 23
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 23
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 23
- 239000000126 substance Substances 0.000 description 23
- 238000009472 formulation Methods 0.000 description 22
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 21
- 239000000243 solution Substances 0.000 description 21
- 239000002585 base Substances 0.000 description 18
- 235000013399 edible fruits Nutrition 0.000 description 18
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 15
- 239000003921 oil Substances 0.000 description 14
- 235000019198 oils Nutrition 0.000 description 14
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 14
- 230000000670 limiting effect Effects 0.000 description 13
- 239000012074 organic phase Substances 0.000 description 13
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 12
- 235000019502 Orange oil Nutrition 0.000 description 12
- 238000004440 column chromatography Methods 0.000 description 12
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 12
- 239000000463 material Substances 0.000 description 12
- 239000010502 orange oil Substances 0.000 description 12
- 239000000741 silica gel Substances 0.000 description 12
- 229910002027 silica gel Inorganic materials 0.000 description 12
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 11
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 11
- 239000003054 catalyst Substances 0.000 description 11
- 239000003112 inhibitor Substances 0.000 description 11
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 10
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 10
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 10
- NNBZCPXTIHJBJL-UHFFFAOYSA-N decalin Chemical compound C1CCCC2CCCCC21 NNBZCPXTIHJBJL-UHFFFAOYSA-N 0.000 description 10
- 239000003995 emulsifying agent Substances 0.000 description 10
- 238000010353 genetic engineering Methods 0.000 description 10
- UAEPNZWRGJTJPN-UHFFFAOYSA-N methylcyclohexane Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 description 10
- 239000002689 soil Substances 0.000 description 10
- 238000005507 spraying Methods 0.000 description 10
- 125000003118 aryl group Chemical group 0.000 description 9
- 239000002270 dispersing agent Substances 0.000 description 9
- 150000002170 ethers Chemical class 0.000 description 9
- 239000002023 wood Substances 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 8
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 8
- 239000012298 atmosphere Substances 0.000 description 8
- 239000000975 dye Substances 0.000 description 8
- 229910052763 palladium Inorganic materials 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 229910052723 transition metal Inorganic materials 0.000 description 8
- 150000003624 transition metals Chemical class 0.000 description 8
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 description 7
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 description 7
- IDPWXVBDDIYDKT-UHFFFAOYSA-N 2-phenoxyquinoline Chemical class C=1C=C2C=CC=CC2=NC=1OC1=CC=CC=C1 IDPWXVBDDIYDKT-UHFFFAOYSA-N 0.000 description 7
- XTDZGXBTXBEZDN-UHFFFAOYSA-N 3-(difluoromethyl)-N-(9-isopropyl-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl)-1-methylpyrazole-4-carboxamide Chemical compound CC(C)C1C2CCC1C1=C2C=CC=C1NC(=O)C1=CN(C)N=C1C(F)F XTDZGXBTXBEZDN-UHFFFAOYSA-N 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 7
- 239000005799 Isopyrazam Substances 0.000 description 7
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 7
- 241000209140 Triticum Species 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 239000008187 granular material Substances 0.000 description 7
- 125000000466 oxiranyl group Chemical group 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- 230000009466 transformation Effects 0.000 description 7
- 230000009261 transgenic effect Effects 0.000 description 7
- 238000010626 work up procedure Methods 0.000 description 7
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 6
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 6
- 240000002791 Brassica napus Species 0.000 description 6
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 6
- 241000223218 Fusarium Species 0.000 description 6
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 6
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 6
- 101100464779 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CNA1 gene Proteins 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 235000021307 Triticum Nutrition 0.000 description 6
- 239000000853 adhesive Substances 0.000 description 6
- 230000001070 adhesive effect Effects 0.000 description 6
- 229910052786 argon Inorganic materials 0.000 description 6
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 6
- 244000038559 crop plants Species 0.000 description 6
- 230000002068 genetic effect Effects 0.000 description 6
- 229910052736 halogen Inorganic materials 0.000 description 6
- 150000002367 halogens Chemical class 0.000 description 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 6
- 235000019341 magnesium sulphate Nutrition 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- 230000035772 mutation Effects 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- 239000010695 polyglycol Substances 0.000 description 6
- 229920000151 polyglycol Polymers 0.000 description 6
- 229920000136 polysorbate Polymers 0.000 description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 230000003449 preventive effect Effects 0.000 description 6
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 6
- 238000009331 sowing Methods 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 125000001424 substituent group Chemical group 0.000 description 6
- 239000008096 xylene Substances 0.000 description 6
- LZDKZFUFMNSQCJ-UHFFFAOYSA-N 1,2-diethoxyethane Chemical compound CCOCCOCC LZDKZFUFMNSQCJ-UHFFFAOYSA-N 0.000 description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 5
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 description 5
- 241000223600 Alternaria Species 0.000 description 5
- 241000228212 Aspergillus Species 0.000 description 5
- 235000006008 Brassica napus var napus Nutrition 0.000 description 5
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 5
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 5
- 241000736122 Parastagonospora nodorum Species 0.000 description 5
- 240000008042 Zea mays Species 0.000 description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 5
- 230000036579 abiotic stress Effects 0.000 description 5
- 125000002723 alicyclic group Chemical group 0.000 description 5
- 125000001931 aliphatic group Chemical group 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 5
- 239000003899 bactericide agent Substances 0.000 description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 239000012535 impurity Substances 0.000 description 5
- 239000012770 industrial material Substances 0.000 description 5
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 5
- GYNNXHKOJHMOHS-UHFFFAOYSA-N methyl-cycloheptane Natural products CC1CCCCCC1 GYNNXHKOJHMOHS-UHFFFAOYSA-N 0.000 description 5
- 239000003208 petroleum Substances 0.000 description 5
- 229920000728 polyester Polymers 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- 230000001681 protective effect Effects 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 description 5
- HVZJRWJGKQPSFL-UHFFFAOYSA-N tert-Amyl methyl ether Chemical compound CCC(C)(C)OC HVZJRWJGKQPSFL-UHFFFAOYSA-N 0.000 description 5
- 239000002562 thickening agent Substances 0.000 description 5
- PXXNTAGJWPJAGM-UHFFFAOYSA-N vertaline Natural products C1C2C=3C=C(OC)C(OC)=CC=3OC(C=C3)=CC=C3CCC(=O)OC1CC1N2CCCC1 PXXNTAGJWPJAGM-UHFFFAOYSA-N 0.000 description 5
- CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 description 4
- LAWFJRVRJCPWCX-UHFFFAOYSA-N 1-(2-trimethylsilylphenoxy)propan-2-one Chemical compound C[Si](C1=C(OCC(=O)C)C=CC=C1)(C)C LAWFJRVRJCPWCX-UHFFFAOYSA-N 0.000 description 4
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 4
- IMJOBVDESJIVAH-UHFFFAOYSA-N 3-(3-fluorophenoxy)quinoline Chemical compound FC=1C=C(OC=2C=NC3=CC=CC=C3C=2)C=CC=1 IMJOBVDESJIVAH-UHFFFAOYSA-N 0.000 description 4
- ADLVDYMTBOSDFE-UHFFFAOYSA-N 5-chloro-6-nitroisoindole-1,3-dione Chemical compound C1=C(Cl)C([N+](=O)[O-])=CC2=C1C(=O)NC2=O ADLVDYMTBOSDFE-UHFFFAOYSA-N 0.000 description 4
- 241000228197 Aspergillus flavus Species 0.000 description 4
- 241000123650 Botrytis cinerea Species 0.000 description 4
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 4
- 240000008067 Cucumis sativus Species 0.000 description 4
- 241000223195 Fusarium graminearum Species 0.000 description 4
- 241000238631 Hexapoda Species 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical class [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 239000005909 Kieselgur Substances 0.000 description 4
- 239000002841 Lewis acid Substances 0.000 description 4
- 241001459558 Monographella nivalis Species 0.000 description 4
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- 241000228143 Penicillium Species 0.000 description 4
- 241001123663 Penicillium expansum Species 0.000 description 4
- 241000228453 Pyrenophora Species 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- 241000959260 Typhula Species 0.000 description 4
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 4
- 230000000895 acaricidal effect Effects 0.000 description 4
- 239000000642 acaricide Substances 0.000 description 4
- 239000003905 agrochemical Substances 0.000 description 4
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 4
- 125000002877 alkyl aryl group Chemical group 0.000 description 4
- 125000000129 anionic group Chemical group 0.000 description 4
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 4
- 125000004429 atom Chemical group 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 4
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 4
- 238000010668 complexation reaction Methods 0.000 description 4
- CNXMDTWQWLGCPE-UHFFFAOYSA-N ditert-butyl-(2-phenylphenyl)phosphane Chemical group CC(C)(C)P(C(C)(C)C)C1=CC=CC=C1C1=CC=CC=C1 CNXMDTWQWLGCPE-UHFFFAOYSA-N 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 239000004009 herbicide Substances 0.000 description 4
- 229930195733 hydrocarbon Natural products 0.000 description 4
- 150000002430 hydrocarbons Chemical group 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- 239000002917 insecticide Substances 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 150000007517 lewis acids Chemical class 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000006138 lithiation reaction Methods 0.000 description 4
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
- OVEHNNQXLPJPPL-UHFFFAOYSA-N lithium;n-propan-2-ylpropan-2-amine Chemical compound [Li].CC(C)NC(C)C OVEHNNQXLPJPPL-UHFFFAOYSA-N 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 229910052749 magnesium Inorganic materials 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 235000009973 maize Nutrition 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000005645 nematicide Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 4
- 239000000123 paper Substances 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 150000002989 phenols Chemical class 0.000 description 4
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 4
- 238000002953 preparative HPLC Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 description 4
- 235000011152 sodium sulphate Nutrition 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- 239000000080 wetting agent Substances 0.000 description 4
- CXNIUSPIQKWYAI-UHFFFAOYSA-N xantphos Chemical compound C=12OC3=C(P(C=4C=CC=CC=4)C=4C=CC=CC=4)C=CC=C3C(C)(C)C2=CC=CC=1P(C=1C=CC=CC=1)C1=CC=CC=C1 CXNIUSPIQKWYAI-UHFFFAOYSA-N 0.000 description 4
- MKZKXUHSTCLDIL-UHFFFAOYSA-N (4-chlorophenyl)-dimethyl-[2-(quinolin-3-ylmethyl)phenyl]silane Chemical compound ClC1=CC=C(C=C1)[Si](C1=C(CC=2C=NC3=CC=CC=C3C=2)C=CC=C1)(C)C MKZKXUHSTCLDIL-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- QUGBSHWCQLGNED-UHFFFAOYSA-N 2-chloro-3-(3-fluorophenoxy)quinoline Chemical compound ClC1=NC2=CC=CC=C2C=C1OC1=CC(=CC=C1)F QUGBSHWCQLGNED-UHFFFAOYSA-N 0.000 description 3
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 3
- CYXLHQVJLCLJPR-UHFFFAOYSA-N 3-(3-fluorophenoxy)-1-oxidoquinolin-1-ium Chemical compound FC=1C=C(OC=2C=[N+](C3=CC=CC=C3C=2)[O-])C=CC=1 CYXLHQVJLCLJPR-UHFFFAOYSA-N 0.000 description 3
- 235000016068 Berberis vulgaris Nutrition 0.000 description 3
- 241000335053 Beta vulgaris Species 0.000 description 3
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 3
- PFHBBBJOCGEHHM-UHFFFAOYSA-N BrC1=C(C(OC2OCCCC2)I)C=CC=C1 Chemical compound BrC1=C(C(OC2OCCCC2)I)C=CC=C1 PFHBBBJOCGEHHM-UHFFFAOYSA-N 0.000 description 3
- 241000219198 Brassica Species 0.000 description 3
- QMSNDRFXMIHZDW-UHFFFAOYSA-N C[Si](C)(C(C=CC=C1)=C1OC1=NC2=C(CF)C(CF)=CC=C2C=C1)O Chemical compound C[Si](C)(C(C=CC=C1)=C1OC1=NC2=C(CF)C(CF)=CC=C2C=C1)O QMSNDRFXMIHZDW-UHFFFAOYSA-N 0.000 description 3
- 239000004215 Carbon black (E152) Substances 0.000 description 3
- 241000222290 Cladosporium Species 0.000 description 3
- 241000222199 Colletotrichum Species 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 3
- 241000371644 Curvularia ravenelii Species 0.000 description 3
- SFCXIVSXRNNJRQ-UHFFFAOYSA-N FCC1=CC=C(C=C(C=N2)OC(C=CC=C3)=C3Br)C2=C1CF Chemical compound FCC1=CC=C(C=C(C=N2)OC(C=CC=C3)=C3Br)C2=C1CF SFCXIVSXRNNJRQ-UHFFFAOYSA-N 0.000 description 3
- 239000004606 Fillers/Extenders Substances 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 241000223194 Fusarium culmorum Species 0.000 description 3
- 229930191978 Gibberellin Natural products 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 244000299507 Gossypium hirsutum Species 0.000 description 3
- 241000228457 Leptosphaeria maculans Species 0.000 description 3
- 241001330975 Magnaporthe oryzae Species 0.000 description 3
- 244000070406 Malus silvestris Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 231100000678 Mycotoxin Toxicity 0.000 description 3
- CWMFAXDPCJCTFK-UHFFFAOYSA-N NC(C=CC=C1)=C1OC1=NC2=C(CF)C(CF)=CC=C2C=C1 Chemical compound NC(C=CC=C1)=C1OC1=NC2=C(CF)C(CF)=CC=C2C=C1 CWMFAXDPCJCTFK-UHFFFAOYSA-N 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 241001361634 Rhizoctonia Species 0.000 description 3
- 241000813090 Rhizoctonia solani Species 0.000 description 3
- 101100464782 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CMP2 gene Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
- 241001360088 Zymoseptoria tritici Species 0.000 description 3
- AASHTWWKQFRBIF-UHFFFAOYSA-N [2-(2-chloroquinolin-3-yl)oxy-6-fluorophenyl]-methyl-phenylsilane Chemical compound ClC1=NC2=CC=CC=C2C=C1OC1=C(C(=CC=C1)F)[SiH](C1=CC=CC=C1)C AASHTWWKQFRBIF-UHFFFAOYSA-N 0.000 description 3
- DNOCGNGTESQCCV-UHFFFAOYSA-N [2-(bromomethyl)phenyl]-(4-chlorophenyl)-dimethylsilane Chemical compound BrCC1=C(C=CC=C1)[Si](C)(C)C1=CC=C(C=C1)Cl DNOCGNGTESQCCV-UHFFFAOYSA-N 0.000 description 3
- PWFDYKBHLGKZPK-UHFFFAOYSA-N [O-][N+](C(C=CC=C1)=C1OC1=NC2=C(CF)C(CF)=CC=C2C=C1)=O Chemical compound [O-][N+](C(C=CC=C1)=C1OC1=NC2=C(CF)C(CF)=CC=C2C=C1)=O PWFDYKBHLGKZPK-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000012868 active agrochemical ingredient Substances 0.000 description 3
- 150000001342 alkaline earth metals Chemical class 0.000 description 3
- 125000003342 alkenyl group Chemical group 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 150000001638 boron Chemical class 0.000 description 3
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 229910000024 caesium carbonate Inorganic materials 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 239000006184 cosolvent Substances 0.000 description 3
- 125000000753 cycloalkyl group Chemical group 0.000 description 3
- 229930002954 deoxynivalenol Natural products 0.000 description 3
- GUVUOGQBMYCBQP-UHFFFAOYSA-N dmpu Chemical compound CN1CCCN(C)C1=O GUVUOGQBMYCBQP-UHFFFAOYSA-N 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000010410 dusting Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000003337 fertilizer Substances 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 235000003869 genetically modified organism Nutrition 0.000 description 3
- 230000035784 germination Effects 0.000 description 3
- 239000003448 gibberellin Substances 0.000 description 3
- IXORZMNAPKEEDV-OBDJNFEBSA-N gibberellin A3 Chemical class C([C@@]1(O)C(=C)C[C@@]2(C1)[C@H]1C(O)=O)C[C@H]2[C@]2(C=C[C@@H]3O)[C@H]1[C@]3(C)C(=O)O2 IXORZMNAPKEEDV-OBDJNFEBSA-N 0.000 description 3
- 150000004795 grignard reagents Chemical class 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000010985 leather Substances 0.000 description 3
- 239000002636 mycotoxin Substances 0.000 description 3
- 231100001184 nonphytotoxic Toxicity 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 150000002940 palladium Chemical class 0.000 description 3
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 229920002689 polyvinyl acetate Polymers 0.000 description 3
- 239000011118 polyvinyl acetate Substances 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 description 3
- 235000011181 potassium carbonates Nutrition 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000012552 review Methods 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 239000011435 rock Substances 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- 125000000547 substituted alkyl group Chemical group 0.000 description 3
- 239000011593 sulfur Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 3
- RRBVVTKCNUYFLX-UHFFFAOYSA-N trimethyl-[2-(2-methylquinolin-3-yl)oxyphenyl]silane Chemical compound CC1=NC2=CC=CC=C2C=C1OC1=C(C=CC=C1)[Si](C)(C)C RRBVVTKCNUYFLX-UHFFFAOYSA-N 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- LINOMUASTDIRTM-UHFFFAOYSA-N vomitoxin hydrate Natural products OCC12C(O)C(=O)C(C)=CC1OC1C(O)CC2(C)C11CO1 LINOMUASTDIRTM-UHFFFAOYSA-N 0.000 description 3
- JLIDBLDQVAYHNE-YKALOCIXSA-N (+)-Abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 description 2
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- QFMZQPDHXULLKC-UHFFFAOYSA-N 1,2-bis(diphenylphosphino)ethane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)CCP(C=1C=CC=CC=1)C1=CC=CC=C1 QFMZQPDHXULLKC-UHFFFAOYSA-N 0.000 description 2
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 2
- NFDXQGNDWIPXQL-UHFFFAOYSA-N 1-cyclooctyldiazocane Chemical compound C1CCCCCCC1N1NCCCCCC1 NFDXQGNDWIPXQL-UHFFFAOYSA-N 0.000 description 2
- PAMIQIKDUOTOBW-UHFFFAOYSA-N 1-methylpiperidine Chemical compound CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 description 2
- YRAJNWYBUCUFBD-UHFFFAOYSA-N 2,2,6,6-tetramethylheptane-3,5-dione Chemical compound CC(C)(C)C(=O)CC(=O)C(C)(C)C YRAJNWYBUCUFBD-UHFFFAOYSA-N 0.000 description 2
- ZEMZPXWZVTUONV-UHFFFAOYSA-N 2-(2-dicyclohexylphosphanylphenyl)-n,n-dimethylaniline Chemical group CN(C)C1=CC=CC=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 ZEMZPXWZVTUONV-UHFFFAOYSA-N 0.000 description 2
- ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 description 2
- UIGHARXPLDWFHA-UHFFFAOYSA-N 2-trimethylsilylphenol Chemical compound C[Si](C)(C)C1=CC=CC=C1O UIGHARXPLDWFHA-UHFFFAOYSA-N 0.000 description 2
- QDFXRVAOBHEBGJ-UHFFFAOYSA-N 3-(cyclononen-1-yl)-4,5,6,7,8,9-hexahydro-1h-diazonine Chemical compound C1CCCCCCC=C1C1=NNCCCCCC1 QDFXRVAOBHEBGJ-UHFFFAOYSA-N 0.000 description 2
- WADSJYLPJPTMLN-UHFFFAOYSA-N 3-(cycloundecen-1-yl)-1,2-diazacycloundec-2-ene Chemical compound C1CCCCCCCCC=C1C1=NNCCCCCCCC1 WADSJYLPJPTMLN-UHFFFAOYSA-N 0.000 description 2
- PIBNLNYVNDLCPQ-UHFFFAOYSA-N 3-[3-fluoro-2-(1-methylsiletan-1-yl)phenoxy]quinoline Chemical compound FC=1C(=C(OC=2C=NC3=CC=CC=C3C=2)C=CC=1)[Si]1(CCC1)C PIBNLNYVNDLCPQ-UHFFFAOYSA-N 0.000 description 2
- ZGIKWINFUGEQEO-UHFFFAOYSA-N 3-bromoquinoline Chemical compound C1=CC=CC2=CC(Br)=CN=C21 ZGIKWINFUGEQEO-UHFFFAOYSA-N 0.000 description 2
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- 244000291564 Allium cepa Species 0.000 description 2
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- 244000105624 Arachis hypogaea Species 0.000 description 2
- 241000235349 Ascomycota Species 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- 235000007319 Avena orientalis Nutrition 0.000 description 2
- 244000075850 Avena orientalis Species 0.000 description 2
- 241000221198 Basidiomycota Species 0.000 description 2
- 241000190150 Bipolaris sorokiniana Species 0.000 description 2
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 2
- 241001465180 Botrytis Species 0.000 description 2
- RBOKTZJBTKTLDP-UHFFFAOYSA-N BrC(C(COC1OCCCC1)=CC=C1)=C1NC1=NC2=CC=CC=C2C=C1 Chemical compound BrC(C(COC1OCCCC1)=CC=C1)=C1NC1=NC2=CC=CC=C2C=C1 RBOKTZJBTKTLDP-UHFFFAOYSA-N 0.000 description 2
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 2
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 2
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 2
- 244000178937 Brassica oleracea var. capitata Species 0.000 description 2
- 241000219193 Brassicaceae Species 0.000 description 2
- JHECIKUHDQURFN-UHFFFAOYSA-N C[Si](C)(C(C(F)=CC=C1)=C1OCC(C=CC1=CC=C2F)=NC1=C2F)F Chemical compound C[Si](C)(C(C(F)=CC=C1)=C1OCC(C=CC1=CC=C2F)=NC1=C2F)F JHECIKUHDQURFN-UHFFFAOYSA-N 0.000 description 2
- YOUXDPWJNZZBOG-UHFFFAOYSA-N C[Si](C)(C1=C2C=CC=C1)OC2NC1=NC2=CC=CC=C2C=C1 Chemical compound C[Si](C)(C1=C2C=CC=C1)OC2NC1=NC2=CC=CC=C2C=C1 YOUXDPWJNZZBOG-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000871189 Chenopodiaceae Species 0.000 description 2
- 241000221760 Claviceps Species 0.000 description 2
- 241000221751 Claviceps purpurea Species 0.000 description 2
- 241000228437 Cochliobolus Species 0.000 description 2
- 240000007154 Coffea arabica Species 0.000 description 2
- 241001600093 Coniophora Species 0.000 description 2
- 229910021589 Copper(I) bromide Inorganic materials 0.000 description 2
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 2
- 241001529717 Corticium <basidiomycota> Species 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- MDNWOSOZYLHTCG-UHFFFAOYSA-N Dichlorophen Chemical compound OC1=CC=C(Cl)C=C1CC1=CC(Cl)=CC=C1O MDNWOSOZYLHTCG-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- 241000879295 Fusarium equiseti Species 0.000 description 2
- 241000223221 Fusarium oxysporum Species 0.000 description 2
- 241000223247 Gloeocercospora Species 0.000 description 2
- 241000461774 Gloeosporium Species 0.000 description 2
- 239000007818 Grignard reagent Substances 0.000 description 2
- 244000020551 Helianthus annuus Species 0.000 description 2
- 235000003222 Helianthus annuus Nutrition 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 235000003228 Lactuca sativa Nutrition 0.000 description 2
- 240000008415 Lactuca sativa Species 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- LGDSHSYDSCRFAB-UHFFFAOYSA-N Methyl isothiocyanate Chemical compound CN=C=S LGDSHSYDSCRFAB-UHFFFAOYSA-N 0.000 description 2
- 241000005782 Monographella Species 0.000 description 2
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical compound CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 241000233654 Oomycetes Species 0.000 description 2
- ZRWPUFFVAOMMNM-UHFFFAOYSA-N Patulin Chemical compound OC1OCC=C2OC(=O)C=C12 ZRWPUFFVAOMMNM-UHFFFAOYSA-N 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 241000233614 Phytophthora Species 0.000 description 2
- 235000010582 Pisum sativum Nutrition 0.000 description 2
- 240000004713 Pisum sativum Species 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- 241000233639 Pythium Species 0.000 description 2
- 241000918584 Pythium ultimum Species 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 241000235527 Rhizopus Species 0.000 description 2
- 229910020008 S(O) Inorganic materials 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 2
- 235000007238 Secale cereale Nutrition 0.000 description 2
- 244000082988 Secale cereale Species 0.000 description 2
- 241001533598 Septoria Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 241000208292 Solanaceae Species 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 244000062793 Sorghum vulgare Species 0.000 description 2
- 235000021536 Sugar beet Nutrition 0.000 description 2
- 241001061127 Thione Species 0.000 description 2
- 108700019146 Transgenes Proteins 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 235000019714 Triticale Nutrition 0.000 description 2
- 241000317942 Venturia <ichneumonid wasp> Species 0.000 description 2
- 241000228452 Venturia inaequalis Species 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 2
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 150000001448 anilines Chemical class 0.000 description 2
- 235000021016 apples Nutrition 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- CJPQIRJHIZUAQP-MRXNPFEDSA-N benalaxyl-M Chemical compound CC=1C=CC=C(C)C=1N([C@H](C)C(=O)OC)C(=O)CC1=CC=CC=C1 CJPQIRJHIZUAQP-MRXNPFEDSA-N 0.000 description 2
- 235000019445 benzyl alcohol Nutrition 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000004790 biotic stress Effects 0.000 description 2
- LLEMOWNGBBNAJR-UHFFFAOYSA-N biphenyl-2-ol Chemical compound OC1=CC=CC=C1C1=CC=CC=C1 LLEMOWNGBBNAJR-UHFFFAOYSA-N 0.000 description 2
- YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- KVNRLNFWIYMESJ-UHFFFAOYSA-N butyronitrile Chemical compound CCCC#N KVNRLNFWIYMESJ-UHFFFAOYSA-N 0.000 description 2
- XJHCXCQVJFPJIK-UHFFFAOYSA-M caesium fluoride Chemical compound [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000013877 carbamide Nutrition 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 239000012677 causal agent Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 235000016213 coffee Nutrition 0.000 description 2
- 235000013353 coffee beverage Nutrition 0.000 description 2
- 239000005068 cooling lubricant Substances 0.000 description 2
- 150000001879 copper Chemical class 0.000 description 2
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- NKNDPYCGAZPOFS-UHFFFAOYSA-M copper(i) bromide Chemical compound Br[Cu] NKNDPYCGAZPOFS-UHFFFAOYSA-M 0.000 description 2
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 2
- BERDEBHAJNAUOM-UHFFFAOYSA-N copper(i) oxide Chemical compound [Cu]O[Cu] BERDEBHAJNAUOM-UHFFFAOYSA-N 0.000 description 2
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 2
- QTMDXZNDVAMKGV-UHFFFAOYSA-L copper(ii) bromide Chemical compound [Cu+2].[Br-].[Br-] QTMDXZNDVAMKGV-UHFFFAOYSA-L 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- NXQGGXCHGDYOHB-UHFFFAOYSA-L cyclopenta-1,4-dien-1-yl(diphenyl)phosphane;dichloropalladium;iron(2+) Chemical compound [Fe+2].Cl[Pd]Cl.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 NXQGGXCHGDYOHB-UHFFFAOYSA-L 0.000 description 2
- LINOMUASTDIRTM-QGRHZQQGSA-N deoxynivalenol Chemical compound C([C@@]12[C@@]3(C[C@@H](O)[C@H]1O[C@@H]1C=C(C([C@@H](O)[C@@]13CO)=O)C)C)O2 LINOMUASTDIRTM-QGRHZQQGSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000012973 diazabicyclooctane Substances 0.000 description 2
- 229940117389 dichlorobenzene Drugs 0.000 description 2
- 229960003887 dichlorophen Drugs 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- FDPIMTJIUBPUKL-UHFFFAOYSA-N dimethylacetone Natural products CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 229960002125 enilconazole Drugs 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- GWIVSKPSMYHUAK-UHFFFAOYSA-N ethoxy-[ethoxy(dimethyl)silyl]-dimethylsilane Chemical compound CCO[Si](C)(C)[Si](C)(C)OCC GWIVSKPSMYHUAK-UHFFFAOYSA-N 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000009368 gene silencing by RNA Effects 0.000 description 2
- 238000007429 general method Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 239000003630 growth substance Substances 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 125000004438 haloalkoxy group Chemical group 0.000 description 2
- 230000002363 herbicidal effect Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 2
- LRDFRRGEGBBSRN-UHFFFAOYSA-N isobutyronitrile Chemical compound CC(C)C#N LRDFRRGEGBBSRN-UHFFFAOYSA-N 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- ULKSWZAXQDJMJT-UHFFFAOYSA-M magnesium;2,2,6,6-tetramethylpiperidin-1-ide;chloride Chemical compound [Cl-].CC1(C)CCCC(C)(C)N1[Mg+] ULKSWZAXQDJMJT-UHFFFAOYSA-M 0.000 description 2
- QUXHCILOWRXCEO-UHFFFAOYSA-M magnesium;butane;chloride Chemical compound [Mg+2].[Cl-].CCC[CH2-] QUXHCILOWRXCEO-UHFFFAOYSA-M 0.000 description 2
- IUYHWZFSGMZEOG-UHFFFAOYSA-M magnesium;propane;chloride Chemical compound [Mg+2].[Cl-].C[CH-]C IUYHWZFSGMZEOG-UHFFFAOYSA-M 0.000 description 2
- ZQEIXNIJLIKNTD-GFCCVEGCSA-N metalaxyl-M Chemical compound COCC(=O)N([C@H](C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-GFCCVEGCSA-N 0.000 description 2
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 2
- YLGXILFCIXHCMC-JHGZEJCSSA-N methyl cellulose Chemical compound COC1C(OC)C(OC)C(COC)O[C@H]1O[C@H]1C(OC)C(OC)C(OC)OC1COC YLGXILFCIXHCMC-JHGZEJCSSA-N 0.000 description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
- DVSDBMFJEQPWNO-UHFFFAOYSA-N methyllithium Chemical compound C[Li] DVSDBMFJEQPWNO-UHFFFAOYSA-N 0.000 description 2
- 239000002679 microRNA Substances 0.000 description 2
- 230000003641 microbiacidal effect Effects 0.000 description 2
- 235000019713 millet Nutrition 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 125000002757 morpholinyl group Chemical group 0.000 description 2
- JIKUXBYRTXDNIY-UHFFFAOYSA-N n-methyl-n-phenylformamide Chemical compound O=CN(C)C1=CC=CC=C1 JIKUXBYRTXDNIY-UHFFFAOYSA-N 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- 125000000018 nitroso group Chemical group N(=O)* 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 2
- 239000003973 paint Substances 0.000 description 2
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 2
- 235000020232 peanut Nutrition 0.000 description 2
- IZUPBVBPLAPZRR-UHFFFAOYSA-N pentachlorophenol Chemical compound OC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl IZUPBVBPLAPZRR-UHFFFAOYSA-N 0.000 description 2
- JGCSKOVQDXEQHI-UHFFFAOYSA-N phenazine-1-carboxylic acid Chemical compound C1=CC=C2N=C3C(C(=O)O)=CC=CC3=NC2=C1 JGCSKOVQDXEQHI-UHFFFAOYSA-N 0.000 description 2
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical compound OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 229920005862 polyol Chemical class 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 239000011736 potassium bicarbonate Substances 0.000 description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 2
- 235000012015 potatoes Nutrition 0.000 description 2
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000035806 respiratory chain Effects 0.000 description 2
- 239000012047 saturated solution Substances 0.000 description 2
- 239000003620 semiochemical Substances 0.000 description 2
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 2
- 125000001174 sulfone group Chemical group 0.000 description 2
- 150000003457 sulfones Chemical class 0.000 description 2
- 150000003462 sulfoxides Chemical class 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- LJYNEQKSBXVOHZ-UHFFFAOYSA-N trimethyl-(2-quinolin-3-yloxyphenyl)silane Chemical compound C[Si](C1=C(OC=2C=NC3=CC=CC=C3C=2)C=CC=C1)(C)C LJYNEQKSBXVOHZ-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- COIOYMYWGDAQPM-UHFFFAOYSA-N tris(2-methylphenyl)phosphane Chemical compound CC1=CC=CC=C1P(C=1C(=CC=CC=1)C)C1=CC=CC=C1C COIOYMYWGDAQPM-UHFFFAOYSA-N 0.000 description 2
- BWHDROKFUHTORW-UHFFFAOYSA-N tritert-butylphosphane Chemical compound CC(C)(C)P(C(C)(C)C)C(C)(C)C BWHDROKFUHTORW-UHFFFAOYSA-N 0.000 description 2
- 150000003672 ureas Chemical class 0.000 description 2
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 241000228158 x Triticosecale Species 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- SLRCCWJSBJZJBV-TUVASFSCSA-N (+)-sparteine Chemical compound C1N2CCCC[C@@H]2[C@H]2CN3CCCC[C@H]3[C@@H]1C2 SLRCCWJSBJZJBV-TUVASFSCSA-N 0.000 description 1
- XERJKGMBORTKEO-VZUCSPMQSA-N (1e)-2-(ethylcarbamoylamino)-n-methoxy-2-oxoethanimidoyl cyanide Chemical compound CCNC(=O)NC(=O)C(\C#N)=N\OC XERJKGMBORTKEO-VZUCSPMQSA-N 0.000 description 1
- UKSZBOKPHAQOMP-SVLSSHOZSA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 UKSZBOKPHAQOMP-SVLSSHOZSA-N 0.000 description 1
- JRHPOFJADXHYBR-HTQZYQBOSA-N (1r,2r)-1-n,2-n-dimethylcyclohexane-1,2-diamine Chemical compound CN[C@@H]1CCCC[C@H]1NC JRHPOFJADXHYBR-HTQZYQBOSA-N 0.000 description 1
- SSJXIUAHEKJCMH-PHDIDXHHSA-N (1r,2r)-cyclohexane-1,2-diamine Chemical compound N[C@@H]1CCCC[C@H]1N SSJXIUAHEKJCMH-PHDIDXHHSA-N 0.000 description 1
- PRQUJNCOMDYCMC-UHFFFAOYSA-N (2-bromo-3-iodophenyl)methanol Chemical compound OCC1=CC=CC(I)=C1Br PRQUJNCOMDYCMC-UHFFFAOYSA-N 0.000 description 1
- ZMYFCFLJBGAQRS-IRXDYDNUSA-N (2R,3S)-epoxiconazole Chemical compound C1=CC(F)=CC=C1[C@@]1(CN2N=CN=C2)[C@H](C=2C(=CC=CC=2)Cl)O1 ZMYFCFLJBGAQRS-IRXDYDNUSA-N 0.000 description 1
- RYAUSSKQMZRMAI-ALOPSCKCSA-N (2S,6R)-4-[3-(4-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine Chemical compound C=1C=C(C(C)(C)C)C=CC=1CC(C)CN1C[C@H](C)O[C@H](C)C1 RYAUSSKQMZRMAI-ALOPSCKCSA-N 0.000 description 1
- OREKERSNHHDONJ-HSZRJFAPSA-N (2r)-n-[4-(benzimidazol-1-yl)-2-fluorophenyl]-2-(5-carbamimidoyl-1h-indol-3-yl)-3-phenylpropanamide Chemical compound C([C@H](C1=CNC2=CC=C(C=C21)C(=N)N)C(=O)NC=1C(=CC(=CC=1)N1C2=CC=CC=C2N=C1)F)C1=CC=CC=C1 OREKERSNHHDONJ-HSZRJFAPSA-N 0.000 description 1
- LDVVMCZRFWMZSG-OLQVQODUSA-N (3ar,7as)-2-(trichloromethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)Cl)C(=O)[C@H]21 LDVVMCZRFWMZSG-OLQVQODUSA-N 0.000 description 1
- PPDBOQMNKNNODG-NTEUORMPSA-N (5E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1,2,4-triazol-1-ylmethyl)cyclopentanol Chemical compound C1=NC=NN1CC1(O)C(C)(C)CC\C1=C/C1=CC=C(Cl)C=C1 PPDBOQMNKNNODG-NTEUORMPSA-N 0.000 description 1
- BKBSMMUEEAWFRX-NBVRZTHBSA-N (E)-flumorph Chemical compound C1=C(OC)C(OC)=CC=C1C(\C=1C=CC(F)=CC=1)=C\C(=O)N1CCOCC1 BKBSMMUEEAWFRX-NBVRZTHBSA-N 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- RMOGWMIKYWRTKW-UONOGXRCSA-N (S,S)-paclobutrazol Chemical compound C([C@@H]([C@@H](O)C(C)(C)C)N1N=CN=C1)C1=CC=C(Cl)C=C1 RMOGWMIKYWRTKW-UONOGXRCSA-N 0.000 description 1
- QNBTYORWCCMPQP-JXAWBTAJSA-N (Z)-dimethomorph Chemical compound C1=C(OC)C(OC)=CC=C1C(\C=1C=CC(Cl)=CC=1)=C/C(=O)N1CCOCC1 QNBTYORWCCMPQP-JXAWBTAJSA-N 0.000 description 1
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 1
- GCMNJUJAKQGROZ-UHFFFAOYSA-N 1,2-Dihydroquinolin-2-imine Chemical compound C1=CC=CC2=NC(N)=CC=C21 GCMNJUJAKQGROZ-UHFFFAOYSA-N 0.000 description 1
- TUBQDCKAWGHZPF-UHFFFAOYSA-N 1,3-benzothiazol-2-ylsulfanylmethyl thiocyanate Chemical compound C1=CC=C2SC(SCSC#N)=NC2=C1 TUBQDCKAWGHZPF-UHFFFAOYSA-N 0.000 description 1
- OTOSIXGMLYKKOW-UHFFFAOYSA-M 1,3-bis(2,4,6-trimethylphenyl)imidazol-1-ium;chloride Chemical compound [Cl-].CC1=CC(C)=CC(C)=C1N1C=[N+](C=2C(=CC(C)=CC=2C)C)C=C1 OTOSIXGMLYKKOW-UHFFFAOYSA-M 0.000 description 1
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 description 1
- FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical group N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 description 1
- DDAPSNKEOHDLKB-UHFFFAOYSA-N 1-(2-aminonaphthalen-1-yl)naphthalen-2-amine Chemical compound C1=CC=C2C(C3=C4C=CC=CC4=CC=C3N)=C(N)C=CC2=C1 DDAPSNKEOHDLKB-UHFFFAOYSA-N 0.000 description 1
- JWUCHKBSVLQQCO-UHFFFAOYSA-N 1-(2-fluorophenyl)-1-(4-fluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanol Chemical compound C=1C=C(F)C=CC=1C(C=1C(=CC=CC=1)F)(O)CN1C=NC=N1 JWUCHKBSVLQQCO-UHFFFAOYSA-N 0.000 description 1
- PXMNMQRDXWABCY-UHFFFAOYSA-N 1-(4-chlorophenyl)-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3-ol Chemical compound C1=NC=NN1CC(O)(C(C)(C)C)CCC1=CC=C(Cl)C=C1 PXMNMQRDXWABCY-UHFFFAOYSA-N 0.000 description 1
- IAQLCKZJGNTRDO-UHFFFAOYSA-N 1-(4-{4-[5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone Chemical compound CC1=CC(C(F)(F)F)=NN1CC(=O)N1CCC(C=2SC=C(N=2)C=2CC(ON=2)C=2C(=CC=CC=2F)F)CC1 IAQLCKZJGNTRDO-UHFFFAOYSA-N 0.000 description 1
- MFOFHNZPLFQBCM-UHFFFAOYSA-N 1-(fluoromethyl)pyrazole-3-carboxamide Chemical compound FCN1N=C(C=C1)C(=O)N MFOFHNZPLFQBCM-UHFFFAOYSA-N 0.000 description 1
- XVTXMTOYQVRHSK-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-2-prop-2-enoxyethyl]imidazole;sulfuric acid Chemical compound OS(O)(=O)=O.ClC1=CC(Cl)=CC=C1C(OCC=C)CN1C=NC=C1 XVTXMTOYQVRHSK-UHFFFAOYSA-N 0.000 description 1
- LQDARGUHUSPFNL-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-3-(1,1,2,2-tetrafluoroethoxy)propyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(COC(F)(F)C(F)F)CN1C=NC=N1 LQDARGUHUSPFNL-UHFFFAOYSA-N 0.000 description 1
- PZBPKYOVPCNPJY-UHFFFAOYSA-N 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole Chemical compound ClC1=CC(Cl)=CC=C1C(OCC=C)CN1C=NC=C1 PZBPKYOVPCNPJY-UHFFFAOYSA-N 0.000 description 1
- MGNFYQILYYYUBS-UHFFFAOYSA-N 1-[3-(4-tert-butylphenyl)-2-methylpropyl]piperidine Chemical compound C=1C=C(C(C)(C)C)C=CC=1CC(C)CN1CCCCC1 MGNFYQILYYYUBS-UHFFFAOYSA-N 0.000 description 1
- VLFSEIYWMBKMHO-UHFFFAOYSA-N 1-[5-methyl-3-(trifluoromethyl)pyrazol-1-yl]ethanone Chemical compound CC(=O)N1N=C(C(F)(F)F)C=C1C VLFSEIYWMBKMHO-UHFFFAOYSA-N 0.000 description 1
- YIKWKLYQRFRGPM-UHFFFAOYSA-N 1-dodecylguanidine acetate Chemical compound CC(O)=O.CCCCCCCCCCCCN=C(N)N YIKWKLYQRFRGPM-UHFFFAOYSA-N 0.000 description 1
- PWKNBLFSJAVFAB-UHFFFAOYSA-N 1-fluoro-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1F PWKNBLFSJAVFAB-UHFFFAOYSA-N 0.000 description 1
- PFFIDZXUXFLSSR-UHFFFAOYSA-N 1-methyl-N-[2-(4-methylpentan-2-yl)-3-thienyl]-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound S1C=CC(NC(=O)C=2C(=NN(C)C=2)C(F)(F)F)=C1C(C)CC(C)C PFFIDZXUXFLSSR-UHFFFAOYSA-N 0.000 description 1
- DBSMXZFYDNXILM-UHFFFAOYSA-N 1-methylpyrazole-3-carboxamide Chemical compound CN1C=CC(C(N)=O)=N1 DBSMXZFYDNXILM-UHFFFAOYSA-N 0.000 description 1
- DRGAZIDRYFYHIJ-UHFFFAOYSA-N 2,2':6',2''-terpyridine Chemical compound N1=CC=CC=C1C1=CC=CC(C=2N=CC=CC=2)=N1 DRGAZIDRYFYHIJ-UHFFFAOYSA-N 0.000 description 1
- KBLAMUYRMZPYLS-UHFFFAOYSA-N 2,3-bis(2-methylpropyl)naphthalene-1-sulfonic acid Chemical class C1=CC=C2C(S(O)(=O)=O)=C(CC(C)C)C(CC(C)C)=CC2=C1 KBLAMUYRMZPYLS-UHFFFAOYSA-N 0.000 description 1
- NIOPZPCMRQGZCE-WEVVVXLNSA-N 2,4-dinitro-6-(octan-2-yl)phenyl (E)-but-2-enoate Chemical compound CCCCCCC(C)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1OC(=O)\C=C\C NIOPZPCMRQGZCE-WEVVVXLNSA-N 0.000 description 1
- YTOPFCCWCSOHFV-UHFFFAOYSA-N 2,6-dimethyl-4-tridecylmorpholine Chemical compound CCCCCCCCCCCCCN1CC(C)OC(C)C1 YTOPFCCWCSOHFV-UHFFFAOYSA-N 0.000 description 1
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical class CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 1
- PSKHBOYPKJSALS-UHFFFAOYSA-N 2-(2,2-dimethylpropanoyl)cyclohexan-1-one Chemical compound CC(C)(C)C(=O)C1CCCCC1=O PSKHBOYPKJSALS-UHFFFAOYSA-N 0.000 description 1
- PFOYYSGBGILOQZ-UHFFFAOYSA-N 2-(2-methylpropanoyl)cyclohexan-1-one Chemical compound CC(C)C(=O)C1CCCCC1=O PFOYYSGBGILOQZ-UHFFFAOYSA-N 0.000 description 1
- KVQOPSMIYFSHPW-UHFFFAOYSA-N 2-(2-tert-butylphosphanylphenyl)-N,N-dimethylaniline Chemical group CN(C)C1=C(C=CC=C1)C1=C(PC(C)(C)C)C=CC=C1 KVQOPSMIYFSHPW-UHFFFAOYSA-N 0.000 description 1
- HZJKXKUJVSEEFU-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile Chemical compound C=1C=C(Cl)C=CC=1C(CCCC)(C#N)CN1C=NC=N1 HZJKXKUJVSEEFU-UHFFFAOYSA-N 0.000 description 1
- UFNOUKDBUJZYDE-UHFFFAOYSA-N 2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1CC(O)(C=1C=CC(Cl)=CC=1)C(C)C1CC1 UFNOUKDBUJZYDE-UHFFFAOYSA-N 0.000 description 1
- KWLVWJPJKJMCSH-UHFFFAOYSA-N 2-(4-chlorophenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]ethyl}-2-(prop-2-yn-1-yloxy)acetamide Chemical compound C1=C(OCC#C)C(OC)=CC(CCNC(=O)C(OCC#C)C=2C=CC(Cl)=CC=2)=C1 KWLVWJPJKJMCSH-UHFFFAOYSA-N 0.000 description 1
- AGVACZYQCJRDQE-UHFFFAOYSA-N 2-(6-benzylpyridin-2-yl)quinazoline Chemical compound C=1C=CC(C=2N=C3C=CC=CC3=CN=2)=NC=1CC1=CC=CC=C1 AGVACZYQCJRDQE-UHFFFAOYSA-N 0.000 description 1
- QCQYCVNGWLKUMH-UHFFFAOYSA-N 2-(chloromethyl)-3-[(4-chlorophenyl)methyl]-2-methyl-1-(1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol Chemical compound ClC1=CC=C(CC2C(C(CC2)(O)CN2N=CN=C2)(C)CCl)C=C1 QCQYCVNGWLKUMH-UHFFFAOYSA-N 0.000 description 1
- SPXBEYPYQKZKGX-UHFFFAOYSA-N 2-(chloromethyl)-5-[(4-chlorophenyl)methyl]-2-methyl-1-(1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol Chemical compound C1=NC=NN1CC1(O)C(C)(CCl)CCC1CC1=CC=C(Cl)C=C1 SPXBEYPYQKZKGX-UHFFFAOYSA-N 0.000 description 1
- QKJJCZYFXJCKRX-HZHKWBLPSA-N 2-[(2s,3s,6r)-6-[4-amino-5-(hydroxymethyl)-2-oxopyrimidin-1-yl]-3-[[(2s)-2-amino-3-hydroxypropanoyl]amino]-3,6-dihydro-2h-pyran-2-yl]-5-(diaminomethylideneamino)-2,4-dihydroxypentanoic acid Chemical compound O1[C@H](C(O)(CC(O)CN=C(N)N)C(O)=O)[C@@H](NC(=O)[C@H](CO)N)C=C[C@@H]1N1C(=O)N=C(N)C(CO)=C1 QKJJCZYFXJCKRX-HZHKWBLPSA-N 0.000 description 1
- NUMYETXZBQVFDX-UHFFFAOYSA-N 2-[(dimethylamino)methyl]pyridin-3-ol Chemical compound CN(C)CC1=NC=CC=C1O NUMYETXZBQVFDX-UHFFFAOYSA-N 0.000 description 1
- MNHVNIJQQRJYDH-UHFFFAOYSA-N 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-1,2-dihydro-1,2,4-triazole-3-thione Chemical compound N1=CNC(=S)N1CC(C1(Cl)CC1)(O)CC1=CC=CC=C1Cl MNHVNIJQQRJYDH-UHFFFAOYSA-N 0.000 description 1
- KIGIDUCZMHPDCX-UHFFFAOYSA-N 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)pentan-1-ol Chemical compound ClC1=CC=C(OC2=CC(=C(C=C2)C(C(O)N2N=CN=C2)CCC)C(F)(F)F)C=C1 KIGIDUCZMHPDCX-UHFFFAOYSA-N 0.000 description 1
- HMZBHVYEKPJCRW-UHFFFAOYSA-N 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)propan-1-ol Chemical compound ClC1=CC=C(OC2=CC(=C(C=C2)C(C(O)N2N=CN=C2)C)C(F)(F)F)C=C1 HMZBHVYEKPJCRW-UHFFFAOYSA-N 0.000 description 1
- JERZEQUMJNCPRJ-UHFFFAOYSA-N 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol Chemical compound C=1C=C(OC=2C=CC(Cl)=CC=2)C=C(C(F)(F)F)C=1C(O)(C)CN1C=NC=N1 JERZEQUMJNCPRJ-UHFFFAOYSA-N 0.000 description 1
- SIIJJFOXEOHODQ-UHFFFAOYSA-N 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-3-methyl-1-(1,2,4-triazol-1-yl)butan-2-ol Chemical compound C=1C=C(OC=2C=CC(Cl)=CC=2)C=C(C(F)(F)F)C=1C(O)(C(C)C)CN1C=NC=N1 SIIJJFOXEOHODQ-UHFFFAOYSA-N 0.000 description 1
- VNSVUCYVBBYLQR-UHFFFAOYSA-N 2-[[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl]-1h-1,2,4-triazole-3-thione Chemical compound FC1=CC(F)=CC=C1C1(CN2C(NC=N2)=S)C(C=2C(=CC=CC=2)Cl)O1 VNSVUCYVBBYLQR-UHFFFAOYSA-N 0.000 description 1
- PVTHJAPFENJVNC-UHFFFAOYSA-N 2-amino-2-[5-amino-2-methyl-6-(2,3,4,5,6-pentahydroxycyclohexyl)oxyoxan-3-yl]iminoacetic acid Chemical compound NC1CC(N=C(N)C(O)=O)C(C)OC1OC1C(O)C(O)C(O)C(O)C1O PVTHJAPFENJVNC-UHFFFAOYSA-N 0.000 description 1
- FXWFZIRWWNPPOV-UHFFFAOYSA-N 2-aminobenzaldehyde Chemical compound NC1=CC=CC=C1C=O FXWFZIRWWNPPOV-UHFFFAOYSA-N 0.000 description 1
- QFFSRVHYJDRHQS-UHFFFAOYSA-N 2-bromo-3-(5,6-difluoroquinoxalin-2-yl)oxybenzaldehyde Chemical compound BrC1=C(C=O)C=CC=C1OC1=NC2=CC=C(C(=C2N=C1)F)F QFFSRVHYJDRHQS-UHFFFAOYSA-N 0.000 description 1
- OKDGRDCXVWSXDC-UHFFFAOYSA-N 2-chloropyridine Chemical compound ClC1=CC=CC=N1 OKDGRDCXVWSXDC-UHFFFAOYSA-N 0.000 description 1
- IULJSGIJJZZUMF-UHFFFAOYSA-N 2-hydroxybenzenesulfonic acid Chemical class OC1=CC=CC=C1S(O)(=O)=O IULJSGIJJZZUMF-UHFFFAOYSA-N 0.000 description 1
- BNFJFJLLGCJKKI-UHFFFAOYSA-N 2-methyl-5-(trifluoromethyl)-n-[2-[2-(trifluoromethyl)phenyl]phenyl]-1h-pyrazole-5-carboxamide Chemical compound C1=CN(C)NC1(C(F)(F)F)C(=O)NC1=CC=CC=C1C1=CC=CC=C1C(F)(F)F BNFJFJLLGCJKKI-UHFFFAOYSA-N 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical class CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- 229940061334 2-phenylphenol Drugs 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- INYOWBPHDXGQJR-UHFFFAOYSA-N 2-triethylsilylphenol Chemical compound CC[Si](CC)(CC)C1=CC=CC=C1O INYOWBPHDXGQJR-UHFFFAOYSA-N 0.000 description 1
- NPAXPTHCUCUHPT-UHFFFAOYSA-N 3,4,7,8-tetramethyl-1,10-phenanthroline Chemical compound CC1=CN=C2C3=NC=C(C)C(C)=C3C=CC2=C1C NPAXPTHCUCUHPT-UHFFFAOYSA-N 0.000 description 1
- SOUGWDPPRBKJEX-UHFFFAOYSA-N 3,5-dichloro-N-(1-chloro-3-methyl-2-oxopentan-3-yl)-4-methylbenzamide Chemical compound ClCC(=O)C(C)(CC)NC(=O)C1=CC(Cl)=C(C)C(Cl)=C1 SOUGWDPPRBKJEX-UHFFFAOYSA-N 0.000 description 1
- 125000004211 3,5-difluorophenyl group Chemical group [H]C1=C(F)C([H])=C(*)C([H])=C1F 0.000 description 1
- NRAYWXLNSHEHQO-UHFFFAOYSA-N 3-(1-benzothiophen-2-yl)-5,6-dihydro-1,4,2-oxathiazine 4-oxide Chemical compound O=S1CCON=C1C1=CC2=CC=CC=C2S1 NRAYWXLNSHEHQO-UHFFFAOYSA-N 0.000 description 1
- FSCWZHGZWWDELK-UHFFFAOYSA-N 3-(3,5-dichlorophenyl)-5-ethenyl-5-methyl-2,4-oxazolidinedione Chemical compound O=C1C(C)(C=C)OC(=O)N1C1=CC(Cl)=CC(Cl)=C1 FSCWZHGZWWDELK-UHFFFAOYSA-N 0.000 description 1
- DGOAXBPOVUPPEB-UHFFFAOYSA-N 3-(difluoromethyl)-N-methoxy-1-methyl-N-[1-(2,4,6-trichlorophenyl)propan-2-yl]pyrazole-4-carboxamide Chemical compound C=1N(C)N=C(C(F)F)C=1C(=O)N(OC)C(C)CC1=C(Cl)C=C(Cl)C=C1Cl DGOAXBPOVUPPEB-UHFFFAOYSA-N 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- RXCSTWRZZIQURB-UHFFFAOYSA-N 3-fluoro-2-triethylsilylphenol Chemical compound FC=1C(=C(C=CC=1)O)[Si](CC)(CC)CC RXCSTWRZZIQURB-UHFFFAOYSA-N 0.000 description 1
- SJTBRFHBXDZMPS-UHFFFAOYSA-N 3-fluorophenol Chemical compound OC1=CC=CC(F)=C1 SJTBRFHBXDZMPS-UHFFFAOYSA-N 0.000 description 1
- KLSHLVYGWJEKPC-UHFFFAOYSA-N 3-phenoxy-1,8-naphthyridine Chemical class O(C1=CC=CC=C1)C=1C=NC2=NC=CC=C2C=1 KLSHLVYGWJEKPC-UHFFFAOYSA-N 0.000 description 1
- HSRXLAJZZXXCNQ-UHFFFAOYSA-N 4,4,5-trifluoro-3,3-dimethyl-1-quinolin-3-ylisoquinoline Chemical compound C12=CC=CC(F)=C2C(F)(F)C(C)(C)N=C1C1=CN=C(C=CC=C2)C2=C1 HSRXLAJZZXXCNQ-UHFFFAOYSA-N 0.000 description 1
- SWTPIYGGSMJRTB-UHFFFAOYSA-N 4,4-difluoro-3,3-dimethyl-1-quinolin-3-ylisoquinoline Chemical compound C12=CC=CC=C2C(F)(F)C(C)(C)N=C1C1=CN=C(C=CC=C2)C2=C1 SWTPIYGGSMJRTB-UHFFFAOYSA-N 0.000 description 1
- ZPGVCQYKXIQWTP-UHFFFAOYSA-N 4,7-dimethoxy-1,10-phenanthroline Chemical compound C1=CC2=C(OC)C=CN=C2C2=C1C(OC)=CC=N2 ZPGVCQYKXIQWTP-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- FXSRCEOKVUFSGM-UHFFFAOYSA-N 4-(4-chlorophenyl)-5-(2,6-difluorophenyl)-3,6-dimethylpyridazine Chemical compound C=1C=C(Cl)C=CC=1C=1C(C)=NN=C(C)C=1C1=C(F)C=CC=C1F FXSRCEOKVUFSGM-UHFFFAOYSA-N 0.000 description 1
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 1
- OBXUXLBEGTZOSY-UHFFFAOYSA-N 4-amino-1-fluoropyrimidin-2-one Chemical compound NC=1C=CN(F)C(=O)N=1 OBXUXLBEGTZOSY-UHFFFAOYSA-N 0.000 description 1
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 description 1
- BCJVBDBJSMFBRW-UHFFFAOYSA-N 4-diphenylphosphanylbutyl(diphenyl)phosphane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)CCCCP(C=1C=CC=CC=1)C1=CC=CC=C1 BCJVBDBJSMFBRW-UHFFFAOYSA-N 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- PFDRKWSBABBSID-UHFFFAOYSA-N 4-oxo-2-(2-phenylethylamino)butanoic acid Chemical compound O=CCC(C(=O)O)NCCC1=CC=CC=C1 PFDRKWSBABBSID-UHFFFAOYSA-N 0.000 description 1
- 125000004608 5,6,7,8-tetrahydroquinolinyl group Chemical group N1=C(C=CC=2CCCCC12)* 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- GDGIVSREGUOIJZ-UHFFFAOYSA-N 5-amino-3h-1,3,4-thiadiazole-2-thione Chemical compound NC1=NN=C(S)S1 GDGIVSREGUOIJZ-UHFFFAOYSA-N 0.000 description 1
- NRTLIYOWLVMQBO-UHFFFAOYSA-N 5-chloro-1,3-dimethyl-N-(1,1,3-trimethyl-1,3-dihydro-2-benzofuran-4-yl)pyrazole-4-carboxamide Chemical compound C=12C(C)OC(C)(C)C2=CC=CC=1NC(=O)C=1C(C)=NN(C)C=1Cl NRTLIYOWLVMQBO-UHFFFAOYSA-N 0.000 description 1
- GOFJDXZZHFNFLV-UHFFFAOYSA-N 5-fluoro-1,3-dimethyl-N-[2-(4-methylpentan-2-yl)phenyl]pyrazole-4-carboxamide Chemical compound CC(C)CC(C)C1=CC=CC=C1NC(=O)C1=C(F)N(C)N=C1C GOFJDXZZHFNFLV-UHFFFAOYSA-N 0.000 description 1
- GUAJDZDQNOHLPX-UHFFFAOYSA-N 5-fluoro-2-[(4-fluorophenyl)methoxy]pyrimidine Chemical compound C1=CC(F)=CC=C1COC1=NC=C(F)C=N1 GUAJDZDQNOHLPX-UHFFFAOYSA-N 0.000 description 1
- GNUDLKJUYSXMNO-UHFFFAOYSA-N 5-fluoro-3,3,4,4-tetramethyl-1-quinolin-3-ylisoquinoline Chemical compound C12=CC=CC(F)=C2C(C)(C)C(C)(C)N=C1C1=CN=C(C=CC=C2)C2=C1 GNUDLKJUYSXMNO-UHFFFAOYSA-N 0.000 description 1
- PCCSBWNGDMYFCW-UHFFFAOYSA-N 5-methyl-5-(4-phenoxyphenyl)-3-(phenylamino)-1,3-oxazolidine-2,4-dione Chemical compound O=C1C(C)(C=2C=CC(OC=3C=CC=CC=3)=CC=2)OC(=O)N1NC1=CC=CC=C1 PCCSBWNGDMYFCW-UHFFFAOYSA-N 0.000 description 1
- GABNAHQQEVWYNS-UHFFFAOYSA-N 5-phenyl-2,3-dihydro-1,4-dithiine 1,1,4,4-tetraoxide Chemical compound O=S1(=O)CCS(=O)(=O)C(C=2C=CC=CC=2)=C1 GABNAHQQEVWYNS-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 230000002407 ATP formation Effects 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000005964 Acibenzolar-S-methyl Substances 0.000 description 1
- 244000202285 Acrocomia mexicana Species 0.000 description 1
- 229930195730 Aflatoxin Natural products 0.000 description 1
- 244000087596 Aglaonema pictum Species 0.000 description 1
- 241000919511 Albugo Species 0.000 description 1
- 241000919507 Albugo candida Species 0.000 description 1
- RGCKGOZRHPZPFP-UHFFFAOYSA-N Alizarin Natural products C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 1
- 241000123646 Allioideae Species 0.000 description 1
- 240000006108 Allium ampeloprasum Species 0.000 description 1
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 1
- 241000223602 Alternaria alternata Species 0.000 description 1
- 241001157812 Alternaria brassicicola Species 0.000 description 1
- 241000213004 Alternaria solani Species 0.000 description 1
- 239000005726 Ametoctradin Substances 0.000 description 1
- 239000005727 Amisulbrom Substances 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical class [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 241000208223 Anacardiaceae Species 0.000 description 1
- 241001444083 Aphanomyces Species 0.000 description 1
- 241001444080 Aphanomyces euteiches Species 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 241000222195 Ascochyta Species 0.000 description 1
- 241001198951 Ascochyta lentis Species 0.000 description 1
- 241000228193 Aspergillus clavatus Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241000131308 Aspergillus nomius Species 0.000 description 1
- 241000122824 Aspergillus ochraceus Species 0.000 description 1
- 241000228230 Aspergillus parasiticus Species 0.000 description 1
- 241001465318 Aspergillus terreus Species 0.000 description 1
- 241001530056 Athelia rolfsii Species 0.000 description 1
- 241000223651 Aureobasidium Species 0.000 description 1
- 241000223678 Aureobasidium pullulans Species 0.000 description 1
- 239000005730 Azoxystrobin Substances 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- 235000021537 Beetroot Nutrition 0.000 description 1
- 239000005734 Benalaxyl Substances 0.000 description 1
- 239000005735 Benalaxyl-M Substances 0.000 description 1
- 239000005736 Benthiavalicarb Substances 0.000 description 1
- 239000005737 Benzovindiflupyr Substances 0.000 description 1
- 241000219495 Betulaceae Species 0.000 description 1
- 241001465178 Bipolaris Species 0.000 description 1
- 241001450781 Bipolaris oryzae Species 0.000 description 1
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical group N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 1
- 239000005738 Bixafen Substances 0.000 description 1
- 241001480060 Blumeria Species 0.000 description 1
- 241001480061 Blumeria graminis Species 0.000 description 1
- 239000005739 Bordeaux mixture Substances 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 239000005740 Boscalid Substances 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- UPJZVKQAIOLOBE-UHFFFAOYSA-N BrC(C(COC1OCCCC1)=CC=C1)=C1N1C2=CC=CC=C2C=CC1 Chemical compound BrC(C(COC1OCCCC1)=CC=C1)=C1N1C2=CC=CC=C2C=CC1 UPJZVKQAIOLOBE-UHFFFAOYSA-N 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000004221 Brassica oleracea var gemmifera Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 244000308368 Brassica oleracea var. gemmifera Species 0.000 description 1
- 244000304217 Brassica oleracea var. gongylodes Species 0.000 description 1
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 description 1
- 244000221633 Brassica rapa subsp chinensis Species 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- 241000233684 Bremia Species 0.000 description 1
- 241000233685 Bremia lactucae Species 0.000 description 1
- 239000007848 Bronsted acid Substances 0.000 description 1
- DTHLKBCRDIUBAF-UHFFFAOYSA-N C(C)N1C(C=2SC=3C(=NSC=3C#N)SC=2C1=O)=O Chemical compound C(C)N1C(C=2SC=3C(=NSC=3C#N)SC=2C1=O)=O DTHLKBCRDIUBAF-UHFFFAOYSA-N 0.000 description 1
- JKELUANDRHKGBX-UHFFFAOYSA-N C(COCC1)N1PC1=C(C2(CC(C3)C4)CC4CC3C2)C(C2(CC(C3)C4)CC4CC3C2)=CC=C1 Chemical compound C(COCC1)N1PC1=C(C2(CC(C3)C4)CC4CC3C2)C(C2(CC(C3)C4)CC4CC3C2)=CC=C1 JKELUANDRHKGBX-UHFFFAOYSA-N 0.000 description 1
- FILRLZNBFWWYCQ-UHFFFAOYSA-N C1=CC(=C(C(=C1)F)CC2=C(N=NC=C2C3=CC=C(C=C3)Cl)Cl)F Chemical compound C1=CC(=C(C(=C1)F)CC2=C(N=NC=C2C3=CC=C(C=C3)Cl)Cl)F FILRLZNBFWWYCQ-UHFFFAOYSA-N 0.000 description 1
- 125000000041 C6-C10 aryl group Chemical group 0.000 description 1
- HTKCFOOGNOHLRP-UHFFFAOYSA-N CC#CN(C1=CC=CC=C1)NS(C(S1)=CC=C1Cl)(=O)=O Chemical compound CC#CN(C1=CC=CC=C1)NS(C(S1)=CC=C1Cl)(=O)=O HTKCFOOGNOHLRP-UHFFFAOYSA-N 0.000 description 1
- RUJONPGGISMZGB-UHFFFAOYSA-N CC#COC1=C(C(C2)ON=C2C2=CSC(C(CC3)CCN3C(CN3N=C(C(F)F)C=C3C(F)F)=O)=N2)C=CC=C1 Chemical compound CC#COC1=C(C(C2)ON=C2C2=CSC(C(CC3)CCN3C(CN3N=C(C(F)F)C=C3C(F)F)=O)=N2)C=CC=C1 RUJONPGGISMZGB-UHFFFAOYSA-N 0.000 description 1
- LLRGGXSRTVIUMG-UHFFFAOYSA-N CC#COC1=CC=CC(C(C2)ON=C2C2=CSC(C(CC3)CCN3C(CN3N=C(C(F)F)C=C3C(F)F)=O)=N2)=C1Cl Chemical compound CC#COC1=CC=CC(C(C2)ON=C2C2=CSC(C(CC3)CCN3C(CN3N=C(C(F)F)C=C3C(F)F)=O)=N2)=C1Cl LLRGGXSRTVIUMG-UHFFFAOYSA-N 0.000 description 1
- UYEKUKBLZCJKDV-UHFFFAOYSA-N CC(C(N1N=CN=C1)O)C(C=CC=C1OC(C=CC(Cl)=C2)=C2Cl)=C1Cl Chemical compound CC(C(N1N=CN=C1)O)C(C=CC=C1OC(C=CC(Cl)=C2)=C2Cl)=C1Cl UYEKUKBLZCJKDV-UHFFFAOYSA-N 0.000 description 1
- HFRAICOIYZBHOG-UHFFFAOYSA-N CC(C)(C)C1=C(CN(C2CC2)C(C2=NN(CF)C=C2C(F)F)=O)C=CC=C1 Chemical compound CC(C)(C)C1=C(CN(C2CC2)C(C2=NN(CF)C=C2C(F)F)=O)C=CC=C1 HFRAICOIYZBHOG-UHFFFAOYSA-N 0.000 description 1
- DQZRQTVSZKMYJI-UHFFFAOYSA-N CC(C)C(C1=CC=CC(Cl)=C1)N(C1CC1)C(C1=NN(CF)C=C1C(F)F)=O Chemical compound CC(C)C(C1=CC=CC(Cl)=C1)N(C1CC1)C(C1=NN(CF)C=C1C(F)F)=O DQZRQTVSZKMYJI-UHFFFAOYSA-N 0.000 description 1
- QSFPMIVBZABJHF-UHFFFAOYSA-N CC(C)C(CN(C1CC1)C(C(C(C(F)F)=C1)=NN1F)=O)C(C=CC=C1)=C1F Chemical compound CC(C)C(CN(C1CC1)C(C(C(C(F)F)=C1)=NN1F)=O)C(C=CC=C1)=C1F QSFPMIVBZABJHF-UHFFFAOYSA-N 0.000 description 1
- MMUPYEWRHAUGFS-UHFFFAOYSA-N CC(C)C(CN(C1CC1)C(C(C(C(F)F)=C1)=NN1F)=O)C1=CC=CC(F)=C1 Chemical compound CC(C)C(CN(C1CC1)C(C(C(C(F)F)=C1)=NN1F)=O)C1=CC=CC(F)=C1 MMUPYEWRHAUGFS-UHFFFAOYSA-N 0.000 description 1
- NGHXRGSLXIQLNK-UHFFFAOYSA-N CC(C)C(OCOCOC1=CC=CN=C1C(NCC(C(CC1=CC=CC=C1)C(OCCC1)=O)(OC(C(C)C)=O)OC1=O)=O)=O Chemical compound CC(C)C(OCOCOC1=CC=CN=C1C(NCC(C(CC1=CC=CC=C1)C(OCCC1)=O)(OC(C(C)C)=O)OC1=O)=O)=O NGHXRGSLXIQLNK-UHFFFAOYSA-N 0.000 description 1
- VZIZXAUDKGOFIH-UHFFFAOYSA-N CC(C)C1=C(C(C)CN(C2CC2)C(C(C(C(F)F)=C2)=NN2F)=O)C=CC=C1 Chemical compound CC(C)C1=C(C(C)CN(C2CC2)C(C(C(C(F)F)=C2)=NN2F)=O)C=CC=C1 VZIZXAUDKGOFIH-UHFFFAOYSA-N 0.000 description 1
- DYKNDOHAQIBPFG-UHFFFAOYSA-N CC(C)C1=C(CCN(C2CC2)C(C(C(C(F)F)=C2)=NN2F)=O)C=CC=C1 Chemical compound CC(C)C1=C(CCN(C2CC2)C(C(C(C(F)F)=C2)=NN2F)=O)C=CC=C1 DYKNDOHAQIBPFG-UHFFFAOYSA-N 0.000 description 1
- DAGSFJPHENMPRJ-UHFFFAOYSA-N CC(C)C1=C(CCN(C2CC2)C(C(C(C(F)F)=C2)=NN2F)=S)C=CC=C1 Chemical compound CC(C)C1=C(CCN(C2CC2)C(C(C(C(F)F)=C2)=NN2F)=S)C=CC=C1 DAGSFJPHENMPRJ-UHFFFAOYSA-N 0.000 description 1
- LCITXPWALBYPIT-UHFFFAOYSA-N CC(C)c1cc(C(C)C)c(c(c1)C(C)C)-c1ccccc1P(C(C)(C)C)C(C)(C)C.CC(C)c1cc(C(C)C)c(c(c1)C(C)C)-c1ccccc1P(C1CCCCC1)C1CCCCC1 Chemical group CC(C)c1cc(C(C)C)c(c(c1)C(C)C)-c1ccccc1P(C(C)(C)C)C(C)(C)C.CC(C)c1cc(C(C)C)c(c(c1)C(C)C)-c1ccccc1P(C1CCCCC1)C1CCCCC1 LCITXPWALBYPIT-UHFFFAOYSA-N 0.000 description 1
- HIZUMIXWCSZVBM-UHFFFAOYSA-N CC(C1=C(C(C)(C)C)C=CC=C1)N(C1CC1)C(C1=NN(CF)C=C1C(F)F)=O Chemical compound CC(C1=C(C(C)(C)C)C=CC=C1)N(C1CC1)C(C1=NN(CF)C=C1C(F)F)=O HIZUMIXWCSZVBM-UHFFFAOYSA-N 0.000 description 1
- NFKSPAZQLPXXMA-UHFFFAOYSA-N CC(C=C1)=CC(C)=C1C1=NN(CC2=CC(CNC(OC)=O)=CC=C2)C=C1 Chemical compound CC(C=C1)=CC(C)=C1C1=NN(CC2=CC(CNC(OC)=O)=CC=C2)C=C1 NFKSPAZQLPXXMA-UHFFFAOYSA-N 0.000 description 1
- GAANSLOWDVGXQO-UHFFFAOYSA-N CC(C=C1)=CC=C1S(N(C=C(CN1)C=NF)C1=O)(=O)=O Chemical compound CC(C=C1)=CC=C1S(N(C=C(CN1)C=NF)C1=O)(=O)=O GAANSLOWDVGXQO-UHFFFAOYSA-N 0.000 description 1
- GEXPXHYWEBIMMS-UHFFFAOYSA-N CC(CCCC(C)(C)C)C(C(C=CC(Cl)=C1)=C1Cl)(N1N=CNC1=S)O Chemical compound CC(CCCC(C)(C)C)C(C(C=CC(Cl)=C1)=C1Cl)(N1N=CNC1=S)O GEXPXHYWEBIMMS-UHFFFAOYSA-N 0.000 description 1
- HMIZEDIBPGGEHF-UHFFFAOYSA-N CC(CCNC(OCC(F)(F)F)=O)CNC(C1=CC=C(C)C=C1)=O Chemical compound CC(CCNC(OCC(F)(F)F)=O)CNC(C1=CC=C(C)C=C1)=O HMIZEDIBPGGEHF-UHFFFAOYSA-N 0.000 description 1
- SCLKTSOTASGCCX-UHFFFAOYSA-N CC(CO)C(C=CC=C1F)=C1OC1=NC2=C(CF)C(CF)=CC=C2C=C1 Chemical compound CC(CO)C(C=CC=C1F)=C1OC1=NC2=C(CF)C(CF)=CC=C2C=C1 SCLKTSOTASGCCX-UHFFFAOYSA-N 0.000 description 1
- GRAXJGRHAOMXAA-UHFFFAOYSA-N CC(CO)C(C=CC=C1OC2=NC3=C(CF)C=CC=C3C=C2)=C1F Chemical compound CC(CO)C(C=CC=C1OC2=NC3=C(CF)C=CC=C3C=C2)=C1F GRAXJGRHAOMXAA-UHFFFAOYSA-N 0.000 description 1
- DLWVPUMDHCXFPJ-UHFFFAOYSA-N CC1(C)OC(C(F)=CC=C2)=C2C=NC1C1=NC2=CC=CC=C2C=C1 Chemical compound CC1(C)OC(C(F)=CC=C2)=C2C=NC1C1=NC2=CC=CC=C2C=C1 DLWVPUMDHCXFPJ-UHFFFAOYSA-N 0.000 description 1
- ZOVUSKNVUVNHOI-UHFFFAOYSA-N CC1(NC(C(F)=CC=C2)=C2F)NN(C)C=C1C(C=CC=C1F)=C1Br Chemical compound CC1(NC(C(F)=CC=C2)=C2F)NN(C)C=C1C(C=CC=C1F)=C1Br ZOVUSKNVUVNHOI-UHFFFAOYSA-N 0.000 description 1
- KHCMBPVBUKFANK-UHFFFAOYSA-N CC1(NC(C(F)=CC=C2)=C2F)NN(C)C=C1C(C=CC=C1F)=C1Cl Chemical compound CC1(NC(C(F)=CC=C2)=C2F)NN(C)C=C1C(C=CC=C1F)=C1Cl KHCMBPVBUKFANK-UHFFFAOYSA-N 0.000 description 1
- YPWFVZFVRDWDSF-UHFFFAOYSA-N CC1(NC(C=CC=C2)=C2Br)NN(C)C=C1C(C=CC=C1F)=C1Br Chemical compound CC1(NC(C=CC=C2)=C2Br)NN(C)C=C1C(C=CC=C1F)=C1Br YPWFVZFVRDWDSF-UHFFFAOYSA-N 0.000 description 1
- QSXJCTWTEPAIBR-UHFFFAOYSA-N CC1(NC(C=CC=C2)=C2Cl)NN(C)C=C1C(C=CC(F)=C1)=C1Cl Chemical compound CC1(NC(C=CC=C2)=C2Cl)NN(C)C=C1C(C=CC(F)=C1)=C1Cl QSXJCTWTEPAIBR-UHFFFAOYSA-N 0.000 description 1
- WHRHYOFLZDLAIF-UHFFFAOYSA-N CC1(NC(C=CC=C2)=C2Cl)NN(C)C=C1C(C=CC=C1F)=C1Br Chemical compound CC1(NC(C=CC=C2)=C2Cl)NN(C)C=C1C(C=CC=C1F)=C1Br WHRHYOFLZDLAIF-UHFFFAOYSA-N 0.000 description 1
- GKDJYTWTNJPIGF-UHFFFAOYSA-N CC1(NC(C=CC=C2)=C2F)NN(C)C=C1C(C=CC=C1F)=C1Br Chemical compound CC1(NC(C=CC=C2)=C2F)NN(C)C=C1C(C=CC=C1F)=C1Br GKDJYTWTNJPIGF-UHFFFAOYSA-N 0.000 description 1
- HYWAYHLZCIJJAL-UHFFFAOYSA-N CC1(NC(C=CC=C2)=C2F)NN(C)C=C1C(C=CC=C1F)=C1Cl Chemical compound CC1(NC(C=CC=C2)=C2F)NN(C)C=C1C(C=CC=C1F)=C1Cl HYWAYHLZCIJJAL-UHFFFAOYSA-N 0.000 description 1
- IAUIOZGDIAFJFV-UHFFFAOYSA-N CC1(NC(C=CC=C2F)=C2Br)NN(C)C=C1C(C=CC=C1F)=C1Br Chemical compound CC1(NC(C=CC=C2F)=C2Br)NN(C)C=C1C(C=CC=C1F)=C1Br IAUIOZGDIAFJFV-UHFFFAOYSA-N 0.000 description 1
- KYOBMHLLELJGRL-UHFFFAOYSA-N CC1(NC(C=CC=C2F)=C2Br)NN(C)C=C1C(C=CC=C1F)=C1Cl Chemical compound CC1(NC(C=CC=C2F)=C2Br)NN(C)C=C1C(C=CC=C1F)=C1Cl KYOBMHLLELJGRL-UHFFFAOYSA-N 0.000 description 1
- GTKRBYIRCSCRQI-UHFFFAOYSA-N CC1(NC(C=CC=C2F)=C2Cl)NN(C)C=C1C(C=CC=C1F)=C1Br Chemical compound CC1(NC(C=CC=C2F)=C2Cl)NN(C)C=C1C(C=CC=C1F)=C1Br GTKRBYIRCSCRQI-UHFFFAOYSA-N 0.000 description 1
- FKKJDGZLMGBOCI-UHFFFAOYSA-N CC1(NC(C=CC=C2F)=C2Cl)NN(C)C=C1C(C=CC=C1F)=C1Cl Chemical compound CC1(NC(C=CC=C2F)=C2Cl)NN(C)C=C1C(C=CC=C1F)=C1Cl FKKJDGZLMGBOCI-UHFFFAOYSA-N 0.000 description 1
- IXLRGWAAJBJMSQ-UHFFFAOYSA-N CC1=C(OC2=C(C=CC=C2)N=CN(C)CC)C=C(C=C1)C Chemical compound CC1=C(OC2=C(C=CC=C2)N=CN(C)CC)C=C(C=C1)C IXLRGWAAJBJMSQ-UHFFFAOYSA-N 0.000 description 1
- KPYSAJYVJDVYMK-UHFFFAOYSA-N CC1=CC(C(C(F)(F)F)N(C2CC2)C(C2=NN(CF)C=C2C(F)F)=O)=CC=C1 Chemical compound CC1=CC(C(C(F)(F)F)N(C2CC2)C(C2=NN(CF)C=C2C(F)F)=O)=CC=C1 KPYSAJYVJDVYMK-UHFFFAOYSA-N 0.000 description 1
- TWDQAZDFUMJIKJ-UHFFFAOYSA-N CC1=CC(OCC2=C(COCC(NC)=O)C=CC=C2)=C(C)C=C1 Chemical compound CC1=CC(OCC2=C(COCC(NC)=O)C=CC=C2)=C(C)C=C1 TWDQAZDFUMJIKJ-UHFFFAOYSA-N 0.000 description 1
- NTZINMSCSNMXDO-UHFFFAOYSA-N CC1=CC=C(COC2=NC(N)=NC=C2F)C=C1 Chemical compound CC1=CC=C(COC2=NC(N)=NC=C2F)C=C1 NTZINMSCSNMXDO-UHFFFAOYSA-N 0.000 description 1
- AVRQRWHRNMIFDT-UHFFFAOYSA-N CC1=NC2=CC=CC=C2N=C1OC(C=CC(Cl)=C1)=C1F Chemical compound CC1=NC2=CC=CC=C2N=C1OC(C=CC(Cl)=C1)=C1F AVRQRWHRNMIFDT-UHFFFAOYSA-N 0.000 description 1
- LGJKYWAMWLLUMP-UHFFFAOYSA-N CC1C2=CC=CC(F)=C2C(C)(C)C1CNC(C1(C(F)F)NNC=C1)=O Chemical compound CC1C2=CC=CC(F)=C2C(C)(C)C1CNC(C1(C(F)F)NNC=C1)=O LGJKYWAMWLLUMP-UHFFFAOYSA-N 0.000 description 1
- MJDWAOQTHAKNCL-UHFFFAOYSA-N CC1C2=CC=CC=C2C(C)(C)C1N(C(C1=C(C(F)(F)F)C=CC=C1)=O)F Chemical compound CC1C2=CC=CC=C2C(C)(C)C1N(C(C1=C(C(F)(F)F)C=CC=C1)=O)F MJDWAOQTHAKNCL-UHFFFAOYSA-N 0.000 description 1
- URJFQUSRCTVJCV-UHFFFAOYSA-N CC1C2=CC=CC=C2C(C)(C)C1N(C(F)F)C(C1=NN(C)C=C1)=O Chemical compound CC1C2=CC=CC=C2C(C)(C)C1N(C(F)F)C(C1=NN(C)C=C1)=O URJFQUSRCTVJCV-UHFFFAOYSA-N 0.000 description 1
- FBQRHAVXNBRJJZ-UHFFFAOYSA-N CC1C2=CC=CC=C2C(C)(C)C1NC(C1(C)NN(C)C=C1)=O Chemical compound CC1C2=CC=CC=C2C(C)(C)C1NC(C1(C)NN(C)C=C1)=O FBQRHAVXNBRJJZ-UHFFFAOYSA-N 0.000 description 1
- CXAMCOZRBYJACN-UHFFFAOYSA-N CCC(C)(C1)CC(C)(C)CC1C(NNC(C(C=CC=C1)=C1O)=O)=O Chemical compound CCC(C)(C1)CC(C)(C)CC1C(NNC(C(C=CC=C1)=C1O)=O)=O CXAMCOZRBYJACN-UHFFFAOYSA-N 0.000 description 1
- BQQPGDLQJFZZKE-UHFFFAOYSA-N CCC(NC(C1=NN(C)C=C1C(F)F)=O)OCC(C=CC(Cl)=C1)=C1Cl Chemical compound CCC(NC(C1=NN(C)C=C1C(F)F)=O)OCC(C=CC(Cl)=C1)=C1Cl BQQPGDLQJFZZKE-UHFFFAOYSA-N 0.000 description 1
- VHWVYBOWUDJRPE-UHFFFAOYSA-N CCC1=C(C(C)N(C2CC2)C(C2=NN(CF)C=C2C(F)F)=O)C=CC=C1 Chemical compound CCC1=C(C(C)N(C2CC2)C(C2=NN(CF)C=C2C(F)F)=O)C=CC=C1 VHWVYBOWUDJRPE-UHFFFAOYSA-N 0.000 description 1
- GMEUJAKRZYPUMO-UHFFFAOYSA-N CCC1=C(C(N(C2CC2)C(C2=NN(CF)C=C2C(F)F)=O)F)C=CC=C1 Chemical compound CCC1=C(C(N(C2CC2)C(C2=NN(CF)C=C2C(F)F)=O)F)C=CC=C1 GMEUJAKRZYPUMO-UHFFFAOYSA-N 0.000 description 1
- IACVULDDEFGEPW-UHFFFAOYSA-N CCN(C)C=NC(C(C)=NC=C1Br)=C1OC1C2=CC=CC=C2CC1 Chemical compound CCN(C)C=NC(C(C)=NC=C1Br)=C1OC1C2=CC=CC=C2CC1 IACVULDDEFGEPW-UHFFFAOYSA-N 0.000 description 1
- IVLCSSRIQQHUNZ-UHFFFAOYSA-N CCN(C)C=NC(C(COC(C)C1=CC(F)=CC(F)=C1)=C1)=NC=C1Br Chemical compound CCN(C)C=NC(C(COC(C)C1=CC(F)=CC(F)=C1)=C1)=NC=C1Br IVLCSSRIQQHUNZ-UHFFFAOYSA-N 0.000 description 1
- OKOPWSLBBXEIJB-UHFFFAOYSA-N CCN(C)C=NC1=C(C)C(OC2=CC(SC(C(F)F)(F)F)=CC=C2)=CC(C)=C1 Chemical compound CCN(C)C=NC1=C(C)C(OC2=CC(SC(C(F)F)(F)F)=CC=C2)=CC(C)=C1 OKOPWSLBBXEIJB-UHFFFAOYSA-N 0.000 description 1
- JPOZDHZZNFMDBI-UHFFFAOYSA-N CCN(C)C=NC1=C(C)C(OC2=CC(SCC(C(F)F)(F)F)=CC=C2)=CC(C)=C1 Chemical compound CCN(C)C=NC1=C(C)C(OC2=CC(SCC(C(F)F)(F)F)=CC=C2)=CC(C)=C1 JPOZDHZZNFMDBI-UHFFFAOYSA-N 0.000 description 1
- XMXOSWKVGDMAIJ-UHFFFAOYSA-N CCN(C)C=NC1=C(C)C(SC2=CC(OC(C(F)(F)F)(F)F)=CC=C2)=CC(C)=C1 Chemical compound CCN(C)C=NC1=C(C)C(SC2=CC(OC(C(F)(F)F)(F)F)=CC=C2)=CC(C)=C1 XMXOSWKVGDMAIJ-UHFFFAOYSA-N 0.000 description 1
- ZQUHBBGHWWOSFR-UHFFFAOYSA-N CCN(C)C=NC1=C(C)C(SC2=CC(OC(C(F)F)(F)F)=CC=C2)=CC(C)=C1 Chemical compound CCN(C)C=NC1=C(C)C(SC2=CC(OC(C(F)F)(F)F)=CC=C2)=CC(C)=C1 ZQUHBBGHWWOSFR-UHFFFAOYSA-N 0.000 description 1
- HWYDUQRYNURIDR-UHFFFAOYSA-N CCN(C)C=NC1=C(C)C(SC2=CC(OCC(F)(F)F)=CC=C2)=CC(C)=C1 Chemical compound CCN(C)C=NC1=C(C)C(SC2=CC(OCC(F)(F)F)=CC=C2)=CC(C)=C1 HWYDUQRYNURIDR-UHFFFAOYSA-N 0.000 description 1
- MMINILZEVQHMLJ-UHFFFAOYSA-N CCN(C)C=Nc1cc(C)c(Sc2cccc(OCC(F)(F)C(F)F)c2)cc1C Chemical compound CCN(C)C=Nc1cc(C)c(Sc2cccc(OCC(F)(F)C(F)F)c2)cc1C MMINILZEVQHMLJ-UHFFFAOYSA-N 0.000 description 1
- GRIRJFYNNQKABB-RLBMWQAVSA-N CC[C@@H](C([C@@H](C1)C1(Cl)Cl)(N1N=CN=C1)O)C1(CC1)Cl Chemical compound CC[C@@H](C([C@@H](C1)C1(Cl)Cl)(N1N=CN=C1)O)C1(CC1)Cl GRIRJFYNNQKABB-RLBMWQAVSA-N 0.000 description 1
- GRIRJFYNNQKABB-LSLJNABFSA-N CC[C@@H](C([C@H](C1)C1(Cl)Cl)(N1N=CN=C1)O)C1(CC1)Cl Chemical compound CC[C@@H](C([C@H](C1)C1(Cl)Cl)(N1N=CN=C1)O)C1(CC1)Cl GRIRJFYNNQKABB-LSLJNABFSA-N 0.000 description 1
- GRIRJFYNNQKABB-VTGJNACWSA-N CC[C@H](C([C@@H](C1)C1(Cl)Cl)(N1N=CN=C1)O)C1(CC1)Cl Chemical compound CC[C@H](C([C@@H](C1)C1(Cl)Cl)(N1N=CN=C1)O)C1(CC1)Cl GRIRJFYNNQKABB-VTGJNACWSA-N 0.000 description 1
- GRIRJFYNNQKABB-JIMHFIIXSA-N CC[C@H](C([C@H](C1)C1(Cl)Cl)(N1N=CN=C1)O)C1(CC1)Cl Chemical compound CC[C@H](C([C@H](C1)C1(Cl)Cl)(N1N=CN=C1)O)C1(CC1)Cl GRIRJFYNNQKABB-JIMHFIIXSA-N 0.000 description 1
- HOZSZURIBXAHKO-NIVTXAMTSA-N CN1N=C(C(N[C@]2(C3)C4=CC=CC=C4[C@H]3CC2=C(Cl)Cl)=O)C(C(F)F)=C1 Chemical compound CN1N=C(C(N[C@]2(C3)C4=CC=CC=C4[C@H]3CC2=C(Cl)Cl)=O)C(C(F)F)=C1 HOZSZURIBXAHKO-NIVTXAMTSA-N 0.000 description 1
- GZOGYLKTIWGXBR-PVIMSTIJSA-N CNC(/C(\C1=C(CO/N=C/CC2=CC(O/C=C(\C3=CC=CC=C3)/F)=CC=C2)C=CC=C1)=N/OC)=O Chemical compound CNC(/C(\C1=C(CO/N=C/CC2=CC(O/C=C(\C3=CC=CC=C3)/F)=CC=C2)C=CC=C1)=N/OC)=O GZOGYLKTIWGXBR-PVIMSTIJSA-N 0.000 description 1
- RVXDFSYTWKVXGG-UHFFFAOYSA-N CS(OC1=C(C2C(C3=CSC(C(CCCC4)N4C(CN4N=C(C(F)F)C=C4C(F)F)=O)=N3)=NOC2)C=CC=C1)(=O)=O Chemical compound CS(OC1=C(C2C(C3=CSC(C(CCCC4)N4C(CN4N=C(C(F)F)C=C4C(F)F)=O)=N3)=NOC2)C=CC=C1)(=O)=O RVXDFSYTWKVXGG-UHFFFAOYSA-N 0.000 description 1
- OKMUDDLXKAHMPD-IPPDQLOFSA-N C[C@@H]1C2=CC=CC=C2C(C)(C)C1(CNC(C1(C(F)F)NNC=C1)=O)F Chemical compound C[C@@H]1C2=CC=CC=C2C(C)(C)C1(CNC(C1(C(F)F)NNC=C1)=O)F OKMUDDLXKAHMPD-IPPDQLOFSA-N 0.000 description 1
- KIEADCTUPFRLII-NWCKJHLDSA-N C[C@@H]1C2=CC=CC=C2C(C)(C)C1NC(C1(C(F)F)NN(C)C=C1)=O Chemical compound C[C@@H]1C2=CC=CC=C2C(C)(C)C1NC(C1(C(F)F)NN(C)C=C1)=O KIEADCTUPFRLII-NWCKJHLDSA-N 0.000 description 1
- OUIFTJNCMRZTFV-ZVDHGWRTSA-N C[C@@H]1C2=CC=CC=C2C(C)(C)C1NC(C1=NNC(C)=C1C)=O Chemical compound C[C@@H]1C2=CC=CC=C2C(C)(C)C1NC(C1=NNC(C)=C1C)=O OUIFTJNCMRZTFV-ZVDHGWRTSA-N 0.000 description 1
- OKMUDDLXKAHMPD-NVWNAPEYSA-N C[C@H]1C2=CC=CC=C2C(C)(C)C1(CNC(C1(C(F)F)NNC=C1)=O)F Chemical compound C[C@H]1C2=CC=CC=C2C(C)(C)C1(CNC(C1(C(F)F)NNC=C1)=O)F OKMUDDLXKAHMPD-NVWNAPEYSA-N 0.000 description 1
- KIEADCTUPFRLII-JCDGYTILSA-N C[C@H]1C2=CC=CC=C2C(C)(C)C1NC(C1(C(F)F)NN(C)C=C1)=O Chemical compound C[C@H]1C2=CC=CC=C2C(C)(C)C1NC(C1(C(F)F)NN(C)C=C1)=O KIEADCTUPFRLII-JCDGYTILSA-N 0.000 description 1
- FBQRHAVXNBRJJZ-RTYYOJRZSA-N C[C@H]1C2=CC=CC=C2C(C)(C)C1NC(C1(C)NN(C)C=C1)=O Chemical compound C[C@H]1C2=CC=CC=C2C(C)(C)C1NC(C1(C)NN(C)C=C1)=O FBQRHAVXNBRJJZ-RTYYOJRZSA-N 0.000 description 1
- BSTOCZRSICHCNP-UHFFFAOYSA-N C[SiH](C1=CC=CC=C1)C(C(Cl)=NC1=CC=CC=C11)=C1OC1=CC(F)=CC=C1 Chemical compound C[SiH](C1=CC=CC=C1)C(C(Cl)=NC1=CC=CC=C11)=C1OC1=CC(F)=CC=C1 BSTOCZRSICHCNP-UHFFFAOYSA-N 0.000 description 1
- JGLRARHWGXPLIB-UHFFFAOYSA-N C[Si](C)(C(C=CC=C1F)=C1OC1=NC2=C(CF)C(CF)=CC=C2C=C1)O Chemical compound C[Si](C)(C(C=CC=C1F)=C1OC1=NC2=C(CF)C(CF)=CC=C2C=C1)O JGLRARHWGXPLIB-UHFFFAOYSA-N 0.000 description 1
- HWYGYPKDEIEJET-UHFFFAOYSA-N C[Si](C)(C)C(C(F)=CC=C1)=C1OCC(C=CC1=CC=C2F)=NC1=C2F Chemical compound C[Si](C)(C)C(C(F)=CC=C1)=C1OCC(C=CC1=CC=C2F)=NC1=C2F HWYGYPKDEIEJET-UHFFFAOYSA-N 0.000 description 1
- JIIHNUXGPGSRJM-UHFFFAOYSA-N C[Si](C)(C)C(C=C(C=C1)F)=C1OC(C=CC1=CC=C2)=NC1=C2Cl Chemical compound C[Si](C)(C)C(C=C(C=C1)F)=C1OC(C=CC1=CC=C2)=NC1=C2Cl JIIHNUXGPGSRJM-UHFFFAOYSA-N 0.000 description 1
- HDWCFACGONIFLY-UHFFFAOYSA-N C[Si](C)(C)CC(C=CC=C1)=C1OC1=NC2=C(CF)C(CF)=CC=C2C=C1 Chemical compound C[Si](C)(C)CC(C=CC=C1)=C1OC1=NC2=C(CF)C(CF)=CC=C2C=C1 HDWCFACGONIFLY-UHFFFAOYSA-N 0.000 description 1
- PGSWDVOTGIIGMJ-UHFFFAOYSA-N C[Si](C)(C1=C2C=CC=C1)OC2N1C2=CC=CC=C2C=CC1 Chemical compound C[Si](C)(C1=C2C=CC=C1)OC2N1C2=CC=CC=C2C=CC1 PGSWDVOTGIIGMJ-UHFFFAOYSA-N 0.000 description 1
- FJZMWBMBQGGURC-LIVXRWSZSA-N C\C(/C(\C(NC)=O)=N\OC)=C(/C)\OC(C=C1)=NN1C(C=CC(Cl)=C1)=C1F Chemical compound C\C(/C(\C(NC)=O)=N\OC)=C(/C)\OC(C=C1)=NN1C(C=CC(Cl)=C1)=C1F FJZMWBMBQGGURC-LIVXRWSZSA-N 0.000 description 1
- 229910021532 Calcite Inorganic materials 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-IGMARMGPSA-N Calcium-40 Chemical compound [40Ca] OYPRJOBELJOOCE-IGMARMGPSA-N 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 239000005745 Captan Substances 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- TWFZGCMQGLPBSX-UHFFFAOYSA-N Carbendazim Natural products C1=CC=C2NC(NC(=O)OC)=NC2=C1 TWFZGCMQGLPBSX-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000005746 Carboxin Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- 241000221866 Ceratocystis Species 0.000 description 1
- 241001157813 Cercospora Species 0.000 description 1
- 241000530549 Cercospora beticola Species 0.000 description 1
- 241000221955 Chaetomium Species 0.000 description 1
- 241001515917 Chaetomium globosum Species 0.000 description 1
- 235000021538 Chard Nutrition 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 239000005747 Chlorothalonil Substances 0.000 description 1
- 241000760356 Chytridiomycetes Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- DWKKAFXUWSDLHJ-UHFFFAOYSA-N ClC[SiH]1CCC1 Chemical compound ClC[SiH]1CCC1 DWKKAFXUWSDLHJ-UHFFFAOYSA-N 0.000 description 1
- 241001149955 Cladosporium cladosporioides Species 0.000 description 1
- 241001149956 Cladosporium herbarum Species 0.000 description 1
- 241000124224 Claviceps paspali Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 241001123534 Colletotrichum coccodes Species 0.000 description 1
- 241001529387 Colletotrichum gloeosporioides Species 0.000 description 1
- JJLJMEJHUUYSSY-UHFFFAOYSA-L Copper hydroxide Chemical compound [OH-].[OH-].[Cu+2] JJLJMEJHUUYSSY-UHFFFAOYSA-L 0.000 description 1
- 239000005750 Copper hydroxide Substances 0.000 description 1
- 239000005751 Copper oxide Substances 0.000 description 1
- 239000005752 Copper oxychloride Substances 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- 229910021590 Copper(II) bromide Inorganic materials 0.000 description 1
- 229910021592 Copper(II) chloride Inorganic materials 0.000 description 1
- 244000018951 Cordia abyssinica Species 0.000 description 1
- 241000222356 Coriolus Species 0.000 description 1
- 241000186031 Corynebacteriaceae Species 0.000 description 1
- 235000009075 Cucumis anguria Nutrition 0.000 description 1
- 241000219104 Cucurbitaceae Species 0.000 description 1
- 239000005754 Cyazofamid Substances 0.000 description 1
- 239000005755 Cyflufenamid Substances 0.000 description 1
- 239000005756 Cymoxanil Substances 0.000 description 1
- 239000005757 Cyproconazole Substances 0.000 description 1
- 239000005758 Cyprodinil Substances 0.000 description 1
- 241001508802 Diaporthe Species 0.000 description 1
- 241001645342 Diaporthe citri Species 0.000 description 1
- 241000382787 Diaporthe sojae Species 0.000 description 1
- 241001273416 Didymella arachidicola Species 0.000 description 1
- 239000005759 Diethofencarb Substances 0.000 description 1
- 239000005760 Difenoconazole Substances 0.000 description 1
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 1
- 239000005761 Dimethomorph Substances 0.000 description 1
- 239000005762 Dimoxystrobin Substances 0.000 description 1
- 239000005764 Dithianon Substances 0.000 description 1
- 239000005766 Dodine Substances 0.000 description 1
- 102000015782 Electron Transport Complex III Human genes 0.000 description 1
- 108010024882 Electron Transport Complex III Proteins 0.000 description 1
- 241000125117 Elsinoe Species 0.000 description 1
- 241000125118 Elsinoe fawcettii Species 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 239000005767 Epoxiconazole Substances 0.000 description 1
- 241000588698 Erwinia Species 0.000 description 1
- 241000588694 Erwinia amylovora Species 0.000 description 1
- 241000221785 Erysiphales Species 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 241000221997 Exobasidium Species 0.000 description 1
- 241001661371 Exobasidium vexans Species 0.000 description 1
- DKENXAOMOONIDD-UHFFFAOYSA-N FC(C1=CC(OC2=CC=CC(CCNC(N=CC3=C(C=C4)F)=NC3=C4F)=C2F)=NC=C1)(F)F Chemical compound FC(C1=CC(OC2=CC=CC(CCNC(N=CC3=C(C=C4)F)=NC3=C4F)=C2F)=NC=C1)(F)F DKENXAOMOONIDD-UHFFFAOYSA-N 0.000 description 1
- UZVMWYZJXGRJCT-UHFFFAOYSA-N FC(F)SC=1C=C(OC2=CC(=C(C=C2C)N=CN(C)CC)C)C=CC=1 Chemical compound FC(F)SC=1C=C(OC2=CC(=C(C=C2C)N=CN(C)CC)C)C=CC=1 UZVMWYZJXGRJCT-UHFFFAOYSA-N 0.000 description 1
- KPEOGSUSQGHGLQ-UHFFFAOYSA-N FC1=C(CC2=CN=NC(Cl)=C2C2=CC=CC=C2)C(F)=CC=C1 Chemical compound FC1=C(CC2=CN=NC(Cl)=C2C2=CC=CC=C2)C(F)=CC=C1 KPEOGSUSQGHGLQ-UHFFFAOYSA-N 0.000 description 1
- LZCOIDXQFDVPRI-UHFFFAOYSA-N FCOC1=CC=CC(CC2=CC=CC(C3=NC4=CC=CC=C4C=N3)=N2)=C1 Chemical compound FCOC1=CC=CC(CC2=CC=CC(C3=NC4=CC=CC=C4C=N3)=N2)=C1 LZCOIDXQFDVPRI-UHFFFAOYSA-N 0.000 description 1
- 241000219428 Fagaceae Species 0.000 description 1
- 239000005772 Famoxadone Substances 0.000 description 1
- 239000005774 Fenamidone Substances 0.000 description 1
- 239000005776 Fenhexamid Substances 0.000 description 1
- 239000005777 Fenpropidin Substances 0.000 description 1
- 239000005778 Fenpropimorph Substances 0.000 description 1
- 239000005779 Fenpyrazamine Substances 0.000 description 1
- 239000005780 Fluazinam Substances 0.000 description 1
- 239000005781 Fludioxonil Substances 0.000 description 1
- 239000005782 Fluopicolide Substances 0.000 description 1
- 239000005783 Fluopyram Substances 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 239000005784 Fluoxastrobin Substances 0.000 description 1
- 239000005785 Fluquinconazole Substances 0.000 description 1
- 239000005786 Flutolanil Substances 0.000 description 1
- 239000005787 Flutriafol Substances 0.000 description 1
- 239000005788 Fluxapyroxad Substances 0.000 description 1
- 239000005789 Folpet Substances 0.000 description 1
- 241001240951 Fomitiporia mediterranea Species 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 241000223193 Fusarium acuminatum Species 0.000 description 1
- 241000784413 Fusarium asiaticum Species 0.000 description 1
- 241000122692 Fusarium avenaceum Species 0.000 description 1
- 241000567163 Fusarium cerealis Species 0.000 description 1
- 241001208371 Fusarium incarnatum Species 0.000 description 1
- 241000786450 Fusarium langsethiae Species 0.000 description 1
- 241001302802 Fusarium musarum Species 0.000 description 1
- 241001489200 Fusarium poae Species 0.000 description 1
- 241000690372 Fusarium proliferatum Species 0.000 description 1
- 241001451172 Fusarium pseudograminearum Species 0.000 description 1
- 241000221779 Fusarium sambucinum Species 0.000 description 1
- 241000427940 Fusarium solani Species 0.000 description 1
- 241000145502 Fusarium subglutinans Species 0.000 description 1
- 241000879141 Fusarium tricinctum Species 0.000 description 1
- 241000233732 Fusarium verticillioides Species 0.000 description 1
- 241001149504 Gaeumannomyces Species 0.000 description 1
- 241001149475 Gaeumannomyces graminis Species 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 241000401653 Ganoderma orbiforme Species 0.000 description 1
- 241000594821 Globulostylis uncinula Species 0.000 description 1
- 241000123332 Gloeophyllum Species 0.000 description 1
- 241001620302 Glomerella <beetle> Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241001481828 Glyptocephalus cynoglossus Species 0.000 description 1
- 235000004341 Gossypium herbaceum Nutrition 0.000 description 1
- 240000002024 Gossypium herbaceum Species 0.000 description 1
- 241000555709 Guignardia Species 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000221557 Gymnosporangium Species 0.000 description 1
- 241001409809 Gymnosporangium sabinae Species 0.000 description 1
- 241000592938 Helminthosporium solani Species 0.000 description 1
- 241001181537 Hemileia Species 0.000 description 1
- 241001181532 Hemileia vastatrix Species 0.000 description 1
- 241000223198 Humicola Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 239000005795 Imazalil Substances 0.000 description 1
- 239000005796 Ipconazole Substances 0.000 description 1
- 239000005867 Iprodione Substances 0.000 description 1
- 239000005797 Iprovalicarb Substances 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 239000005798 Isofetamid Substances 0.000 description 1
- 241000758791 Juglandaceae Species 0.000 description 1
- 239000005800 Kresoxim-methyl Substances 0.000 description 1
- NWUWYYSKZYIQAE-ZBFHGGJFSA-N L-(R)-iprovalicarb Chemical compound CC(C)OC(=O)N[C@@H](C(C)C)C(=O)N[C@H](C)C1=CC=C(C)C=C1 NWUWYYSKZYIQAE-ZBFHGGJFSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 241000218195 Lauraceae Species 0.000 description 1
- 241000222418 Lentinus Species 0.000 description 1
- 241000222451 Lentinus tigrinus Species 0.000 description 1
- 235000007849 Lepidium sativum Nutrition 0.000 description 1
- 244000211187 Lepidium sativum Species 0.000 description 1
- 241000228456 Leptosphaeria Species 0.000 description 1
- 229920001732 Lignosulfonate Polymers 0.000 description 1
- 239000004117 Lignosulphonate Substances 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 241001495424 Macrophomina Species 0.000 description 1
- 241001495426 Macrophomina phaseolina Species 0.000 description 1
- 241001344133 Magnaporthe Species 0.000 description 1
- 241001344131 Magnaporthe grisea Species 0.000 description 1
- 239000005802 Mancozeb Substances 0.000 description 1
- 239000005804 Mandipropamid Substances 0.000 description 1
- 239000005806 Meptyldinocap Substances 0.000 description 1
- 239000005807 Metalaxyl Substances 0.000 description 1
- 239000005808 Metalaxyl-M Substances 0.000 description 1
- 239000005868 Metconazole Substances 0.000 description 1
- 239000005809 Metiram Substances 0.000 description 1
- 239000005810 Metrafenone Substances 0.000 description 1
- 108700011259 MicroRNAs Proteins 0.000 description 1
- 241001668538 Mollisia Species 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- UVPSSGJTBLNVRE-UHFFFAOYSA-N Moniliformin Natural products O=C1C(OC)=CC(=O)C=2C1=C1C(=O)C(OC)=CC(=O)C1=CC=2 UVPSSGJTBLNVRE-UHFFFAOYSA-N 0.000 description 1
- 241001518729 Monilinia Species 0.000 description 1
- 241000862466 Monilinia laxa Species 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 241000235395 Mucor Species 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 241000234615 Musaceae Species 0.000 description 1
- 239000005811 Myclobutanil Substances 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 241000131448 Mycosphaerella Species 0.000 description 1
- GSXBQYOCCGDDKZ-UHFFFAOYSA-N N#CSC1=NN(CC2(C(C=CC(F)=C3)=C3F)OC2C(C=CC=C2)=C2Cl)C=N1 Chemical compound N#CSC1=NN(CC2(C(C=CC(F)=C3)=C3F)OC2C(C=CC=C2)=C2Cl)C=N1 GSXBQYOCCGDDKZ-UHFFFAOYSA-N 0.000 description 1
- HTAXFABWEJKJSM-UHFFFAOYSA-N N'-[2,5-dimethyl-3-[3-(1,1,2,2,2-pentafluoroethylsulfanyl)phenoxy]phenyl]-N-ethyl-N-methylmethanimidamide Chemical compound CC1=C(C=C(C=C1OC1=CC(=CC=C1)SC(C(F)(F)F)(F)F)C)N=CN(C)CC HTAXFABWEJKJSM-UHFFFAOYSA-N 0.000 description 1
- AWJHGJSZDGHLQA-UHFFFAOYSA-N N'-[2,5-dimethyl-3-[3-(2,2,2-trifluoroethylsulfanyl)phenoxy]phenyl]-N-ethyl-N-methylmethanimidamide Chemical compound CC1=C(C=C(C=C1OC1=CC(=CC=C1)SCC(F)(F)F)C)N=CN(C)CC AWJHGJSZDGHLQA-UHFFFAOYSA-N 0.000 description 1
- GSCCALZHGUWNJW-UHFFFAOYSA-N N-Cyclohexyl-N-methylcyclohexanamine Chemical compound C1CCCCC1N(C)C1CCCCC1 GSCCALZHGUWNJW-UHFFFAOYSA-N 0.000 description 1
- CCCGEKHKTPTUHJ-UHFFFAOYSA-N N-[9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=CC2=C1C1CCC2C1=C(Cl)Cl CCCGEKHKTPTUHJ-UHFFFAOYSA-N 0.000 description 1
- NQRFDNJEBWAUBL-UHFFFAOYSA-N N-[cyano(2-thienyl)methyl]-4-ethyl-2-(ethylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(NCC)=NC(CC)=C1C(=O)NC(C#N)C1=CC=CS1 NQRFDNJEBWAUBL-UHFFFAOYSA-N 0.000 description 1
- XQJQCBDIXRIYRP-UHFFFAOYSA-N N-{2-[1,1'-bi(cyclopropyl)-2-yl]phenyl}-3-(difluoromethyl)-1-methyl-1pyrazole-4-carboxamide Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=CC=C1C1C(C2CC2)C1 XQJQCBDIXRIYRP-UHFFFAOYSA-N 0.000 description 1
- VYIMTYRAXWNXFU-JFMUQQRKSA-N N1=C(C=CC=C1)\C=N\C1C(CCCC1)/N=C/C1=NC=CC=C1 Chemical compound N1=C(C=CC=C1)\C=N\C1C(CCCC1)/N=C/C1=NC=CC=C1 VYIMTYRAXWNXFU-JFMUQQRKSA-N 0.000 description 1
- 241000379990 Nakataea oryzae Species 0.000 description 1
- 241000498271 Necator Species 0.000 description 1
- 241001226034 Nectria <echinoderm> Species 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 241000556984 Neonectria galligena Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- VJAWBEFMCIINFU-UHFFFAOYSA-N Nitrothal-isopropyl Chemical group CC(C)OC(=O)C1=CC(C(=O)OC(C)C)=CC([N+]([O-])=O)=C1 VJAWBEFMCIINFU-UHFFFAOYSA-N 0.000 description 1
- UKOTXHQERFPCBU-YQPARWETSA-N Nivalenol Chemical compound C([C@]12[C@@]3([C@H](O)[C@@H](O)[C@H]1O[C@@H]1C=C(C([C@@H](O)[C@@]13CO)=O)C)C)O2 UKOTXHQERFPCBU-YQPARWETSA-N 0.000 description 1
- ITCSWEBPTQLQKN-UHFFFAOYSA-N Nivalenol Natural products CC1=CC2OC3C(O)C(O)C(C2(CO)CC1=O)C34CO4 ITCSWEBPTQLQKN-UHFFFAOYSA-N 0.000 description 1
- XYQKSZWTWURJOO-UHFFFAOYSA-N O=C(C1=NN(CF)C=C1C(F)F)N(C(C(F)(F)F)C(C=CC=C1)=C1Cl)C1CC1 Chemical compound O=C(C1=NN(CF)C=C1C(F)F)N(C(C(F)(F)F)C(C=CC=C1)=C1Cl)C1CC1 XYQKSZWTWURJOO-UHFFFAOYSA-N 0.000 description 1
- REOCQAZSMHEZAH-UHFFFAOYSA-N O=C(C1=NN(CF)C=C1C(F)F)N(C(C(F)(F)F)C1=CC=CC(Cl)=C1)C1CC1 Chemical compound O=C(C1=NN(CF)C=C1C(F)F)N(C(C(F)(F)F)C1=CC=CC(Cl)=C1)C1CC1 REOCQAZSMHEZAH-UHFFFAOYSA-N 0.000 description 1
- HNLDMJSCQVITNS-UHFFFAOYSA-N O=C(C1=NN(CF)C=C1C(F)F)N(C(C1=C(C2CC2)C=CC=C1)F)C1CC1 Chemical compound O=C(C1=NN(CF)C=C1C(F)F)N(C(C1=C(C2CC2)C=CC=C1)F)C1CC1 HNLDMJSCQVITNS-UHFFFAOYSA-N 0.000 description 1
- RPATYALDSWOBTO-UHFFFAOYSA-N O=C(C1=NN(CF)C=C1C(F)F)N(C(C1=C(C2CCCC2)C=CC=C1)F)C1CC1 Chemical compound O=C(C1=NN(CF)C=C1C(F)F)N(C(C1=C(C2CCCC2)C=CC=C1)F)C1CC1 RPATYALDSWOBTO-UHFFFAOYSA-N 0.000 description 1
- LJHWQOXBRIHQED-UHFFFAOYSA-N O=C(C1=NN(CF)C=C1C(F)F)N(C(C1=CC(Cl)=CC=C1C(F)(F)F)F)C1CC1 Chemical compound O=C(C1=NN(CF)C=C1C(F)F)N(C(C1=CC(Cl)=CC=C1C(F)(F)F)F)C1CC1 LJHWQOXBRIHQED-UHFFFAOYSA-N 0.000 description 1
- DLNPSWRNLXZXPN-UHFFFAOYSA-N O=C(C1=NN(CF)C=C1C(F)F)N(CC1=C(C2CC2)C=CC=C1)C1CC1 Chemical compound O=C(C1=NN(CF)C=C1C(F)F)N(CC1=C(C2CC2)C=CC=C1)C1CC1 DLNPSWRNLXZXPN-UHFFFAOYSA-N 0.000 description 1
- VXTZDFBCOKEIBS-UHFFFAOYSA-N O=C(C1=NN(CF)C=C1C(F)F)N(CC1=C(CC2CC2)C=CC=C1)C1CC1 Chemical compound O=C(C1=NN(CF)C=C1C(F)F)N(CC1=C(CC2CC2)C=CC=C1)C1CC1 VXTZDFBCOKEIBS-UHFFFAOYSA-N 0.000 description 1
- WPSMRNZFWZZCBU-UHFFFAOYSA-N OC(C1=C(C(C=CC(F)=C2)=C2F)ON=C1C(C=CC(Cl)=C1)=C1F)C1=NC=CC=C1 Chemical compound OC(C1=C(C(C=CC(F)=C2)=C2F)ON=C1C(C=CC(Cl)=C1)=C1F)C1=NC=CC=C1 WPSMRNZFWZZCBU-UHFFFAOYSA-N 0.000 description 1
- CILSRXNHTMDCAX-UHFFFAOYSA-N OC1=NC2=C(CF)C(CF)=CC=C2C=C1 Chemical compound OC1=NC2=C(CF)C(CF)=CC=C2C=C1 CILSRXNHTMDCAX-UHFFFAOYSA-N 0.000 description 1
- WPSMRNZFWZZCBU-HXUWFJFHSA-N O[C@@H](C1=C(C(C=CC(F)=C2)=C2F)ON=C1C(C=CC(Cl)=C1)=C1F)C1=NC=CC=C1 Chemical compound O[C@@H](C1=C(C(C=CC(F)=C2)=C2F)ON=C1C(C=CC(Cl)=C1)=C1F)C1=NC=CC=C1 WPSMRNZFWZZCBU-HXUWFJFHSA-N 0.000 description 1
- WPSMRNZFWZZCBU-FQEVSTJZSA-N O[C@H](C1=C(C(C=CC(F)=C2)=C2F)ON=C1C(C=CC(Cl)=C1)=C1F)C1=NC=CC=C1 Chemical compound O[C@H](C1=C(C(C=CC(F)=C2)=C2F)ON=C1C(C=CC(Cl)=C1)=C1F)C1=NC=CC=C1 WPSMRNZFWZZCBU-FQEVSTJZSA-N 0.000 description 1
- 241000144610 Oculimacula acuformis Species 0.000 description 1
- 241000207834 Oleaceae Species 0.000 description 1
- 241000221871 Ophiostoma Species 0.000 description 1
- 239000005812 Oxathiapiprolin Substances 0.000 description 1
- YXLXNENXOJSQEI-UHFFFAOYSA-L Oxine-copper Chemical compound [Cu+2].C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1 YXLXNENXOJSQEI-UHFFFAOYSA-L 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000005985 Paclobutrazol Substances 0.000 description 1
- 241001236817 Paecilomyces <Clavicipitaceae> Species 0.000 description 1
- 239000005814 Pencycuron Substances 0.000 description 1
- 239000005815 Penflufen Substances 0.000 description 1
- 241000228153 Penicillium citrinum Species 0.000 description 1
- 240000000064 Penicillium roqueforti Species 0.000 description 1
- 241000864266 Penicillium verrucosum Species 0.000 description 1
- 241000864371 Penicillium viridicatum Species 0.000 description 1
- 241001149509 Penicillium vulpinum Species 0.000 description 1
- 239000005816 Penthiopyrad Substances 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241001223281 Peronospora Species 0.000 description 1
- 241000201565 Peronospora viciae f. sp. pisi Species 0.000 description 1
- 241000143552 Petriella Species 0.000 description 1
- 241000263269 Phaeoacremonium minimum Species 0.000 description 1
- 241000047853 Phaeomoniella chlamydospora Species 0.000 description 1
- 241000555275 Phaeosphaeria Species 0.000 description 1
- 241000440444 Phakopsora Species 0.000 description 1
- 241000440445 Phakopsora meibomiae Species 0.000 description 1
- 241000682645 Phakopsora pachyrhizi Species 0.000 description 1
- JKIJEFPNVSHHEI-UHFFFAOYSA-N Phenol, 2,4-bis(1,1-dimethylethyl)-, phosphite (3:1) Chemical compound CC(C)(C)C1=CC(C(C)(C)C)=CC=C1OP(OC=1C(=CC(=CC=1)C(C)(C)C)C(C)(C)C)OC1=CC=C(C(C)(C)C)C=C1C(C)(C)C JKIJEFPNVSHHEI-UHFFFAOYSA-N 0.000 description 1
- 241001503951 Phoma Species 0.000 description 1
- 241001480007 Phomopsis Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000210649 Phyllosticta ampelicida Species 0.000 description 1
- 241001149949 Phytophthora cactorum Species 0.000 description 1
- 241000233622 Phytophthora infestans Species 0.000 description 1
- 231100000674 Phytotoxicity Toxicity 0.000 description 1
- 239000005818 Picoxystrobin Substances 0.000 description 1
- 241001503464 Plasmodiophora Species 0.000 description 1
- 241001503436 Plasmodiophora brassicae Species 0.000 description 1
- 241001503460 Plasmodiophorida Species 0.000 description 1
- 241000233626 Plasmopara Species 0.000 description 1
- 241001281803 Plasmopara viticola Species 0.000 description 1
- 241000222350 Pleurotus Species 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 241000896242 Podosphaera Species 0.000 description 1
- 241000317981 Podosphaera fuliginea Species 0.000 description 1
- 241001337928 Podosphaera leucotricha Species 0.000 description 1
- 241000222640 Polyporus Species 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000005820 Prochloraz Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 239000005821 Propamocarb Substances 0.000 description 1
- MKIMSXGUTQTKJU-UHFFFAOYSA-N Propamocarb hydrochloride Chemical compound [Cl-].CCCOC(=O)NCCC[NH+](C)C MKIMSXGUTQTKJU-UHFFFAOYSA-N 0.000 description 1
- 239000005822 Propiconazole Substances 0.000 description 1
- 239000005823 Propineb Substances 0.000 description 1
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 1
- 239000005824 Proquinazid Substances 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 239000005825 Prothioconazole Substances 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000087479 Pseudocercospora fijiensis Species 0.000 description 1
- 241000947836 Pseudomonadaceae Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000521936 Pseudomonas amygdali pv. lachrymans Species 0.000 description 1
- 241001281802 Pseudoperonospora Species 0.000 description 1
- 241001281805 Pseudoperonospora cubensis Species 0.000 description 1
- 241000342307 Pseudoperonospora humuli Species 0.000 description 1
- 241000221300 Puccinia Species 0.000 description 1
- 241000221301 Puccinia graminis Species 0.000 description 1
- 241001123569 Puccinia recondita Species 0.000 description 1
- 241001123583 Puccinia striiformis Species 0.000 description 1
- 239000005869 Pyraclostrobin Substances 0.000 description 1
- 241000228454 Pyrenophora graminea Species 0.000 description 1
- 241000520648 Pyrenophora teres Species 0.000 description 1
- 241000190117 Pyrenophora tritici-repentis Species 0.000 description 1
- 241000231139 Pyricularia Species 0.000 description 1
- 239000005828 Pyrimethanil Substances 0.000 description 1
- 239000005829 Pyriofenone Substances 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 239000005831 Quinoxyfen Substances 0.000 description 1
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 1
- 108091030071 RNAI Proteins 0.000 description 1
- 241000173767 Ramularia Species 0.000 description 1
- 241000173769 Ramularia collo-cygni Species 0.000 description 1
- 241000196686 Ramulariopsis gossypii Species 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241001633102 Rhizobiaceae Species 0.000 description 1
- 240000005384 Rhizopus oryzae Species 0.000 description 1
- 235000013752 Rhizopus oryzae Nutrition 0.000 description 1
- 241000235546 Rhizopus stolonifer Species 0.000 description 1
- 241001515786 Rhynchosporium Species 0.000 description 1
- 241001515790 Rhynchosporium secalis Species 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 241001107098 Rubiaceae Species 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000800293 Sarocladium Species 0.000 description 1
- 241000800294 Sarocladium oryzae Species 0.000 description 1
- 244000007853 Sarothamnus scoparius Species 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 241000221662 Sclerotinia Species 0.000 description 1
- 241000221696 Sclerotinia sclerotiorum Species 0.000 description 1
- 239000005834 Sedaxane Substances 0.000 description 1
- 239000004113 Sepiolite Substances 0.000 description 1
- 241001597359 Septoria apiicola Species 0.000 description 1
- 241001533580 Septoria lycopersici Species 0.000 description 1
- 241001599571 Serpula <basidiomycete> Species 0.000 description 1
- 239000005835 Silthiofam Substances 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 241001250060 Sphacelotheca Species 0.000 description 1
- 241000579741 Sphaerotheca <fungi> Species 0.000 description 1
- 241000011575 Spilocaea Species 0.000 description 1
- 239000005837 Spiroxamine Substances 0.000 description 1
- 241001250070 Sporisorium reilianum Species 0.000 description 1
- 241001279361 Stachybotrys Species 0.000 description 1
- 241000533281 Stagonospora Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000204060 Streptomycetaceae Species 0.000 description 1
- 241000907561 Sydowia polyspora Species 0.000 description 1
- 241001540751 Talaromyces ruber Species 0.000 description 1
- 241000228446 Taphrina Species 0.000 description 1
- 241000228448 Taphrina deformans Species 0.000 description 1
- 239000005839 Tebuconazole Substances 0.000 description 1
- 239000005840 Tetraconazole Substances 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 241000865903 Thielaviopsis Species 0.000 description 1
- 241000561282 Thielaviopsis basicola Species 0.000 description 1
- 239000005842 Thiophanate-methyl Substances 0.000 description 1
- 239000005843 Thiram Substances 0.000 description 1
- 241000722133 Tilletia Species 0.000 description 1
- 241000722093 Tilletia caries Species 0.000 description 1
- 241000722096 Tilletia controversa Species 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 239000005845 Tolclofos-methyl Substances 0.000 description 1
- 241000222355 Trametes versicolor Species 0.000 description 1
- 239000005846 Triadimenol Substances 0.000 description 1
- 241000223259 Trichoderma Species 0.000 description 1
- 241000223261 Trichoderma viride Species 0.000 description 1
- 241001114492 Trichurus Species 0.000 description 1
- 239000005857 Trifloxystrobin Substances 0.000 description 1
- 239000005859 Triticonazole Substances 0.000 description 1
- 241001646063 Tyromyces Species 0.000 description 1
- 241000510929 Uncinula Species 0.000 description 1
- 241001154828 Urocystis <tapeworm> Species 0.000 description 1
- 241000157667 Urocystis occulta Species 0.000 description 1
- 241000221576 Uromyces Species 0.000 description 1
- 241000221577 Uromyces appendiculatus Species 0.000 description 1
- 241000221561 Ustilaginales Species 0.000 description 1
- 241000221566 Ustilago Species 0.000 description 1
- 241000007070 Ustilago nuda Species 0.000 description 1
- 239000005860 Valifenalate Substances 0.000 description 1
- 241000905623 Venturia oleaginea Species 0.000 description 1
- 241000082085 Verticillium <Phyllachorales> Species 0.000 description 1
- 241001123668 Verticillium dahliae Species 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical class ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 241000726445 Viroids Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 241000589634 Xanthomonas Species 0.000 description 1
- 241001272684 Xanthomonas campestris pv. oryzae Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000005870 Ziram Substances 0.000 description 1
- 239000005863 Zoxamide Substances 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- YULOYAUMWFHYQS-UHFFFAOYSA-N [2-[(4-chlorophenyl)-dimethylsilyl]phenyl]methanol Chemical compound C=1C=CC=C(CO)C=1[Si](C)(C)C1=CC=C(Cl)C=C1 YULOYAUMWFHYQS-UHFFFAOYSA-N 0.000 description 1
- PUJLFJFEGJTJDJ-UHFFFAOYSA-N [2-fluoro-6-(1,5-naphthyridin-4-yloxy)phenyl]-trimethylsilane Chemical compound FC=1C(=C(OC2=CC=NC3=CC=CN=C23)C=CC=1)[Si](C)(C)C PUJLFJFEGJTJDJ-UHFFFAOYSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- UELITFHSCLAHKR-UHFFFAOYSA-N acibenzolar-S-methyl Chemical group CSC(=O)C1=CC=CC2=C1SN=N2 UELITFHSCLAHKR-UHFFFAOYSA-N 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000005409 aflatoxin Substances 0.000 description 1
- 230000009418 agronomic effect Effects 0.000 description 1
- 238000004378 air conditioning Methods 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- HFVAFDPGUJEFBQ-UHFFFAOYSA-M alizarin red S Chemical compound [Na+].O=C1C2=CC=CC=C2C(=O)C2=C1C=C(S([O-])(=O)=O)C(O)=C2O HFVAFDPGUJEFBQ-UHFFFAOYSA-M 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910000318 alkali metal phosphate Inorganic materials 0.000 description 1
- 229910000316 alkaline earth metal phosphate Inorganic materials 0.000 description 1
- 150000004996 alkyl benzenes Chemical class 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 239000011717 all-trans-retinol Substances 0.000 description 1
- 235000019169 all-trans-retinol Nutrition 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 1
- GGKQIOFASHYUJZ-UHFFFAOYSA-N ametoctradin Chemical compound NC1=C(CCCCCCCC)C(CC)=NC2=NC=NN21 GGKQIOFASHYUJZ-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- BREATYVWRHIPIY-UHFFFAOYSA-N amisulbrom Chemical compound CN(C)S(=O)(=O)N1C=NC(S(=O)(=O)N2C3=CC(F)=CC=C3C(Br)=C2C)=N1 BREATYVWRHIPIY-UHFFFAOYSA-N 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- LDDQLRUQCUTJBB-UHFFFAOYSA-N ammonium fluoride Chemical class [NH4+].[F-] LDDQLRUQCUTJBB-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000000433 anti-nutritional effect Effects 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 239000002519 antifouling agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000012300 argon atmosphere Substances 0.000 description 1
- 238000000065 atmospheric pressure chemical ionisation Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229960000892 attapulgite Drugs 0.000 description 1
- WFDXOXNFNRHQEC-GHRIWEEISA-N azoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1OC1=CC(OC=2C(=CC=CC=2)C#N)=NC=N1 WFDXOXNFNRHQEC-GHRIWEEISA-N 0.000 description 1
- GYSCAQFHASJXRS-FFCOJMSVSA-N beauvericin Chemical compound C([C@H]1C(=O)O[C@@H](C(N(C)[C@@H](CC=2C=CC=CC=2)C(=O)O[C@@H](C(=O)N(C)[C@@H](CC=2C=CC=CC=2)C(=O)O[C@@H](C(=O)N1C)C(C)C)C(C)C)=O)C(C)C)C1=CC=CC=C1 GYSCAQFHASJXRS-FFCOJMSVSA-N 0.000 description 1
- GYSCAQFHASJXRS-UHFFFAOYSA-N beauvericin Natural products CN1C(=O)C(C(C)C)OC(=O)C(CC=2C=CC=CC=2)N(C)C(=O)C(C(C)C)OC(=O)C(CC=2C=CC=CC=2)N(C)C(=O)C(C(C)C)OC(=O)C1CC1=CC=CC=C1 GYSCAQFHASJXRS-UHFFFAOYSA-N 0.000 description 1
- 108010079684 beauvericin Proteins 0.000 description 1
- VVSLYIKSEBPRSN-PELKAZGASA-N benthiavalicarb Chemical compound C1=C(F)C=C2SC([C@@H](C)NC(=O)[C@@H](NC(O)=O)C(C)C)=NC2=C1 VVSLYIKSEBPRSN-PELKAZGASA-N 0.000 description 1
- MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical group C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 description 1
- 238000010352 biotechnological method Methods 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- NYENCOMLZDQKNH-UHFFFAOYSA-K bis(trifluoromethylsulfonyloxy)bismuthanyl trifluoromethanesulfonate Chemical compound [Bi+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F NYENCOMLZDQKNH-UHFFFAOYSA-K 0.000 description 1
- OIPMQULDKWSNGX-UHFFFAOYSA-N bis[[ethoxy(oxo)phosphaniumyl]oxy]alumanyloxy-ethoxy-oxophosphanium Chemical compound [Al+3].CCO[P+]([O-])=O.CCO[P+]([O-])=O.CCO[P+]([O-])=O OIPMQULDKWSNGX-UHFFFAOYSA-N 0.000 description 1
- LDLMOOXUCMHBMZ-UHFFFAOYSA-N bixafen Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=C(F)C=C1C1=CC=C(Cl)C(Cl)=C1 LDLMOOXUCMHBMZ-UHFFFAOYSA-N 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 229940118790 boscalid Drugs 0.000 description 1
- WYEMLYFITZORAB-UHFFFAOYSA-N boscalid Chemical compound C1=CC(Cl)=CC=C1C1=CC=CC=C1NC(=O)C1=CC=CN=C1Cl WYEMLYFITZORAB-UHFFFAOYSA-N 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- JHRWWRDRBPCWTF-OLQVQODUSA-N captafol Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)C(Cl)Cl)C(=O)[C@H]21 JHRWWRDRBPCWTF-OLQVQODUSA-N 0.000 description 1
- 229940117949 captan Drugs 0.000 description 1
- 239000006013 carbendazim Substances 0.000 description 1
- JNPZQRQPIHJYNM-UHFFFAOYSA-N carbendazim Chemical compound C1=C[CH]C2=NC(NC(=O)OC)=NC2=C1 JNPZQRQPIHJYNM-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- GYSSRZJIHXQEHQ-UHFFFAOYSA-N carboxin Chemical compound S1CCOC(C)=C1C(=O)NC1=CC=CC=C1 GYSSRZJIHXQEHQ-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 150000001793 charged compounds Chemical class 0.000 description 1
- ALLOLPOYFRLCCX-UHFFFAOYSA-N chembl1986529 Chemical compound COC1=CC=CC=C1N=NC1=C(O)C=CC2=CC=CC=C12 ALLOLPOYFRLCCX-UHFFFAOYSA-N 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- HKMOPYJWSFRURD-UHFFFAOYSA-N chloro hypochlorite;copper Chemical compound [Cu].ClOCl HKMOPYJWSFRURD-UHFFFAOYSA-N 0.000 description 1
- IPAIXTZQWAGRPZ-UHFFFAOYSA-N chloro-methyl-phenylsilicon Chemical compound C[Si](Cl)C1=CC=CC=C1 IPAIXTZQWAGRPZ-UHFFFAOYSA-N 0.000 description 1
- BULLHNJGPPOUOX-UHFFFAOYSA-N chloroacetone Chemical compound CC(=O)CCl BULLHNJGPPOUOX-UHFFFAOYSA-N 0.000 description 1
- 150000008422 chlorobenzenes Chemical class 0.000 description 1
- CRQQGFGUEAVUIL-UHFFFAOYSA-N chlorothalonil Chemical compound ClC1=C(Cl)C(C#N)=C(Cl)C(C#N)=C1Cl CRQQGFGUEAVUIL-UHFFFAOYSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000008199 coating composition Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000000498 cooling water Substances 0.000 description 1
- 150000004699 copper complex Chemical class 0.000 description 1
- 229910001956 copper hydroxide Inorganic materials 0.000 description 1
- 229940120693 copper naphthenate Drugs 0.000 description 1
- 229910000431 copper oxide Inorganic materials 0.000 description 1
- RFKZUAOAYVHBOY-UHFFFAOYSA-M copper(1+);acetate Chemical compound [Cu+].CC([O-])=O RFKZUAOAYVHBOY-UHFFFAOYSA-M 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 1
- SFJMFSWCBVEHBA-UHFFFAOYSA-M copper(i)-thiophene-2-carboxylate Chemical compound [Cu+].[O-]C(=O)C1=CC=CS1 SFJMFSWCBVEHBA-UHFFFAOYSA-M 0.000 description 1
- SBTSVTLGWRLWOD-UHFFFAOYSA-L copper(ii) triflate Chemical compound [Cu+2].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F SBTSVTLGWRLWOD-UHFFFAOYSA-L 0.000 description 1
- LJNKLCWPWAPYME-UHFFFAOYSA-N copper;2,2,6,6-tetramethylheptane-3,5-dione Chemical compound [Cu].CC(C)(C)C(=O)CC(=O)C(C)(C)C.CC(C)(C)C(=O)CC(=O)C(C)(C)C LJNKLCWPWAPYME-UHFFFAOYSA-N 0.000 description 1
- SEVNKWFHTNVOLD-UHFFFAOYSA-L copper;3-(4-ethylcyclohexyl)propanoate;3-(3-ethylcyclopentyl)propanoate Chemical compound [Cu+2].CCC1CCC(CCC([O-])=O)C1.CCC1CCC(CCC([O-])=O)CC1 SEVNKWFHTNVOLD-UHFFFAOYSA-L 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- CWVRPJSBNHNJSI-XQNSMLJCSA-N coumoxystrobin Chemical compound C1=C2OC(=O)C(CCCC)=C(C)C2=CC=C1OCC1=CC=CC=C1\C(=C/OC)C(=O)OC CWVRPJSBNHNJSI-XQNSMLJCSA-N 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- YXKMMRDKEKCERS-UHFFFAOYSA-N cyazofamid Chemical compound CN(C)S(=O)(=O)N1C(C#N)=NC(Cl)=C1C1=CC=C(C)C=C1 YXKMMRDKEKCERS-UHFFFAOYSA-N 0.000 description 1
- PHQKZMYRTMPOBK-UHFFFAOYSA-N cyclohexanone;4-methylpentan-2-one Chemical compound CC(C)CC(C)=O.O=C1CCCCC1 PHQKZMYRTMPOBK-UHFFFAOYSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- XCIXKGXIYUWCLL-UHFFFAOYSA-N cyclopentanol Chemical compound OC1CCCC1 XCIXKGXIYUWCLL-UHFFFAOYSA-N 0.000 description 1
- ACMXQHFNODYQAT-UHFFFAOYSA-N cyflufenamid Chemical compound FC1=CC=C(C(F)(F)F)C(C(NOCC2CC2)=NC(=O)CC=2C=CC=CC=2)=C1F ACMXQHFNODYQAT-UHFFFAOYSA-N 0.000 description 1
- HAORKNGNJCEJBX-UHFFFAOYSA-N cyprodinil Chemical compound N=1C(C)=CC(C2CC2)=NC=1NC1=CC=CC=C1 HAORKNGNJCEJBX-UHFFFAOYSA-N 0.000 description 1
- OAWUUPVZMNKZRY-UHFFFAOYSA-N cyprosulfamide Chemical compound COC1=CC=CC=C1C(=O)NS(=O)(=O)C1=CC=C(C(=O)NC2CC2)C=C1 OAWUUPVZMNKZRY-UHFFFAOYSA-N 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000023753 dehiscence Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical compound C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 1
- BOUYBUIVMHNXQB-UHFFFAOYSA-N dicyclohexyl(2-dicyclohexylphosphanylethyl)phosphane Chemical compound C1CCCCC1P(C1CCCCC1)CCP(C1CCCCC1)C1CCCCC1 BOUYBUIVMHNXQB-UHFFFAOYSA-N 0.000 description 1
- WNZGLXFLSFWPMP-UHFFFAOYSA-N dicyclohexyl(4-dicyclohexylphosphanylbutyl)phosphane Chemical compound C1CCCCC1P(C1CCCCC1)CCCCP(C1CCCCC1)C1CCCCC1 WNZGLXFLSFWPMP-UHFFFAOYSA-N 0.000 description 1
- DPOGTJDEMBEUSH-UHFFFAOYSA-N dicyclohexyl(ethyl)phosphane Chemical compound C1CCCCC1P(CC)C1CCCCC1 DPOGTJDEMBEUSH-UHFFFAOYSA-N 0.000 description 1
- LCSNDSFWVKMJCT-UHFFFAOYSA-N dicyclohexyl-(2-phenylphenyl)phosphane Chemical group C1CCCCC1P(C=1C(=CC=CC=1)C=1C=CC=CC=1)C1CCCCC1 LCSNDSFWVKMJCT-UHFFFAOYSA-N 0.000 description 1
- YKPNDMFDKUEKIH-UHFFFAOYSA-N dicyclohexyl-[1-methoxy-2-(2-methoxyphenyl)cyclohexa-2,4-dien-1-yl]phosphane Chemical group COC1=CC=CC=C1C1=CC=CCC1(OC)P(C1CCCCC1)C1CCCCC1 YKPNDMFDKUEKIH-UHFFFAOYSA-N 0.000 description 1
- MXFYYFVVIIWKFE-UHFFFAOYSA-N dicyclohexyl-[2-[2,6-di(propan-2-yloxy)phenyl]phenyl]phosphane Chemical group CC(C)OC1=CC=CC(OC(C)C)=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 MXFYYFVVIIWKFE-UHFFFAOYSA-N 0.000 description 1
- LNJNFVJKDJYTEU-UHFFFAOYSA-N diethofencarb Chemical compound CCOC1=CC=C(NC(=O)OC(C)C)C=C1OCC LNJNFVJKDJYTEU-UHFFFAOYSA-N 0.000 description 1
- BQYJATMQXGBDHF-UHFFFAOYSA-N difenoconazole Chemical compound O1C(C)COC1(C=1C(=CC(OC=2C=CC(Cl)=CC=2)=CC=1)Cl)CN1N=CN=C1 BQYJATMQXGBDHF-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 108700003601 dimethylglycine Proteins 0.000 description 1
- WXUZAHCNPWONDH-DYTRJAOYSA-N dimoxystrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1COC1=CC(C)=CC=C1C WXUZAHCNPWONDH-DYTRJAOYSA-N 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- FPKXBFWMIYHCID-UHFFFAOYSA-N dipymetitrone Chemical compound S1C=2C(=O)N(C)C(=O)C=2SC2=C1C(=O)N(C)C2=O FPKXBFWMIYHCID-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- LZWLLMFYVGUUAL-UHFFFAOYSA-L ditert-butyl(cyclopenta-1,3-dien-1-yl)phosphane;dichloropalladium;iron(2+) Chemical compound [Fe+2].Cl[Pd]Cl.CC(C)(C)P(C(C)(C)C)C1=CC=C[CH-]1.CC(C)(C)P(C(C)(C)C)C1=CC=C[CH-]1 LZWLLMFYVGUUAL-UHFFFAOYSA-L 0.000 description 1
- SACNIGZYDTUHKB-UHFFFAOYSA-N ditert-butyl-[2-[2,4,6-tri(propan-2-yl)phenyl]phenyl]phosphane Chemical group CC(C)C1=CC(C(C)C)=CC(C(C)C)=C1C1=CC=CC=C1P(C(C)(C)C)C(C)(C)C SACNIGZYDTUHKB-UHFFFAOYSA-N 0.000 description 1
- PYZSVQVRHDXQSL-UHFFFAOYSA-N dithianon Chemical compound S1C(C#N)=C(C#N)SC2=C1C(=O)C1=CC=CC=C1C2=O PYZSVQVRHDXQSL-UHFFFAOYSA-N 0.000 description 1
- 239000010459 dolomite Substances 0.000 description 1
- 229910000514 dolomite Inorganic materials 0.000 description 1
- 230000002222 downregulating effect Effects 0.000 description 1
- 125000005610 enamide group Chemical group 0.000 description 1
- MIZMDSVSLSIMSC-OGLSAIDSSA-N enniatin Chemical compound CC(C)C1OC(=O)[C@H](C(C)C)N(C)C(=O)C(C(C)C)OC(=O)[C@H](C(C)C)N(C)C(=O)C(C(C)C)OC(=O)[C@H](C(C)C)N(C)C1=O MIZMDSVSLSIMSC-OGLSAIDSSA-N 0.000 description 1
- 229930191716 enniatin Natural products 0.000 description 1
- VMNULHCTRPXWFJ-UJSVPXBISA-N enoxastrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1CO\N=C(/C)\C=C\C1=CC=C(Cl)C=C1 VMNULHCTRPXWFJ-UJSVPXBISA-N 0.000 description 1
- 230000008686 ergosterol biosynthesis Effects 0.000 description 1
- 229960003133 ergot alkaloid Drugs 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 150000002194 fatty esters Chemical class 0.000 description 1
- LMVPQMGRYSRMIW-KRWDZBQOSA-N fenamidone Chemical compound O=C([C@@](C)(N=C1SC)C=2C=CC=CC=2)N1NC1=CC=CC=C1 LMVPQMGRYSRMIW-KRWDZBQOSA-N 0.000 description 1
- VDLGAVXLJYLFDH-UHFFFAOYSA-N fenhexamid Chemical compound C=1C=C(O)C(Cl)=C(Cl)C=1NC(=O)C1(C)CCCCC1 VDLGAVXLJYLFDH-UHFFFAOYSA-N 0.000 description 1
- UTOHZQYBSYOOGC-UHFFFAOYSA-N fenpyrazamine Chemical compound O=C1N(C(C)C)N(C(=O)SCC=C)C(N)=C1C1=CC=CC=C1C UTOHZQYBSYOOGC-UHFFFAOYSA-N 0.000 description 1
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical compound C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- UZCGKGPEKUCDTF-UHFFFAOYSA-N fluazinam Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=C(Cl)C([N+]([O-])=O)=C1NC1=NC=C(C(F)(F)F)C=C1Cl UZCGKGPEKUCDTF-UHFFFAOYSA-N 0.000 description 1
- XRECTZIEBJDKEO-UHFFFAOYSA-N flucytosine Chemical compound NC1=NC(=O)NC=C1F XRECTZIEBJDKEO-UHFFFAOYSA-N 0.000 description 1
- MUJOIMFVNIBMKC-UHFFFAOYSA-N fludioxonil Chemical compound C=12OC(F)(F)OC2=CC=CC=1C1=CNC=C1C#N MUJOIMFVNIBMKC-UHFFFAOYSA-N 0.000 description 1
- MBHXIQDIVCJZTD-RVDMUPIBSA-N flufenoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=C(C(F)(F)F)C=C1Cl MBHXIQDIVCJZTD-RVDMUPIBSA-N 0.000 description 1
- GBOYJIHYACSLGN-UHFFFAOYSA-N fluopicolide Chemical compound ClC1=CC(C(F)(F)F)=CN=C1CNC(=O)C1=C(Cl)C=CC=C1Cl GBOYJIHYACSLGN-UHFFFAOYSA-N 0.000 description 1
- KVDJTXBXMWJJEF-UHFFFAOYSA-N fluopyram Chemical compound ClC1=CC(C(F)(F)F)=CN=C1CCNC(=O)C1=CC=CC=C1C(F)(F)F KVDJTXBXMWJJEF-UHFFFAOYSA-N 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- UFEODZBUAFNAEU-NLRVBDNBSA-N fluoxastrobin Chemical compound C=1C=CC=C(OC=2C(=C(OC=3C(=CC=CC=3)Cl)N=CN=2)F)C=1C(=N/OC)\C1=NOCCO1 UFEODZBUAFNAEU-NLRVBDNBSA-N 0.000 description 1
- IJJVMEJXYNJXOJ-UHFFFAOYSA-N fluquinconazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1N1C(=O)C2=CC(F)=CC=C2N=C1N1C=NC=N1 IJJVMEJXYNJXOJ-UHFFFAOYSA-N 0.000 description 1
- KGXUEPOHGFWQKF-ZCXUNETKSA-N flutianil Chemical compound COC1=CC=CC=C1N(CCS\1)C/1=C(C#N)/SC1=CC(C(F)(F)F)=CC=C1F KGXUEPOHGFWQKF-ZCXUNETKSA-N 0.000 description 1
- PTCGDEVVHUXTMP-UHFFFAOYSA-N flutolanil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C(F)(F)F)=C1 PTCGDEVVHUXTMP-UHFFFAOYSA-N 0.000 description 1
- SXSGXWCSHSVPGB-UHFFFAOYSA-N fluxapyroxad Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=CC=C1C1=CC(F)=C(F)C(F)=C1 SXSGXWCSHSVPGB-UHFFFAOYSA-N 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- HKIOYBQGHSTUDB-UHFFFAOYSA-N folpet Chemical compound C1=CC=C2C(=O)N(SC(Cl)(Cl)Cl)C(=O)C2=C1 HKIOYBQGHSTUDB-UHFFFAOYSA-N 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003008 fumonisin Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 229930183235 fusarin Natural products 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 230000008570 general process Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 150000005826 halohydrocarbons Chemical class 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000003898 horticulture Methods 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- QTYCMDBMOLSEAM-UHFFFAOYSA-N ipconazole Chemical compound C1=NC=NN1CC1(O)C(C(C)C)CCC1CC1=CC=C(Cl)C=C1 QTYCMDBMOLSEAM-UHFFFAOYSA-N 0.000 description 1
- ONUFESLQCSAYKA-UHFFFAOYSA-N iprodione Chemical compound O=C1N(C(=O)NC(C)C)CC(=O)N1C1=CC(Cl)=CC(Cl)=C1 ONUFESLQCSAYKA-UHFFFAOYSA-N 0.000 description 1
- DCYOBGZUOMKFPA-UHFFFAOYSA-N iron(2+);iron(3+);octadecacyanide Chemical compound [Fe+2].[Fe+2].[Fe+2].[Fe+3].[Fe+3].[Fe+3].[Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] DCYOBGZUOMKFPA-UHFFFAOYSA-N 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- WMKZDPFZIZQROT-UHFFFAOYSA-N isofetamid Chemical compound CC1=CC(OC(C)C)=CC=C1C(=O)C(C)(C)NC(=O)C1=C(C)C=CS1 WMKZDPFZIZQROT-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- WLPCAERCXQSYLQ-UHFFFAOYSA-N isotianil Chemical compound ClC1=NSC(C(=O)NC=2C(=CC=CC=2)C#N)=C1Cl WLPCAERCXQSYLQ-UHFFFAOYSA-N 0.000 description 1
- PVTHJAPFENJVNC-MHRBZPPQSA-N kasugamycin Chemical compound N[C@H]1C[C@H](NC(=N)C(O)=O)[C@@H](C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O PVTHJAPFENJVNC-MHRBZPPQSA-N 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- ZOTBXTZVPHCKPN-HTXNQAPBSA-N kresoxim-methyl Chemical compound CO\N=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=CC=C1C ZOTBXTZVPHCKPN-HTXNQAPBSA-N 0.000 description 1
- 150000003951 lactams Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000004611 light stabiliser Substances 0.000 description 1
- 235000019357 lignosulphonate Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 1
- ANYSGBYRTLOUPO-UHFFFAOYSA-N lithium tetramethylpiperidide Chemical compound [Li]N1C(C)(C)CCCC1(C)C ANYSGBYRTLOUPO-UHFFFAOYSA-N 0.000 description 1
- CCZVEWRRAVASGL-UHFFFAOYSA-N lithium;2-methanidylpropane Chemical compound [Li+].CC(C)[CH2-] CCZVEWRRAVASGL-UHFFFAOYSA-N 0.000 description 1
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 1
- WGOPGODQLGJZGL-UHFFFAOYSA-N lithium;butane Chemical compound [Li+].CC[CH-]C WGOPGODQLGJZGL-UHFFFAOYSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- CCERQOYLJJULMD-UHFFFAOYSA-M magnesium;carbanide;chloride Chemical compound [CH3-].[Mg+2].[Cl-] CCERQOYLJJULMD-UHFFFAOYSA-M 0.000 description 1
- YCCXQARVHOPWFJ-UHFFFAOYSA-M magnesium;ethane;chloride Chemical compound [Mg+2].[Cl-].[CH2-]C YCCXQARVHOPWFJ-UHFFFAOYSA-M 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- YKSNLCVSTHTHJA-UHFFFAOYSA-L maneb Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S YKSNLCVSTHTHJA-UHFFFAOYSA-L 0.000 description 1
- 229920000940 maneb Polymers 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical class [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000004579 marble Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910001507 metal halide Inorganic materials 0.000 description 1
- 150000005309 metal halides Chemical class 0.000 description 1
- XWPZUHJBOLQNMN-UHFFFAOYSA-N metconazole Chemical compound C1=NC=NN1CC1(O)C(C)(C)CCC1CC1=CC=C(Cl)C=C1 XWPZUHJBOLQNMN-UHFFFAOYSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- ITYJDNHFRZSTJY-UHFFFAOYSA-N methanesulfonyl bromide Chemical compound CS(Br)(=O)=O ITYJDNHFRZSTJY-UHFFFAOYSA-N 0.000 description 1
- AGJSNMGHAVDLRQ-IWFBPKFRSA-N methyl (2s)-2-[[(2s)-2-[[(2s)-2-[[(2r)-2-amino-3-sulfanylpropanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxy-2,3-dimethylphenyl)propanoyl]amino]-4-methylsulfanylbutanoate Chemical compound SC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)OC)CC1=CC=C(O)C(C)=C1C AGJSNMGHAVDLRQ-IWFBPKFRSA-N 0.000 description 1
- ZQEIXNIJLIKNTD-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-(methoxyacetyl)alaninate Chemical compound COCC(=O)N(C(C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-UHFFFAOYSA-N 0.000 description 1
- CJPQIRJHIZUAQP-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-(phenylacetyl)alaninate Chemical compound CC=1C=CC=C(C)C=1N(C(C)C(=O)OC)C(=O)CC1=CC=CC=C1 CJPQIRJHIZUAQP-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229920000257 metiram Polymers 0.000 description 1
- HIIRDDUVRXCDBN-OBGWFSINSA-N metominostrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1OC1=CC=CC=C1 HIIRDDUVRXCDBN-OBGWFSINSA-N 0.000 description 1
- AMSPWOYQQAWRRM-UHFFFAOYSA-N metrafenone Chemical compound COC1=CC=C(Br)C(C)=C1C(=O)C1=C(C)C=C(OC)C(OC)=C1OC AMSPWOYQQAWRRM-UHFFFAOYSA-N 0.000 description 1
- 108091070501 miRNA Proteins 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 229940124561 microbicide Drugs 0.000 description 1
- 239000002855 microbicide agent Substances 0.000 description 1
- KCIRYJNISRMYFI-UHFFFAOYSA-N mildiomycin Natural products NC(CO)C(=O)NC1C=CC(OC1C(O)(CC(O)CNC(=N)N)C(=O)O)N2CN=C(N)C(=C2)CO KCIRYJNISRMYFI-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 239000011490 mineral wool Substances 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- KGPQKNJSZNXOPV-UHFFFAOYSA-N moniliformin Chemical compound OC1=CC(=O)C1=O KGPQKNJSZNXOPV-UHFFFAOYSA-N 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- DILRJUIACXKSQE-UHFFFAOYSA-N n',n'-dimethylethane-1,2-diamine Chemical compound CN(C)CCN DILRJUIACXKSQE-UHFFFAOYSA-N 0.000 description 1
- XFGGMWATACYBEU-UHFFFAOYSA-N n'-[4-[(4,5-dichloro-1,3-thiazol-2-yl)oxy]-2,5-dimethylphenyl]-n-ethyl-n-methylmethanimidamide Chemical compound C1=C(C)C(N=CN(C)CC)=CC(C)=C1OC1=NC(Cl)=C(Cl)S1 XFGGMWATACYBEU-UHFFFAOYSA-N 0.000 description 1
- FXLMOAQSXRPYGT-UHFFFAOYSA-N n'-[4-[3-(difluoromethoxy)phenyl]sulfanyl-2,5-dimethylphenyl]-n-ethyl-n-methylmethanimidamide Chemical compound C1=C(C)C(N=CN(C)CC)=CC(C)=C1SC1=CC=CC(OC(F)F)=C1 FXLMOAQSXRPYGT-UHFFFAOYSA-N 0.000 description 1
- KVKFRMCSXWQSNT-UHFFFAOYSA-N n,n'-dimethylethane-1,2-diamine Chemical compound CNCCNC KVKFRMCSXWQSNT-UHFFFAOYSA-N 0.000 description 1
- ZVYXEXAXXWINEH-UHFFFAOYSA-N n,n-diethyl-2-hydroxybenzamide Chemical compound CCN(CC)C(=O)C1=CC=CC=C1O ZVYXEXAXXWINEH-UHFFFAOYSA-N 0.000 description 1
- BLCKKNLGFULNRC-UHFFFAOYSA-L n,n-dimethylcarbamodithioate;nickel(2+) Chemical compound [Ni+2].CN(C)C([S-])=S.CN(C)C([S-])=S BLCKKNLGFULNRC-UHFFFAOYSA-L 0.000 description 1
- 229940078490 n,n-dimethylglycine Drugs 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- ODXGUKYYNHKQBC-UHFFFAOYSA-N n-(pyrrolidin-3-ylmethyl)cyclopropanamine Chemical compound C1CNCC1CNC1CC1 ODXGUKYYNHKQBC-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- QKSQEJXIILKPDX-UHFFFAOYSA-N n-cyclohexyl-1-phenylmethanimine Chemical compound C1CCCCC1N=CC1=CC=CC=C1 QKSQEJXIILKPDX-UHFFFAOYSA-N 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical class C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 239000004311 natamycin Substances 0.000 description 1
- 235000010298 natamycin Nutrition 0.000 description 1
- NCXMLFZGDNKEPB-FFPOYIOWSA-N natamycin Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C[C@@H](C)OC(=O)/C=C/[C@H]2O[C@@H]2C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 NCXMLFZGDNKEPB-FFPOYIOWSA-N 0.000 description 1
- 229960003255 natamycin Drugs 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229940042880 natural phospholipid Drugs 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- IYRGXJIJGHOCFS-UHFFFAOYSA-N neocuproine Chemical compound C1=C(C)N=C2C3=NC(C)=CC=C3C=CC2=C1 IYRGXJIJGHOCFS-UHFFFAOYSA-N 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229930183344 ochratoxin Natural products 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 235000010292 orthophenyl phenol Nutrition 0.000 description 1
- JHIPUJPTQJYEQK-ZLHHXESBSA-N orysastrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1CO\N=C(/C)\C(=N\OC)\C(\C)=N\OC JHIPUJPTQJYEQK-ZLHHXESBSA-N 0.000 description 1
- 230000008723 osmotic stress Effects 0.000 description 1
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 1
- 125000004043 oxo group Chemical group O=* 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
- 229960000625 oxytetracycline Drugs 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- PENAXHPKEVTBLF-UHFFFAOYSA-L palladium(2+);prop-1-ene;dichloride Chemical compound [Pd+]Cl.[Pd+]Cl.[CH2-]C=C.[CH2-]C=C PENAXHPKEVTBLF-UHFFFAOYSA-L 0.000 description 1
- LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 description 1
- 229910052625 palygorskite Inorganic materials 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- OGYFATSSENRIKG-UHFFFAOYSA-N pencycuron Chemical compound C1=CC(Cl)=CC=C1CN(C(=O)NC=1C=CC=CC=1)C1CCCC1 OGYFATSSENRIKG-UHFFFAOYSA-N 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000010451 perlite Substances 0.000 description 1
- 235000019362 perlite Nutrition 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- WRAQQYDMVSCOTE-UHFFFAOYSA-N phenyl prop-2-enoate Chemical compound C=CC(=O)OC1=CC=CC=C1 WRAQQYDMVSCOTE-UHFFFAOYSA-N 0.000 description 1
- NHKJPPKXDNZFBJ-UHFFFAOYSA-N phenyllithium Chemical compound [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- YXJYBPXSEKMEEJ-UHFFFAOYSA-N phosphoric acid;sulfuric acid Chemical compound OP(O)(O)=O.OS(O)(=O)=O YXJYBPXSEKMEEJ-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 239000001007 phthalocyanine dye Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000000885 phytotoxic effect Effects 0.000 description 1
- IBSNKSODLGJUMQ-SDNWHVSQSA-N picoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=CC(C(F)(F)F)=N1 IBSNKSODLGJUMQ-SDNWHVSQSA-N 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 230000008121 plant development Effects 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 230000037039 plant physiology Effects 0.000 description 1
- 230000004260 plant-type cell wall biogenesis Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000011120 plywood Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 229920001021 polysulfide Polymers 0.000 description 1
- 239000005077 polysulfide Substances 0.000 description 1
- 150000008117 polysulfides Polymers 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 230000032361 posttranscriptional gene silencing Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- DJEHXEMURTVAOE-UHFFFAOYSA-M potassium bisulfite Chemical compound [K+].OS([O-])=O DJEHXEMURTVAOE-UHFFFAOYSA-M 0.000 description 1
- 229940099427 potassium bisulfite Drugs 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- 235000010259 potassium hydrogen sulphite Nutrition 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- WHHIPMZEDGBUCC-UHFFFAOYSA-N probenazole Chemical compound C1=CC=C2C(OCC=C)=NS(=O)(=O)C2=C1 WHHIPMZEDGBUCC-UHFFFAOYSA-N 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- TVLSRXXIMLFWEO-UHFFFAOYSA-N prochloraz Chemical compound C1=CN=CN1C(=O)N(CCC)CCOC1=C(Cl)C=C(Cl)C=C1Cl TVLSRXXIMLFWEO-UHFFFAOYSA-N 0.000 description 1
- QXJKBPAVAHBARF-BETUJISGSA-N procymidone Chemical compound O=C([C@]1(C)C[C@@]1(C1=O)C)N1C1=CC(Cl)=CC(Cl)=C1 QXJKBPAVAHBARF-BETUJISGSA-N 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- WZZLDXDUQPOXNW-UHFFFAOYSA-N propamocarb Chemical compound CCCOC(=O)NCCCN(C)C WZZLDXDUQPOXNW-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- STJLVHWMYQXCPB-UHFFFAOYSA-N propiconazole Chemical compound O1C(CCC)COC1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 STJLVHWMYQXCPB-UHFFFAOYSA-N 0.000 description 1
- KKMLIVYBGSAJPM-UHFFFAOYSA-L propineb Chemical compound [Zn+2].[S-]C(=S)NC(C)CNC([S-])=S KKMLIVYBGSAJPM-UHFFFAOYSA-L 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- FLVBXVXXXMLMOX-UHFFFAOYSA-N proquinazid Chemical compound C1=C(I)C=C2C(=O)N(CCC)C(OCCC)=NC2=C1 FLVBXVXXXMLMOX-UHFFFAOYSA-N 0.000 description 1
- 235000019624 protein content Nutrition 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 229960003351 prussian blue Drugs 0.000 description 1
- 239000013225 prussian blue Substances 0.000 description 1
- 239000008262 pumice Substances 0.000 description 1
- HZRSNVGNWUDEFX-UHFFFAOYSA-N pyraclostrobin Chemical compound COC(=O)N(OC)C1=CC=CC=C1COC1=NN(C=2C=CC(Cl)=CC=2)C=C1 HZRSNVGNWUDEFX-UHFFFAOYSA-N 0.000 description 1
- DWTVBEZBWMDXIY-UHFFFAOYSA-N pyrametostrobin Chemical compound COC(=O)N(OC)C1=CC=CC=C1COC1=C(C)C(C=2C=CC=CC=2)=NN1C DWTVBEZBWMDXIY-UHFFFAOYSA-N 0.000 description 1
- URXNNPCNKVAQRA-XMHGGMMESA-N pyraoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC(C=2C=CC(Cl)=CC=2)=NN1C URXNNPCNKVAQRA-XMHGGMMESA-N 0.000 description 1
- KKEJMLAPZVXPOF-UHFFFAOYSA-N pyraziflumid Chemical compound C1=C(F)C(F)=CC=C1C1=CC=CC=C1NC(=O)C1=NC=CN=C1C(F)(F)F KKEJMLAPZVXPOF-UHFFFAOYSA-N 0.000 description 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
- ZDYVRSLAEXCVBX-UHFFFAOYSA-N pyridinium p-toluenesulfonate Chemical compound C1=CC=[NH+]C=C1.CC1=CC=C(S([O-])(=O)=O)C=C1 ZDYVRSLAEXCVBX-UHFFFAOYSA-N 0.000 description 1
- ZLIBICFPKPWGIZ-UHFFFAOYSA-N pyrimethanil Chemical compound CC1=CC(C)=NC(NC=2C=CC=CC=2)=N1 ZLIBICFPKPWGIZ-UHFFFAOYSA-N 0.000 description 1
- BAUQXSYUDSNRHL-UHFFFAOYSA-N pyrimorph Chemical compound C1=CC(C(C)(C)C)=CC=C1C(C=1C=NC(Cl)=CC=1)=CC(=O)N1CCOCC1 BAUQXSYUDSNRHL-UHFFFAOYSA-N 0.000 description 1
- NMVCBWZLCXANER-UHFFFAOYSA-N pyriofenone Chemical compound COC1=C(OC)C(OC)=CC(C)=C1C(=O)C1=C(C)C(Cl)=CN=C1OC NMVCBWZLCXANER-UHFFFAOYSA-N 0.000 description 1
- DHTJFQWHCVTNRY-OEMAIJDKSA-N pyrisoxazole Chemical compound C1([C@@]2(C)CC(ON2C)C=2C=CC(Cl)=CC=2)=CC=CN=C1 DHTJFQWHCVTNRY-OEMAIJDKSA-N 0.000 description 1
- WRHZVMBBRYBTKZ-UHFFFAOYSA-N pyrrole-2-carboxylic acid Chemical compound OC(=O)C1=CC=CN1 WRHZVMBBRYBTKZ-UHFFFAOYSA-N 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- UIQFAODJHJZOHK-UHFFFAOYSA-N quinolin-2-yl hydrogen sulfate Chemical compound C1=CC=CC2=NC(OS(=O)(=O)O)=CC=C21 UIQFAODJHJZOHK-UHFFFAOYSA-N 0.000 description 1
- YGDICLRMNDWZAK-UHFFFAOYSA-N quinolin-3-ylboronic acid Chemical compound C1=CC=CC2=CC(B(O)O)=CN=C21 YGDICLRMNDWZAK-UHFFFAOYSA-N 0.000 description 1
- FBQQHUGEACOBDN-UHFFFAOYSA-N quinomethionate Chemical compound N1=C2SC(=O)SC2=NC2=CC(C)=CC=C21 FBQQHUGEACOBDN-UHFFFAOYSA-N 0.000 description 1
- WRPIRSINYZBGPK-UHFFFAOYSA-N quinoxyfen Chemical compound C1=CC(F)=CC=C1OC1=CC=NC2=CC(Cl)=CC(Cl)=C12 WRPIRSINYZBGPK-UHFFFAOYSA-N 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 229940043267 rhodamine b Drugs 0.000 description 1
- 230000002786 root growth Effects 0.000 description 1
- ORIHZIZPTZTNCU-YVMONPNESA-N salicylaldoxime Chemical compound O\N=C/C1=CC=CC=C1O ORIHZIZPTZTNCU-YVMONPNESA-N 0.000 description 1
- HZXJVDYQRYYYOR-UHFFFAOYSA-K scandium(iii) trifluoromethanesulfonate Chemical compound [Sc+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F HZXJVDYQRYYYOR-UHFFFAOYSA-K 0.000 description 1
- 235000019355 sepiolite Nutrition 0.000 description 1
- 229910052624 sepiolite Inorganic materials 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 230000007330 shade avoidance Effects 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- MXMXHPPIGKYTAR-UHFFFAOYSA-N silthiofam Chemical compound CC=1SC([Si](C)(C)C)=C(C(=O)NCC=C)C=1C MXMXHPPIGKYTAR-UHFFFAOYSA-N 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- NTUROZDXWLPVHB-UHFFFAOYSA-M sodium;3-diphenylphosphanylbenzenesulfonate Chemical compound [Na+].[O-]S(=O)(=O)C1=CC=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 NTUROZDXWLPVHB-UHFFFAOYSA-M 0.000 description 1
- IYYIUOWKEMQYNV-UHFFFAOYSA-N sodium;ethoxy-oxido-oxophosphanium Chemical compound [Na+].CCO[P+]([O-])=O IYYIUOWKEMQYNV-UHFFFAOYSA-N 0.000 description 1
- 238000000935 solvent evaporation Methods 0.000 description 1
- SLRCCWJSBJZJBV-AJNGGQMLSA-N sparteine Chemical compound C1N2CCCC[C@H]2[C@@H]2CN3CCCC[C@H]3[C@H]1C2 SLRCCWJSBJZJBV-AJNGGQMLSA-N 0.000 description 1
- 229960001945 sparteine Drugs 0.000 description 1
- PUYXTUJWRLOUCW-UHFFFAOYSA-N spiroxamine Chemical compound O1C(CN(CC)CCC)COC11CCC(C(C)(C)C)CC1 PUYXTUJWRLOUCW-UHFFFAOYSA-N 0.000 description 1
- 230000004763 spore germination Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 125000005415 substituted alkoxy group Chemical group 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 125000003375 sulfoxide group Chemical group 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000004548 suspo-emulsion Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical class NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- LWLJEQHTPVPKSJ-UHFFFAOYSA-N tebufloquin Chemical compound C1=C(C(C)(C)C)C=C2C(OC(=O)C)=C(C)C(C)=NC2=C1F LWLJEQHTPVPKSJ-UHFFFAOYSA-N 0.000 description 1
- ROZUQUDEWZIBHV-UHFFFAOYSA-N tecloftalam Chemical compound OC(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C(=O)NC1=CC=CC(Cl)=C1Cl ROZUQUDEWZIBHV-UHFFFAOYSA-N 0.000 description 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
- ISIJQEHRDSCQIU-UHFFFAOYSA-N tert-butyl 2,7-diazaspiro[4.5]decane-7-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCCC11CNCC1 ISIJQEHRDSCQIU-UHFFFAOYSA-N 0.000 description 1
- URHWNXDZOULUHC-UHFFFAOYSA-N tert-butyl n-[6-[[[(1-methyltetrazol-5-yl)-phenylmethylidene]amino]oxymethyl]pyridin-2-yl]carbamate Chemical compound CN1N=NN=C1C(C=1C=CC=CC=1)=NOCC1=CC=CC(NC(=O)OC(C)(C)C)=N1 URHWNXDZOULUHC-UHFFFAOYSA-N 0.000 description 1
- IOGXOCVLYRDXLW-UHFFFAOYSA-N tert-butyl nitrite Chemical compound CC(C)(C)ON=O IOGXOCVLYRDXLW-UHFFFAOYSA-N 0.000 description 1
- 239000012414 tert-butyl nitrite Substances 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000004308 thiabendazole Substances 0.000 description 1
- 235000010296 thiabendazole Nutrition 0.000 description 1
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 1
- 229960004546 thiabendazole Drugs 0.000 description 1
- QGHREAKMXXNCOA-UHFFFAOYSA-N thiophanate-methyl Chemical group COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC QGHREAKMXXNCOA-UHFFFAOYSA-N 0.000 description 1
- 229960002447 thiram Drugs 0.000 description 1
- KUAZQDVKQLNFPE-UHFFFAOYSA-N thiram Chemical compound CN(C)C(=S)SSC(=S)N(C)C KUAZQDVKQLNFPE-UHFFFAOYSA-N 0.000 description 1
- 230000009974 thixotropic effect Effects 0.000 description 1
- VJQYLJSMBWXGDV-UHFFFAOYSA-N tiadinil Chemical compound N1=NSC(C(=O)NC=2C=C(Cl)C(C)=CC=2)=C1C VJQYLJSMBWXGDV-UHFFFAOYSA-N 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 1
- OBZIQQJJIKNWNO-UHFFFAOYSA-N tolclofos-methyl Chemical compound COP(=S)(OC)OC1=C(Cl)C=C(C)C=C1Cl OBZIQQJJIKNWNO-UHFFFAOYSA-N 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- MBMQEIFVQACCCH-UHFFFAOYSA-N trans-Zearalenon Natural products O=C1OC(C)CCCC(=O)CCCC=CC2=CC(O)=CC(O)=C21 MBMQEIFVQACCCH-UHFFFAOYSA-N 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- BAZVSMNPJJMILC-UHFFFAOYSA-N triadimenol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)OC1=CC=C(Cl)C=C1 BAZVSMNPJJMILC-UHFFFAOYSA-N 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- DQJCHOQLCLEDLL-UHFFFAOYSA-N tricyclazole Chemical compound CC1=CC=CC2=C1N1C=NN=C1S2 DQJCHOQLCLEDLL-UHFFFAOYSA-N 0.000 description 1
- WLPUWLXVBWGYMZ-UHFFFAOYSA-N tricyclohexylphosphine Chemical compound C1CCCCC1P(C1CCCCC1)C1CCCCC1 WLPUWLXVBWGYMZ-UHFFFAOYSA-N 0.000 description 1
- RXJKFRMDXUJTEX-UHFFFAOYSA-N triethylphosphine Chemical compound CCP(CC)CC RXJKFRMDXUJTEX-UHFFFAOYSA-N 0.000 description 1
- 150000008648 triflates Chemical class 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- ONCZDRURRATYFI-TVJDWZFNSA-N trifloxystrobin Chemical compound CO\N=C(\C(=O)OC)C1=CC=CC=C1CO\N=C(/C)C1=CC=CC(C(F)(F)F)=C1 ONCZDRURRATYFI-TVJDWZFNSA-N 0.000 description 1
- AHZJKOKFZJYCLG-UHFFFAOYSA-K trifluoromethanesulfonate;ytterbium(3+) Chemical compound [Yb+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F AHZJKOKFZJYCLG-UHFFFAOYSA-K 0.000 description 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- QXJQHYBHAIHNGG-UHFFFAOYSA-N trimethylolethane Chemical compound OCC(C)(CO)CO QXJQHYBHAIHNGG-UHFFFAOYSA-N 0.000 description 1
- 229910000404 tripotassium phosphate Inorganic materials 0.000 description 1
- 235000019798 tripotassium phosphate Nutrition 0.000 description 1
- IERBVBGUKBHALB-UHFFFAOYSA-K tripotassium;phosphate;dihydrate Chemical compound O.O.[K+].[K+].[K+].[O-]P([O-])([O-])=O IERBVBGUKBHALB-UHFFFAOYSA-K 0.000 description 1
- IIOSDXGZLBPOHD-UHFFFAOYSA-N tris(2-methoxyphenyl)phosphane Chemical compound COC1=CC=CC=C1P(C=1C(=CC=CC=1)OC)C1=CC=CC=C1OC IIOSDXGZLBPOHD-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- DBXFMOWZRXXBRN-LWKPJOBUSA-N valifenalate Chemical compound CC(C)OC(=O)N[C@@H](C(C)C)C(=O)NC(CC(=O)OC)C1=CC=C(Cl)C=C1 DBXFMOWZRXXBRN-LWKPJOBUSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- AMHNZOICSMBGDH-UHFFFAOYSA-L zineb Chemical compound [Zn+2].[S-]C(=S)NCCNC([S-])=S AMHNZOICSMBGDH-UHFFFAOYSA-L 0.000 description 1
- DUBNHZYBDBBJHD-UHFFFAOYSA-L ziram Chemical compound [Zn+2].CN(C)C([S-])=S.CN(C)C([S-])=S DUBNHZYBDBBJHD-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/18—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/42—Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
- C07F7/0816—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring comprising Si as a ring atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
Abstract
The present disclosure relates to fungicidal trisubstitutedsilylphenoxyheterocycle compounds, of formula (I) and analogues thereof, processes and, intermediates for their preparation and use thereof as fungicidal compound, particularly in the form of fungicide compositions. The present disclosure also relates to methods for the control of phytopathogenic fungi of plants using these compounds or compositions comprising thereof. so relates to methods for the control of phytopathogenic fungi of plants using these compounds or compositions comprising thereof.
Description
TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES TECHNICAL FIELD The present disclosure relates to fungicidal active compounds, more specifically to trisubstitutedsilylphenoxyheterocycles and analogues thereof, processes and intermediates for their preparation and use thereof as fungicidal active compound, particularly in the form of fungicide compositions. The present disclosure also relates to methods for the control of phytopathogenic fungi of plants using these compounds or compositions comprising thereof.
BACKGROUND In Japanese patent application JP-2014/124411 and in international patent application , certain phenoxyquinolines are generically embraced in a broad disclosure of numerous compounds of the following formula: wherein D and E represent a 5- to 7-membered ring, X represents O, NH or N-C1-C8-alkyl, B (or Y) represents C or N, and R represents among various groups, an optionally substituted alkoxy group, an optionally disubstituted amino group, an optionally substituted and optionally oxidized alkylsulfanyl group, or a nitro group. However, JP-2014/124411 and WO2013/002205 do not disclose nor suggest providing compounds wherein R represents a substituted silylated group.
In Japanese patent application JP-2014/166991 certain phenoxyquinolines are generically embraced in a broad disclosure of numerous compounds of the following formula: wherein A represents a 5- to 7-membered ring, D represents a 5- to 7-membered hydrocarbon or heterocycle ring, X represents O, S, NH or N-C -C -alkyl, Z and B independently represent C or N, and R represents among various groups, an optionally substituted alkyl group such as a trisubstitutedsilylalkyl group, an optionally substituted ketone group, an optionally substituted C6-C10-aryl group, an optionally substituted C2-C8-alkynyl group, or a cyano group. However, JP-2014/166991 does not disclose nor suggest providing compounds wherein R represents a substituted silylated group.
In international patent application certain phenoxyquinolines are generically embraced in a broad disclosure of numerous compounds of the following formula: wherein A and D represent a 5- to 7-membered hydrocarbon or heterocycle ring, X represents O, S, S(O), S(O)2, an optionally substituted C, or an optionally substituted N, Y and Z independently represent C or N, and R represents an optionally substituted alkyl group, an optionally substituted C C -aryl group, or a 6- 10 cyano group. However, does not disclose nor suggest providing compounds wherein R represents a substituted silylated group.
In international patent application certain phenoxyquinolines are generically embraced in a broad disclosure of numerous compounds of the following formula: 1 2 3 4 wherein D represents a 5- to 7-membered ring, A , A , A and A independently represent C or N provided at least one of A is N, and R represents an optionally substituted alkyl group or a cyano group.
However, does not disclose nor suggest providing compounds wherein R represents a substituted silylated group.
In international patent application certain phenoxyquinolines are generically embraced in a broad disclosure of numerous compounds of the following formula: wherein D and E represent a 5- to 7-membered hydrocarbon or heterocycle ring, X represents O, S, C(O) or CH(OH), B represents C or N, and Cy represents an optionally substituted oxiranyl, or an optionally substituted 5- or 6-membered heterocyclyl group. However, does not disclose nor suggest providing compounds wherein Cy represents a substituted silylated cycle.
In European patent application EP 0326330 certain phenoxyquinolines are generically embraced in a broad disclosure of numerous compounds of the following formula: R Z A 5 6 6 wherein X and Y can represent CR and R represents H, Cl or Br, Z can represent O, NR and R can represent various substituents among which an hydrogen or an alkyl group, and A can represent various groups among which an ortho-trisubstitutedsilylphenyl group. However, EP 0326330 does not disclose nor suggest providing compounds wherein the ortho-trisubstitutedsilylphenoxy –Z-A group is attached in the 3- position of the quinoline moiety.
In European patent application EP 0410762 certain phenoxyquinolines are generically embraced in a broad disclosure of numerous compounds of the following formula: 1 1 2 wherein one of the A, B, E or D is N and the others are CR , R and R are independently a hydrogen or a 3 4 5 halogen atom, X can represent O, NR or CR R , Y can be a direct bond, and Z can represent various groups among which an ortho-trisubstitutedsilylphenyl group. However, EP 0410762 does not disclose nor suggest providing compounds wherein the ortho-trisubstitutedsilylphenoxy –X-Y-Z group is attached in the 3- position of the naphthyridine moiety.
Nowadays, environmental and economic demands are continuously increasing with regard for instance to the spectrum of action, toxicity, selectivity, application rate, formation of residues, and preparation processes of fungicides. Some pathogens have also been found to develop resistance to used fungicides.
Therefore, in agriculture, there is a continuous need to provide new fungicide compounds that may answer these environmental and economic requirements and/or alleviate the problems associated with pathogens resistance.
SUMMARY OF THE INVENTION The present invention provides a compound of formula (I) wherein • A represents a partially saturated or unsaturated fused bicyclic 9-, 10- or 11-membered heterocyclyl ring comprising at least 1 nitrogen atom and from 0 to 4 more heteroatoms independently selected in the list consisting of N, O and S ; • Z is selected from the group consisting of hydrogen atom, halogen atom, unsubstituted or substituted C -C -alkyl, C -C -halogenoalkyl comprising up to 9 halogen atoms that can be the 1 8 1 8 same or different, unsubstituted or substituted C2-C8-alkenyl, C2-C8-halogenoalkenyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C2-C8- alkynyl, C -C -halogenoalkynyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C -C -cycloalkyl, unsubstituted or substituted C -C - 3 7 4 7 cycloalkenyl, hydroxyl, unsubstituted or substituted C1-C8-alkoxy, C1-C8-halogenoalkoxy comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted aryl, unsubstituted or substituted heterocyclyl, formyl, unsubstituted or substituted C1-C8- alkylcarbonyl, unsubstituted or substituted (hydroxyimino)C -C -alkyl, unsubstituted or substituted (C -C -alkoxyimino)C -C -alkyl, carboxyl, unsubstituted or substituted C -C -alkoxycarbonyl, 1 8 1 8 1 8 carbamoyl, unsubstituted or substituted C1-C8-alkylcarbamoyl, unsubstituted or substituted di-C1- C8-alkylcarbamoyl, amino, unsubstituted or substituted C1-C8-alkylamino, unsubstituted or substituted di-C -C -alkylamino, sulfanyl, unsubstituted or substituted C -C -alkylsulfanyl, 1 8 1 8 unsubstituted or substituted C -C -alkylsulfinyl, unsubstituted or substituted C -C -alkylsulfonyl, 1 8 1 8 unsubstituted or substituted C1-C6-trialkylsilyl, cyano and nitro ; • n represents 0, 1, 2, 3 or 4 ; • p represents 0, 1, 2, 3, 4 or 5 ; 4 5 6 • L represents O, S, SO, SO , CR R or NR wherein o R and R are independently selected from the group consisting of hydrogen atom, halogen atom, hydroxyl, unsubstituted or substituted C1-C8-alkoxy and unsubstituted or substituted C -C alkyl, or they may form together with the carbon atom to which they are linked a carbonyl group ; o R is selected from the group consisting of hydrogen atom, substituted or non- substituted C1-C8-alkyl, C1-C8-halogenoalkyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C2-C8-alkenyl, C2-C8- halogenoalkenyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C3-C8-alkynyl, C3-C8-halogenoalkynyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C3-C7- cycloalkyl, C -C -halogenocycloalkyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C -C -cycloalkyl-C -C -alkyl, 3 7 1 8 formyl, unsubstituted or substituted C -C -alkylcarbonyl, C -C -halogenoalkylcarbonyl 1 8 1 8 comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C1-C8-alkoxycarbonyl, C1-C8-halogenoalkoxycarbonyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C -C - alkylsulfonyl, C -C -halogenoalkylsulfonyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted aryl-C -C -alkyl and unsubstituted or substituted phenylsulfonyl ; • X is independently selected from the group consisting of halogen atom, unsubstituted or substituted C -C -alkyl, C -C -halogenoalkyl comprising up to 9 halogen atoms that can be the 1 8 1 8 same or different, unsubstituted or substituted C2-C8-alkenyl, C2-C8-halogenoalkenyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C2-C8- alkynyl, C2-C8-halogenoalkynyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C -C -cycloalkyl, unsubstituted or substituted C -C - 3 7 4 7 cycloalkenyl, hydroxyl, unsubstituted or substituted C1-C8-alkoxy, C1-C8-halogenoalkoxy comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted aryl, unsubstituted or substituted heterocyclyl, formyl, unsubstituted or substituted C1-C8- alkylcarbonyl, unsubstituted or substituted (hydroxyimino)C -C -alkyl, unsubstituted or substituted (C -C -alkoxyimino)C -C -alkyl, carboxyl, unsubstituted or substituted C -C -alkoxycarbonyl, 1 8 1 8 1 8 carbamoyl, unsubstituted or substituted C1-C8-alkylcarbamoyl, unsubstituted or substituted di-C1- C8-alkylcarbamoyl, amino, unsubstituted or substituted C1-C8-alkylamino, unsubstituted or substituted di-C1-C8-alkylamino, sulfanyl, unsubstituted or substituted C1-C8-alkylsulfanyl, unsubstituted or substituted C -C -alkylsulfinyl, unsubstituted or substituted C -C -alkylsulfonyl, 1 8 1 8 unsubstituted or substituted C -C -trialkylsilyl, cyano, nitro, hydroxymethyl and (tetrahydro-2H- pyranyloxy)methyl ; • Y is independently selected from the group consisting of halogen atom, unsubstituted or substituted C -C -alkyl, C -C -halogenoalkyl comprising up to 9 halogen atoms that can be the 1 8 1 8 same or different, unsubstituted or substituted C2-C8-alkenyl, C2-C8-halogenoalkenyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C2-C8- alkynyl, C2-C8-halogenoalkynyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C -C -cycloalkyl, unsubstituted or substituted C -C - 3 7 4 7 cycloalkenyl, hydroxyl, unsubstituted or substituted C -C -alkoxy, C -C -halogenoalkoxy 1 8 1 8 comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted aryl, unsubstituted or substituted heterocyclyl, formyl, unsubstituted or substituted C1-C8- alkylcarbonyl, unsubstituted or substituted (hydroxyimino)C1-C8-alkyl, unsubstituted or substituted (C -C -alkoxyimino)C -C -alkyl, carboxyl, unsubstituted or substituted C -C -alkoxycarbonyl, 1 8 1 8 1 8 40 carbamoyl, unsubstituted or substituted C1-C8-alkylcarbamoyl, unsubstituted or substituted di-C1- C8-alkylcarbamoyl, amino, unsubstituted or substituted C1-C8-alkylamino, unsubstituted or substituted di-C1-C8-alkylamino, sulfanyl, unsubstituted or substituted C1-C8-alkylsulfanyl, unsubstituted or substituted C1-C8-alkylsulfinyl, unsubstituted or substituted C1-C8-alkylsulfonyl, unsubstituted or substituted C -C -trialkylsilyl, cyano and nitro ; • R is selected from the group consisting of unsubstituted or substituted C1-C8-alkyl, unsubstituted or substituted C2-C8-alkenyl, unsubstituted or substituted C2-C8-alkynyl, unsubstituted or substituted C3-C7-cycloalkyl, unsubstituted or substituted C4-C7-cycloalkenyl, unsubstituted or substituted aryl and unsubstituted or substituted heterocyclyl ; • R is selected from the group consisting of hydroxyl, unsubstituted or substituted C1-C8-alkoxy, unsubstituted or substituted C1-C8-alkyl, unsubstituted or substituted C2-C8-alkenyl, unsubstituted or substituted C2-C8-alkynyl, unsubstituted or substituted C3-C7-cycloalkyl, unsubstituted or substituted C -C -cycloalkenyl, unsubstituted or substituted aryl and unsubstituted or substituted heterocyclyl ; • When R and R represent an unsubstituted or substituted C1-C8 alkyl or an unsubstituted or substituted C -C alkenyl, they can form, together with the silicon atom to which they are linked, an unsubstituted or substituted C -C -silacycloalkyl ring or an unsubstituted or substituted C -C - 3 8 4 8 silacycloalkenyl ring ; • R is selected from the group consisting of hydrogen atom, halogen atom, unsubstituted or substituted C -C -alkyl, C -C -halogenoalkyl comprising up to 9 halogen atoms that can be the 1 8 1 8 same or different, unsubstituted or substituted C -C -alkenyl, unsubstituted or substituted C -C - 2 8 2 8 alkynyl, unsubstituted or substituted C3-C7-cycloalkyl, unsubstituted or substituted C4-C7- cycloalkenyl, hydroxyl, unsubstituted or substituted C1-C8-alkoxy, unsubstituted or substituted aryl, unsubstituted or substituted aryl-C -C -alkyl, unsubstituted or substituted heterocyclyl, unsubstituted or substituted heterocyclyl-C -C -alkyl, unsubstituted or substituted hydroxy-C -C - 1 8 1 8 alkyl, unsubstituted or substituted C1-C8-alkoxy-C1-C8-alkyl, unsubstituted or substituted C1-C8- alkylcarbonyloxy-C1-C8-alkyl, unsubstituted or substituted aryloxy-C1-C8-alkyl, unsubstituted or substituted heterocyclyloxy-C1-C8-alkyl, unsubstituted or substituted amino-C1-C8-alkyl, unsubstituted or substituted C -C -alkylamino-C -C -alkyl, unsubstituted or substituted di-C -C - 1 8 1 8 1 8 alkylamino-C -C -alkyl, unsubstituted or substituted arylamino-C -C -alkyl, unsubstituted or 1 8 1 8 substituted di-arylamino-C1-C8-alkyl, unsubstituted or substituted heterocyclylamino-C1-C8-alkyl, unsubstituted or substituted C1-C8-alkylcarbonylamino-C1-C8-alkyl, unsubstituted or substituted C -C -alkoxycarbonylamino-C -C -alkyl, unsubstituted or substituted C -C -alkylsulfanyl-C -C - 1 8 1 8 1 8 1 8 alkyl, unsubstituted or substituted C -C -alkylsulfinyl-C -C -alkyl, unsubstituted or substituted C - 1 8 1 8 1 C8-alkylsulfonyl-C1-C8-alkyl and unsubstituted or substituted cyano-C1-C8-alkyl ; 3 1 2 3 • R and X, when said X is vicinal to SiR R R , may form, together with the silicon and carbon atoms to which they are respectively attached, an unsubstituted or substituted 5-, 6- or 7- membered, partially saturated, heterocycle ; • When R represents an unsubstituted or substituted C1-C8-alkoxy and R represents an unsubstituted or substituted C -C -alkoxy or an unsubstituted or substituted C -C alkyl, they can 1 8 1 8 form, together with the silicon atom to which they are linked an unsubstituted or substituted 5-, 6- 40 or 7-membered heterocycle ; as well as its salts, N-oxides, metal complexes, metalloid complexes and optically active isomers or geometric isomers.
The present invention also provides a composition comprising one or more compounds according to the invention and one or more acceptable carriers.
Further, the present invention provides a method for controlling unwanted phytopathogenic microorganisms which comprises the step of applying one or more compounds according to the invention or a composition according to the invention to the microorganisms and/or in their habitats.
Additionally, the present invention provides a process for preparing a compound according to the invention which comprises the step of : - reacting a halogenoaryl of formula (II) or one of its salts: (II) wherein A, L, n, p, X, Y and Z are as disclosed herein and U represents a chlorine atom, a bromine atom, an iodine atom, a mesyl group, a tosyl group or a triflyl group, with a disilyl derivative of formula (IIIa): (IIIa) 1 2 3 wherein R , R and R are as disclosed herein ; or - reacting a compound of formula (VI) or one of its salts: (VI) wherein A, L, n, p, X, Y and Z are as disclosed herein and M represents an alkali metal that can be complexed by 1 to 2 ligands or a halogenomagnesium that can be complexed by 1 to 2 ligands, with a silyl derivative of formula (IIIb) or a silyl derivative of formula (IIIc): (IIIb) (IIIc) 1 2 3 2 wherein R , R and R are as disclosed herein and U represents a chlorine atom, a bromine atom, an iodine atom or an unsubstituted or substituted C1-C6-alkoxy ; or - reacting a compound of formula (VIII) or one of its salts with a compound of formula (IX) : (VIII) (IX) (I) wherein L represents O, S or NR ; U represents a chlorine atom, a bromine atom, an iodine atom, a mesyl group, a tosyl group or a triflyl group ; 1a 2a R and R independently represent an unsubstituted or substituted C -C -alkyl, an unsubstituted or substituted C -C -alkenyl, an unsubstituted or substituted C -C -cycloalkyl, an unsubstituted or 2 8 3 7 substituted aryl or an unsubstituted or substituted heterocyclyl ; and R represents a hydrogen atom, an unsubstituted or substituted C1-C8-alkyl, a C1-C8- halogenoalkyl comprising up to 9 halogen atoms that can be the same or different, an unsubstituted or substituted C -C -alkenyl, an unsubstituted or substituted C -C -alkynyl, an unsubstituted or substituted 2 8 2 8 C3-C7-cycloalkyl, an unsubstituted or substituted C4-C7-cycloalkenyl, an unsubstituted or substituted aryl, an unsubstituted or substituted aryl-C1-C8-alkyl, an unsubstituted or substituted heterocyclyl, an unsubstituted or substituted heterocyclyl-C1-C8-alkyl, an unsubstituted or substituted hydroxy-C1-C8-alkyl, an unsubstituted or substituted C -C -alkoxy-C -C -alkyl, an unsubstituted or substituted C -C - 1 8 1 8 1 8 alkylcarbonyloxy-C -C -alkyl, an unsubstituted or substituted aryloxy-C -C -alkyl, an unsubstituted or 1 8 1 8 substituted heterocyclyloxy-C1-C8-alkyl, an unsubstituted or substituted amino-C1-C8-alkyl, an unsubstituted or substituted C1-C8-alkylamino-C1-C8-alkyl, an unsubstituted or substituted di-C1-C8- alkylamino-C1-C8-alkyl, an unsubstituted or substituted arylamino-C1-C8-alkyl, an unsubstituted or substituted di-arylamino-C -C -alkyl, an unsubstituted or substituted heterocyclylamino-C -C -alkyl, an 1 8 1 8 unsubstituted or substituted C -C -alkylcarbonylamino-C -C -alkyl, an unsubstituted or substituted C -C - 1 8 1 8 1 8 alkoxycarbonylamino-C1-C8-alkyl, an unsubstituted or substituted C1-C8-alkylsulfanyl-C1-C8-alkyl, an unsubstituted or substituted C1-C8-alkylsulfinyl-C1-C8-alkyl, an unsubstituted or substituted C1-C8- alkylsulfonyl-C -C -alkyl, or an unsubstituted or substituted cyano-C -C -alkyl ; and 1 8 1 8 A, n, p, X, Y, R and Z are as disclosed herein ; or - reacting a compound of formula (X) or one of its salts with a compound of formula (XI) : (X) (XI) (I) wherein L represents CR R ; R and R independently represent a hydrogen atom or an unsubstituted or substituted C -C alkyl ; U represents a bromine atom, a chlorine atom, an iodine atom, a mesyl group, a tosyl group or a triflyl group ; W represents a boronic acid, a boronic ester or a potassium trifluoroborate ; 1a 2a R and R independently represent an unsubstituted or substituted C -C -alkyl, an unsubstituted or substituted C2-C8-alkenyl, an unsubstituted or substituted C3-C7- cycloalkyl, an unsubstituted or substituted aryl or an unsubstituted or substituted heterocyclyl ; R represents a hydrogen atom, an unsubstituted or substituted C -C -alkyl, a C -C - 1 8 1 8 halogenoalkyl comprising up to 9 halogen atoms that can be the same or different, an unsubstituted or substituted C2-C8-alkenyl, an unsubstituted or substituted C2-C8-alkynyl, an unsubstituted or substituted C3-C7-cycloalkyl, an unsubstituted or substituted C4-C7- cycloalkenyl, an unsubstituted or substituted aryl, an unsubstituted or substituted aryl-C - C -alkyl, an unsubstituted or substituted heterocyclyl, an unsubstituted or substituted heterocyclyl-C1-C8-alkyl, an unsubstituted or substituted hydroxy-C1-C8-alkyl, an unsubstituted or substituted C1-C8-alkoxy-C1-C8-alkyl, an unsubstituted or substituted C1- C8-alkylcarbonyloxy-C1-C8-alkyl, an unsubstituted or substituted aryloxy-C1-C8-alkyl, an unsubstituted or substituted heterocyclyloxy-C -C -alkyl, an unsubstituted or substituted amino-C -C -alkyl, an unsubstituted or substituted C -C -alkylamino-C -C -alkyl, an 1 8 1 8 1 8 unsubstituted or substituted di-C -C -alkylamino-C -C -alkyl, an unsubstituted or 1 8 1 8 substituted arylamino-C1-C8-alkyl, an unsubstituted or substituted di-arylamino-C1-C8- alkyl, an unsubstituted or substituted heterocyclylamino-C1-C8-alkyl, an unsubstituted or substituted C -C -alkylcarbonylamino-C -C -alkyl, an unsubstituted or substituted C -C - 1 8 1 8 1 8 alkoxycarbonylamino-C -C -alkyl, an unsubstituted or substituted C -C -alkylsulfanyl-C - 1 8 1 8 1 C8-alkyl, an unsubstituted or substituted C1-C8-alkylsulfinyl-C1-C8-alkyl, an unsubstituted or substituted C1-C8-alkylsulfonyl-C1-C8-alkyl or an unsubstituted or substituted cyano-C1- C -alkyl ; and A, n, p, X, Y and Z are as disclosed herein ; or - reacting a compound of formula (VIII) or one of its salts with a compound of formula (XII) : (VIII) (XII) (I) wherein L represents CR R ; R and R independently represent a hydrogen atom, an unsubstituted or substituted C -C - alkoxy or an unsubstituted or substituted C1-C8 alkyl ; U represents a bromine atom, a chlorine atom, an iodine atom , a mesyl group, a tosyl group or a triflyl group ; W represents a boronic acid, a boronic ester or a potassium trifluoroborate ; 1a 2a R and R independently represent an unsubstituted or substituted C1-C8-alkyl, an unsubstituted or substituted C2-C8-alkenyl, an unsubstituted or substituted C3-C7-cycloalkyl, an unsubstituted or substituted aryl or an unsubstituted or substituted heterocyclyl ; R represents a hydrogen atom, an unsubstituted or substituted C -C -alkyl, a C -C - 1 8 1 8 halogenoalkyl comprising up to 9 halogen atoms that can be the same or different, an unsubstituted or substituted C2-C8-alkenyl, an unsubstituted or substituted C2-C8-alkynyl, an unsubstituted or substituted C3-C7-cycloalkyl, an unsubstituted or substituted C4-C7-cycloalkenyl, an unsubstituted or substituted aryl, an unsubstituted or substituted aryl-C1-C8-alkyl, an unsubstituted or substituted heterocyclyl, an unsubstituted or substituted heterocyclyl-C -C -alkyl, an unsubstituted or substituted hydroxy-C -C -alkyl, 1 8 1 8 an unsubstituted or substituted C -C -alkoxy-C -C -alkyl, an unsubstituted or substituted C -C - 1 8 1 8 1 8 alkylcarbonyloxy-C1-C8-alkyl, an unsubstituted or substituted aryloxy-C1-C8-alkyl, an unsubstituted or substituted heterocyclyloxy-C1-C8-alkyl, an unsubstituted or substituted amino-C1-C8-alkyl, an unsubstituted or substituted C -C -alkylamino-C -C -alkyl, an unsubstituted or substituted di-C -C - 1 8 1 8 1 8 alkylamino-C -C -alkyl, an unsubstituted or substituted arylamino-C -C -alkyl, an unsubstituted or 1 8 1 8 substituted di-arylamino-C1-C8-alkyl, an unsubstituted or substituted heterocyclylamino-C1-C8-alkyl, an unsubstituted or substituted C1-C8-alkylcarbonylamino-C1-C8-alkyl, an unsubstituted or substituted C1-C8- alkoxycarbonylamino-C1-C8-alkyl, an unsubstituted or substituted C1-C8-alkylsulfanyl-C1-C8-alkyl, an unsubstituted or substituted C -C -alkylsulfinyl-C -C -alkyl, an unsubstituted or substituted C -C - 1 8 1 8 1 8 alkylsulfonyl-C -C -alkyl or an unsubstituted or substituted cyano-C -C -alkyl ; and 1 8 1 8 A, n, p, X, Y and Z are as disclosed herein ; or - reacting a compound of formula (XIII) or one of its salts with a compound of formula (XIV) : (XIII) (XIV) (I) wherein T represents a hydrogen atom, an unsubstituted or substituted C -C alkyl, an unsubstituted or substituted C -C -cycloalkyl, an unsubstituted or substituted aryl or an unsubstituted or substituted heterocyclyl ; p represents 0, 1, 2, 3 or 4 ; Z represents an unsubstituted or substituted C -C -alkyl, an unsubstituted or substituted C -C - 1 8 3 7 cycloalkyl, an unsubstituted or substituted aryl or an unsubstituted or substituted heterocyclyl ; 1a 2a R and R independently represent an unsubstituted or substituted C -C -alkyl, an unsubstituted or substituted C2-C8-alkenyl, an unsubstituted or substituted C3-C7-cycloalkyl, an unsubstituted or substituted aryl oran unsubstituted or substituted heterocyclyl ; R represents a hydrogen atom or an unsubstituted or substituted C -C -alkyl, a C -C - 1 8 1 8 halogenoalkyl comprising up to 9 halogen atoms that can be the same or different, an unsubstituted or substituted C2-C8-alkenyl, an unsubstituted or substituted C2-C8-alkynyl, an unsubstituted or substituted C3-C7-cycloalkyl, an unsubstituted or substituted C4-C7-cycloalkenyl, an unsubstituted or substituted aryl, an unsubstituted or substituted aryl-C1-C8-alkyl, an unsubstituted or substituted heterocyclyl, an unsubstituted or substituted heterocyclyl-C -C -alkyl, an unsubstituted or substituted hydroxy-C -C -alkyl, 1 8 1 8 an unsubstituted or substituted C -C -alkoxy-C -C -alkyl, an unsubstituted or substituted C -C - 1 8 1 8 1 8 alkylcarbonyloxy-C1-C8-alkyl, an unsubstituted or substituted aryloxy-C1-C8-alkyl, an unsubstituted or substituted heterocyclyloxy-C1-C8-alkyl, an unsubstituted or substituted amino-C1-C8-alkyl, an unsubstituted or substituted C1-C8-alkylamino-C1-C8-alkyl, an unsubstituted or substituted di-C1-C8- alkylamino-C -C -alkyl, an unsubstituted or substituted arylamino-C -C -alkyl, an unsubstituted or 1 8 1 8 substituted di-arylamino-C -C -alkyl, an unsubstituted or substituted heterocyclylamino-C -C -alkyl, an 1 8 1 8 unsubstituted or substituted C1-C8-alkylcarbonylamino-C1-C8-alkyl, an unsubstituted or substituted C1-C8- alkoxycarbonylamino-C1-C8-alkyl, an unsubstituted or substituted C1-C8-alkylsulfanyl-C1-C8-alkyl, an unsubstituted or substituted C -C -alkylsulfinyl-C -C -alkyl, an unsubstituted or substituted C -C - 1 8 1 8 1 8 alkylsulfonyl-C -C -alkyl or an unsubstituted or substituted cyano-C -C -alkyl ; and 1 8 1 8 n, X and Y are as disclosed herein.
In the description in this specification reference may be made to subject matter that is not within the scope of the claims of the current application. That subject matter should be readily identifiable to a person skilled in the art and may assist in putting into practice the invention as defined in the claims of this application.
DETAILED DESCRIPTION Accordingly, the present invention provides trisubstitutedsilylphenoxyquinolines and analogues thereof as decribed herein below that may be used as microbicide, preferably as fungicide active compounds.
Active compounds The present invention provides compounds of formula (I) wherein • A represents a partially saturated or unsaturated fused bicyclic 9-, 10- or 11-membered heterocyclyl ring comprising at least 1 nitrogen atom and from 0 to 4 more heteroatoms independently selected in the list consisting of N, O and S ; • Z is selected from the group consisting of hydrogen atom, halogen atom, unsubstituted or substituted C -C -alkyl, C -C -halogenoalkyl comprising up to 9 halogen atoms that can be the 1 8 1 8 same or different, unsubstituted or substituted C2-C8-alkenyl, C2-C8-halogenoalkenyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C2-C8- alkynyl, C -C -halogenoalkynyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C -C -cycloalkyl, unsubstituted or substituted C -C - 3 7 4 7 cycloalkenyl, hydroxyl, unsubstituted or substituted C1-C8-alkoxy, C1-C8-halogenoalkoxy comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted aryl, unsubstituted or substituted heterocyclyl, formyl, unsubstituted or substituted C1-C8- alkylcarbonyl, unsubstituted or substituted (hydroxyimino)C -C -alkyl, unsubstituted or substituted (C -C -alkoxyimino)C -C -alkyl, carboxyl, unsubstituted or substituted C -C -alkoxycarbonyl, 1 8 1 8 1 8 carbamoyl, unsubstituted or substituted C1-C8-alkylcarbamoyl, unsubstituted or substituted di-C1- C8-alkylcarbamoyl, amino, unsubstituted or substituted C1-C8-alkylamino, unsubstituted or substituted di-C1-C8-alkylamino, sulfanyl, unsubstituted or substituted C1-C8-alkylsulfanyl, unsubstituted or substituted C -C -alkylsulfinyl, unsubstituted or substituted C -C -alkylsulfonyl, 1 8 1 8 unsubstituted or substituted C -C -trialkylsilyl, cyano and nitro, preferably Z is selected from the group consisting of hydrogen atom, halogen atom, unsubstituted or substituted C1-C8-alkyl, C1- C8-halogenoalkyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C -C -alkenyl, hydroxyl, unsubstituted or substituted C -C -alkoxy, 2 8 1 8 C1-C8-halogenoalkoxy comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted aryl, unsubstituted or substituted heterocyclyl and cyano ; • n represents 0, 1, 2, 3 or 4 ; • p represents 0, 1, 2, 3, 4 or 5 ; 4 5 6 • L represents O, S, SO, SO , CR R or NR wherein o R and R are independently selected from the group consisting of hydrogen atom, halogen atom, hydroxyl, unsubstituted or substituted C -C -alkoxy and unsubstituted or substituted C1-C8 alkyl, or they may form together with the carbon atom to which they are linked a carbonyl group ; o R is selected from the group consisting of hydrogen atom, substituted or non- substituted C1-C8-alkyl, C1-C8-halogenoalkyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C2-C8-alkenyl, C2-C8- halogenoalkenyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C -C -alkynyl, C -C -halogenoalkynyl comprising up to 9 3 8 3 8 halogen atoms that can be the same or different, unsubstituted or substituted C3-C7- cycloalkyl, C3-C7-halogenocycloalkyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C -C -cycloalkyl-C -C -alkyl, 3 7 1 8 formyl, unsubstituted or substituted C -C -alkylcarbonyl, C -C -halogenoalkylcarbonyl 1 8 1 8 comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C1-C8-alkoxycarbonyl, C1-C8-halogenoalkoxycarbonyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C1-C8- alkylsulfonyl, C -C -halogenoalkylsulfonyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted aryl-C -C -alkyl and unsubstituted or substituted phenylsulfonyl ; • X is independently selected from the group consisting of halogen atom, unsubstituted or substituted C -C -alkyl, C -C -halogenoalkyl comprising up to 9 halogen atoms that can be the 1 8 1 8 same or different, unsubstituted or substituted C -C -alkenyl, C -C -halogenoalkenyl comprising 2 8 2 8 up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C2-C8- alkynyl, C2-C8-halogenoalkynyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C -C -cycloalkyl, unsubstituted or substituted C -C - 3 7 4 7 cycloalkenyl, hydroxyl, unsubstituted or substituted C -C -alkoxy, C -C -halogenoalkoxy 1 8 1 8 comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted aryl, unsubstituted or substituted heterocyclyl, formyl, unsubstituted or substituted C1-C8- alkylcarbonyl, unsubstituted or substituted (hydroxyimino)C1-C8-alkyl, unsubstituted or substituted (C -C -alkoxyimino)C -C -alkyl, carboxyl, unsubstituted or substituted C -C -alkoxycarbonyl, 1 8 1 8 1 8 carbamoyl, unsubstituted or substituted C -C -alkylcarbamoyl, unsubstituted or substituted di-C - 1 8 1 C8-alkylcarbamoyl, amino, unsubstituted or substituted C1-C8-alkylamino, unsubstituted or substituted di-C1-C8-alkylamino, sulfanyl, unsubstituted or substituted C1-C8-alkylsulfanyl, unsubstituted or substituted C -C -alkylsulfinyl, unsubstituted or substituted C -C -alkylsulfonyl, 1 8 1 8 40 unsubstituted or substituted C -C -trialkylsilyl, cyano, nitro, hydroxymethyl and (tetrahydro-2H- pyranyloxy)methyl, preferably X is independently selected from the group consisting of halogen atom, unsubstituted or substituted C1-C8-alkyl, C1-C8-halogenoalkyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C -C -alkoxy, C - 1 8 1 C -halogenoalkoxy comprising up to 9 halogen atoms that can be the same or different, amino, cyano and nitro ; • Y is independently selected from the group consisting of halogen atom, unsubstituted or substituted C1-C8-alkyl, C1-C8-halogenoalkyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C -C -alkenyl, C -C -halogenoalkenyl comprising 2 8 2 8 up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C -C - alkynyl, C2-C8-halogenoalkynyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C3-C7-cycloalkyl, unsubstituted or substituted C4-C7- cycloalkenyl, hydroxyl, unsubstituted or substituted C -C -alkoxy, C -C -halogenoalkoxy 1 8 1 8 comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted aryl, unsubstituted or substituted heterocyclyl, formyl, unsubstituted or substituted C -C - alkylcarbonyl, unsubstituted or substituted (hydroxyimino)C1-C8-alkyl, unsubstituted or substituted (C1-C8-alkoxyimino)C1-C8-alkyl, carboxyl, unsubstituted or substituted C1-C8-alkoxycarbonyl, carbamoyl, unsubstituted or substituted C -C -alkylcarbamoyl, unsubstituted or substituted di-C - 1 8 1 C -alkylcarbamoyl, amino, unsubstituted or substituted C -C -alkylamino, unsubstituted or 8 1 8 substituted di-C1-C8-alkylamino, sulfanyl, unsubstituted or substituted C1-C8-alkylsulfanyl, unsubstituted or substituted C1-C8-alkylsulfinyl, unsubstituted or substituted C1-C8-alkylsulfonyl, unsubstituted or substituted C1-C6-trialkylsilyl, cyano and nitro, preferably Y is independently selected from the group consisting of halogen atom, unsubstituted or substituted C -C -alkyl, C - 1 8 1 C -halogenoalkyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C1-C8-alkoxy, C1-C8-halogenoalkoxy comprising up to 9 halogen atoms that can be the same or different, hydroxyl and cyano ; • R is selected from the group consisting of unsubstituted or substituted C -C -alkyl, unsubstituted or substituted C2-C8-alkenyl, unsubstituted or substituted C2-C8-alkynyl, unsubstituted or substituted C3-C7-cycloalkyl, unsubstituted or substituted C4-C7-cycloalkenyl, unsubstituted or substituted aryl and unsubstituted or substituted heterocyclyl, preferably R is selected from the group consisting of unsubstituted or substituted C -C -alkyl ; • R is selected from the group consisting of hydroxyl, unsubstituted or substituted C1-C8-alkoxy, unsubstituted or substituted C1-C8-alkyl, unsubstituted or substituted C2-C8-alkenyl, unsubstituted or substituted C -C -alkynyl, unsubstituted or substituted C -C -cycloalkyl, unsubstituted or 2 8 3 7 substituted C -C -cycloalkenyl, unsubstituted or substituted aryl and unsubstituted or substituted heterocyclyl, preferably R is selected from the group consisting of unsubstituted or substituted C1-C8-alkyl and unsubstituted or substituted aryl ; • When R and R represent an unsubstituted or substituted C -C alkyl or an unsubstituted or substituted C -C alkenyl, they can form, together with the silicon atom to which they are linked, an unsubstituted or substituted C3-C8-silacycloalkyl ring or an unsubstituted or substituted C4-C8- silacycloalkenyl ring ; • R is selected from the group consisting of hydrogen atom, halogen atom, unsubstituted or substituted C -C -alkyl, C -C -halogenoalkyl comprising up to 9 halogen atoms that can be the 1 8 1 8 same or different, unsubstituted or substituted C2-C8-alkenyl, unsubstituted or substituted C2-C8- alkynyl, unsubstituted or substituted C3-C7-cycloalkyl, unsubstituted or substituted C4-C7- cycloalkenyl, hydroxyl, unsubstituted or substituted C -C -alkoxy, unsubstituted or substituted aryl, unsubstituted or substituted aryl-C -C -alkyl, unsubstituted or substituted heterocyclyl, unsubstituted or substituted heterocyclyl-C1-C8-alkyl, unsubstituted or substituted hydroxy-C1-C8- alkyl, unsubstituted or substituted C1-C8-alkoxy-C1-C8-alkyl, unsubstituted or substituted C1-C8- alkylcarbonyloxy-C1-C8-alkyl, unsubstituted or substituted aryloxy-C1-C8-alkyl, unsubstituted or substituted heterocyclyloxy-C -C -alkyl, unsubstituted or substituted amino-C -C -alkyl, 1 8 1 8 unsubstituted or substituted C -C -alkylamino-C -C -alkyl, unsubstituted or substituted di-C -C - 1 8 1 8 1 8 alkylamino-C1-C8-alkyl, unsubstituted or substituted arylamino-C1-C8-alkyl, unsubstituted or substituted di-arylamino-C1-C8-alkyl, unsubstituted or substituted heterocyclylamino-C1-C8-alkyl, unsubstituted or substituted C1-C8-alkylcarbonylamino-C1-C8-alkyl, unsubstituted or substituted C -C -alkoxycarbonylamino-C -C -alkyl, unsubstituted or substituted C -C -alkylsulfanyl-C -C - 1 8 1 8 1 8 1 8 alkyl, unsubstituted or substituted C1-C8-alkylsulfinyl-C1-C8-alkyl, unsubstituted or substituted C1- C8-alkylsulfonyl-C1-C8-alkyl and unsubstituted or substituted cyano-C1-C8-alkyl, preferably R is selected from the group consisting of hydrogen atom, halogen atom, unsubstituted or substituted C -C -alkyl, C -C -halogenoalkyl comprising up to 9 halogen atoms that can be the same or 1 8 1 8 different, unsubstituted or substituted C -C -cycloalkyl, unsubstituted or substituted C -C -alkenyl, 3 7 2 8 unsubstituted or substituted aryl, unsubstituted or substituted aryl-C1-C8-alkyl, hydroxyl, unsubstituted or substituted heterocyclyl and unsubstituted or substituted heterocyclyl-C1-C8- alkyl ; 3 1 2 3 • R and X, when said X is vicinal to SiR R R , may form, together with the silicon and carbon atoms to which they are respectively attached, an unsubstituted or substituted 5-, 6- or 7- membered, partially saturated, heterocycle ; • When R represents an unsubstituted or substituted C -C -alkoxy and R represents an unsubstituted or substituted C1-C8-alkoxy or an unsubstituted or substituted C1-C8 alkyl, they can form, together with the silicon atom to which they are linked an unsubstituted or substituted 5-, 6- or 7-membered heterocycle ; as well as their salts, N-oxides, metal complexes, metalloid complexes and optically active isomers or geometric isomers.
As used herein, when a group is said to be "substituted", the one or more substituants of said substituted group may be independently selected from the group consisting of halogen atom, nitro, hydroxyl, cyano, amino, sulfanyl, pentafluoro- λ -sulfanyl, formyl, carbamoyl, carbamate, C1-C8-alkyl, tri(C1-C8-alkyl)silyl, C -C -cycloalkyl, C -C -halogenoalkyl having 1 to 5 halogen atoms, C -C -halogenocycloalkyl having 1 to 3 7 1 8 3 8 40 5 halogen atoms, C -C -alkenyl, C -C -alkynyl, C -C -alkylamino, di-C -C -alkylamino, C -C -alkoxy, C - 2 8 2 8 1 8 1 8 1 8 1 C8-halogenoalkoxy having 1 to 5 halogen atoms, C1-C8-alkylsulfanyl, C1-C8-halogenoalkylsulfanyl having 1 to 5 halogen atoms, C1-C8-alkylcarbonyl, C1-C8-halogenoalkylcarbonyl having 1 to 5 halogen atoms, C1- C -alkylcarbamoyl, di-C -C -alkylcarbamoyl, C -C -alkoxycarbonyl, C -C -halogenoalkoxycarbonyl having 8 1 8 1 8 1 8 1 to 5 halogen atoms, C -C -alkylcarbonyloxy, C -C -halogenoalkylcarbonyloxy having 1 to 5 halogen 1 8 1 8 atoms, C -C -alkylcarbonylamino, C -C -halogenoalkylcarbonylamino having 1 to 5 halogen atoms, C - 1 8 1 8 1 C8-alkylsulfanyl, C1-C8-halogenoalkylsulfanyl having 1 to 5 halogen atoms, C1-C8-alkylsulfinyl, C1-C8- halogenoalkylsulfinyl having 1 to 5 halogen atoms, C1-C8-alkylsulfonyl and C1-C8-halogenoalkylsulfonyl having 1 to 5 halogen atoms.
As used herein, halogen means fluorine, chlorine, bromine or iodine ; formyl means –CH(=O) ; carboxyl means -C(=O)OH ; carbonyl means -C(=O)- ; carbamoyl means -C(=O)NH2 ; N-hydroxycarbamoyl means -C(=O)NHOH ; triflyl means -SO2-CF3 ; SO represents a sulfoxide group ; SO2 represents a sulfone group ; heteroatom means sulfur, nitrogen or oxygen ; methylene means the diradical -CH -; aryl typically means phenyl or naphthyl ; unless provided differently, heterocyclyl means a 5- to 7-membered ring, preferably a 5- to 6-membered ring, which may be saturated, partially saturated or unsaturated, comprising from 1 to 4 heteroatoms independently selected in the list consisting of N, O, S.
The term "membered" as used herein in the expression "9-, 10- or 11-membered heterocyclyl ring" or "5- to 6-membered ring" designates the number of skeletal atoms that constitutes the ring.
As used herein, the expression "partially saturated or unsaturated fused bicyclic "9-, 10- or 11-membered heterocyclyl ring" designates fused bicyclic ring systems comprising a saturated ring fused with an unsaturated ring or two fused unsaturated rings, the bicyclic ring system being constituted from 9 to 11 skeletal atoms.
As used herein, an alkyl group, an alkenyl group and an alkynyl group as well as moieties containing these terms, can be linear or branched.
When an amino group or the amino moiety of any other amino-containing group is substituted by two substituents that can be the same or different, the two substituents together with the nitrogen atom to which they are linked can form a heterocyclyl group, preferably a 5- to 7-membered heterocyclyl group, that can be substituted or that can include other hetero atoms, for example a morpholino group or piperidinyl group.
The term "comprising" as used in this specification and claims means "consisting at least in part of".
When interpreting statements in this specification and claims which include the term "comprising", other features besides the features prefaced by this term in each statement can also be present. Related terms such as "comprise" and "comprises" are to be interpreted in similar manner.
Any of the compounds of the present invention can exist in one or more optical or chiral isomer forms depending on the number of asymmetric centres in the compound. The invention thus relates equally to all optical isomers and racemic or scalemic mixtures thereof (the term "scalemic" denotes a mixture of enantiomers in different proportions) and to mixtures of all possible stereoisomers, in all proportions. The diastereoisomers and/or the optical isomers can be separated according to methods which are known 40 per se by the man ordinary skilled in the art.
Any of the compounds of the present invention can also exist in one or more geometric isomer forms depending on the number of double bonds in the compound. The invention thus relates equally to all geometric isomers and to all possible mixtures, in all proportions. The geometric isomers can be separated according to general methods, which are known per se by the man ordinary skilled in the art.
Any of the compounds of the present invention can also exist in one or more geometric isomer forms depending on the relative position (syn/anti or cis/trans) of the substituents of the chain or ring. The invention thus relates equally to all syn/anti (or cis/trans) isomers and to all possible syn/anti (or cis/trans) mixtures, in all proportions. The syn/anti (or cis/trans) isomers can be separated according to general methods, which are known per se by the man ordinary skilled in the art.
When a compound of the invention can be present in tautomeric form, the invention also encompasses any tautomeric forms of such compound, even when this is not expressly mentioned.
Compounds of formula (I) are herein referred to as "active compound(s)".
In the above formula (I), Z is preferably selected from the group consisting of hydrogen atom, halogen atom, hydroxyl, unsubstituted or substituted C -C -alkyl, C -C -halogenoalkyl comprising up to 9 halogen 1 6 1 6 atoms that can be the same or different, unsubstituted or substituted C1-C6-alkoxy, C1-C6-halogenoalkoxy comprising up to 9 halogen atoms that can be the same or different and cyano, more preferably Z is a hydrogen atom or an unsubstituted or substituted C1-C6-alkyl, even more preferably Z is a hydrogen atom or a methyl group.
In the above formula (I), n is preferably 0 or 1.
In the above formula (I), p is preferably 0, 1, 2 or 3.
In the above formula (I), L is preferably O or CH .
In the above formula (I), X is preferably independently a halogen atom or an unsubstituted or substituted C -C -alkyl group, more preferably X is independently a chlorine atom, a fluorine atom or a methyl group.
In the above formula (I), Y is preferably independently selected from the group consisting of halogen atom, unsubstituted or substituted C1-C6-alkyl, C1-C6-halogenoalkyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C1-C6-alkoxy, C1-C6-halogenoalkoxy comprising up to 9 halogen atoms that can be the same or different and cyano, more preferably Y is independently selected from the group consisting of halogen atom and unsubstituted or substituted C -C - alkyl, even more preferably Y is independently a fluorine atom, a chlorine atom or a methyl group.
In the above formula (I), R is preferably an unsubstituted or substituted C1-C6-alkyl, more preferably a methyl group.
In the above formula (I), R is preferably an unsubstituted or substituted C1-C6-alkyl, more preferably a 40 methyl group.
In the above formula (I), R is preferably selected from the group consisting of hydrogen atom, unsubstituted or substituted C1-C6-alkyl, unsubstituted or substituted C3-C7-cycloalkyl, unsubstituted or substituted aryl, unsubstituted or substituted aryl-C -C -alkyl, unsubstituted or substituted heterocyclyl, unsubstituted or substituted heterocyclyl-C -C -alkyl and hydroxyl, more preferably R is selected from the group consisting of hydrogen atom, unsubstituted or substituted C -C -alkyl, unsubstituted or substituted aryl, unsubstituted or substituted aryl-C1-C6-alkyl and hydroxyl, even more preferably R is a hydrogen atom, a hydroxyl, a methyl group, a phenyl group or a benzyl group.
In some embodiments, the compounds of the present invention are compounds of formula (I) wherein: Y is independently selected from the group consisting of halogen atom, unsubstituted or substituted C1-C6-alkyl, C1-C6-halogenoalkyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C1-C6-alkoxy, C1-C6-halogenoalkoxy comprising up to 9 halogen atoms that can be the same or different and cyano ; Z is selected from the group consisting of hydrogen atom, halogen atom, hydroxyl, unsubstituted or substituted C1-C6-alkyl, C1-C6-halogenoalkyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C1-C6-alkoxy, C1-C6-halogenoalkoxy comprising up to 9 halogen atoms that can be the same or different and cyano ; and 1 2 3 A, R , R , R , X, n, p and L are disclosed herein.
Some preferred compounds according to the invention are compounds of formula (I) wherein A is selected in the list consisting of: ( ) 1 2 3 (A ) (A ) (A ) 4 5 6 (A ) (A ) (A ) 7 8 9 (A ) (A ) (A ) 11 12 (A ) (A ) (A ) 13 14 15 (A ) (A ) (A ) 16 17 (A ) (A ) wherein : W is CY or N ; Q is O, S or NY with Y being a hydrogen atom or an unsubstituted or substituted C -C -alkyl ; 1 2 3 4 5 1 2 3 Y , Y , Y , Y and Y are independently a hydrogen atom or Y as disclosed above, preferably, Y , Y , Y , Y and Y are independently selected from the group consisting of hydrogen atom, halogen atom, substituted or unsubstituted C1-C6-alkyl, C1-C6-halogenoalkyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C -C -alkoxy, C -C -halogenoalkoxy comprising up 1 6 1 6 1 2 3 4 5 to 9 halogen atoms that can be the same or different and cyano, more preferably Y , Y , Y , Y and Y are independently selected from the group consisting of hydrogen atom, halogen atom and unsubstituted or 1 2 3 4 5 substituted C1-C6-alkyl, even more preferably Y , Y , Y , Y and Y are independently a hydrogen atom, a fluorine atom, a chlorine atom or a methyl group ; Z is as disclosed above, preferably Z is selected from the group consisting of hydrogen atom, halogen atom, hydroxyl, unsubstituted or substituted C -C -alkyl, C -C -halogenoalkyl comprising up to 9 1 6 1 6 halogen atoms that can be the same or different, unsubstituted or substituted C1-C6-alkoxy, C1-C6- halogenoalkoxy comprising up to 9 halogen atoms that can be the same or different and cyano, more preferably Z is a hydrogen atom or an unsubstituted or substituted C1-C6-alkyl, even more preferably Z is a hydrogen atom or a methyl group ; m is 1, 2 or 3 ; and 1 2 3 n, X, L, R , R and R are as disclosed herein. 1 17 Preferably, in these embodiments wherein A is selected in the list consisting of A to A , L is O or CH , more preferably O ; and/or R is an unsubstituted or substituted C1-C6-alkyl, more preferably a methyl group ; and/or R is an unsubstituted or substituted C1-C6-alkyl, more preferably a methyl group; and/or R is selected from the group consisting of hydrogen atom, unsubstituted or substituted C -C - alkyl, unsubstituted or substituted C -C -cycloalkyl, unsubstituted or substituted aryl, unsubstituted or substituted aryl-C -C -alkyl, unsubstituted or substituted heterocyclyl, unsubstituted or substituted heterocyclyl-C1-C6-alkyl and hydroxyl, more preferably R is selected from the group consisting of hydrogen atom, unsubstituted or substituted C1-C6-alkyl, unsubstituted or substituted aryl, unsubstituted or substituted aryl-C -C -alkyl and hydroxyl, even more preferably R is a hydrogen atom, a hydroxyl, a methyl group, a phenyl group or a benzyl group ; and/or n represents 0 or 1 ; and/or X is a halogen atom or an unsubstituted or substituted C1-C6-alkyl group, more preferably X is a chlorine atom, a fluorine atom or a methyl group.
Some preferred compounds according to the invention are compounds of formula (I) wherein A is 1 2 3 5 10 12 17 1 selected from the list consisting of A , A , A , A , A , A and A as disclosed above, wherein W, Q, Y , 2 3 4 5 1 2 3 Y , Y , Y ,Y , m, n, X, L, R , R and R are as disclosed herein.
Some preferred compounds according to the invention are compounds of formula (I) wherein A is a 1 1 2 3 4 5 1 2 3 heterocycle of formula A as disclosed above wherein W, Y , Y , Y , Y ,Y , n, X, L, R , R and R are as disclosed herein.
Some more preferred compounds according to the invention are compounds of formula (I) wherein : A represents a heterocycle of formula (A ) wherein : W is CY or N ; Y to Y independently represent a hydrogen atom, a fluorine atom or a methyl group, 1 2 3 preferably a hydrogen atom or fluorine atom, more preferably Y , Y and Y represent a hydrogen atom and Y and Y independently represent a hydrogen atom or a fluorine atom ; Z represents a hydrogen atom or a methyl group ; 1 2 3 1 2 R , R , R , X, n and L are as defined above, preferably R and R represent an unsubstituted or a substituted C1-C6-alkyl, R is selected in the group consisting of unsubstituted or substituted C1-C6-alkyl, unsubstituted or substituted C3-C7-cycloalkyl, unsubstituted or substituted aryl, unsubstituted or substituted heterocyclyl and hydroxyl, preferably R is an unsubstituted or substituted C -C -alkyl or a hydroxyl, and X is a chlorine atom, a fluorine atom or a methyl group. Preferably, in some embodiments 1 2 3 of these more preferred compounds, n represents 0 or 1 with X being vicinal to SiR R R when n represents 1.
The above mentioned preferences with regard to the substituents of the compounds according to the invention can be combined in various manners. These combinations of preferred features thus provide sub-classes of compounds according to the invention. Examples of such sub-classes of preferred 40 compounds according to the invention are: 1 2 3 - preferred features of A with one or more preferred features of L, R , R , R , n, p, X, Y and Z; 1 2 3 - preferred features of L with one or more preferred features of A, R , R , R , n, p, X, Y and Z; 1 2 3 - preferred features of R with one or more preferred features of A, L, R , R , n, p, X, Y and Z; 2 1 3 - preferred features of R with one or more preferred features of A, L, R , R , n, p, X, Y and Z; 3 1 2 - preferred features of R with one or more preferred features of A, L, R , R , n, p, X, Y and Z; 1 2 3 - preferred features of n with one or more preferred features of A, L, R , R , R , p, X, Y and Z; 1 2 3 - preferred features of p with one or more preferred features of A, L, R , R , R , n, X, Y and Z; 1 2 3 - preferred features of X with one or more preferred features of A, L, R , R , R , n, p, Y and Z; 1 2 3 - preferred features of Y with one or more preferred features of A, L, R , R , R , n, p, X and Z; 1 2 3 - preferred features of Z with one or more preferred features of A, L, R , R , R , n, p, X and Y.
In these combinations of preferred features of the substituents of the compounds according to the invention, the said preferred features can also be selected among the more preferred features of each of 1 2 3 A, L, R , R , R , n, p, X, Y and Z so as to form most preferred subclasses of compounds according to the invention.
Processes for the preparation of the active compounds The present invention also relates to processes for the preparation of compounds of formula (I).
Compounds of formula (I) as herein-defined can be prepared by a process P1 which comprises the step of reacting a halogenoaryl of formula (II) or one of its salts: (II) wherein A, L, n, p, X, Y and Z are as herein-defined and U represents a chlorine atom, a bromine atom, an iodine atom, a mesyl group, a tosyl group or a triflyl group, with a disilyl derivative of formula (IIIa): (IIIa) 1 2 3 wherein R , R and R are as herein-defined.
Process P1 can be performed in the presence of a transition metal catalyst such as palladium and if appropriate in the presence of a phosphine ligand or a N-heterocyclic carbene ligand, if appropriate in the presence of a base and if appropriate in the presence of a solvent according to known processes (Organic Letters (2003), 5, 3483, Organic Letters (2007), 9, 3785 and cited references therein).
Derivatives of formula (II) wherein wherein A, L, n, p, X, Y and Z are as herein-defined and U represents a chlorine atom, a bromine atom or an iodine atom, can be prepared by diazotation of an aniline of formula (IV) or one of its salts: (IV) wherein A, L, n, p, X, Y and Z are as herein-defined, according to known processes (Patai's Chemistry of Functional Groups - Amino, Nitroso, Nitro and Related Groups - 1996).
Derivatives of formula (II) can also be prepared by aromatic nucleophilic substitution according to known processes (Journal of Heterocyclic Chemistry (2008), 45, 1199 and Synthetic Communications (1999), 29, 1393).
Derivatives of formula (II) can also be prepared from compounds of formula (VIII) by condensation of the corresponding ortho-substituted [thio]phenols or anilines according to known processes (US- 2012/289702).
Derivatives of formula (II) can also be prepared by process P6 described below.
Anilines of formula (IV) wherein wherein A, L, n, p, X, Y and Z are as herein-defined can be prepared by reduction of a nitro group of formula (V) or one of its salts: wherein A, L, n, p, X, Y and Z are as herein-defined according to known processes (Patai's Chemistry of Functional Groups - Amino, Nitroso, Nitro and Related Groups - 1996).
Disilyl derivatives of formula (IIIa) are known or can be prepared by known processes.
Compounds of formula (I) wherein R represents a hydroxyl can be prepared from compounds of formula (I) wherein R represents an unsubstituted or substituted C1-C6-alkoxy (themselves prepared by process P1) by an acidic hydrolysis according to known processes (Organic Letters (2003), 5, 3483) Compounds of formula (I) wherein R represents a fluorine atom can be prepared from compounds of formula (I) wherein R represents an unsubstituted or substituted C -C -alkoxy (themselves prepared by process P1) by known processes (Synlett (2012), 23, 1064 and cited references therein) or can be prepared from compounds of formula (I) wherein R represents a hydroxyl by known processes (EP1908472) Process P1 can be carried out in the presence of a catalyst, such as a metal salt or complex. Suitable metal derivatives for this purpose are transition metal catalysts such as palladium. Suitable metal salts or complexes for this purpose are for example, palladium chloride, palladium acetate, tetrakis(triphenylphosphine)palladium(0), bis(dibenzylideneacetone)palladium(0), tris(dibenzylideneacetone)dipalladium(0), bis(triphenylphosphine)palladium(II) dichloride, [1,1’- bis(diphenylphosphino)ferrocene]dichloropalladium(II), bis(cinnamyl)dichlorodipalladium(II), bis(allyl)- dichlorodipalladium(II) or [1,1’-Bis(di-tert-butylphosphino)ferrocene]dichloropalladium(II).
It is also possible to generate a palladium complex in the reaction mixture by separate addition to the reaction of a palladium salt and a ligand or salt, such as triethylphosphine, tri-tert-butylphosphine, tri-tert- butylphosphonium tetrafluoroborate, tricyclohexylphosphine, 2-(dicyclohexylphosphino)biphenyl, 2-(di- tert-butylphosphino)biphenyl, 2-(dicyclohexylphosphino)-2'-(N,N-dimethylamino)biphenyl, 2-(tert- butylphosphino)-2'-(N,N-dimethylamino)biphenyl, 2-di-tert-butylphosphino-2’,4’,6’-triisopropylbiphenyl 2- dicyclohexylphosphino-2’,4’,6’-triisopropylbiphenyl, 2-dicyclohexylphosphino-2,6’-dimethoxybiphenyl, 2- dicyclohexylphosphino-2’,6’-diisopropoxybiphenyl, triphenyl-phosphine, tris-(o-tolyl)phosphine, sodium 3- (diphenylphosphino)benzenesulfonate, tris(methoxy-phenyl)phosphine, 2,2'-bis(diphenylphosphino)- 1,1'-binaphthyl, 1,4-bis(diphenylphosphino)butane, 1,2-bis(diphenylphosphino) ethane, 1,4- bis(dicyclohexylphosphino)butane, 1,2-bis(dicyclohexylphosphino)-ethane, 2-(dicyclohexylphosphino)-2'- (N,N-dimethylamino)-biphenyl, 1,1’-bis(diphenylphosphino)-ferrocene, (R)-(-)[(S)diphenyl- phosphino)ferrocenyl]ethyldicyclohexylphosphine, tris-(2,4-tert-butyl-phenyl)phosphite, di(1-adamantyl) morpholinophenylphosphine or 1,3-bis(2,4,6-trimethylphenyl)imidazolium chloride.
It is also advantageous to choose the appropriate catalyst and/or ligand from commercial catalogues such as "Metal Catalysts for Organic Synthesis" by Strem Chemicals or "Phosphorous Ligands and Compounds" by Strem Chemicals.
Suitable bases for carrying out process P1 can be inorganic and organic bases which are customary for such reactions. Preference is given to using alkaline earth metal or alkali metal hydroxides, such as sodium hydroxide, calcium hydroxide, potassium hydroxide or other ammonium hydroxide derivatives ; alkaline earth metal, alkali metal or ammonium fluorides such as potassium fluoride, caesium fluoride or tetrabutylammonium fluoride ; alkaline earth metal or alkali metal carbonates, such as sodium carbonate, potassium carbonate, potassium bicarbonate, sodium bicarbonate or caesium carbonate ; alkali metal or alkaline earth metal acetates, such as sodium acetate, lithium acetate, potassium acetate or calcium 40 acetate ; alkali metal or alkaline earth metal phosphate, such as tripotassium phosphate alkali ; alkali metal alcoholates, such as potassium tert-butoxide or sodium tert-butoxide ; tertiary amines, such as trimethylamine, triethylamine, tributylamine, N,N-dimethylaniline, N,N-dicyclohexylmethylamine, N,N- diisopropylethylamine, N-methylpiperidine, N,N-dimethylaminopyridine, diazabicyclooctane (DABCO), diazabicyclononene (DBN) or diazabicycloundecene (DBU) ; and also aromatic bases, such as pyridine, picolines, lutidines or collidines.
Suitable solvents for carrying out process P1 can be customary inert organic solvents. Preference is given to using optionally halogen atomated aliphatic, alicyclic or aromatic hydrocarbons, such as petroleum ether, pentane, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene or decalin ; chlorobenzene, dichlorobenzene, dichloromethane, chloroform, carbon tetrachloride, dichloroethane or trichloroethane ; ethers, such as diethyl ether, diisopropyl ether, methyl tert-butyl ether, methyl tert-amyl ether, dioxane, tetrahydrofuran, 2-methyltetrahydrofuran, 1,2-dimethoxyethane, 1,2- diethoxyethane or anisole ; nitriles, such as acetonitrile, propionitrile, n- or iso-butyronitrile or benzonitrile ; amides, such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methylformanilide, N- methylpyrrolidone or hexamethylphosphoric triamide ; ureas, such as 1,3-dimethyl-3,4,5,6-tetrahydro- 2(1H)-pyrimidinone ; esters, such as methyl acetate or ethyl acetate, sulfoxides, such as dimethyl sulfoxide, or sulfones, such as sulfolane; and a mixture thereof.
It can also be advantageous to carry out process P1 with a co-solvent such as water or an alcohol such as methanol, ethanol, propanol, isopropanol or tert-butanol.
Process P1 may be performed in an inert atmosphere such as argon or nitrogen atmosphere. When carrying out process P1, 1 mole or an excess of compound of formula (III) and from 1 to 5 moles of base and from 0.01 to 20 mole percent of a palladium complex can be employed per mole of compound of formula (II). It is also possible to employ the reaction components in other ratios. Work-up is carried out by known methods.
Compounds of formula (I) as herein-defined can be prepared by a process P2 which comprises the step of reacting a compound of formula (VI) or one of its salts: (VI) wherein A, L, n, p, X, Y and Z are as herein-defined and M represents an alkali metal such as lithium that can be complexed by 1 to 2 ligands or a halogenomagnesium that can be complexed by 1 to 2 ligands, with a silyl derivative of formula (IIIb) or a silyl derivative of formula (IIIc): (IIIb) (IIIc) 1 2 3 2 wherein R , R and R are as herein-defined and U represents a chlorine atom, a bromine atom, an iodine atom or an unsubstituted or substituted C1-C6-alkoxy.
A compound of formula (VI) can be obtained from a halogenoaryl derivative of formula (II) by the reaction with magnesium metal or lithium metal ; or by halogen/metal exchange using an alkyllithium reagent or a Grignard reagent or a manufactured complex prepared from an alkyllithium reagent or a Grignard reagent preferably under anhydrous conditions. Optionally lithium chloride can be used in pre-formed combination with these reagents.
Examples of alkyllithium reagents used in the lithiation process include methyllithium, phenyllithium, n- butyllithium, sec- butyllithium, iso-butyllithium, tert-butyllithium, and the like.
Examples of Grignard reagents used in the magnesium complexation process include methylmagnesium chloride, ethylmagnesium chloride, n-butylmagnesium chloride, iso-propylmagnesium chloride, chloro- (2,2,6,6-tetramethylpiperidyl)magnesium and the like. A manufactured complex prepared from n- butylmagnesium chloride and n-butyllithium may also be used.
Examples of ligands used in the lithiation process or magnesium complexation process include tetramethylethylenediamine, hexamethylphosphotriamide, (+) or (-)-sparteine or 1,3-dimethyl-3,4,5,6- tetrahydro-2(1H)-pyrimidinone.
A solvent used in the lithiation or magnesium complexation is not particularly limited as long as it forms an anhydrous reaction system without dissolving the compound to react therewith or exhibit any particular interaction therewith. Preference is given to using non-halogenated aliphatic, alicyclic or aromatic hydrocarbons, such as petroleum ether, pentane, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene, decalin, ISOPAR (registered trademark) E or ISOPAR (registered trademark) G ; ethers, such as diethyl ether, diisopropyl ether, methyl tert-butyl ether, methyl tert-amyl ether, dioxane, tetrahydrofuran, 2-methyltetrahydrofuran, 1,2-dimethoxyethane or 1,2-diethoxyethane ; and a mixture thereof.
The lithiation or magnesium complexation may be performed in an inert atmosphere and prepared at a temperature of 0 °C to -78 °C.
Alternatively, a compound of formula (VI) can be prepared from a compound of formula (VII) or one of its salts: (VII) wherein A, L, n, p, X, Y and Z are as herein-defined by reaction with a base such as n-butyllithium, lithium di-isopropylamine, lithium tetramethylpiperidide, lithium bis(trimethylsilyl)amine, methyllithium or chloro- (2,2,6,6-tetramethylpiperidyl)magnesium and the like, preferably under anhydrous conditions.
Optionally lithium chloride can be used in pre-formed combination with these reagents.
The solvent used in the reaction of compounds (VII) with a base is not particularly limited as long as it forms an anhydrous reaction system without dissolving the compound to react therewith or exhibit any particular interaction therewith. Preference is given to using non-halogenated aliphatic, alicyclic or aromatic hydrocarbons, such as petroleum ether, pentane, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene, decalin, ISOPAR (registered trademark) E or ISOPAR (registered trademark) G; ethers, such as diethyl ether, diisopropyl ether, methyl tert-butyl ether, methyl tert-amyl ether, dioxane, tetrahydrofuran, 2-methyltetrahydrofuran, 1,2-dimethoxyethane or 1,2- diethoxyethane ; and a mixture thereof.
The reaction may be performed in an inert atmosphere and prepared at a temperature of 0 °C to -78 °C.
Compounds of formula (VII) are known and can be prepared by known processes (Organic Letters (2012), 14, 173, Bioorganic & Medicinal Chemistry, 19, 939 and cited references therein).
Silyl derivatives of formula (IIIb) and (IIIc) are known or can be prepared by known processes.
Compounds of formula (I) wherein R represents a hydroxyl can also be prepared from compounds of formula (I) wherein R represents an hydrogen atom (themselves prepared by process P2) by known processes (Chemistry – A European Journal (2012), 18, 9789, WO-2013/058825 and EP1908472).
Suitable solvents for carrying out process P2 are not particularly limited as long as it forms an anhydrous reaction system without dissolving the compound to react therewith or exhibit any particular interaction therewith. Preference is given to using non-halogenated aliphatic, alicyclic or aromatic hydrocarbons, such as petroleum ether, pentane, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene, decalin, ISOPAR (registered trademark) E or ISOPAR (registered trademark) G; ethers, such as diethyl ether, diisopropyl ether, methyl tert-butyl ether, methyl tert-amyl ether, dioxane, tetrahydrofuran, 2- methyltetrahydrofuran, 1,2-dimethoxyethane or 1,2-diethoxyethane or a mixture thereof.
Process P2 may be performed in an inert atmosphere. When carrying out process P2, 1 mole or an excess of compound of formula (IIIb) or compound of formula (IIIc) can be employed per mole of compound of formula (VII). It is also possible to employ the reaction components in other ratios. Work-up is carried out by known methods.
Compounds of formula (I) as herein-defined can be prepared by a process P3 which comprises the step of reacting a compound of formula (VIII) or one of its salts with a compound of formula (IX) as illustrated by the following reaction scheme : (VIII) (IX) (I) Process P3 wherein L represents O, S or NR ; U represents a chlorine atom, a bromine atom, an iodine atom, a mesyl group, a tosyl group or a triflyl group ; 1a 2a R and R independently represent an unsubstituted or substituted C -C -alkyl, an unsubstituted or substituted C -C -alkenyl, an unsubstituted or substituted C -C -cycloalkyl, an unsubstituted or 2 8 3 7 substituted aryl or an unsubstituted or substituted heterocyclyl ; and R represents a hydrogen atom,an unsubstituted or substituted C1-C8-alkyl ; a C1-C8- halogenoalkyl comprising up to 9 halogen atoms that can be the same or different ; an unsubstituted or substituted C -C -alkenyl ; an unsubstituted or substituted C -C -alkynyl ; an unsubstituted or substituted 2 8 2 8 C -C -cycloalkyl ; an unsubstituted or substituted C -C -cycloalkenyl ; an unsubstituted or substituted 3 7 4 7 aryl ; an unsubstituted or substituted aryl-C1-C8-alkyl ; an unsubstituted or substituted heterocyclyl ; an unsubstituted or substituted heterocyclyl-C1-C8-alkyl ; an unsubstituted or substituted hydroxy-C1-C8- alkyl ; an unsubstituted or substituted C1-C8-alkoxy-C1-C8-alkyl ; an unsubstituted or substituted C1-C8- alkylcarbonyloxy-C -C -alkyl ; an unsubstituted or substituted aryloxy-C -C -alkyl ; an unsubstituted or 1 8 1 8 substituted heterocyclyloxy-C -C -alkyl ; an unsubstituted or substituted amino-C -C-alkyl ; an 1 8 1 8 unsubstituted or substituted C1-C8-alkylamino-C1-C8-alkyl ; an unsubstituted or substituted di-C1-C8- alkylamino-C1-C8-alkyl ; an unsubstituted or substituted arylamino-C1-C8-alkyl ; an unsubstituted or substituted di-arylamino-C -C -alkyl ; an unsubstituted or substituted heterocyclylamino-C -C -alkyl ; an 1 8 1 8 unsubstituted or substituted C -C -alkylcarbonylamino-C -C -alkyl ; an unsubstituted or substituted C -C - 1 8 1 8 1 8 alkoxycarbonylamino-C1-C8-alkyl ; an unsubstituted or substituted C1-C8-alkylsulfanyl-C1-C8-alkyl ; an unsubstituted or substituted C1-C8-alkylsulfinyl-C1-C8-alkyl ; an unsubstituted or substituted C1-C8- alkylsulfonyl-C1-C8-alkyl ; or an unsubstituted or substituted cyano-C1-C8-alkyl ; and A, n, p, X, Y, R and Z are as herein-defined.
Compounds of formula (IX) are commercially available or can be prepared by well known processes.
Process P3 can be performed in the presence of a transition metal catalyst such as palladium and if appropriate in the presence of a phosphine ligand or a N-heterocyclic carbene ligand ; or copper and if appropriate in the presence of a ligand ; and if appropriate in the presence of a base and if appropriate in the presence of a solvent according to known processes (Organic Letters (2012), 14, 170, Organic Letters (2002), 4, 1623 and cited references therein).
Suitable palladium-based catalyst can be as disclosed in connection with process P1.
Suitable copper salts or complexes and their hydrates for this purpose are for example, copper metal, copper(I) iodide, copper(I) chloride, copper(I) bromide, copper(II) chloride, copper(II) bromide, copper(II) oxide, copper(I) oxide, copper(II) acetate, copper(I) acetate, copper(I) thiophenecarboxylate, copper(I) cyanide, copper(II) sulfate, copper bis(2,2,6,6-tetramethyl-3,5-heptanedionate), copper(II) trifluoromethanesulfonate, tetrakis(acetonitrile)copper(I) hexafluorophosphate, tetrakis(acetonitrile)- copper(I) tetrafluoroborate.
It is also possible to generate a copper complex in the reaction mixture by separate addition to the reaction of a copper salt and a ligand or salt, such as ethylenediamine, N,N-dimethylethylenediamine, N,N’-dimethylethylenediamine, rac-trans-1,2-diaminocyclohexane, rac-trans-N,N’-dimethylcyclohexane- 1,2-diamine, 1,1’-binaphthyl-2,2’-diamine, N,N,N’,N’-tetramethylethylenediamine, proline, N,N- dimethylglycine, quinolinol, pyridine, 2-aminopyridine, 4-(dimethylamino)pyridine, 2,2’-bipyridyl, 2,6- di(2-pyridyl)pyridine, 2-picolinic acid, 2-(dimethylaminomethyl)hydroxypyridine, 1,10-phenanthroline, 3,4,7,8-tetramethyl-1,10-phenanthroline, 2,9-dimethyl-1,10-phenanthroline, 4,7-dimethoxy-1,10- phenanthroline, N,N'-bis[(E)-pyridinylmethylidene]cyclohexane-1,2-diamine, N-[(E)-phenylmethylidene], N-[(E)-phenylmethylidene]-cyclohexanamine, 1,1,1-tris(hydroxymethyl)ethane, ethylene glycol, 2,2,6,6- tetramethylheptane-3,5-dione, 2-(2,2-dimethylpropanoyl)cyclohexanone, acetylacetone, dibenzoylmethane, 2-(2-methylpropanoyl)cyclohexanone, biphenylyl(di-tert-butyl)phosphane, ethylenebis-(diphenylphosphine), N,N-diethylsalicylamide, 2-hydroxybenzaldehyde oxime, oxo[(2,4,6- trimethylphenyl)amino]acetic acid or 1H-pyrrolecarboxylic acid.
It is also advantageous to choose the appropriate catalyst and/or ligand from commercial catalogues such as "Metal Catalysts for Organic Synthesis" by Strem Chemicals or from reviews (Chemical Society Reviews (2014), 43, 3525, Coordination Chemistry Reviews (2004), 248, 2337 and references therein).
Suitable bases for carrying out process P3 can be as discosled in connection with process P1.
Suitable solvents for carrying out process P3 can be as disclosed in connection with process P1.
Process P3 may be performed in an inert atmosphere. When carrying out process P3, 1 mole or an excess of compound of formula (IX) and from 1 to 5 moles of base and from 0.01 to 20 mole percent of a transition metal complex can be employed per mole of compound of formula (VIII). It is also possible to employ the reaction components in other ratios. Work-up is carried out by known methods.
Compounds of formula (I) as herein-defined can be prepared by a process P4 which comprises the step of reacting a compound of formula (X) or one of its salts with a compound of formula (XI) as illustrated by the following reaction scheme : (X) (XI) (I) Process P4 wherein L represents CR R ; R and R independently represent a hydrogen atom or an unsubstituted or substituted C1-C8 alkyl ; U represents a bromine atom, a chlorine atom, an iodine atom, a mesyl group, a tosyl group or a triflyl group ; W represents a boron derivative such as a boronic acid, a boronic ester or a potassium trifluoroborate derivative ; 1a 2a R and R independently represent an unsubstituted or substituted C1-C8-alkyl, an unsubstituted or substituted C -C -alkenyl, an unsubstituted or substituted C -C - 2 8 3 7 cycloalkyl, an unsubstituted or substituted aryl or an unsubstituted or substituted heterocyclyl ; R represents a hydrogen atom ; an unsubstituted or substituted C1-C8-alkyl ; a C1-C8- halogenoalkyl comprising up to 9 halogen atoms that can be the same or different ; an unsubstituted or substituted C -C -alkenyl ; an unsubstituted or substituted C -C -alkynyl ; 2 8 2 8 an unsubstituted or substituted C3-C7-cycloalkyl ; an unsubstituted or substituted C4-C7- cycloalkenyl ; an unsubstituted or substituted aryl ; an unsubstituted or substituted aryl- C -C -alkyl ; an unsubstituted or substituted heterocyclyl ; an unsubstituted or substituted heterocyclyl-C -C -alkyl ; an unsubstituted or substituted hydroxy-C -C -alkyl ; an 1 8 1 8 unsubstituted or substituted C1-C8-alkoxy-C1-C8-alkyl ; an unsubstituted or substituted C1- C8-alkylcarbonyloxy-C1-C8-alkyl ; an unsubstituted or substituted aryloxy-C1-C8-alkyl ; an unsubstituted or substituted heterocyclyloxy-C1-C8-alkyl ; an unsubstituted or substituted amino-C -C -alkyl ; an unsubstituted or substituted C -C -alkylamino-C -C -alkyl ; an 1 8 1 8 1 8 unsubstituted or substituted di-C -C -alkylamino-C -C -alkyl ; an unsubstituted or 1 8 1 8 substituted arylamino-C -C -alkyl ; an unsubstituted or substituted di-arylamino-C -C - 1 8 1 8 alkyl ; an unsubstituted or substituted heterocyclylamino-C1-C8-alkyl ; an unsubstituted or substituted C1-C8-alkylcarbonylamino-C1-C8-alkyl ; an unsubstituted or substituted C1-C8- alkoxycarbonylamino-C -C -alkyl ; an unsubstituted or substituted C -C -alkylsulfanyl-C - 1 8 1 8 1 C -alkyl ; an unsubstituted or substituted C -C -alkylsulfinyl-C -C -alkyl ; an unsubstituted 8 1 8 1 8 or substituted C1-C8-alkylsulfonyl-C1-C8-alkyl or an unsubstituted or substituted cyano- C1-C8-alkyl ; and A, n, p, X, Y and Z are as herein-defined.
Compounds of formula (XI) can be prepared by known processes (Journal of the American Chemical Society (1957), 79, 6540; Journal of Organic Chemistry (2000), (65), 4913; Tetrahedron Letters (2002), 43, 8569).
Process P4 can be performed in the presence of a transition metal catalyst such as palladium and if appropriate in the presence of a phosphine ligand or a N-heterocyclic carbene ligand and if appropriate in the presence of a base and if appropriate in the presence of a solvent. Suitable palladium salts or complexes for this purpose can be as disclosed in connection with process P1.
Suitable bases for carrying out process P4 can be as disclosed in connection with process P1.
Suitable solvents for carrying out process P4 can be as disclosed in connection with process P1.
It can also be advantageous to carry out process P4 according to the invention, with a co-solvent such as water or an alcohol such as methanol, ethanol, propanol, isopropanol or tert-butanol.
Process P4 may be performed in an inert atmosphere. When carrying out process P4, 1 mole or an excess of compound of formula (XI) and from 1 to 5 moles of base and from 0.01 to 20 mole percent of a transition metal complex can be employed per mole of compound of formula (X). It is also possible to employ the reaction components in other ratios. Work-up is carried out by known methods.
Compounds of formula (I) as herein-defined can be prepared by a process P5 which comprises the step of reacting a compound of formula (VIII) or one of its salts with a compound of formula (XII) as illustrated by the following reaction scheme : (VIII) (XII) (I) Process P5 wherein L represents CR R ; R and R independently represent a hydrogen atom, an unsubstituted or substituted C1-C8- alkoxy or an unsubstituted or substituted C -C alkyl ; U represents a bromine atom, a chlorine atom, an iodine atom , a mesyl group, a tosyl group or a triflyl group ; W represents a boron derivative such as a boronic acid, a boronic ester or a potassium trifluoroborate derivative ; 1a 2a R and R independently represent an unsubstituted or substituted C -C -alkyl, an unsubstituted or substituted C -C -alkenyl, an unsubstituted or substituted C -C -cycloalkyl, an unsubstituted or 2 8 3 7 substituted aryl or an unsubstituted or substituted heterocyclyl ; R represents a hydrogen atom or an unsubstituted or substituted C1-C8-alkyl ; a C1-C8- halogenoalkyl comprising up to 9 halogen atoms that can be the same or different ; an unsubstituted or substituted C -C -alkenyl ; an unsubstituted or substituted C -C -alkynyl ; an unsubstituted or substituted 2 8 2 8 C -C -cycloalkyl ; an unsubstituted or substituted C -C -cycloalkenyl ; an unsubstituted or substituted 3 7 4 7 aryl ; an unsubstituted or substituted aryl-C -C -alkyl ; an unsubstituted or substituted heterocyclyl ; an unsubstituted or substituted heterocyclyl-C1-C8-alkyl ; an unsubstituted or substituted hydroxy-C1-C8- alkyl ; an unsubstituted or substituted C1-C8-alkoxy-C1-C8-alkyl ; an unsubstituted or substituted C1-C8- alkylcarbonyloxy-C -C -alkyl ; an unsubstituted or substituted aryloxy-C -C -alkyl ; an unsubstituted or 1 8 1 8 substituted heterocyclyloxy-C -C -alkyl ; an unsubstituted or substituted amino-C -C-alkyl ; an 1 8 1 8 unsubstituted or substituted C1-C8-alkylamino-C1-C8-alkyl ; an unsubstituted or substituted di-C1-C8- alkylamino-C1-C8-alkyl ; an unsubstituted or substituted arylamino-C1-C8-alkyl ; an unsubstituted or substituted di-arylamino-C1-C8-alkyl ; an unsubstituted or substituted heterocyclylamino-C1-C8-alkyl ; an unsubstituted or substituted C -C -alkylcarbonylamino-C -C -alkyl ; an unsubstituted or substituted C -C - 1 8 1 8 1 8 alkoxycarbonylamino-C -C -alkyl ; an unsubstituted or substituted C -C -alkylsulfanyl-C -C -alkyl ; an 1 8 1 8 1 8 unsubstituted or substituted C1-C8-alkylsulfinyl-C1-C8-alkyl ; an unsubstituted or substituted C1-C8- alkylsulfonyl-C1-C8-alkyl or an unsubstituted or substituted cyano-C1-C8-alkyl ; and A, n, p, X, Y and Z are as herein-defined.
Compounds of formula (XII) can be prepared from compounds of formula (XI) by known processes (Tetrahedron Letters (2003), 44, 233 and Chemistry Letters (2002), 780).
Process P5 can be performed in the presence of a transition metal catalyst such as palladium and if appropriate in the presence of a phosphine ligand or a N-heterocyclic carbene ligand and if appropriate in the presence of a base and if appropriate in the presence of a solvent. Suitable palladium salts or complexes for this purpose can be as disclosed in connection with process P1.
Suitable bases for carrying out process P5 can be as disclosed in connection with process P1.
Suitable solvents for carrying out process P5 can be as disclosed in connection with process P1.
It can also be advantageous to carry out process P5 according to the invention, with a co-solvent such as water or an alcohol such as methanol, ethanol, propanol, isopropanol or tert-butanol.
Process P5 may be performed in an inert atmosphere. When carrying out process P5, 1 mole or an excess of compound of formula (XII) and from 1 to 5 moles of base and from 0.01 to 20 mole percent of a transition metal complex can be employed per mole of compound of formula (VIII). It is also possible to 40 employ the reaction components in other ratios. Work-up is carried out by known methods.
Compounds of formula (I) as herein-defined can be prepared by a process P6 which comprises the step of reacting a compound of formula (XIII) or one of its salts with a compound of formula (XIV) as illustrated by the following reaction scheme : (XIII) (XIV) (I) Process P6 wherein T represents a hydrogen atom, an unsubstituted or substituted C1-C8 alkyl, an unsubstituted or substituted C3-C7-cycloalkyl, an unsubstituted or substituted aryl or an unsubstituted or substituted heterocyclyl ; p represents 0, 1, 2, 3 or 4 ; Z represents an unsubstituted or substituted C -C -alkyl, an unsubstituted or substituted C -C - 1 8 3 7 cycloalkyl, an unsubstituted or substituted aryl or an unsubstituted or substituted heterocyclyl ; 1a 2a R and R independently represent an unsubstituted or substituted C1-C8-alkyl, an unsubstituted or substituted C -C -alkenyl, an unsubstituted or substituted C -C -cycloalkyl, an unsubstituted or 2 8 3 7 substituted aryl oran unsubstituted or substituted heterocyclyl ; R represents a hydrogen atom or an unsubstituted or substituted C1-C8-alkyl ; a C1-C8- halogenoalkyl comprising up to 9 halogen atoms that can be the same or different ; an unsubstituted or substituted C2-C8-alkenyl ; an unsubstituted or substituted C2-C8-alkynyl ; an unsubstituted or substituted C -C -cycloalkyl ; an unsubstituted or substituted C -C -cycloalkenyl ; an unsubstituted or substituted 3 7 4 7 aryl ; an unsubstituted or substituted aryl-C -C -alkyl ; an unsubstituted or substituted heterocyclyl ; an unsubstituted or substituted heterocyclyl-C1-C8-alkyl ; an unsubstituted or substituted hydroxy-C1-C8- alkyl ; an unsubstituted or substituted C1-C8-alkoxy-C1-C8-alkyl ; an unsubstituted or substituted C1-C8- alkylcarbonyloxy-C1-C8-alkyl ; an unsubstituted or substituted aryloxy-C1-C8-alkyl ; an unsubstituted or substituted heterocyclyloxy-C -C -alkyl ; an unsubstituted or substituted amino-C -C-alkyl ; an 1 8 1 8 unsubstituted or substituted C -C -alkylamino-C -C -alkyl ; an unsubstituted or substituted di-C -C - 1 8 1 8 1 8 alkylamino-C1-C8-alkyl ; an unsubstituted or substituted arylamino-C1-C8-alkyl ; an unsubstituted or substituted di-arylamino-C1-C8-alkyl ; an unsubstituted or substituted heterocyclylamino-C1-C8-alkyl ; an unsubstituted or substituted C -C -alkylcarbonylamino-C -C -alkyl ; an unsubstituted or substituted C -C - 1 8 1 8 1 8 alkoxycarbonylamino-C -C -alkyl ; an unsubstituted or substituted C -C -alkylsulfanyl-C -C -alkyl ; an 1 8 1 8 1 8 unsubstituted or substituted C -C -alkylsulfinyl-C -C -alkyl ; an unsubstituted or substituted C -C - 1 8 1 8 1 8 alkylsulfonyl-C1-C8-alkyl or an unsubstituted or substituted cyano-C1-C8-alkyl ; and n, X and Y are as herein-defined.
Process P6 can be performed, if appropriate, in the presence of a suitable base or, if appropriate, in the presence of a suitable Brønsted or Lewis acid, and if appropriate in the presence of a solvent.
Compounds of formula (XIII) are commercially available or can be prepared by well known processes.
Compounds of formula (XIV) can be prepared by known processes from corresponding phenols (IX) and corresponding alpha-halo ketones (Organic and Biomolecular Chemistry (2006), 4, 4193).
Process P6 can as well be used for the preparation 3-phenoxynaphthyridines.
Suitable bases for carrying out process P6 can be as disclosed in connection with process P1.
Suitable Lewis acids for carrying out process P6 can be inorganic and organic Lewis acids which are customary for such reactions. Preference is given to using metal halides, such as aluminium(III) chloride, iron(III) chloride, zinc(II) chloride, titanium tetrachloride, boron trifluoride ; triflates, such as scandium(III) triflate, bismuth(III) triflate or ytterbium(III) triflate and also iodine.
Suitable Brønsted acids for carrying out process P6 can be inorganic and organic Lewis acids which are customary for such reactions. Preference is given to using hydrogen halides, such as hydrogen chloride or hydrogen bromide ; sulfonic acids such as p-toluenesulfonic acid, camphorsulfonic acid, methanesulfonic acid or trifluoromethanesulfonic acid and also polyphosphoric acid, phosphoric acid sulfuric acid, potassium bisulfite, trifluoroacetic acid or acetic acid.
Suitable solvents for carrying out process P6 can be customary inert organic solvents. Preference is given to using water, an alcohol such as methanol, ethanol, propanol, isopropanol, tert-butanol or tert- amyl alcohol, optionally halogen atomated aliphatic, alicyclic or aromatic hydrocarbons, such as petroleum ether, pentane, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene or decalin ; chlorobenzene, dichlorobenzene, dichloromethane, chloroform, carbon tetrachloride, dichloroethane or trichloroethane ; ethers, such as diethyl ether, diisopropyl ether, methyl tert-butyl ether, methyl tert-amyl ether, dioxane, tetrahydrofuran, 2-methyltetrahydrofuran, 1,2-dimethoxyethane, 1,2- diethoxyethane or anisole ; nitriles, such as acetonitrile, propionitrile, n- or iso-butyronitrile or benzonitrile ; amides, such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methylformanilide, N- methylpyrrolidone or hexamethylphosphoric triamide ; ureas, such as 1,3-dimethyl-3,4,5,6-tetrahydro- 2(1H)-pyrimidinone ; esters, such as methyl acetate or ethyl acetate, sulfoxides, such as dimethyl sulfoxide, or sulfones, such as sulfolane; and a mixture thereof.
Process P6 may be performed in an inert atmosphere. When carrying out process P6, 1 mole or an excess of compound of formula (XIV) and from 0.01 to 5 moles of base or from 0.01 to 5 moles percent of suitable acid can be employed per mole of compound of formula (XIII). It is also possible to employ the 40 reaction components in other ratios. Work-up is carried out by known methods.
Processes P1, P2, P3, P4, P5 and P6 are generally carried out under atmospheric pressure. It is also possible to operate under elevated or reduced pressure.
When carrying out processes P1, P2, P3, P4, P5 and P6, the reaction temperatures can be varied within a relatively wide range. In general, these processes are carried out at temperatures from - 78 °C to 200 °C, preferably from - 78 °C to 150 °C. A way to control the temperature for the processes is to use microwave technology.
In general, the reaction mixture is concentrated under reduced pressure. The residue that remains can be freed by known methods, such as chromatography or crystallization, from any impurities that can still be present.
Work-up is carried out by customary methods. Generally, the reaction mixture is treated with water and the organic phase is separated off and, after drying, concentrated under reduced pressure. If appropriate, the remaining residue can, be freed by customary methods, such as chromatography, crystallization or distillation, from any impurities that may still be present.
The compounds of formula (I) can be prepared according to the general processes of preparation described above. It will nevertheless be understood that, on the basis of his general knowledge and of available publications, the skilled worker will be able to adapt the methods according to the specifics of each compound, which it is desired to synthesize.
Intermediates for the preparation of the active compounds Also described are intermediates for the preparation of compounds of formula (I).
Thus, described herein are compounds of formula (IIa) as well as their acceptable salts: (IIa) wherein: L represents O, S, CH or NR ; U represents a chlorine atom, a bromine atom, a iodine atom, a mesyl group, a tosyl group or a triflyl group ; X represents a halogen atom, a C -C -alkyl group, a C -C -halogenoalkyl group comprising 2 to 1 8 1 8 9 halogen atoms that can be the same or different, a C -C -alkoxy group, a C -C -halogenoalkoxy group 1 8 1 8 comprising up to 9 halogen atoms that can be the same or different, a C -C -alkylsulfanyl group, a C -C - 1 8 1 8 halogenoalkylsulfanyl group comprising up to 9 halogen atoms that can be the same or different, or cyano ; Z represents a hydrogen atom, a halogen atom, a C1-C8-alkyl group, a C1-C8-halogenoalkyl group comprising up to 9 halogen atoms that can be the same or different, a C1-C8-alkoxy group, a C1-C8- halogenoalkoxy group comprising up to 9 halogen atoms that can be the same or different, a C -C - alkylsulfanyl group, or a C -C -halogenoalkylsulfanyl group comprising up to 9 halogen atoms that can be the same or different ; and n, p, Y and R are as herein-defined, provided that the compound of formula (IIa) does not represent : - 3-(2-chlorobenzyl)methoxy(pyridinyl)quinoline [15745327], - 3-chloro(quinolinylamino)benzonitrile [14073016], - 8-fluoro(3-fluoroiodophenoxy)quinoline [13140127], - 3-[(2-bromophenyl)sulfanyl]quinoline [12993988], - N-(2-chlorophenyl)quinolinamine [10213289], - 6-bromo(2-chlorobenzyl)methoxyquinoline [9304065], - 2-chloro(2-chlorobenzyl)fluoroquinoline [9246588], - 2-chloro(2-chlorobenzyl)quinoline [9246582], - N-[2-bromo(trifluoromethyl)phenyl]quinolinamine [8917793], - N-(2-bromochlorophenyl)quinolinamine [8917791], - N-(2-bromomethylphenyl)quinolinamine [8917797], - 3-(2-bromo-4,5-dimethoxybenzyl)quinolinol [8561007], - 3-(2-bromo-4,5-dimethoxybenzyl)chloroquinoline [8560899], - 3-(2-chlorobenzyl)phenyl(trifluoromethyl)quinoline [8547709], - N-(2-bromophenyl)quinolinamine [8480863], and - 3-[(2-chlorophenyl)sulfanyl]nitroquinoline [6077433].
The following compounds of formula (IIa) are also mentioned in chemical databases and/or suppliers' databases but without any references or information which enable these to be prepared and separated : - 3-chloro(quinolinyloxy)benzonitrile [19651674], - 3-bromo(quinolinyloxy)benzonitrile [19254806], - 3-bromo(quinolinylamino)benzonitrile [15519352], - 6-bromochloro(2-chlorobenzyl)quinoline [14297504], - 6-bromo(2,4-dichlorobenzyl)methoxyquinoline [9304458], and - 6-bromo(2,3-dichlorobenzyl)methoxyquinoline [9304068].
Preferred compounds of formula (IIa) are : - 3-(3-fluoroiodophenoxy)quinoline, - 3-(2-iodophenoxy)quinoline, - 3-(2-bromophenoxy)quinoline, - 3-(2-bromophenoxy)fluoroquinoline, - 3-(2-bromophenoxy)fluoromethylquinoline, 40 - 3-(2-bromophenoxy)-7,8-difluoroquinoline, - 3-(2-bromophenoxy)-7,8-difluoromethylquinoline, - 3-(2-bromophenoxy)methylquinoline, - 3-(2-bromofluorophenoxy)-7,8-difluoromethylquinoline, - 3-(2-bromofluorophenoxy)-7,8-difluoromethylquinoline, - 3-(2-bromofluorophenoxy)chloroquinoline, - 3-(2-bromofluorophenoxy)-7,8-difluoromethylquinoline, - 3-(2-bromofluorophenoxy)methylquinoline, - 3-(2-bromomethoxyphenoxy)-7,8-difluoromethylquinoline, - 3-(2-bromofluorophenoxy)-7,8-difluoroquinoline, - 3-(2-bromofluorophenoxy)-7,8-difluoromethylquinoline, - 3-(2-bromofluorophenoxy)methylquinoline, - 3-(2-bromofluorophenoxy)methylquinoline, - 3-(2-bromofluorophenoxy)(difluoromethyl)quinoline, - 3-(2-bromochlorophenoxy)-7,8-difluoromethylquinoline, - 3-(2-bromochlorophenoxy)methylquinoline, - N-(2-bromofluorophenyl)(difluoromethyl)quinolinamine, - 8-chloro(2-chlorofluorophenoxy)quinoline, - 3-[2-bromo(trifluoromethoxy)phenoxy]-7,8-difluoromethylquinoline, - 3-[2-bromo(trifluoromethoxy)phenoxy]methylquinoline, and - 3-(2-bromochlorophenoxy)methylquinoline.
Other preferred compounds of formula (II) are : - 2-iodo(quinolinyloxy)benzaldehyde, - [2-iodo(quinolinyloxy)phenyl]methanol, - 2-{2-bromo[(2-methylquinolinyl)oxy]phenyl}ethanol, - N-{2-bromo[(tetrahydro-2H-pyranyloxy)methyl]phenyl}quinolinamine, - 3-{2-iodo[(tetrahydro-2H-pyranyloxy)methyl]phenoxy}quinoline, - 3-(2-bromonitrophenoxy)-7,8-difluoromethylquinoline, - (2-bromophenyl)(quinolinyl)methanone, and - 3-[2-bromo(2-chloroethyl)phenoxy]methylquinoline.
Also described are compounds of formula (IIb) as well as their acceptable salts: (IIb) wherein: a 6 1 L represents O, S, CH or NR ; U represents a chlorine atom, a bromine atom, a iodine atom, a mesyl group, a tosyl group or a triflyl group ; X represents a halogen atom, a C1-C8-alkyl group, a C1-C8-halogenoalkyl group comprising 2 to 9 halogen atoms that can be the same or different, a C1-C8-alkoxy group, a C1-C8-halogenoalkoxy group comprising up to 9 halogen atoms that can be the same or different, a C -C -alkylsulfanyl group, a C -C - 1 8 1 8 halogenoalkylsulfanyl group comprising up to 9 halogen atoms that can be the same or different, or cyano ; Z represents a hydrogen atom, a halogen atom, a C1-C8-alkyl group, a C1-C8-halogenoalkyl group comprising up to 9 halogen atoms that can be the same or different, a C1-C8-alkoxy group, a C1-C8- halogenoalkoxy group comprising up to 9 halogen atoms that can be the same or different, a C -C - alkylsulfanyl group, or a C -C -halogenoalkylsulfanyl group comprising up to 9 halogen atoms that can be the same or different ; and n, p, Y and R are as herein-defined, provided that the compound of formula (IIb) does not represent : - 2-(2-chlorophenoxy)methylquinoxaline [17929862], - 2-bromo[(2-bromochlorophenyl)sulfanyl]quinoxaline [16743811], - 2-bromo(2-bromochlorophenoxy)quinoxaline [16743806], - 2-(2-iodophenoxy)quinoxaline [10551902], - N-[2,6-dichloro(trifluoromethyl)phenyl](trifluoromethyl)quinoxalinamine [8037265], - N-(2-chlorophenyl)methylquinoxalinamine [4384811], - 2-[(2-chlorophenyl)sulfanyl](trifluoromethyl)quinoxaline [3387732], - 2-[(2-chlorophenyl)sulfanyl]quinoxaline [3383943], - 2-(2-bromophenoxy)quinoxaline [2235925], - 2-(2-chlorophenoxy)quinoxaline [2235927], - N-(2,4-dichlorophenyl)quinoxalinamine [1284992], and - 2-(2-chlorobenzyl)quinoxaline [1088522].
The following compounds of formula (IIb) are also mentioned in chemical databases and/or suppliers' databases but without any references or information which enable these to be prepared and separated : - 2-(2-bromomethoxyphenoxy)methylquinoxaline [19213307], - 2-(2-bromomethoxyphenoxy)quinoxaline [19189293], - 2-(2-bromophenoxy)chloroquinoxaline [15467238], - 2-(2-bromofluorophenoxy)methylquinoxaline [15401988], - 2-(2-bromofluorophenoxy)quinoxaline [15034317], - 2-(5-bromochlorophenoxy)quinoxaline [14687419], - 2-(2-bromofluorophenoxy)quinoxaline [14603429], - 2-(2-bromofluorophenoxy)methylquinoxaline [14582207], - 2-(2-iodophenoxy)methylquinoxaline [14571705], - 2-(2-bromomethylphenoxy)methylquinoxaline [14552564], - 2-(5-bromochlorophenoxy)methylquinoxaline [14068472], - 2-(2-bromochlorophenoxy)quinoxaline [13567502], 40 - 2-(2-bromophenoxy)methylquinoxaline [12856657], - 2-(2-bromomethylphenoxy)quinoxaline [12751447], - 2-(2-chlorofluorophenoxy)methylquinoxaline [11815133], - N-(2-chlorofluorophenyl)quinoxalinamine [10297543], - N-(2-chloromethylphenyl)quinoxalinamine [9330293], - 2-chloro(2-chlorophenoxy)quinoxaline [9300376], - 6,7-dichloro(2,4,6-trichlorophenoxy)(trifluoromethyl)quinoxaline [4780403], - 6,7-dichloro(2,6-dichlorophenoxy)(trifluoromethyl)quinoxaline [4780401], - N-(2,4-dichlorophenyl)methylquinoxalinamine [4384819], and - 3-chloro-N-(2-chlorophenyl)quinoxalinamine [3721725].
Preferred compounds of formula (IIb) are : - 2-(2-bromophenoxy)-5,6-difluoroquinoxaline, - 2-(2-bromophenoxy)-5,6-difluoromethylquinoxaline, - 2-(2-bromomethylphenoxy)-5,6-difluoromethylquinoxaline, - 2-(2-bromofluorophenoxy)-5,6-difluoromethylquinoxaline, - 2-(2-bromochlorophenoxy)-5,6-difluoromethylquinoxaline, - 2-(2-bromomethylphenoxy)-5,6-difluoromethylquinoxaline, - 2-(2-bromofluorophenoxy)-5,6-difluoromethylquinoxaline, - 2-(2-bromochlorophenoxy)-5,6-difluoromethylquinoxaline, - 2-(2-bromomethylphenoxy)-5,6-difluoromethylquinoxaline, - 2-(2-bromofluorophenoxy)-5,6-difluoromethylquinoxaline, - 2-(2-bromochlorophenoxy)-5,6-difluoromethylquinoxaline, - 2-(2-bromomethylphenoxy)-5,6-difluoromethylquinoxaline, - 2-(2-bromomethoxyphenoxy)-5,6-difluoromethylquinoxaline, - 2-(2-bromofluorophenoxy)quinoxaline, - 2-(2-bromofluorophenoxy)-5,6-difluoroquinoxaline, - 2-(2-bromofluorophenoxy)-5,6-difluoromethylquinoxaline, - 2-(2-bromofluorophenoxy)methylquinoxaline, - 2-(2-bromochlorophenoxy)-5,6-difluoromethylquinoxaline, - 5-bromo[(5,6-difluoroquinoxalinyl)oxy]fluorobenzonitrile, - 4-bromo[(5,6-difluoromethylquinoxalinyl)oxy]benzonitrile, - 3-bromo[(5,6-difluoroquinoxalinyl)oxy]fluorobenzonitrile, - 2-bromo[(5,6-difluoromethylquinoxalinyl)oxy]benzonitrile, and - 2-[2-bromo(trifluoromethoxy)phenoxy]-5,6-difluoromethylquinoxaline.
Another preferred compound of formula (II) is 2-bromo[(5,6-difluoroquinoxalinyl)oxy]benzaldehyde.
Also described are compounds of formula (IVa) as well as their acceptable salts: (X ) (IVa) wherein: L represents O, S, CH or NR ; X represents a halogen atom, a C1-C8-alkyl group, a C1-C8-halogenoalkyl group comprising up to 9 halogen atoms that can be the same or different, a C1-C8-alkoxy group, a C1-C8-halogenoalkoxy group comprising up to 9 halogen atoms that can be the same or different, a C1-C8-alkylsulfanyl group, a C1-C8- halogenoalkylsulfanyl group comprising up to 9 halogen atoms that can be the same or different, or cyano ; and n, p, Y, Z and R are as herein-defined, provided that the compound of formula (IVa) does not represent : - 2-chloro[(8-fluoroquinolinyl)oxy]aniline [14171928], - 2-fluoro[(8-fluoroquinolinyl)oxy]aniline [14171927], - 4-[3-(2-aminophenoxy)chloroquinolinyl]methoxymethyl-2,4-dihydro-3H-1,2,4-triazolone id="p-10995070"
id="p-10995070"
[10995070], - 3-[(2-aminophenyl)sulfanyl]chlorophenylquinolin-2(1H)-one [7273737], and - 2-[(2-methylquinolinyl)methyl]aniline [4123366].
The following compounds of formula (IVa) are also mentioned in chemical databases and/or suppliers' databases but without any references or information which enable these to be prepared and separated : - 2-chloro(quinolinyloxy)aniline [19651740], - 2-ethoxy(quinolinyloxy)aniline [19624331], - 3-amino(quinolinyloxy)benzonitrile [19624330], - 3,4-difluoro(quinolinyloxy)aniline [19616978], - 4-chlorofluoro(quinolinyloxy)aniline [19367769], - 2-methyl(quinolinyloxy)aniline [19314757], - 3-methyl(quinolinyloxy)aniline [19292340], - 5-chlorofluoro(quinolinyloxy)aniline [19292346], - 4-chloro(quinolinyloxy)aniline [19292317], - 2-amino(quinolinyloxy)benzonitrile [19290053], - 4-methoxy(quinolinyloxy)aniline [19289904], - 5-methyl(quinolinyloxy)aniline [19289909], - 4-bromo(quinolinyloxy)aniline [19288571], - 5-bromo(quinolinyloxy)aniline [19288570], - 5-chloro(quinolinyloxy)aniline [19288579], - 4-methyl(quinolinyloxy)aniline [19288578], - 5-fluoro(quinolinyloxy)aniline [19286207], - 5-fluoromethoxy(quinolinyloxy)aniline [19286205], - 4,5-dichloro(quinolinyloxy)aniline [19275063], - 2-methoxy(quinolinyloxy)aniline [19275061], - 4-amino(quinolinyloxy)benzonitrile [19275065], - 4-fluoroiodo(quinolinyloxy)aniline [19271394], - 2-(quinolinyloxy)aniline [19271393], - 2-fluoro(quinolinyloxy)aniline [19270749], - 2,4-difluoro(quinolinyloxy)aniline [19269354], - 4-fluoro(quinolinyloxy)aniline [19269347], - 3-chloro(quinolinyloxy)aniline [19256204], - 4-bromofluoro(quinolinyloxy)aniline [19256200], - 5-bromofluoro(quinolinyloxy)aniline [19256205], - 5-iodo(quinolinyloxy)aniline [19254805], - 5-fluoromethyl(quinolinyloxy)aniline [19254807], and - 5-methoxy(quinolinyloxy)aniline [19254805].
Preferred compounds of formula (IVa) are : - N-(quinolinyl)benzene-1,2-diamine, - 2-fluoro[(2-methylquinolinyl)oxy]aniline, - 2-[(7,8-difluoroquinolinyl)oxy]aniline, - 2-[(7,8-difluoroquinolinyl)oxy]fluoroaniline, - 2-[(7,8-difluoromethylquinolinyl)oxy]aniline, - 2-[(7,8-difluoromethylquinolinyl)oxy]fluoroaniline and - 2-[(2-methylquinolinyl)oxy]aniline.
Also described are compounds of formula (Va) as well as their acceptable salts: (Va) wherein : L represents O, S, CH2 or NR ; and n, p, X, Y, Z and R are as herein-defined, provided that the compound of formula (Va) does not represent : - N-[2,6-dinitro(trifluoromethyl)phenyl]quinolinamine [16385023], - N-(2,4-dinitrophenyl)quinolinamine [16385021], - 3-(3-chloronitrophenoxy)fluoroquinoline [14171925], - 8-fluoro(3-fluoronitrophenoxy)quinoline [14171924], - 3-(2-nitrophenoxy)quinoline [14171923], - N-(4,6-dimethyloxo-1,2-dihydroquinolinyl)-N-(5-methyl-2,4-dinitrophenyl)acetamide [1074030], - N-(4,6-dimethyloxo-1,2-dihydroquinolinyl)-N-(2-nitrophenyl)acetamide [1074039], - 4,6-dimethyl[(5-methyl-2,4-dinitrophenyl)amino]quinolin-2(1H)-one [1074038], - 4,6-dimethyl[(2-nitrophenyl)amino]quinolin-2(1H)-one [1074037], and - 3-[(2-nitrophenyl)sulfanyl]quinoline [1004617].
The following compounds of formula (Va) are also mentioned in chemical databases and/or suppliers' databases but without any references or information which enable these to be prepared and separated : - 3-(4-bromonitrophenoxy)quinoline [19737292], - 2-nitro(quinolinyloxy)aniline [19617520], - 3-(3-chloronitrophenoxy)quinoline [19288571], - 3-(3-fluoronitrophenoxy)quinoline [19288576], - N-(4-bromonitrophenyl)quinolinamine [14087346], - 4-hydroxy[(2-nitrophenyl)sulfanyl]quinolin-2(1H)-one [6858902], and - 4-[(7-methoxyquinolinyl)amino]nitrophthalonitrile [5405124].
Preferred compounds of formula (Va) are : - 7,8-difluoro(3-fluoronitrophenoxy)quinoline, - 7,8-difluoro(3-fluoronitrophenoxy)methylquinoline, - 7,8-difluoro(2-nitrophenoxy)quinoline, - 7,8-difluoromethyl(2-nitrophenoxy)quinoline, - 3-(3-fluoronitrophenoxy)quinoline, - 3-(3-fluoronitrophenoxy)methylquinoline, and - 2-methyl(2-nitrophenoxy)quinoline.
Also described are compounds of formula (IXa): (IXa) wherein : X represents a hydrogen atom, a chlorine atom or a fluorine atom ; L represents O, S and NH ; and R represents a hydrogen atom or an unsubstituted or substituted C -C -alkyl ; a C -C - 1 8 1 8 halogenoalkyl comprising up to 9 halogen atoms that can be the same or different ; an unsubstituted or substituted C2-C8-alkenyl ; an unsubstituted or substituted C2-C8-alkynyl ; an unsubstituted or substituted C3-C7-cycloalkyl ; an unsubstituted or substituted C4-C7-cycloalkenyl ; an unsubstituted or substituted aryl ; an unsubstituted or substituted aryl-C -C -alkyl ; an unsubstituted or substituted heterocyclyl ; an unsubstituted or substituted heterocyclyl-C1-C8-alkyl ; an unsubstituted or substituted hydroxy-C1-C8- alkyl ; an unsubstituted or substituted C1-C8-alkoxy-C1-C8-alkyl ; an unsubstituted or substituted C1-C8- alkylcarbonyloxy-C -C -alkyl ; an unsubstituted or substituted aryloxy-C -C -alkyl ; an unsubstituted or 1 8 1 8 substituted heterocyclyloxy-C -C -alkyl ; an unsubstituted or substituted amino-C -C-alkyl ; an 1 8 1 8 unsubstituted or substituted C -C -alkylamino-C -C -alkyl ; an unsubstituted or substituted di-C -C - 1 8 1 8 1 8 alkylamino-C1-C8-alkyl ; an unsubstituted or substituted arylamino-C1-C8-alkyl ; an unsubstituted or substituted di-arylamino-C1-C8-alkyl ; an unsubstituted or substituted heterocyclylamino-C1-C8-alkyl ; an unsubstituted or substituted C -C -alkylcarbonylamino-C -C -alkyl ; an unsubstituted or substituted C -C - 1 8 1 8 1 8 alkoxycarbonylamino-C -C -alkyl ; an unsubstituted or substituted C -C -alkylsulfanyl-C -C -alkyl ; an 1 8 1 8 1 8 unsubstituted or substituted C -C -alkylsulfinyl-C -C -alkyl ; an unsubstituted or substituted C -C - 1 8 1 8 1 8 alkylsulfonyl-C1-C8-alkyl ; or an unsubstituted or substituted cyano-C1-C8-alkyl ; provided that the compound of formula (IXa) does not represent : - 2-[dimethyl(phenyl)silyl]aniline [18193680], - 3-fluoro(trimethylsilyl)phenol [18089205], - 3-chloro(trimethylsilyl)phenol [18089202], - 2-[heptyl(dimethyl)silyl]aniline [14277720], - 2-[hexyl(dimethyl)silyl]aniline [2176625], - 2,2'-(dimethylsilanediyl)diphenol [1223977], - 2,2'-(dimethylsilanediyl)dibenzenethiol [1175269], - 2-{dimethyl[(trimethylsilyl)methyl]silyl}benzenethiol [1175266], - 2-[tert-butyl(dimethyl)silyl]benzenethiol [1175266], - 2-[tert-butyl(dimethyl)silyl]phenol [827720], - 2-(trimethylsilyl)aniline [577923], - 2-(dimethylsilyl)phenol [333679], - 2-(trimethylsilyl)benzenethiol [333565], and - 2-(trimethylsilyl)phenol [152886].
The following compounds of formula (IXa) are also mentioned in chemical databases and/or suppliers' databases but without any references or information which enable these to be prepared and separated : - 2-[{4-[(2-ethylhexyl)oxy]phenyl}(dimethyl)silyl]phenol [13980440], and - 2-[allyl(dimethyl)silyl]benzenethiol [6995327].
Preferred compounds of formula (IXa) are : - 3-fluoro[isopropyl(dimethyl)silyl]phenol, - 2-[isopropyl(dimethyl)silyl]phenol, - 2-[isobutyl(dimethyl)silyl]phenol, - 2-[ethyl(dimethyl)silyl]phenol, - 2-[cyclohexyl(dimethyl)silyl]phenol, and - 2-[benzyl(dimethyl)silyl]phenol.
Other preferred compounds of formula (IXa) are 2-(triethylsilyl)phenol and 3-fluoro(triethylsilyl)phenol.
Also described are compounds of formula (XIa): (XIa) wherein : X represents a hydrogen atom, a chlorine atom or a fluorine atom ; U represents a bromine atom, a chlorine atom, an iodine atom, a mesyl group, a tosyl group or a triflyl group ; and R represents a hydrogen atom or an unsubstituted or substituted C1-C8-alkyl ; a C1-C8- halogenoalkyl comprising up to 9 halogen atoms that can be the same or different ; an unsubstituted or substituted C -C -alkenyl ; an unsubstituted or substituted C -C -alkynyl ; an unsubstituted or substituted 2 8 2 8 C -C -cycloalkyl ; an unsubstituted or substituted C -C -cycloalkenyl ; an unsubstituted or substituted 3 7 4 7 aryl ; an unsubstituted or substituted aryl-C -C -alkyl ; an unsubstituted or substituted heterocyclyl ; an unsubstituted or substituted heterocyclyl-C1-C8-alkyl ; an unsubstituted or substituted hydroxy-C1-C8- alkyl ; an unsubstituted or substituted C1-C8-alkoxy-C1-C8-alkyl ; an unsubstituted or substituted C1-C8- alkylcarbonyloxy-C -C -alkyl ; an unsubstituted or substituted aryloxy-C -C -alkyl ; an unsubstituted or 1 8 1 8 substituted heterocyclyloxy-C -C -alkyl ; an unsubstituted or substituted amino-C -C-alkyl ; an 1 8 1 8 unsubstituted or substituted C1-C8-alkylamino-C1-C8-alkyl ; an unsubstituted or substituted di-C1-C8- alkylamino-C1-C8-alkyl ; an unsubstituted or substituted arylamino-C1-C8-alkyl ; an unsubstituted or substituted di-arylamino-C1-C8-alkyl ; an unsubstituted or substituted heterocyclylamino-C1-C8-alkyl ; an unsubstituted or substituted C -C -alkylcarbonylamino-C -C -alkyl ; an unsubstituted or substituted C -C - 1 8 1 8 1 8 alkoxycarbonylamino-C -C -alkyl ; an unsubstituted or substituted C -C -alkylsulfanyl-C -C -alkyl ; an 1 8 1 8 1 8 unsubstituted or substituted C1-C8-alkylsulfinyl-C1-C8-alkyl ; an unsubstituted or substituted C1-C8- alkylsulfonyl-C1-C8-alkyl ; or an unsubstituted or substituted cyano-C1-C8-alkyl ; provided that the compound of formula (XIa) does not represent : - [2-(chloromethyl)phenyl](trimethyl)silane [13792346], - [2-(bromomethyl)phenyl](3-chloropropyl)dimethylsilane [1302849], - [2-(iodomethyl)phenyl](trimethyl)silane [1263287], - [2-(bromomethyl)phenyl](chloromethyl)dimethylsilane [548482], - bis[2-(bromomethyl)phenyl](dimethyl)silane [194219], and - [2-(bromomethyl)phenyl](trimethyl)silane [179034].
Preferred compounds of formula (XIa) are : - 5-{[2-(bromomethyl)phenyl](dimethyl)silyl}chloropyridine, - [2-(iodomethyl)phenyl](dimethyl)phenylsilane, - [2-(bromomethyl)phenyl](dimethyl)phenylsilane, - [2-(bromomethyl)phenyl](dimethyl)2-thienylsilane, - [2-(bromomethyl)phenyl](dimethyl)(4-phenoxyphenyl)silane, - [2-(bromomethyl)phenyl](4-chlorophenyl)dimethylsilane, - benzyl[2-(bromomethyl)phenyl]dimethylsilane, - biphenylyl[2-(bromomethyl)phenyl]dimethylsilane, and - (4-benzylphenyl)[2-(bromomethyl)phenyl]dimethylsilane.
Also described are compounds of formula (XIIa): (XIIa) wherein : W represents a boron derivative such as a boronic acid, a boronic ester or a potassium 1a 2a trifluoroborate derivative ; R and R independently represent an unsubstituted or substituted C -C - alkyl, an unsubstituted or substituted C2-C8-alkenyl, an unsubstituted or substituted C3-C7-cycloalkyl, an unsubstituted or substituted aryl, an unsubstituted or substituted heterocyclyl ; R represents a hydrogen atom or an unsubstituted or substituted C -C -alkyl ; a C -C - 1 8 1 8 halogenoalkyl comprising up to 9 halogen atoms that can be the same or different ; an unsubstituted or substituted C2-C8-alkenyl ; an unsubstituted or substituted C2-C8-alkynyl ; an unsubstituted or substituted C3-C7-cycloalkyl ; an unsubstituted or substituted C4-C7-cycloalkenyl ; an unsubstituted or substituted aryl ; an unsubstituted or substituted aryl-C1-C8-alkyl ; an unsubstituted or substituted heterocyclyl ; an unsubstituted or substituted heterocyclyl-C -C -alkyl ; an unsubstituted or substituted hydroxy-C -C - 1 8 1 8 alkyl ; an unsubstituted or substituted C -C -alkoxy-C -C -alkyl ; an unsubstituted or substituted C -C - 1 8 1 8 1 8 alkylcarbonyloxy-C1-C8-alkyl ; an unsubstituted or substituted aryloxy-C1-C8-alkyl ; an unsubstituted or substituted heterocyclyloxy-C1-C8-alkyl ; an unsubstituted or substituted amino-C1-C8-alkyl ; an unsubstituted or substituted C -C -alkylamino-C -C -alkyl ; an unsubstituted or substituted di-C -C - 1 8 1 8 1 8 alkylamino-C -C -alkyl ; an unsubstituted or substituted arylamino-C -C -alkyl ; an unsubstituted or 1 8 1 8 substituted di-arylamino-C -C -alkyl ; an unsubstituted or substituted heterocyclylamino-C -C -alkyl ; an 1 8 1 8 unsubstituted or substituted C1-C8-alkylcarbonylamino-C1-C8-alkyl ; an unsubstituted or substituted C1-C8- alkoxycarbonylamino-C1-C8-alkyl ; an unsubstituted or substituted C1-C8-alkylsulfanyl-C1-C8-alkyl ; an unsubstituted or substituted C -C -alkylsulfinyl-C -C -alkyl ; an unsubstituted or substituted C -C - 1 8 1 8 1 8 alkylsulfonyl-C -C -alkyl ; or an unsubstituted or substituted cyano-C -C -alkyl ; and 1 8 1 8 n and X are as herein-defined, provided that the compound of formula (XIIa) does not represent : - dimethyl{2-[(4,4,5,5-tetramethyl-1,3,2-dioxaborolanyl)methyl]phenyl}silane [16393678], - methyl(phenyl){2-[(4,4,5,5-tetramethyl-1,3,2-dioxaborolanyl)methyl]phenyl}silane [16393679], and - diphenyl{2-[(4,4,5,5-tetramethyl-1,3,2-dioxaborolanyl)methyl]phenyl}silane [16393670].
A preferred compound of formula (XIIa) is - trimethyl{2-[(4,4,5,5-tetramethyl-1,3,2-dioxaborolanyl)methyl]phenyl}silane.
Also described are compounds of formula (VIIa) as well as their acceptable salts: (VIIa) wherein : L represents O or S ; X represents a halogen atom, a C1-C8-alkyl group, a C1-C8-halogenoalkyl group comprising up to 9 halogen atoms that can be the same or different, a C -C -alkoxy group, a C -C -halogenoalkoxy group 1 8 1 8 comprising up to 9 halogen atoms that can be the same or different, a C -C -alkylsulfanyl group, a C -C - 1 8 1 8 halogenoalkylsulfanyl group comprising up to 9 halogen atoms that can be the same or different, or cyano ; Z represents a hydrogen atom, a halogen atom, a C -C -alkyl group, a C -C -halogenoalkyl 1 8 1 8 group comprising up to 9 halogen atoms that can be the same or different, a C -C -alkoxy group, a C -C - 1 8 1 8 halogenoalkoxy group comprising up to 9 halogen atoms that can be the same or different, a C1-C8- alkylsulfanyl group, or a C1-C8-halogenoalkylsulfanyl group comprising up to 9 halogen atoms that can be the same or different ; and n, p and Y are as herein-defined, provided that the compound of formula (VIIa) does not represent : - 3-[(3-fluorophenyl)sulfanyl]quinoline [12993984], - 8-chloro[(3-fluorophenyl)sulfanyl]quinoline [10605791], - 3-[(3-fluorophenyl)sulfanyl]iodoquinoline [6077438], - 3-[(3-fluorophenyl)sulfanyl]quinolinamine [6077435], and - 3-[(3-fluorophenyl)sulfanyl]nitroquinoline [6077439].
The following compounds of formula (VIIa) are also mentioned in chemical databases and/or suppliers' databases but without any references or information which enable these to be prepared and separated : - 3-fluoro(quinolinyloxy)benzonitrile [19616984], and - 3-[3-(chloromethyl)fluorophenoxy]quinoline [19275078].
Preferred compounds of formula (VIIa) are : - 2-chloro(3-fluorophenoxy)quinoline, - 2-ethoxy(3-fluorophenoxy)quinoline, - 3-(3-fluorophenoxy)(methylsulfanyl)quinoline, - 3-(3-fluorophenoxy)methylquinoline, - 3-(3-fluorophenoxy)quinoline, and - 3-(3-fluorophenoxy)quinoline 1-oxide.
Other preferred compounds of formula (VII) are : - (3-fluorophenyl)(quinolinyl)methanol, - (3-fluorophenyl)(quinolinyl)methanone, - 2-(difluoromethyl)-N-(3-fluorophenyl)quinolinamine, - 3-[(3-fluorophenyl)sulfinyl]quinoline, and - 3-[(3-fluorophenyl)sulfonyl]quinoline.
Also described are compounds of formula (VIIb) as well as their acceptable salts: (VIIb) wherein : L represents O or S ; X represents a halogen atom, a C1-C8-alkyl group, a C1-C8-halogenoalkyl group comprising up to 9 halogen atoms that can be the same or different, a C -C -alkoxy group, a C -C -halogenoalkoxy group 1 8 1 8 comprising up to 9 halogen atoms that can be the same or different, a C -C -alkylsulfanyl group, a C -C - 1 8 1 8 halogenoalkylsulfanyl group comprising up to 9 halogen atoms that can be the same or different, or cyano ; Z represents a hydrogen atom, a halogen atom, a C1-C8-alkyl group, a C1-C8-halogenoalkyl group comprising up to 9 halogen atoms that can be the same or different, a C -C -alkoxy group, a C -C - 1 8 1 8 halogenoalkoxy group comprising up to 9 halogen atoms that can be the same or different, a C -C - alkylsulfanyl group, or a C1-C8-halogenoalkylsulfanyl group comprising up to 9 halogen atoms that can be the same or different ; and n, p and Y are as herein-defined, provided that the compound of formula (VIIb) does not represent 2-(4-chlorofluorophenoxy) methylquinoxaline [4778706].
The following compounds of formula (VIIb) are also mentioned in chemical databases and/or suppliers' databases but without any references or information which enable these to be prepared and separated : - 2-(2-bromofluorophenoxy)methylquinoxaline [15401988], - 2-(3-bromofluorophenoxy)methylquinoxaline [15066118], - 2-(3-bromofluorophenoxy)quinoxaline [15045018], - 2-(2-bromofluorophenoxy)quinoxaline [15034317], - 2-(4-bromofluorophenoxy)methylquinoxaline [14861515], - 2-(4-bromofluorophenoxy)quinoxaline [14782829], and - 6,7-dichloro(4-chlorofluorophenoxy)(trifluoromethyl)quinoxaline [4780396].
Also described are compounds of formula (XIV) as well as their acceptable salts: (XIV) wherein : 1a 2a R and R independently represent an unsubstituted or substituted C1-C8-alkyl, an unsubstituted or substituted C -C -alkenyl, an unsubstituted or substituted C -C -cycloalkyl, an unsubstituted or 2 8 3 7 substituted aryl, an unsubstituted or substituted heterocyclyl ; R represents a hydrogen atom or an unsubstituted or substituted C1-C8-alkyl ; a C1-C8- halogenoalkyl comprising up to 9 halogen atoms that can be the same or different ; an unsubstituted or substituted C2-C8-alkenyl ; an unsubstituted or substituted C2-C8-alkynyl ; an unsubstituted or substituted C -C -cycloalkyl ; an unsubstituted or substituted C -C -cycloalkenyl ; an unsubstituted or substituted 3 7 4 7 aryl ; an unsubstituted or substituted aryl-C -C -alkyl ; an unsubstituted or substituted heterocyclyl ; an unsubstituted or substituted heterocyclyl-C1-C8-alkyl ; an unsubstituted or substituted hydroxy-C1-C8- alkyl ; an unsubstituted or substituted C1-C8-alkoxy-C1-C8-alkyl ; an unsubstituted or substituted C1-C8- alkylcarbonyloxy-C1-C8-alkyl ; an unsubstituted or substituted aryloxy-C1-C8-alkyl ; an unsubstituted or substituted heterocyclyloxy-C -C -alkyl ; an unsubstituted or substituted amino-C -C-alkyl ; an 1 8 1 8 unsubstituted or substituted C1-C8-alkylamino-C1-C8-alkyl ; an unsubstituted or substituted di-C1-C8- alkylamino-C1-C8-alkyl ; an unsubstituted or substituted arylamino-C1-C8-alkyl ; an unsubstituted or substituted di-arylamino-C1-C8-alkyl ; an unsubstituted or substituted heterocyclylamino-C1-C8-alkyl ; an unsubstituted or substituted C -C -alkylcarbonylamino-C -C -alkyl ; an unsubstituted or substituted C -C - 1 8 1 8 1 8 alkoxycarbonylamino-C -C -alkyl ; an unsubstituted or substituted C -C -alkylsulfanyl-C -C -alkyl ; an 1 8 1 8 1 8 unsubstituted or substituted C1-C8-alkylsulfinyl-C1-C8-alkyl ; an unsubstituted or substituted C1-C8- alkylsulfonyl-C1-C8-alkyl ; or an unsubstituted or substituted cyano-C1-C8-alkyl ; and n, X and Z are as herein-defined, provided that the compound of formula (XIV) does not represent : - 2-[2-bromo(trimethylsilyl)phenoxy]phenylethanone [9183046], - methyl {2-[methoxy(dimethyl)silyl]phenoxy}acetate [1878716], - N-[2-(dimethylamino)ethyl][2-(trimethylsilyl)phenoxy]acetamide [1264856], - 2-(dimethylamino)ethyl [2-(trimethylsilyl)phenoxy]acetate [1264851], - butyl {2-[methoxy(dimethyl)silyl]phenoxy}acetate [1223977], - ethyl [2-(trimethylsilyl)phenoxy]acetate [1046536], and - [2-(trimethylsilyl)phenoxy]acetic acid [1046535].
A preferred compound of formula (XIV) is 1-[2-(trimethylsilyl)phenoxy]acetone.
Compositions and formulations The present invention further relates to a composition, in particular a composition for controlling unwanted microorganisms, comprising one or more compounds of formula (I). The composition is preferably is a fungicidal composition.
The composition typically comprises one or more compounds of formula (I) and one or more acceptable carriers, in particular one or more agriculturally acceptable carriers.
A carrier is a natural or synthetic, organic or inorganic substance with which the active ingredients are mixed or combined for better applicability, in particular for better application to plants, plant parts or seeds. The carrier, which may be solid or liquid, is generally inert.
Examples of suitable solid carriers include, but are not limited to, ammonium salts, natural rock flours, such as kaolins, clays, talc, chalk, quartz, attapulgite, montmorillonite or diatomaceous earth, and synthetic rock flours, such as finely divided silica, alumina and silicates. Examples of typically useful solid carriers for preparing granules include, but are not limited to, crushed and fractionated natural rocks such as calcite, marble, pumice, sepiolite and dolomite, synthetic granules of inorganic and organic flours and granules of organic material such as paper, sawdust, coconut shells, maize cobs and tobacco stalks.
Examples of suitable liquid carriers include, but are not limited to, water, polar and nonpolar organic chemical liquids, for example from the classes of aromatic and nonaromatic hydrocarbons (such as cyclohexane, paraffins, alkylbenzenes, xylene, toluene alkylnaphthalenes, chlorinated aromatics or chlorinated aliphatic hydrocarbons such as chlorobenzenes, chloroethylenes or methylene chloride), alcohols and polyols (which may optionally also be substituted, etherified and/or esterified, such as butanol or glycol), ketones (such as acetone, methyl ethyl ketone, methyl isobutyl ketone cyclohexanone), esters (including fats and oils) and (poly)ethers, unsubstituted and substituted amines, amides (such as dimethylformamide),lactams (such as N- alkylpyrrolidones) and lactones, sulphones and sulphoxides (such as dimethyl sulphoxide). The carrier may also be a liquefied gaseous extender, i.e. liquid which is gaseous at standard temperature and under standard pressure, for example aerosol propellants such as halohydrocarbons, butane, propane, nitrogen and carbon dioxide.
The composition may further comprise one or more acceptable auxiliaries which are customary for formulating compositions (e.g. agrochemical compositions), such as one or more surfactants.
Examples of suitable surfactants include emulsifiers and/or foam formers, dispersants or wetting agents having ionic or nonionic properties, or mixtures thereof. Examples thereof are salts of polyacrylic acid, salts of lignosulphonic acid, salts of phenolsulphonic acid or naphthalenesulphonic acid, polycondensates of ethylene and/or propylene oxide with fatty alcohols, fatty acids or fatty amines (polyoxyethylene fatty acid esters, polyoxyethylene fatty alcohol ethers, for example alkylaryl polyglycol ethers), substituted phenols (preferably alkylphenols or arylphenols), salts of sulphosuccinic esters, taurine derivatives (preferably alkyl taurates), phosphoric esters of polyethoxylated alcohols or phenols, fatty esters of polyols, and derivatives of compounds containing sulphates, sulphonates and phosphates, for example alkylaryl polyglycol ethers, alkylsulphonates, alkyl sulphates, arylsulphonates, protein hydrolysates, lignosulphite waste 40 liquors and methylcellulose. A surfactant is typically used when the active ingredient and/or the carrier is insoluble in water and the application is made with water. Then, the amount of surfactants typically ranges from 5 to 40 % by weight of the composition.
Further examples of auxiliaries which are customary for formulating agrochemical compositions include water repellent, siccatives, binder (adhesive, tackifier, fixing agent, such as carboxymethylcellulose, natural and synthetic polymers in the form of powders, granules or latices, such as gum arabic, polyvinyl alcohol and polyvinyl acetate, natural phospholipids such as cephalins and lecithins and synthetic phospholipids, polyvinylpyrrolidone, polyvinyl acetate, polyvinyl alcohol and tylose), thickeners, stabilizers (e.g. cold stabilizers, preservatives, antioxidants, light stabilizers, or other agents which improve chemical and/or physical stability), dyes or pigments (such as inorganic pigments, e.g. iron oxide, titanium oxide and Prussian Blue ; organic dyes, e.g. alizarin, azo and metal phthalocyanine dyes), antifoams (e.g. silicone antifoams and magnesium stearate), preservatives (e.g. dichlorophene and benzyl alcohol hemiformal), secondary thickeners (cellulose derivatives, acrylic acid derivatives, xanthan, modified clays and finely divided silica), stickers, gibberellins and processing auxiliaries, mineral and vegetable oils, perfumes, waxes and nutrients (including trace nutrients, such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc), protective colloids, thixotropic substances, penetrants, sequestering agents and complex formers.
The choice of the carriers and/or auxiliaries will depend on the intended mode of application of the composition and/or on the physical properties of the active ingredient(s).
The compositions may be formulated in the form of any customary formulations, such as solutions (e.g aqueous solutions), emulsions, wettable powders, water- and oil-based suspensions, powders, dusts, pastes, soluble powders, soluble granules, granules for broadcasting, suspoemulsion concentrates, natural products impregnated with the active ingredient(s), synthetic substances impregnated with the active ingredient(s), fertilizers and also microencapsulations in polymeric substances. In the formulation of the composition, the active ingredient may be present in suspended, emulsified or dissolved form.
The compositions may be ready-for-use compositions, i.e. the compositions can be directly applied to the plant or seed by a suitable device, such as a spraying or dusting device. Alternatively, the compositions may be in the form of commercial concentrates which have to be diluted, preferably with water, prior to use.
The compositions can be prepared in conventional manners, for example by mixing the active ingredient(s) with one or more carriers and/or one or more suitable auxiliaries, such as disclosed herein above.
The compositions contain generally from 0.05 to 99% by weight, from 0.01 to 98% by weight, preferably from 0.1 to 95% by weight, more preferably from 0.5 to 90% by weight, most preferably from 10 to 70 % by weight of the active ingredient or mixture thereof.
The compositions described above can be used for controlling unwanted microorganisms. The compositions may be applied to the microorganisms and/or in their habitat.
The compounds of formula (I) can be used as such or in formulations thereof. They can also be mixed or used in combination with known fungicides, bactericides, acaricides, nematicides, insecticides or mixtures thereof. The use of known fungicides, bactericides, acaricides, nematicides or insecticides, may allow to broaden the activity spectrum or to prevent development of resistance. Examples of known fungicides, insecticides, acaricides, nematicides or bactericides are disclosed in Pesticide Manual, 14th ed..
The compounds of formula (I) can also be mixed or used in combination with other known active agents, 40 such as herbicides, or with fertilizers, growth regulators, safeners and/or semiochemicals.
Thus, in some embodiments, the composition further comprises an additional active agent selected from fungicides, bactericides, acaricides, nematicides, insecticides, herbicides, fertilizers, growth regulators, safeners, semiochemicals and mixtures thereof.
Examples of especially preferred fungicides which could be mixed with the compound and the composition of the invention are: 1) Inhibitors of the ergosterol biosynthesis, for example (1.001) cyproconazole, (1.002) difenoconazole, (1.003) epoxiconazole, (1.004) fenhexamid, (1.005) fenpropidin, (1.006) fenpropimorph, (1.007) fenpyrazamine, (1.008) fluquinconazole, (1.009) flutriafol, (1.010) imazalil, (1.011) imazalil sulfate, (1.012) ipconazole, (1.013) metconazole, (1.014) myclobutanil, (1.015) paclobutrazol, (1.016) prochloraz, (1.017) propiconazole, (1.018) prothioconazole, (1.019) Pyrisoxazole, (1.020) spiroxamine, (1.021) tebuconazole, (1.022) tetraconazole, (1.023) triadimenol, (1.024) tridemorph, (1.025) triticonazole, (1.026) (1R,2S,5S) (4-chlorobenzyl)(chloromethyl)methyl(1H-1,2,4-triazolylmethyl)cyclopentanol, (1.027) (1S,2R,5R)(4-chlorobenzyl)(chloromethyl)methyl(1H-1,2,4-triazolylmethyl)cyclopentanol, (1.028) (2R)(1-chlorocyclopropyl)[(1R)-2,2-dichlorocyclopropyl](1H-1,2,4-triazolyl)butanol, (1.029) (2R)(1-chlorocyclopropyl)[(1S)-2,2-dichlorocyclopropyl](1H-1,2,4-triazolyl)butanol, (1.030) (2R)[4-(4-chlorophenoxy)(trifluoromethyl)phenyl](1H-1,2,4-triazolyl)propanol, (1.031) (2S)(1-chlorocyclopropyl)[(1R)-2,2-dichlorocyclopropyl](1H-1,2,4-triazolyl)butanol, (1.032) (2S)(1-chlorocyclopropyl)[(1S)-2,2-dichlorocyclopropyl](1H-1,2,4-triazolyl)butanol, (1.033) (2S)[4-(4-chlorophenoxy)(trifluoromethyl)phenyl](1H-1,2,4-triazolyl)propanol, (1.034) (R)-[3- (4-chlorofluorophenyl)(2,4-difluorophenyl)-1,2-oxazolyl](pyridinyl)methanol, (1.035) (S)-[3-(4- chlorofluorophenyl)(2,4-difluorophenyl)-1,2-oxazolyl](pyridinyl)methanol, (1.036) [3-(4-chloro fluorophenyl)(2,4-difluorophenyl)-1,2-oxazolyl](pyridinyl)methanol, (1.037) 1-({(2R,4S)[2- chloro(4-chlorophenoxy)phenyl]methyl-1,3-dioxolanyl}methyl)-1H-1,2,4-triazole, (1.038) 1- ({(2S,4S)[2-chloro(4-chlorophenoxy)phenyl]methyl-1,3-dioxolanyl}methyl)-1H-1,2,4-triazole, (1.039) 1-{[3-(2-chlorophenyl)(2,4-difluorophenyl)oxiranyl]methyl}-1H-1,2,4-triazolyl thiocyanate, (1.040) 1-{[rel(2R,3R)(2-chlorophenyl)(2,4-difluorophenyl)oxiranyl]methyl}-1H-1,2,4-triazolyl thiocyanate, (1.041) 1-{[rel(2R,3S)(2-chlorophenyl)(2,4-difluorophenyl)oxiranyl]methyl}-1H-1,2,4- triazolyl thiocyanate, (1.042) 2-[(2R,4R,5R)(2,4-dichlorophenyl)hydroxy-2,6,6-trimethylheptan yl]-2,4-dihydro-3H-1,2,4-triazolethione, (1.043) 2-[(2R,4R,5S)(2,4-dichlorophenyl)hydroxy-2,6,6- trimethylheptanyl]-2,4-dihydro-3H-1,2,4-triazolethione, (1.044) 2-[(2R,4S,5R)(2,4-dichlorophenyl)- -hydroxy-2,6,6-trimethylheptanyl]-2,4-dihydro-3H-1,2,4-triazolethione, (1.045) 2-[(2R,4S,5S)(2,4- dichlorophenyl)hydroxy-2,6,6-trimethylheptanyl]-2,4-dihydro-3H-1,2,4-triazolethione, (1.046) 2- [(2S,4R,5R)(2,4-dichlorophenyl)hydroxy-2,6,6-trimethylheptanyl]-2,4-dihydro-3H-1,2,4-triazole thione, (1.047) 2-[(2S,4R,5S)(2,4-dichlorophenyl)hydroxy-2,6,6-trimethylheptanyl]-2,4-dihydro- 3H-1,2,4-triazolethione, (1.048) 2-[(2S,4S,5R)(2,4-dichlorophenyl)hydroxy-2,6,6-trimethylheptan- 4-yl]-2,4-dihydro-3H-1,2,4-triazolethione, (1.049) 2-[(2S,4S,5S)(2,4-dichlorophenyl)hydroxy-2,6,6- trimethylheptanyl]-2,4-dihydro-3H-1,2,4-triazolethione, (1.050) 2-[1-(2,4-dichlorophenyl)hydroxy- 2,6,6-trimethylheptanyl]-2,4-dihydro-3H-1,2,4-triazolethione, (1.051) 2-[2-chloro(2,4- dichlorophenoxy)phenyl](1H-1,2,4-triazolyl)propanol, (1.052) 2-[2-chloro(4- 40 chlorophenoxy)phenyl](1H-1,2,4-triazolyl)butanol, (1.053) 2-[4-(4-chlorophenoxy) (trifluoromethyl)phenyl](1H-1,2,4-triazolyl)butanol, (1.054) 2-[4-(4-chlorophenoxy) (trifluoromethyl)phenyl](1H-1,2,4-triazolyl)pentanol, (1.055) 2-[4-(4-chlorophenoxy) (trifluoromethyl)phenyl](1H-1,2,4-triazolyl)propanol, (1.056) 2-{[3-(2-chlorophenyl)(2,4- difluorophenyl)oxiranyl]methyl}-2,4-dihydro-3H-1,2,4-triazolethione, (1.057) 2-{[rel(2R,3R)(2- chlorophenyl)(2,4-difluorophenyl)oxiranyl]methyl}-2,4-dihydro-3H-1,2,4-triazolethione, (1.058) 2- {[rel(2R,3S)(2-chlorophenyl)(2,4-difluorophenyl)oxiranyl]methyl}-2,4-dihydro-3H-1,2,4-triazole thione, (1.059) 5-(4-chlorobenzyl)(chloromethyl)methyl(1H-1,2,4-triazolylmethyl)cyclopentanol, (1.060) 5-(allylsulfanyl){[3-(2-chlorophenyl)(2,4-difluorophenyl)oxiranyl]methyl}-1H-1,2,4-triazole, (1.061) 5-(allylsulfanyl){[rel(2R,3R)(2-chlorophenyl)(2,4-difluorophenyl)oxiranyl]methyl}-1H- 1,2,4-triazole, (1.062) 5-(allylsulfanyl){[rel(2R,3S)(2-chlorophenyl)(2,4-difluorophenyl)oxiran yl]methyl}-1H-1,2,4-triazole, (1.063) N'-(2,5-dimethyl{[3-(1,1,2,2- tetrafluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamide, (1.064) N'-(2,5-dimethyl{[3- (2,2,2-trifluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamide, (1.065) N'-(2,5-dimethyl- 4-{[3-(2,2,3,3-tetrafluoropropoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamide, (1.066) N'- (2,5-dimethyl{[3-(pentafluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamide, (1.067) N'-(2,5-dimethyl{3-[(1,1,2,2-tetrafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidoformamide, (1.068) N'-(2,5-dimethyl{3-[(2,2,2-trifluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N- methylimidoformamide, (1.069) N'-(2,5-dimethyl{3-[(2,2,3,3-tetrafluoropropyl)sulfanyl]phenoxy}phenyl)- N-ethyl-N-methylimidoformamide, (1.070) N'-(2,5-dimethyl{3- [(pentafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidoformamide, (1.071) N'-(2,5-dimethyl phenoxyphenyl)-N-ethyl-N-methylimidoformamide, (1.072) N'-(4-{[3-(difluoromethoxy)phenyl]sulfanyl}-2,5- dimethylphenyl)-N-ethyl-N-methylimidoformamide, (1.073) N'-(4-{3-[(difluoromethyl)sulfanyl]phenoxy}-2,5- dimethylphenyl)-N-ethyl-N-methylimidoformamide, (1.074) N'-[5-bromo(2,3-dihydro-1H-indenyloxy)- 2-methylpyridinyl]-N-ethyl-N-methylimidoformamide, (1.075) N'-{4-[(4,5-dichloro-1,3-thiazolyl)oxy]- 2,5-dimethylphenyl}-N-ethyl-N-methylimidoformamide, (1.076) N'-{5-bromo[(1R)(3,5-difluorophenyl)- ethoxy]methylpyridinyl}-N-ethyl-N-methylimidoformamide, (1.077) N'-{5-bromo[(1S)(3,5- difluorophenyl)ethoxy]methylpyridinyl}-N-ethyl-N-methylimidoformamide, (1.078) N'-{5-bromo [(cisisopropylcyclohexyl)oxy]methylpyridinyl}-N-ethyl-N-methylimidoformamide, (1.079) N'-{5- bromo[(transisopropylcyclohexyl)oxy]methylpyridinyl}-N-ethyl-N-methylimidoformamide, (1.080) N'-{5-bromo[1-(3,5-difluorophenyl)ethoxy]methylpyridinyl}-N-ethyl-N- methylimidoformamide, (1.081) Mefentrifluconazole, (1.082) Ipfentrifluconazole. 2) Inhibitors of the respiratory chain at complex I or II, for example (2.001) benzovindiflupyr, (2.002) bixafen, (2.003) boscalid, (2.004) carboxin, (2.005) fluopyram, (2.006) flutolanil, (2.007) fluxapyroxad, (2.008) furametpyr, (2.009) Isofetamid, (2.010) isopyrazam (anti-epimeric enantiomer 1R,4S,9S), (2.011) isopyrazam (anti-epimeric enantiomer 1S,4R,9R), (2.012) isopyrazam (anti-epimeric racemate 1RS,4SR,9SR), (2.013) isopyrazam (mixture of syn-epimeric racemate 1RS,4SR,9RS and anti-epimeric racemate 1RS,4SR,9SR), (2.014) isopyrazam (syn-epimeric enantiomer 1R,4S,9R), (2.015) isopyrazam (syn-epimeric enantiomer 1S,4R,9S), (2.016) isopyrazam (syn-epimeric racemate 1RS,4SR,9RS), (2.017) penflufen, (2.018) penthiopyrad, (2.019) pydiflumetofen, (2.020) Pyraziflumid, (2.021) sedaxane, (2.022) 1,3-dimethyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-indenyl)-1H-pyrazolecarboxamide, (2.023) 1,3- 40 dimethyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H-indenyl]-1H-pyrazolecarboxamide, (2.024) 1,3- dimethyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-indenyl]-1H-pyrazolecarboxamide, (2.025) 1-methyl- 3-(trifluoromethyl)-N-[2'-(trifluoromethyl)biphenylyl]-1H-pyrazolecarboxamide, (2.026) 2-fluoro (trifluoromethyl)-N-(1,1,3-trimethyl-2,3-dihydro-1H-indenyl)benzamide, (2.027) 3-(difluoromethyl) methyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-indenyl)-1H-pyrazolecarboxamide, (2.028) 3- (difluoromethyl)methyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H-indenyl]-1H-pyrazolecarboxamide, (2.029) 3-(difluoromethyl)methyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-indenyl]-1H-pyrazole carboxamide, (2.030) 3-(difluoromethyl)-N-(7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-indenyl)methyl- 1H-pyrazolecarboxamide, (2.031) 3-(difluoromethyl)-N-[(3R)fluoro-1,1,3-trimethyl-2,3-dihydro-1H- indenyl]methyl-1H-pyrazolecarboxamide, (2.032) 3-(difluoromethyl)-N-[(3S)fluoro-1,1,3- trimethyl-2,3-dihydro-1H-indenyl]methyl-1H-pyrazolecarboxamide, (2.033) 5,8-difluoro-N-[2-(2- fluoro{[4-(trifluoromethyl)pyridinyl]oxy}phenyl)ethyl]quinazolinamine, (2.034) N-(2-cyclopentyl fluorobenzyl)-N-cyclopropyl(difluoromethyl)fluoromethyl-1H-pyrazolecarboxamide, (2.035) N- (2-tert-butylmethylbenzyl)-N-cyclopropyl(difluoromethyl)fluoromethyl-1H-pyrazole carboxamide, (2.036) N-(2-tert-butylbenzyl)-N-cyclopropyl(difluoromethyl)fluoromethyl-1H- pyrazolecarboxamide, (2.037) N-(5-chloroethylbenzyl)-N-cyclopropyl(difluoromethyl)fluoro methyl-1H-pyrazolecarboxamide, (2.038) N-(5-chloroisopropylbenzyl)-N-cyclopropyl(difluoro- methyl)fluoromethyl-1H-pyrazolecarboxamide, (2.039) N-[(1R,4S)(dichloromethylene)-1,2,3,4- tetrahydro-1,4-methanonaphthalenyl](difluoromethyl)methyl-1H-pyrazolecarboxamide, (2.040) N-[(1S,4R)(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalenyl](difluoromethyl) methyl-1H-pyrazolecarboxamide, (2.041) N-[1-(2,4-dichlorophenyl)methoxypropanyl] (difluoromethyl)methyl-1H-pyrazolecarboxamide, (2.042) N-[2-chloro(trifluoromethyl)benzyl]-N- cyclopropyl(difluoromethyl)fluoromethyl-1H-pyrazolecarboxamide, (2.043) N-[3-chlorofluoro- 6-(trifluoromethyl)benzyl]-N-cyclopropyl(difluoromethyl)fluoromethyl-1H-pyrazolecarboxamide, (2.044) N-[5-chloro(trifluoromethyl)benzyl]-N-cyclopropyl(difluoromethyl)fluoromethyl-1H- pyrazolecarboxamide, (2.045) N-cyclopropyl(difluoromethyl)fluoromethyl-N-[5-methyl (trifluoromethyl)benzyl]-1H-pyrazolecarboxamide, (2.046) N-cyclopropyl(difluoromethyl)fluoro-N- (2-fluoroisopropylbenzyl)methyl-1H-pyrazolecarboxamide, (2.047) N-cyclopropyl (difluoromethyl)fluoro-N-(2-isopropylmethylbenzyl)methyl-1H-pyrazolecarboxamide, (2.048) N- cyclopropyl(difluoromethyl)fluoro-N-(2-isopropylbenzyl)methyl-1H-pyrazolecarbothioamide, (2.049) N-cyclopropyl(difluoromethyl)fluoro-N-(2-isopropylbenzyl)methyl-1H-pyrazole carboxamide, (2.050) N-cyclopropyl(difluoromethyl)fluoro-N-(5-fluoroisopropylbenzyl)methyl- 1H-pyrazolecarboxamide, (2.051) N-cyclopropyl(difluoromethyl)-N-(2-ethyl-4,5-dimethylbenzyl) fluoromethyl-1H-pyrazolecarboxamide, (2.052) N-cyclopropyl(difluoromethyl)-N-(2-ethyl fluorobenzyl)fluoromethyl-1H-pyrazolecarboxamide, (2.053) N-cyclopropyl(difluoromethyl)-N- (2-ethylmethylbenzyl)fluoromethyl-1H-pyrazolecarboxamide, (2.054) N-cyclopropyl-N-(2- cyclopropylfluorobenzyl)(difluoromethyl)fluoromethyl-1H-pyrazolecarboxamide, (2.055) N- cyclopropyl-N-(2-cyclopropylmethylbenzyl)(difluoromethyl)fluoromethyl-1H-pyrazole carboxamide, (2.056) N-cyclopropyl-N-(2-cyclopropylbenzyl)(difluoromethyl)fluoromethyl-1H- pyrazolecarboxamide. 3) Inhibitors of the respiratory chain at complex III, for example (3.001) ametoctradin, (3.002) amisulbrom, 40 (3.003) azoxystrobin, (3.004) coumethoxystrobin, (3.005) coumoxystrobin, (3.006) cyazofamid, (3.007) dimoxystrobin, (3.008) enoxastrobin, (3.009) famoxadone, (3.010) fenamidone, (3.011) flufenoxystrobin, (3.012) fluoxastrobin, (3.013) kresoxim-methyl, (3.014) metominostrobin, (3.015) orysastrobin, (3.016) picoxystrobin, (3.017) pyraclostrobin, (3.018) pyrametostrobin, (3.019) pyraoxystrobin, (3.020) trifloxystrobin, (3.021) (2E){2-[({[(1E)(3-{[(E)fluoro phenylvinyl]oxy}phenyl)ethylidene]amino}oxy)methyl]phenyl}(methoxyimino)-N-methylacetamide, (3.022) (2E,3Z){[1-(4-chlorophenyl)-1H-pyrazolyl]oxy}(methoxyimino)-N,3-dimethylpent enamide, (3.023) (2R){2-[(2,5-dimethylphenoxy)methyl]phenyl}methoxy-N-methylacetamide, (3.024) (2S){2-[(2,5-dimethylphenoxy)methyl]phenyl}methoxy-N-methylacetamide, (3.025) (3S,6S,7R,8R) benzyl[({3-[(isobutyryloxy)methoxy]methoxypyridinyl}carbonyl)amino]methyl-4,9-dioxo-1,5- dioxonanyl 2-methylpropanoate, (3.026) 2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}methoxy-N- methylacetamide, (3.027) N-(3-ethyl-3,5,5-trimethylcyclohexyl)formamidohydroxybenzamide, (3.028) (2E,3Z){[1-(4-chlorofluorophenyl)-1H-pyrazolyl]oxy}(methoxyimino)-N,3-dimethylpent- 3-enamide, (3.029) methyl {5-[3-(2,4-dimethylphenyl)-1H-pyrazolyl]methylbenzyl}carbamate. 4) Inhibitors of the mitosis and cell division, for example (4.001) carbendazim, (4.002) diethofencarb, (4.003) ethaboxam, (4.004) fluopicolide, (4.005) pencycuron, (4.006) thiabendazole, (4.007) thiophanate- methyl, (4.008) zoxamide, (4.009) 3-chloro(2,6-difluorophenyl)methylphenylpyridazine, (4.010) 3- chloro(4-chlorophenyl)(2,6-difluorophenyl)methylpyridazine, (4.011) 3-chloro(6-chloropyridin yl)methyl(2,4,6-trifluorophenyl)pyridazine, (4.012) 4-(2-bromofluorophenyl)-N-(2,6- difluorophenyl)-1,3-dimethyl-1H-pyrazolamine, (4.013) 4-(2-bromofluorophenyl)-N-(2-bromo fluorophenyl)-1,3-dimethyl-1H-pyrazolamine, (4.014) 4-(2-bromofluorophenyl)-N-(2-bromophenyl)- 1,3-dimethyl-1H-pyrazolamine, (4.015) 4-(2-bromofluorophenyl)-N-(2-chlorofluorophenyl)-1,3- dimethyl-1H-pyrazolamine, (4.016) 4-(2-bromofluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H- pyrazolamine, (4.017) 4-(2-bromofluorophenyl)-N-(2-fluorophenyl)-1,3-dimethyl-1H-pyrazolamine, (4.018) 4-(2-chlorofluorophenyl)-N-(2,6-difluorophenyl)-1,3-dimethyl-1H-pyrazolamine, (4.019) 4-(2- chlorofluorophenyl)-N-(2-chlorofluorophenyl)-1,3-dimethyl-1H-pyrazolamine, (4.020) 4-(2-chloro- 4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazolamine, (4.021) 4-(2-chlorofluorophenyl)- N-(2-fluorophenyl)-1,3-dimethyl-1H-pyrazolamine, (4.022) 4-(4-chlorophenyl)(2,6-difluorophenyl)- 3,6-dimethylpyridazine, (4.023) N-(2-bromofluorophenyl)(2-chlorofluorophenyl)-1,3-dimethyl-1H- pyrazolamine, (4.024) N-(2-bromophenyl)(2-chlorofluorophenyl)-1,3-dimethyl-1H-pyrazol amine, (4.025) N-(4-chloro-2,6-difluorophenyl)(2-chlorofluorophenyl)-1,3-dimethyl-1H-pyrazol amine.
) Compounds capable to have a multisite action, for example (5.001) bordeaux mixture, (5.002) captafol, (5.003) captan, (5.004) chlorothalonil, (5.005) copper hydroxide, (5.006) copper naphthenate, (5.007) copper oxide, (5.008) copper oxychloride, (5.009) copper(2+) sulfate, (5.010) dithianon, (5.011) dodine, (5.012) folpet, (5.013) mancozeb, (5.014) maneb, (5.015) metiram, (5.016) metiram zinc, (5.017) oxine- copper, (5.018) propineb, (5.019) sulfur and sulfur preparations including calcium polysulfide, (5.020) thiram, (5.021) zineb, (5.022) ziram, (5.023) 6-ethyl-5,7-dioxo-6,7-dihydro-5H- pyrrolo[3',4':5,6][1,4]dithiino[2,3-c][1,2]thiazolecarbonitrile. 40 6) Compounds capable to induce a host defence, for example (6.001) acibenzolar-S-methyl, (6.002) isotianil, (6.003) probenazole, (6.004) tiadinil. 7) Inhibitors of the amino acid and/or protein biosynthesis, for example (7.001) cyprodinil, (7.002) kasugamycin, (7.003) kasugamycin hydrochloride hydrate, (7.004) oxytetracycline, (7.005) pyrimethanil, (7.006) 3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolinyl)quinoline. 8) Inhibitors of the ATP production, for example (8.001) silthiofam. 9) Inhibitors of the cell wall synthesis, for example (9.001) benthiavalicarb, (9.002) dimethomorph, (9.003) flumorph, (9.004) iprovalicarb, (9.005) mandipropamid, (9.006) pyrimorph, (9.007) valifenalate, (9.008) (2E)(4-tert-butylphenyl)(2-chloropyridinyl)(morpholinyl)propenone, (9.009) (2Z)(4- tert-butylphenyl)(2-chloropyridinyl)(morpholinyl)propenone.
) Inhibitors of the lipid and membrane synthesis, for example (10.001) propamocarb, (10.002) propamocarb hydrochloride, (10.003) tolclofos-methyl. 11) Inhibitors of the melanin biosynthesis, for example (11.001) tricyclazole, (11.002) 2,2,2-trifluoroethyl {3-methyl[(4-methylbenzoyl)amino]butanyl}carbamate. 12) Inhibitors of the nucleic acid synthesis, for example (12.001) benalaxyl, (12.002) benalaxyl-M (kiralaxyl), (12.003) metalaxyl, (12.004) metalaxyl-M (mefenoxam). 13) Inhibitors of the signal transduction, for example (13.001) fludioxonil, (13.002) iprodione, (13.003) procymidone, (13.004) proquinazid, (13.005) quinoxyfen, (13.006) vinclozolin. 14) Compounds capable to act as an uncoupler, for example (14.001) fluazinam, (14.002) meptyldinocap.
) Further compounds, for example (15.001) Abscisic acid, (15.002) benthiazole, (15.003) bethoxazin, (15.004) capsimycin, (15.005) carvone, (15.006) chinomethionat, (15.007) cufraneb, (15.008) cyflufenamid, (15.009) cymoxanil, (15.010) cyprosulfamide, (15.011) flutianil, (15.012) fosetyl-aluminium, (15.013) fosetyl-calcium, (15.014) fosetyl-sodium, (15.015) methyl isothiocyanate, (15.016) metrafenone, (15.017) mildiomycin, (15.018) natamycin, (15.019) nickel dimethyldithiocarbamate, (15.020) nitrothal- isopropyl, (15.021) oxamocarb, (15.022) Oxathiapiprolin, (15.023) oxyfenthiin, (15.024) pentachlorophenol and salts, (15.025) phosphorous acid and its salts, (15.026) propamocarb-fosetylate, (15.027) pyriofenone (chlazafenone), (15.028) tebufloquin, (15.029) tecloftalam, (15.030) tolnifanide, (15.031) 1-(4-{4-[(5R)(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazolyl]-1,3-thiazolyl}piperidinyl) [5-methyl(trifluoromethyl)-1H-pyrazolyl]ethanone, (15.032) 1-(4-{4-[(5S)(2,6-difluorophenyl)-4,5- dihydro-1,2-oxazolyl]-1,3-thiazolyl}piperidinyl)[5-methyl(trifluoromethyl)-1H-pyrazol yl]ethanone, (15.033) 2-(6-benzylpyridinyl)quinazoline, (15.034) 2,6-dimethyl-1H,5H-[1,4]dithiino[2,3- c:5,6-c']dipyrrole-1,3,5,7(2H,6H)-tetrone, (15.035) 2-[3,5-bis(difluoromethyl)-1H-pyrazolyl][4-(4-{5-[2- (propynyloxy)phenyl]-4,5-dihydro-1,2-oxazolyl}-1,3-thiazolyl)piperidinyl]ethanone, (15.036) 40 2-[3,5-bis(difluoromethyl)-1H-pyrazolyl][4-(4-{5-[2-chloro(propynyloxy)phenyl]-4,5-dihydro- 1,2-oxazolyl}-1,3-thiazolyl)piperidinyl]ethanone, (15.037) 2-[3,5-bis(difluoromethyl)-1H-pyrazol yl][4-(4-{5-[2-fluoro(propynyloxy)phenyl]-4,5-dihydro-1,2-oxazolyl}-1,3-thiazolyl)piperidin- 1-yl]ethanone, (15.038) 2-[6-(3-fluoromethoxyphenyl)methylpyridinyl]quinazoline, (15.039) 2- {(5R)[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazolyl]acetyl}piperidinyl)-1,3-thiazolyl]-4,5-dihydro- 1,2-oxazolyl}chlorophenyl methanesulfonate, (15.040) 2-{(5S)[2-(1-{[3,5-bis(difluoromethyl)-1H- pyrazolyl]acetyl}piperidinyl)-1,3-thiazolyl]-4,5-dihydro-1,2-oxazolyl}chlorophenyl methane- sulfonate, (15.041) 2-{2-[(7,8-difluoromethylquinolinyl)oxy]fluorophenyl}propanol, (15.042) 2- {2-fluoro[(8-fluoromethylquinolinyl)oxy]phenyl}propanol, (15.043) 2-{3-[2-(1-{[3,5- bis(difluoromethyl)-1H-pyrazolyl]acetyl}piperidinyl)-1,3-thiazolyl]-4,5-dihydro-1,2-oxazolyl} chlorophenyl methanesulfonate, (15.044) 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol yl]acetyl}piperidinyl)-1,3-thiazolyl]-4,5-dihydro-1,2-oxazolyl}phenyl methanesulfonate, (15.045) 2- phenylphenol and salts, (15.046) 3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolinyl)quinoline, (15.047) 3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolinyl)quinoline, (15.048) 4-amino fluoropyrimidinol (tautomeric form: 4-aminofluoropyrimidin-2(1H)-one), (15.049) 4-oxo[(2- phenylethyl)amino]butanoic acid, (15.050) 5-amino-1,3,4-thiadiazolethiol, (15.051) 5-chloro-N'-phenyl- N'-(propynyl)thiophenesulfonohydrazide, (15.052) 5-fluoro[(4-fluorobenzyl)oxy]pyrimidin amine, (15.053) 5-fluoro[(4-methylbenzyl)oxy]pyrimidinamine, (15.054) 9-fluoro-2,2-dimethyl (quinolinyl)-2,3-dihydro-1,4-benzoxazepine, (15.055) butynyl {6-[({[(Z)-(1-methyl-1H-tetrazol yl)(phenyl)methylene]amino}oxy)methyl]pyridinyl}carbamate, (15.056) ethyl (2Z)aminocyano phenylacrylate, (15.057) phenazinecarboxylic acid, (15.058) propyl 3,4,5-trihydroxybenzoate, (15.059) quinolinol, (15.060) quinolinol sulfate (2:1), (15.061) tert-butyl {6-[({[(1-methyl-1H-tetrazol yl)(phenyl)methylene]amino}oxy)methyl]pyridinyl}carbamate, (15.062) 5-fluoroiminomethyl[(4- methylphenyl)sulfonyl]-3,4-dihydropyrimidin-2(1H)-one.
All named mixing partners of the classes (1) to (15) as described here above can be present in the form of the free compound and/or, if their functional groups enable this, an agriculturally acceptable salt thereof.
Methods and uses The compounds of formula (I) have potent microbicidal activity. Thus, the compounds of formula (I) or compositions comprising thereof can be used for controlling unwanted microorganisms, such as fungi and bacteria. They can be particularly useful in crop protection – they control microorganisms that cause plants diseases- or in the protection of timber, storage goods or various materials, as described in more details herein below. More specifically, the compounds of formula (I) or compositions comprising thereof can be used to protect seeds, germinating plants, emerged seedlings, plants, plant parts, fruits and the soil in which the plants grow from unwanted microorganisms.
The term "control" or "controlling" as used herein encompasses curative and protective control of unwanted microorganisms. The unwanted microorganisms may be pathogenic bacteria or pathogenic fungi, more specifically phytopathogenic bacteria or phytopathogenic fungi. As detailed herein below, these phytopathogenic microorganims are the causal agents of a broad spectrum of plants diseases More specifically, the compounds of the formula (I) or compositions comprising thereof can be used as 40 fungicide. In particular, they can useful in crop protection, for example for the control of unwanted fungi, such as Plasmodiophoromycetes, Oomycetes, Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Deuteromycetes.
The compounds of the formula (I) or compositions comprising thereof can also be used as bactericide. In particular, they can be used in crop protection, for example for the control unwanted bacteria, such as Pseudomonadaceae, Rhizobiaceae, Enterobacteriaceae, Corynebacteriaceae and Streptomycetaceae.
Therefore, the present invention also relates to a method for controlling unwanted phytopathogenic microorganisms, such as fungi and bacteria, comprising the step of applying one or more compound of formula (I) or a composition comprising thereof to the microorganisms and/or in their habitat.
More specifically, described are curative or protective methods for controlling unwanted microorganisms, more specifically phytopathogenic fungi, which comprises the step of applying one or more compound of formula (I) or a composition comprising thereof to the seeds, the plants, the plant parts, the fruit or the soil in which the plants grow.
Typically, when the compounds of formula (I) or the compositions comprising thereof are intended to be used in curative or protective methods for controlling phytopathogenic fungi, an effective and non- phytotoxic amount of one or more compounds of formula (I) or a composition comprising thereof, is typically applied to the plant, plant part, fruit, seed or soil in which the plants grow. The expression "effective and non-phytotoxic amount" means an amount that is sufficient to control or destroy the fungi present or liable to appear on the cropland and that does not entail any appreciable symptom of phytotoxicity for said crops. Such an amount can vary within a wide range depending on the fungus to be controlled, the type of crop, the climatic conditions and the compounds of formula (I). This amount can be determined by systematic field trials that are within the capabilities of a person skilled in the art.
The term "treatment" as used herein refers to the step of applying one or more compound of formula (I) or a composition comprising thereof to the plants, plant parts, fruits, seeds or soil that need(s) to be protected or cured.
Plants and plant parts All plants and plant parts can be treated in accordance with the methods of the invention.
Plants are understood here to mean all plants and plant populations, such as desired and undesired wild plants or crop plants (including naturally occurring crop plants). Crop plants may be plants which can be obtained by conventional breeding and optimization methods or by biotechnological and genetic engineering methods or combinations of these methods, including the transgenic plants and the plant cultivars which are protectable and non-protectable by plant breeders’ rights.
Plant parts are understood to mean all parts and organs of plants above and below the ground, such as shoot, leaf, flower and root, examples of which include leaves, needles, stalks, stems, flowers, fruit bodies, fruits and seeds, and also roots, tubers and rhizomes. The plant parts also include harvested material and vegetative and generative propagation material, for example cuttings, tubers, rhizomes, slips and seeds.
Plants which can be treated in accordance with the methods of the invention include the following: cotton, flax, 40 grapevine, fruit, vegetables, such as Rosaceae sp. (for example pome fruits such as apples and pears, but also stone fruits such as apricots, cherries, almonds and peaches, and soft fruits such as strawberries), Ribesioidae sp., Juglandaceae sp., Betulaceae sp., Anacardiaceae sp., Fagaceae sp., Moraceae sp., Oleaceae sp., Actinidaceae sp., Lauraceae sp., Musaceae sp. (for example banana trees and plantations), Rubiaceae sp. (for example coffee), Theaceae sp., Sterculiceae sp., Rutaceae sp. (for example lemons, oranges and grapefruit); Solanaceae sp. (for example tomatoes), Liliaceae sp., Asteraceae sp. (for example lettuce), Umbelliferae sp., Cruciferae sp., Chenopodiaceae sp., Cucurbitaceae sp. (for example cucumber), Alliaceae sp. (for example leek, onion), Papilionaceae sp. (for example peas); major crop plants, such as Gramineae sp. (for example maize, turf, cereals such as wheat, rye, rice, barley, oats, millet and triticale), Asteraceae sp. (for example sunflower), Brassicaceae sp. (for example white cabbage, red cabbage, broccoli, cauliflower, Brussels sprouts, pak choi, kohlrabi, radishes, and oilseed rape, mustard, horseradish and cress), Fabacae sp. (for example bean, peanuts), Papilionaceae sp. (for example soya bean), Solanaceae sp. (for example potatoes), Chenopodiaceae sp. (for example sugar beet, fodder beet, swiss chard, beetroot); useful plants and ornamental plants for gardens and wooded areas; and genetically modified varieties of each of these plants.
In some preferred embodiments, wild plant species and plant cultivars, or those obtained by conventional biological breeding methods, such as crossing or protoplast fusion, and also parts thereof, are treated in accordance with the methods of the invention.
In some other preferred embodiments, transgenic plants and plant cultivars obtained by genetic engineering methods, if appropriate in combination with conventional methods (Genetically Modified Organisms), and parts thereof are treated in accordance with the methods of the invention. More preferably, plants of the plant cultivars which are commercially available or are in use are treated in accordance with the invention. Plant cultivars are understood to mean plants which have new properties ("traits") and have been obtained by conventional breeding, by mutagenesis or by recombinant DNA techniques. They can be cultivars, varieties, bio- or genotypes.
The methods according to the invention can be used in the treatment of genetically modified organisms (GMOs), e.g. plants or seeds. Genetically modified plants (or transgenic plants) are plants of which a heterologous gene has been stably integrated into genome. The expression "heterologous gene" essentially means a gene which is provided or assembled outside the plant and when introduced in the nuclear, chloroplastic or mitochondrial genome gives the transformed plant new or improved agronomic or other properties by expressing a protein or polypeptide of interest or by downregulating or silencing other gene(s) which are present in the plant (using for example, antisense technology, cosuppression technology, RNA interference – RNAi – technology or microRNA – miRNA - technology). A heterologous gene that is located in the genome is also called a transgene. A transgene that is defined by its particular location in the plant genome is called a transformation or transgenic event.
Plants and plant cultivars which can be treated by the above disclosed methods include all plants which have genetic material which impart particularly advantageous, useful traits to these plants (whether obtained by breeding and/or biotechnological means).
Plants and plant cultivars which can be treated by the above disclosed methods include plants and plant cultivars which are resistant against one or more biotic stresses, i.e. said plants show a better defense against animal and microbial pests, such as against nematodes, insects, mites, phytopathogenic fungi, bacteria, viruses and/or viroids. 40 Plants and plant cultivars which can be treated by the above disclosed methods include those plants which are resistant to one or more abiotic stresses. Abiotic stress conditions may include, for example, drought, cold temperature exposure, heat exposure, osmotic stress, flooding, increased soil salinity, increased mineral exposure, ozone exposure, high light exposure, limited availability of nitrogen nutrients, limited availability of phosphorus nutrients, shade avoidance.
Plants and plant cultivars which can be treated by the above disclosed methods include those plants characterized by enhanced yield characteristics. Increased yield in said plants can be the result of, for example, improved plant physiology, growth and development, such as water use efficiency, water retention efficiency, improved nitrogen use, enhanced carbon assimilation, improved photosynthesis, increased germination efficiency and accelerated maturation. Yield can furthermore be affected by improved plant architecture (under stress and non-stress conditions), including but not limited to, early flowering, flowering control for hybrid seed production, seedling vigor, plant size, internode number and distance, root growth, seed size, fruit size, pod size, pod or ear number, seed number per pod or ear, seed mass, enhanced seed filling, reduced seed dispersal, reduced pod dehiscence and lodging resistance. Further yield traits include seed composition, such as carbohydrate content and composition for example cotton or starch, protein content, oil content and composition, nutritional value, reduction in anti-nutritional compounds, improved processability and better storage stability.
Plants and plant cultivars which can be treated by the above disclosed methods include plants and plant cultivars which are hybrid plants that already express the characteristic of heterosis or hybrid vigor which results in generally higher yield, vigor, health and resistance towards biotic and abiotic stresses.
Plants and plant cultivars (obtained by plant biotechnology methods such as genetic engineering) which can be treated by the above disclosed methods include plants and plant cultivars which are herbicide- tolerant plants, i.e. plants made tolerant to one or more given herbicides. Such plants can be obtained either by genetic transformation, or by selection of plants containing a mutation imparting such herbicide tolerance.
Plants and plant cultivars (obtained by plant biotechnology methods such as genetic engineering) which can be treated by the above disclosed methods include plants and plant cultivars which are insect-resistant transgenic plants, i.e. plants made resistant to attack by certain target insects. Such plants can be obtained by genetic transformation, or by selection of plants containing a mutation imparting such insect resistance.
Plants and plant cultivars (obtained by plant biotechnology methods such as genetic engineering) which can be treated by the above disclosed methods include plants and plant cultivars which are tolerant to abiotic stresses. Such plants can be obtained by genetic transformation, or by selection of plants containing a mutation imparting such stress resistance.
Plants and plant cultivars (obtained by plant biotechnology methods such as genetic engineering) which can be treated by the above disclosed methods include plants and plant cultivars which show altered quantity, quality and/or storage-stability of the harvested product and/or altered properties of specific ingredients of the harvested product.
Plants and plant cultivars (obtained by plant biotechnology methods such as genetic engineering) which can be treated by the above disclosed methods include plants and plant cultivars, such as cotton plants, with altered fiber characteristics. Such plants can be obtained by genetic transformation, or by selection of plants contain a mutation imparting such altered fiber characteristics. 40 Plants and plant cultivars (obtained by plant biotechnology methods such as genetic engineering) which can be treated by the above disclosed methods include plants and plant cultivars, such as oilseed rape or related Brassica plants, with altered oil profile characteristics. Such plants can be obtained by genetic transformation, or by selection of plants contain a mutation imparting such altered oil profile characteristics.
Plants and plant cultivars (obtained by plant biotechnology methods such as genetic engineering) which can be treated by the above disclosed methods include plants and plant cultivars, such as oilseed rape or related Brassica plants, with altered seed shattering characteristics. Such plants can be obtained by genetic transformation, or by selection of plants contain a mutation imparting such altered seed shattering characteristics and include plants such as oilseed rape plants with delayed or reduced seed shattering.
Plants and plant cultivars (obtained by plant biotechnology methods such as genetic engineering) which can be treated by the above disclosed methods include plants and plant cultivars, such as Tobacco plants, with altered post-translational protein modification patterns.
Pathogens and diseases The methods disclosed above can be used to control microorganisms, in particular phytopathogenic fungi, causing diseases, such as: diseases caused by powdery mildew pathogens, such as Blumeria species (e.g. Blumeria graminis), Podosphaera species (e.g. Podosphaera leucotricha), Sphaerotheca species (e.g.Sphaerotheca fuliginea), Uncinula species (e.g. Uncinula necator); diseases caused by rust disease pathogens, such as Gymnosporangium species (e.g.
Gymnosporangium sabinae), Hemileia species (e.g. Hemileia vastatrix), Phakopsora species (e.g.
Phakopsora pachyrhizi or Phakopsora meibomiae), Puccinia species (e.g. Puccinia recondita, Puccinia graminis or Puccinia striiformis), Uromyces species (e.g. Uromyces appendiculatus) ; diseases caused by pathogens from the group of the Oomycetes, such as Albugo species (e.g. Albugo candida), Bremia species (e.g. Bremia lactucae), Peronospora species (e.g. Peronospora pisi or P. brassicae), Phytophthora species (e.g. Phytophthora infestans), Plasmopara species (e.g. Plasmopara viticola), Pseudoperonospora species (e.g. Pseudoperonospora humuli or Pseudoperonospora cubensis), Pythium species (e.g. Pythium ultimum) ; leaf blotch diseases and leaf wilt diseases caused, for example, by Alternaria species (e.g. Alternaria solani), Cercospora species (e.g. Cercospora beticola), Cladiosporium species (e.g. Cladiosporium cucumerinum), Cochliobolus species (e.g. Cochliobolus sativus (conidial form: Drechslera, syn: Helminthosporium) or Cochliobolus miyabeanus), Colletotrichum species (e.g. Colletotrichum lindemuthanium), Cycloconium species (e.g. Cycloconium oleaginum), Diaporthe species (e.g. Diaporthe citri), Elsinoe species (e.g. Elsinoe fawcettii), Gloeosporium species (e.g. Gloeosporium laeticolor), Glomerella species (e.g. Glomerella cingulate), Guignardia species (e.g. Guignardia bidwelli), Leptosphaeria species (e.g. Leptosphaeria maculans), Magnaporthe species (e.g. Magnaporthe grisea), Microdochium species (e.g. Microdochium nivale), Mycosphaerella species (e.g. Mycosphaerella graminicola, Mycosphaerella arachidicola or Mycosphaerella fijiensis), Phaeosphaeria species (e.g.
Phaeosphaeria nodorum), Pyrenophora species (e.g. Pyrenophora teres or Pyrenophora tritici repentis), Ramularia species (e.g. Ramularia collo-cygni or Ramularia areola), Rhynchosporium species (e.g.
Rhynchosporium secalis), Septoria species (e.g. Septoria apii or Septoria lycopersici), Stagonospora 40 species (e.g. Stagonospora nodorum), Typhula species (e.g. Typhula incarnate), Venturia species (e.g.
Venturia inaequalis), root and stem diseases caused, for example, by Corticium species (e.g. Corticium graminearum), Fusarium species (e.g. Fusarium oxysporum), Gaeumannomyces species, (e.g. Gaeumannomyces graminis), Plasmodiophora species, (e.g. Plasmodiophora brassicae), Rhizoctonia species, (e.g.
Rhizoctonia solani), Sarocladium species, (e.g. Sarocladium oryzae), Sclerotium species, (e.g. Sclerotium oryzae), Tapesia species, (e.g. Tapesia acuformis), Thielaviopsis species, (e.g. Thielaviopsis basicola); ear and panicle diseases (including corn cobs) caused, for example, by Alternaria species, (e.g.
Alternaria spp.), Aspergillus species (e.g. Aspergillus flavus), Cladosporium species (e.g. Cladosporium cladosporioides, Claviceps species (e.g. Claviceps purpurea), Fusarium species, (e.g. Fusarium culmorum), Gibberella species (e.g. Gibberella zeae), Monographella species, (e.g. Monographella nivalis), Stagnospora species, (e.g. Stagnospora nodorum); diseases caused by smut fungi, for example Sphacelotheca species (e.g. Sphacelotheca reiliana), Tilletia species (e.g. Tilletia caries or Tilletia controversa), Urocystis species (e.g. Urocystis occulta), Ustilago species (e.g. Ustilago nuda); fruit rot caused, for example, by Aspergillus species (e.g. Aspergillus flavus), Botrytis species (e.g.
Botrytis cinerea), Penicillium species (e.g. Penicillium expansum or Penicillium purpurogenum), Rhizopus species (e.g. Rhizopus stolonifer), Sclerotinia species (e.g. Sclerotinia sclerotiorum), Verticilium species (e.g. Verticilium alboatrum) ; seed- and soil-borne rot and wilt diseases, and also diseases of seedlings, caused, for example, by Alternaria species (e.g. Alternaria brassicicola), Aphanomyces species (e.g. Aphanomyces euteiches), Ascochyta species (e.g. Ascochyta lentis), Aspergillus species (e.g. Aspergillus flavus), Cladosporium species (e.g. Cladosporium herbarum), Cochliobolus species (e.g. Cochliobolus sativus (conidial form: Drechslera, Bipolaris Syn: Helminthosporium)), Colletotrichum species (e.g. Colletotrichum coccodes), Fusarium species (e.g. Fusarium culmorum), Gibberella species (e.g. Gibberella zeae), Macrophomina species (e.g. Macrophomina phaseolina), Microdochium species (e.g. Microdochium nivale), Monographella species (e.g. Monographella nivalis), Penicillium species(e.g. Penicillium expansum), Phoma species (e.g. Phoma lingam), Phomopsis species (e.g. Phomopsis sojae), Phytophthora species (e.g. Phytophthora cactorum), Pyrenophora species (e.g. Pyrenophora graminea), Pyricularia species (e.g. Pyricularia oryzae), Pythium species (e.g. Pythium ultimum), Rhizoctonia species (e.g. Rhizoctonia solani), Rhizopus species (e.g. Rhizopus oryzae), Sclerotium species (e.g. Sclerotium rolfsii), Septoria species (e.g. Septoria nodorum), Typhula species (e.g. Typhula incarnate), Verticillium species (e.g.
Verticillium dahlia); cancers, galls and witches’ broom caused, for example, by Nectria species (e.g. Nectria galligena); wilt diseases caused, for example, by Monilinia species (e.g. Monilinia laxa); deformations of leaves, flowers and fruits caused, for example, by Exobasidium species (e.g.
Exobasidium vexans), Taphrina species (e.g. Taphrina deformans); degenerative diseases in woody plants, caused, for example, by Esca species (e.g. Phaeomoniella chlamydospora, Phaeoacremonium aleophilum or Fomitiporia mediterranea), Ganoderma species (e.g.
Ganoderma boninense); diseases of flowers and seeds caused, for example, by Botrytis species (e.g. Botrytis cinerea); 40 diseases of plant tubers caused, for example, by Rhizoctonia species (e.g. Rhizoctonia solani), Helminthosporium species (e.g. Helminthosporium solani); diseases caused by bacterial pathogens, for example Xanthomonas species (e.g. Xanthomonas campestris pv. Oryzae), Pseudomonas species (e.g. Pseudomonas syringae pv. Lachrymans), Erwinia species (e.g. Erwinia amylovora).
Seed Treatment The method for controlling unwanted microorganisms may be used to protect seeds from phytopathogenic microorganisms, such as fungi.
The term "seed(s)" as used herein include dormant seed, primed seed, pregerminated seed and seed with emerged roots and leaves.
Thus, described is a method for protecting seeds and/or crops from unwanted microorganisms, such as bacteria or fungi, which comprises the step of treating the seeds with one or more compounds of formula (I) or a composition comprising thereof. The treatment of seeds with the compound(s) of formula (I) or a composition comprising thereof not only protects the seeds from phytopathogenic microorganisms, but also the germinating plants, the emerged seedlings and the plants after emergence.
The seeds treatment may be performed prior to sowing, at the time of sowing or shortly thereafter.
When the seeds treatment is performed prior to sowing (e.g. so-called on-seed applications), the seeds treatment may be performed as follows: the seeds may be placed into a mixer with a desired amount of compound(s) of formula (I) or a composition comprising thereof (either as such or after dilution), the seeds and the compound(s) of formula (I) or the composition comprising thereof are mixed until a homogeneous distribution on seeds is achieved. If appropriate, the seeds may then be dried.
Also described are seeds treated with one or more compounds of formula (I) or a composition comprising thereof. As said before, the use of treated seeds allows not only protecting the seeds before and after sowing from unwanted microorganisms, such as phytopathogenic fungi, but also allows protecting the germinating plants and young seedlings emerging from said treated seeds. A large part of the damage to crop plants caused by harmful organisms is triggered by the infection of the seeds before sowing or after germination of the plant. This phase is particularly critical since the roots and shoots of the growing plant are particularly sensitive, and even small damage may result in the death of the plant.
Therefore, described is a method for protecting seeds, germinating plants and emerged seedlings, more generally to a method for protecting crop from phytopathogenic microorganisms, which comprises the step of using seeds treated by one or more compounds of formula (I) or a composition comprising thereof.
Preferably, the seed is treated in a state in which it is sufficiently stable for no damage to occur in the course of treatment. In general, seeds can be treated at any time between harvest and shortly after sowing. It is customary to use seeds which have been separated from the plant and freed from cobs, shells, stalks, coats, hairs or the flesh of the fruits. For example, it is possible to use seeds which have been harvested, cleaned and dried down to a moisture content of less than 15% by weight. Alternatively, it is also possible to use seeds which, after drying, for example, have been treated with water and then dried again, or seeds just after priming, or seeds stored in primed conditions or pre-germinated seeds, or seeds sown on nursery trays, tapes or paper. 40 The amount of compound(s) of formula (I) or composition comprising thereof applied to the seed is typically such that the germination of the seed is not impaired, or that the resulting plant is not damaged.
This must be ensured particularly in case the active ingredients would exhibit phytotoxic effects at certain application rates. The intrinsic phenotypes of transgenic plants should also be taken into consideration when determining the amount of compound(s) of formula (I) or composition comprising thereof to be applied to the seed in order to achieve optimum seed and germinating plant protection with a minimum amount of compound(s) of formula (I) or composition comprising thereof being employed.
As indicated above, the compounds of the formula (I) can be applied, as such, directly to the seeds, i.e. without the use of any other components and without having been diluted, or a composition comprising the compounds of formula (I) can be applied. Preferably, the compositions are applied to the seed in any suitable form. Examples of suitable formulations include solutions, emulsions, suspensions, powders, foams, slurries or combined with other coating compositions for seed, such as film forming materials, pelleting materials, fine iron or other metal powders, granules, coating material for inactivated seeds, and also ULV formulations. The formulations may be ready-to-use formulations or may be concentrates that need to be diluted prior to use.
These formulations are prepared in a known manner, for instance by mixing the active ingredient or mixture thereof with customary additives, for example customary extenders and solvents or diluents, dyes, wetting agents, dispersants, emulsifiers, antifoams, preservatives, secondary thickeners, adhesives, gibberellins, and also water.
These formulations are prepared in a known manner, by mixing the active ingredients or active ingredient combinations with customary additives, for example customary extenders and solvents or diluents, dyes, wetting agents, dispersants, emulsifiers, antifoams, preservatives, secondary thickeners, adhesives, gibberellins, and also water.
Useful dyes which may be present in the seed dressing formulations are all dyes which are customary for such purposes. It is possible to use either pigments, which are sparingly soluble in water, or dyes, which are soluble in water. Examples include the dyes known by the names Rhodamine B, C.I. Pigment Red 112 and C.I. Solvent Red 1. Useful wetting agents which may be present in the seed dressing formulations are all substances which promote wetting and which are conventionally used for the formulation of active agrochemical ingredients. Usable with preference are alkylnaphthalenesulphonates, such as diisopropyl- or diisobutylnaphthalenesulphonates. Useful dispersants and/or emulsifiers which may be present in the seed dressing formulations are all nonionic, anionic and cationic dispersants conventionally used for the formulation of active agrochemical ingredients. Usable with preference are nonionic or anionic dispersants or mixtures of nonionic or anionic dispersants. Useful nonionic dispersants include especially ethylene oxide/propylene oxide block polymers, alkylphenol polyglycol ethers and tristryrylphenol polyglycol ether, and the phosphated or sulphated derivatives thereof. Suitable anionic dispersants are especially lignosulphonates, polyacrylic acid salts and arylsulphonate/formaldehyde condensates. Antifoams which may be present in the seed dressing formulations are all foam-inhibiting substances conventionally used for the formulation of active agrochemical ingredients. Silicone antifoams and magnesium stearate can be used with preference.
Preservatives which may be present in the seed dressing formulations are all substances usable for such purposes in agrochemical compositions. Examples include dichlorophene and benzyl alcohol hemiformal.
Secondary thickeners which may be present in the seed dressing formulations are all substances usable 40 for such purposes in agrochemical compositions. Preferred examples include cellulose derivatives, acrylic acid derivatives, xanthan, modified clays and finely divided silica. Adhesives which may be present in the seed dressing formulations are all customary binders usable in seed dressing products. Preferred examples include polyvinylpyrrolidone, polyvinyl acetate, polyvinyl alcohol and tylose.
The compounds of the formula (I) and the compositions comprising thereof are suitable for protecting seeds of any plant variety which is used in agriculture, in greenhouses, in forests or in horticulture. More particularly, the seed is that of cereals (such as wheat, barley, rye, millet, triticale, and oats), oilseed rape, maize, cotton, soybean, rice, potatoes, sunflower, beans, coffee, peas, beet (e.g. sugar beet and fodder beet), peanut, vegetables (such as tomato, cucumber, onions and lettuce), lawns and ornamental plants.
Of particular significance is the treatment of the seed of wheat, soybean, oilseed rape, maize and rice.
The compounds of formula (I) or the compositions comprising thereof can be used for treating transgenic seeds, in particular seeds of plants capable of expressing a protein which acts against pests, herbicidal damage or abiotic stress, thereby increasing the protective effect. Synergistic effects may also occur in interaction with the substances formed by expression.
Application The active ingredient(s) can be applied as such, in the form of their formulations or in the use forms prepared from said formulations when these are not ready-to-use.
The application to the plant, plant part, fruit, seed or soil is accomplished in a customary manner, for example by watering, spraying, atomizing, broadcasting, dusting, foaming, spreading-on and the like. The active ingredients may also be applied by the ultra-low volume method or be injected into the soil.
The effective and non-phytotoxic amount of compounds of formula (I) or of a composition comprising thereof which is applied to the plant, plant part, fruit, seed or soil will depend on various factors, such as the compound/composition employed, the subject of the treatment (plant, plant part, fruit, seed or soil), the type of treatment (dusting, spraying, seed dressing), the purpose of the treatment (prophylactic or therapeutic) and the type of microorganisms.
When compounds of formula (I) are used as fungicides, the application rates can vary within a relatively wide range, depending on the kind of application. For instance, when compounds of formula (I) are used in the treatment of plant parts, such as leaves, the application rate may range from 0.1 to 10 000 g/ha, preferably from 10 to 1000 g/ha, more preferably from 50 to 300 g/ha (in the case of application by watering or dripping, it is even possible to reduce the application rate, especially when inert substrates such as rockwool or perlite are used). When compounds of formula (I) are used in the treatment of seeds, the application rate may range from 0.1 to 200 g per 100 kg of seed, preferably from 1 to 150 g per 100 kg of seed, more preferably from 2.5 to 25 g per 100 kg of seed, even more preferably from 2.5 to 12.5 g per 100 kg of seed. When compounds of formula (I) are used in the treatment of soil, the application rate may range from 0.1 to 10 000 g/ha, preferably from 1 to 5000 g/ha.
These application rates are merely by way of example and are not limiting for the purposes of the invention.
Mycotoxins In addition, the compounds of the formula (I) or compositions comprising thereof can reduce the 40 mycotoxin content in the harvested material and the foods and feeds prepared therefrom. Mycotoxins include particularly, but not exclusively, the following: deoxynivalenol (DON), nivalenol, 15-Ac-DON, 3-Ac- DON, T2- and HT2-toxin, fumonisins, zearalenon, moniliformin, fusarin, diaceotoxyscirpenol (DAS), beauvericin, enniatin, fusaroproliferin, fusarenol, ochratoxins, patulin, ergot alkaloids and aflatoxins which can be produced, for example, by the following fungi: Fusarium spec., such as F. acuminatum, F. asiaticum, F. avenaceum, F. crookwellense, F. culmorum, F. graminearum (Gibberella zeae), F. equiseti, F. fujikoroi, F. musarum, F. oxysporum, F. proliferatum, F. poae, F. pseudograminearum, F. sambucinum, F. scirpi, F. semitectum, F. solani, F. sporotrichoides, F. langsethiae, F. subglutinans, F. tricinctum, F. verticillioides etc., and also by Aspergillus spec., such as A. flavus, A. parasiticus, A. nomius, A. ochraceus, A. clavatus, A. terreus, A. versicolor, Penicillium spec., such as P. verrucosum, P. viridicatum, P. citrinum, P. expansum, P. claviforme, P. roqueforti, Claviceps spec., such as C. purpurea, C. fusiformis, C. paspali, C. africana, Stachybotrys spec. and others.
Material Protection The compounds of the formula (I) and compositions comprising thereof can be used in the protection of materials, for instance industrial materials, from attack and destruction by microorganisms, such as fungi.
The terms "industrial materials" as used herein designate inanimate materials that may be used in industry.
Examples of industrial materials include, but are not limited to, adhesives, glues, paper, wallpaper, board/cardboard, textiles, carpets, leather, wood, fibers, tissues, paints, plastic articles, cooling lubricants, heat transfer fluids and other materials which can be infected with or destroyed by microorganisms. Preferred industrial materials include adhesives, sizes, paper and card, leather, wood, paints, cooling lubricants and heat transfer fluids, more preferably wood. The compounds of the formula (I) and compositions comprising thereof may prevent adverse effects, such as rotting, decay, discoloration or formation of mould.
Further materials that can be protected by the compounds and compositions of the present invention include parts of production plants and buildings which may be impaired by the proliferation of microorganisms, for example cooling-water circuits, cooling and heating systems and ventilation and air-conditioning units.
In addition, the compounds of the formula (I) and compositions comprising thereof can be used to protect objects which come into contact with saltwater or brackish water, especially hulls, screens, nets, buildings, moorings and signalling systems, from fouling. Therefore, the compounds of the formula (I) and compositions comprising thereof can be used as antifouling agent, alone or in combinations with other active ingredients.
The compounds of the formula (I) and compositions comprising thereof may also be used to treat wood, in particular to treat wood against fungal diseases liable to grow on or inside timber. The term "timber" designates all types and species of wood and all types of construction timber, for example solid wood, high-density wood, laminated wood, and plywood. An exemplary method for treating timber comprises the step of contacting one or more compounds of formula (I) or a composition comprising thereof with the timber. The contacting step may be performed by direct application, spraying, dipping, injection or any other suitable means. 40 The compounds of the formula (I) and compositions comprising thereof can also be used for protecting storage goods. The terms "storage goods" as used herein designate natural substances of vegetable or animal origin or processed products thereof for which long-term protection is desired. Examples of storage goods of vegetable origin that can be protected include plants or plant parts, such as stems, leaves, tubers, seeds, fruits and grains. They can be protected in a freshly harvested state or after being processed, such as by (pre)drying, moistening, comminuting, grinding, pressing and/or roasting. Examples of storage goods of animal origin include hides, leather, furs and hairs. The compounds of the formula (I) or compositions comprising thereof may prevent adverse effects, such as rotting, decay, discoloration or formation of mould.
Microorganisms capable of degrading or altering the industrial materials include, for example, bacteria, fungi, yeasts, algae and slime organisms. The compounds of the formula (I) preferably act against fungi, especially moulds, wood-discoloring and wood-destroying fungi (Ascomycetes, Basidiomycetes, Deuteromycetes and Zygomycetes), and against slime organisms and algae. Examples include microorganisms of the following genera: Alternaria, such as Alternaria tenuis; Aspergillus, such as Aspergillus niger; Chaetomium, such as Chaetomium globosum; Coniophora, such as Coniophora puetana; Lentinus, such as Lentinus tigrinus; Penicillium, such as Penicillium glaucum; Polyporus, such as Polyporus versicolor; Aureobasidium, such as Aureobasidium pullulans; Sclerophoma, such as Sclerophoma pityophila; Trichoderma, such as Trichoderma viride; Ophiostoma spp., Ceratocystis spp., Humicola spp., Petriella spp., Trichurus spp., Coriolus spp., Gloeophyllum spp., Pleurotus spp., Poria spp., Serpula spp. and Tyromyces spp., Cladosporium spp., Paecilomyces spp. Mucor spp., Escherichia, such as Escherichia coli; Pseudomonas, such as Pseudomonas aeruginosa; Staphylococcus, such as Staphylococcus aureus, Candida spp. and Saccharomyces spp., such as Saccharomyces cerevisae.
In this specification where reference has been made to patent specifications, other external documents, or other sources of information, this is generally for the purpose of providing a context for discussing the features of the invention. Unless specifically stated otherwise, reference to such external documents is not to be construed as an admission that such documents, or such sources of information, in any jurisdiction, are prior art, or form part of the common general knowledge in the art.
Aspects of the present teaching may be further understood in light of the following examples, which should not be construed as limiting the scope of the present teaching in any way.
EXAMPLES Table 1 illustrates in a non-limiting manner examples of compounds of formula (I) according to the invention : The compounds of formula (I) which are mentioned in table 1 hereinbelow were prepared in accordance with the procedures detailed hereinbelow in connection with specific examples and with the general description of the processes herein disclosed.
In table 1, unless otherwise specified, M+H (ApcI+) means the molecular ion peak plus 1 a.m.u. (atomic mass unit) as observed in mass spectroscopy via positive atmospheric pressure chemical ionisation.
In table 1, the logP values were determined in accordance with EEC Directive 79/831 Annex V.A8 by HPLC (High Performance Liquid Chromatography) on a reversed-phase column (C 18), using the methods described below : Method A : temperature: 40 °C ; mobile phases : 0.1% aqueous formic acid and acetonitrile ; linear gradient from 10% acetonitrile to 95% acetonitrile; Method B : temperature: 40 °C ; mobile phases : 0.001 molar ammonium acetate solution in water and acetonitrile ; linear gradient from 10% acetonitrile to 95% acetonitrile.
Calibration was carried out using unbranched alkanones (comprising 3 to 16 carbon atoms) with known logP values (determination of the logP values by the retention times using linear interpolation between two successive alkanones). lambda-max-values were determined using UV-spectra from 200 nm to 400 nm and the peak values of the chromatographic signals.
In table 1, the point of attachment of the (X)n residue to the phenyl ring is based on the above numbering of the phenyl ring.
Table 1 : 1 2 3 A R R R (X)n L M+H logP I.001 Me Me Me - O quinolinyl 294 5.17 A I.002 Me Me OH - O quinolinyl 296 2.82 A I.003 Me Me OH 3-F O quinolinyl 314 2.90 A I.004 Me Me -OCH - O quinolinyl 308 3.64 A I.005 Me Me Et 3-F O quinolinyl 326 5.47 A I.006 Me Me vinyl 3-F O quinolinyl 324 5.24 A I.007 Me Me chloromethyl 3-F O quinolinyl 346 5.00 A I.008 -CH CH CH - Me 3-F O quinolinyl 324 5.39 A 2 2 2 I.009 Me Me OH - NH quinolinyl 295 3.20 B I.010 Me Me -OCH2- NH quinolinyl 307 3.15 B I.011 Me Me Me - NH quinolinyl 293 3.46 A I.012 Me Me Me - CH2 quinolinyl 292 4.06 A I.013 Me Me phenyl - CH2 quinolinyl 354 4.20 A Example logP Method 1 2 3 A R R R (X)n L M+H logP I.014 Me Me 4-chlorophenyl - CH2 quinolinyl 388 4.74 A I.015 Me Me 2-thienyl - CH2 quinolinyl 360 4.04 A I.016 Me Me 4-phenoxyphenyl - CH2 quinolinyl 446 5.62 A I.017 Me Me Me 3-F C=O quinolinyl 324 4.49 A I.018 Me Me OH 4-F O 8-chloroquinolinyl 348 3.50 A I.019 Me Me Me 4-F O 8-chloroquinolinyl 346 5.62 A I.020 Me Me Me - O 7,8-difluoroquinolinyl 330 5.39 A I.021 Me Me Me 3-F O 7,8-difluoroquinolinyl 348 5.32 A I.022 Me Me OH 3-F O 7,8-difluoroquinolinyl 350 2.35 A I.023 Me Me OH - O 7,8-difluoroquinolinyl 332 3.27 A I.024 Me Me Me - O 7,8-difluoromethylquinolinyl 344 6.01 A I.025 Me Me OH 3-F O 7,8-difluoromethylquinolinyl 364 3.55 A I.026 Me Me OH - O 7,8-difluoromethylquinolinyl 346 3.51 A I.027 Me Me Me 3-F O 7,8-difluoromethylquinolinyl 362 5.54 B Example logP Method 1 2 3 A R R R (X)n L M+H logP I.028 Me Me phenyl 3-F O 7,8-difluoromethylquinolinyl 424 6.01 A I.029 Me Me Me 5-NH2 O 7,8-difluoromethylquinolinyl 359 4.59 A I.030 Me Me 2-thienyl 3-F O 7,8-difluoromethylquinolinyl 430 5.65 A I.031 Me Me Me 5-NO2 O 7,8-difluoromethylquinolinyl 389 5.34 A I.032 Me Me F 3-F O 7,8-difluoromethylquinolinyl 366 4.75 A I.033 Me Me OH 3-OMe O 7,8-difluoromethylquinolinyl 376 3.69 A I.034 Me Me OH 3-Cl O 7,8-difluoromethylquinolinyl 380 3.83 A I.035 Me Me OH 5-F O 7,8-difluoromethylquinolinyl 364 3.55 A I.036 Me Me OH 3-OCF O 7,8-difluoromethylquinolinyl 430 4.20 A I.037 Me Me OH 4-F O 7,8-difluoromethylquinolinyl 364 3.55 A I.038 Me Me Me 3-OMe O 7,8-difluoromethylquinolinyl 374 5.85 A I.039 Me Me Et 3-CN O 7,8-difluoromethylquinolinyl 383 5.22 A I.040 Me Me Me - CH 7,8-difluoromethylquinolinyl 342 5.54 A I.041 Me Me Et - O 5,6,7,8-tetrahydroquinolinyl 312 3.68 A Example logP Method 1 2 3 A R R R (X)n L M+H logP I.042 Me Me Me 3-F O 4-methylquinolinyl 326 5.62 A 4-[ethyl(dimethyl)silyl]-7,8-difluoro- I.043 Me Me Et 3-CN O 469 7.36 A 2-methylquinolinyl I.044 Me Me Me 3-F O 2-vinylquinolinyl 338 6.30 A I.045 Me Me Me 3-F O 2-phenylquinolinyl 388 6.40 A I.046 Me Me Me 3-F O 2-methylquinolinyl 326 5.08 A I.047 Me Me Me - O 2-methylquinolinyl 308 4.85 A I.048 Me Me OH - O 2-methylquinolinyl 310 2.16 A I.049 Me Me OH 3-F O 2-methylquinolinyl 328 2.41 A I.050 Me Me OH 3-OCF O 2-methylquinolinyl 394 3.35 A I.051 Me Me OH 3-Cl O 2-methylquinolinyl 344 2.80 A I.052 Me Me Et 3-F O 2-methylquinolinyl 340 5.62 A I.053 Me Me H 3-F O 2-methylquinolinyl 312 4.56 A I.054 Me Me Me - NH 2-methylquinolinyl 307 2.46 A I.055 Me Me Me 4-F NH 2-methylquinolinyl 325 2.63 A Example logP Method 1 2 3 A R R R (X)n L M+H logP I.056 Me Me Me - NEt 2-methylquinolinyl 335 3.16 A I.057 Me Me Et 3-F O 2-methyloxidoquinolinyl 356 4.54 A I.058 Me Me Me - NH 2-methyloxidoquinolinyl 323 3.62 A I.059 Me Me Me 3-F O 2-hydroxyquinolinyl 328 3.85 A I.060 Me Me Me 3-F O 2-ethoxyquinolinyl 356 6.79 A I.061 Me Me Me 3-F O 2-cyclopropylquinolinyl 352 6.90 A I.062 Me phenyl H 3-F O 2-chloroquinolinyl 394 5.78 A I.063 Me Me Me 3-F O 2-chloroquinolinyl 346 5.90 A I.064 Me Me Me 3-F O 2-(methylsulfanyl)quinolinyl 358 6.79 A I.065 Me Me Me 3-F O 2-(difluoromethyl)quinolinyl 362 5.45 A I.066 Me Me Me 3-F NH 2-(difluoromethyl)quinolinyl 361 5.68 A I.067 Me Me Me 3-F O 2-(3-thienyl)quinolinyl 394 6.66 A I.068 Me Me Me - O quinoxalinyl 295 5.05 A I.069 Me Me Me 3-F O quinoxalinyl 313 5.22 A Example logP Method 1 2 3 A R R R (X)n L M+H logP I.070 Me Me OH - O quinoxalinyl 297 2.86 A I.071 Me Me OH 3-F O quinoxalinyl 315 3.01 A I.072 Me Me ter-butyl - O quinoxalinyl 337 6.30 A I.073 Me Me isobutyl - O quinoxalinyl 337 6.33 A I.074 Et Et Et - O quinoxalinyl 337 6.43 A I.075 Me Me isopropyl - O quinoxalinyl 323 5.91 A I.076 Me Me Et - O quinoxalinyl 309 5.48 A I.077 Me Me Et - O 5,6-difluoroquinoxalinyl 345 5.62 A I.078 Me Me Me 3-F O 5,6-difluoroquinoxalinyl 349 5.20 A I.079 Me Me Me - O 5,6-difluoroquinoxalinyl 331 5.28 A I.080 Me Me cyclohexyl - O 5,6-difluoroquinoxalinyl 399 6.94 A I.081 Me Me OH - O 5,6-difluoroquinoxalinyl 333 3.23 A I.082 Me Me OH 3-F O 5,6-difluoroquinoxalinyl 351 3.33 A I.083 Me Me F 3-F O 5,6-difluoroquinoxalinyl 353 5.01 A Example logP Method 1 2 3 A R R R (X)n L M+H logP I.084 Me Me Me - NH 5,6-difluoroquinoxalinyl 330 4.49 A I.085 Me Me OH 3-F O 5,6-difluoromethylquinoxalinyl 365 3.67 A I.086 Me Me Me - O 5,6-difluoromethylquinoxalinyl 345 5.46 A I.087 Me Me OH - O 5,6-difluoromethylquinoxalinyl 347 3.35 A I.088 Me Me Me 3-F O 5,6-difluoromethylquinoxalinyl 363 5.65 A I.089 Me Me OH 6-F O 5,6-difluoromethylquinoxalinyl 365 3.62 A I.090 Me Me OH 3-Cl O 5,6-difluoromethylquinoxalinyl 381 3.94 A I.091 Me Me vinyl 3-F O 5,6-difluoromethylquinoxalinyl 375 5.62 A I.092 Me Me F 3-F O 5,6-difluoromethylquinoxalinyl 367 4.75 A I.093 Me Me OH 5-CN O 5,6-difluoromethylquinoxalinyl 372 3.39 A I.094 Me Me OH 3-OMe O 5,6-difluoromethylquinoxalinyl 377 3.60 A I.095 Me Me OH 3-OCF O 5,6-difluoromethylquinoxalinyl 431 4.34 A I.096 Me Me OH 5-Me O 5,6-difluoromethylquinoxalinyl 361 3.76 A I.097 Me Me OH 3-Me O 5,6-difluoromethylquinoxalinyl 361 3.76 A Example logP Method 1 2 3 A R R R (X)n L M+H logP I.098 Me Me OH 4-F O 5,6-difluoromethylquinoxalinyl 365 3.63 A I.099 Me Me OH 4-Me O 5,6-difluoromethylquinoxalinyl 361 3.85 A I.100 Me Me Me 4-F O 5,6-difluoromethylquinoxalinyl 363 5.57 A I.101 Me Me Me 4-Cl O 5,6-difluoromethylquinoxalinyl 379 6.11 A I.102 Me Me OH 4-Cl O 5,6-difluoromethylquinoxalinyl 381 4.01 A I.103 Me Me OH 6-Cl O 5,6-difluoromethylquinoxalinyl 381 3.96 A I.104 Me Me OH 6-Me O 5,6-difluoromethylquinoxalinyl 361 3.73 A I.105 Me Me OH 5-F O 5,6-difluoromethylquinoxalinyl 365 3.58 A I.106 Me Me Me 6-Cl O 5,6-difluoromethylquinoxalinyl 379 6.07 A I.107 Me Me Me 6-Me O 5,6-difluoromethylquinoxalinyl 359 5.88 A I.108 Me Me Me 5-F O 5,6-difluoromethylquinoxalinyl 363 5.57 A I.109 Me Me OH 3-F O 3-methylquinoxalinyl 329 3.25 A I.110 Me Me Me - O 3-methylquinoxalinyl 309 5.31 A I.111 Me Me Me 3-F O 3-methylquinoxalinyl 327 5.45 A Example logP Method 1 2 3 A R R R (X)n L M+H logP I.112 Me Me OH - O 3-methylquinoxalinyl 311 3.01 A I.113 Me Me 2-thienyl 3-F O 3-methylquinoxalinyl 395 5.51 A I.114 Me Me 4-methoxyphenyl 3-F O 3-methylquinoxalinyl 419 5.35 A I.115 Me Me phenyl 3-F O 3-methylquinoxalinyl 389 5.59 A I.116 Me Me Me 3-F O 1,5-naphthyridinyl 313 4.15 A I.117 Me Me OH 3-F O thieno[3,2-b]pyridinyl 320 2.80 A I.118 Me Me Me 3-F O thieno[3,2-b]pyridinyl 318 5.22 A I.119 Me Me OH 3-F O thieno[2,3-b]pyridinyl 320 3.09 A I.120 Me Me Me 3-F O thieno[2,3-b]pyridinyl 318 5.45 A I.121 Me Me OH 3-F O pyrazolo[1,5-a]pyrimidinyl 304 2.07 A I.122 Me Me Me 3-F O pyrazolo[1,5-a]pyrimidinyl 302 4.23 A I.123 Me Me Me - O pyrazolo[1,5-a]pyrimidinyl 284 4.11 A I.124 Me Me Me - O imidazo[1,2-a]pyrimidinyl 284 2.78 A I.125 Me Me OH - O imidazo[1,2-a]pyrimidinyl 286 2.10 A Example logP Method 1 2 3 A R R R (X)n L M+H logP I.126 Me Me OH - O 3-fluoropyrazolo[1,5-a]pyrimidinyl 304 2.50 A I.127 Me Me OH 3-F O 3-fluoropyrazolo[1,5-a]pyrimidinyl 322 2.60 A I.128 Me Me Me 3-F O 3-fluoropyrazolo[1,5-a]pyrimidinyl 320 4.61 A I.129 Me Me Me - O 3-fluoropyrazolo[1,5-a]pyrimidinyl 302 4.56 A I.130 Me Me Me - CH 4-methylquinolinyl 306 3.19 A I.131 Me Me Me 3-F S quinolinyl 328 5.72 A I.132 Me Me Me 3-F S(=O) quinolinyl 344 3.63 A I.133 Me Me Me 3-F CH(OH) quinolinyl 326 4.16 A I.134 Me Me Me 4-Cl O 2-methylquinolinyl 342 5.68 A I.135 Me Me Me 4-phenyl O 2-methylquinolinyl 384 6.27 A I.136 Me Me Me 4-cyclopropyl O 2-methylquinolinyl 348 5.68 A I.137 Me Me Me 4-vinyl O 2-methylquinolinyl 334 5.51 A I.138 Me Me Me 4-(3-thienyl) O 2-methylquinolinyl 390 5.85 A I.139 Me Me Me - CH 2-methylquinolinyl 306 2.76 A Example logP Method 1 2 3 A R R R (X)n L M+H logP I.140 Me Me phenyl - CH2 2-methylquinolinyl 368 2.88 A I.141 Me Me phenyl - CH2 1,5-naphthyridinyl 355 4.14 A I.142 Me Me benzyl - CH2 quinolinyl 368 4.94 A I.143 Me Me 4-benzylphenyl - CH2 quinolinyl 444 5.78 A Note : Me : methyl; Et : ethyl Example logP Method Table 2 illustrates in a non-limiting manner examples of compounds of formula (IIa) as well as their acceptable salts : (IIa) In table 2, M+H (ApcI+) and logP are defined as for table 1.
In table 2, the point of attachment of the (X ) residue to the phenyl ring is based on the above numbering of the phenyl ring.
Table 2: 1 a a U (X )n L M+H logP IIa.01 I 3-F O quinolinyl 366 3.71 A IIa.02 I - O quinolinyl 348 3.71 A IIa.03 Br - O quinolinyl 3.47 A IIa.04 Br - O 8-fluoroquinolinyl 318 3.61 A 8-fluoromethyl IIa.05 Br - O 332 3.96 A quinolinyl IIa.06 Br - O 7,8-difluoroquinolinyl 336 3.92 A 7,8-difluoro- IIa.07 Br - O 350 4.25 A 2-methylquinolinyl IIa.08 Br - O 2-methylquinolinyl 314 3.96 A 7,8-difluoro- IIa.09 Br 6-F O 368 4.25 A 2-methylquinolinyl 7,8-difluoro- IIa.10 Br 5-F O 368 4.34 A 2-methylquinolinyl IIa.11 Br 4-F O 8-chloroquinolinyl 352 4.18 A 7,8-difluoro- IIa.12 Br 4-F O 368 4.25 A 2-methylquinolinyl Example logP Method 1 a a U (X ) L M+H logP IIa.13 Br 4-F O 2-methylquinolinyl 332 3.35 A 7,8-difluoro- IIa.14 Br 3-OMe O 380 4.11 A 2-methylquinolinyl IIa.15 Br 3-F O 7,8-difluoroquinolinyl 354 3.90 A 7,8-difluoro- IIa.16 Br 3-F O 368 4.29 A 2-methylquinolinyl IIa.17 Br 3-F O 4-methylquinolinyl 332 3.89 A IIa.18 Br 3-F O 2-methylquinolinyl 332 3.58 A 2-(difluoromethyl) IIa.19 Br 3-F O 368 3.99 A quinolinyl 7,8-difluoro- IIa.20 Br 3-Cl O 384 4.72 A 2-methylquinolinyl IIa.21 Br 3-Cl O 2-methylquinolinyl 348 3.99 A 2-(difluoromethyl) IIa.22 Br 3-F NH 367 4.34 A quinolinyl IIa.23 Cl 4-F O 8-chloroquinolinyl 308 4.11 A 7,8-difluoro- IIa.24 Br 3-OCF O 434 4.90 A 2-methylquinolinyl IIa.25 Br 3-OCF3 O 2-methylquinolinyl 398 4.30 A IIa.26 Br 4-Cl O 2-methylquinolinyl 348 4.13 A Note : Me : methyl Table 3 illustrates in a non-limiting manner examples of compounds of formula (IIb) as well as their acceptable salts : (X ) (IIb) Example logP Method In table 3, M+H (ApcI+) and logP are defined as for table 1.
In table 3, the point of attachment of the (X ) residue to the phenyl ring is based on the above numbering of the phenyl ring.
Table 3: 1 a a U (X )n L M+H logP IIb.01 Br - O 5,6-difluoroquinoxalinyl 337 3.92 A ,6-difluoro- IIb.02 Br - O 351 4.38 A 3-methylquinoxalinyl ,6-difluoro- IIb.03 Br 6-Me O 365 4.80 A 3-methylquinoxalinyl ,6-difluoro- IIb.04 Br 6-F O 369 2.67 A 3-methylquinoxalinyl ,6-difluoro- IIb.05 Br 6-Cl O 385 4.87 A 3-methylquinoxalinyl ,6-difluoro- IIb.06 Br 5-Me O 365 4.85 A 3-methylquinoxalinyl ,6-difluoro- IIb.07 Br 5-F O 369 4.51 A 3-methylquinoxalinyl ,6-difluoro- IIb.08 Br 5-Cl O 385 5.05 A 3-methylquinoxalinyl ,6-difluoro- IIb.09 Br 4-Me O 365 4.92 A 3-methylquinoxalinyl ,6-difluoro- IIb.10 Br 4-F O 369 4.54 A 3-methylquinoxalinyl ,6-difluoro- IIb.11 Br 4-Cl O 385 5.16 A 3-methylquinoxalinyl ,6-difluoro- IIb.12 Br 3-Me O 365 4.85 A 3-methylquinoxalinyl ,6-difluoro- IIb.13 Br 3-OMe O 381 4.19 A 3-methylquinoxalinyl IIb.14 Br 3-F O quinoxalinyl 319 3.78 A IIb.15 Br 3-F O 5,6-difluoroquinoxalinyl 355 3.97 A ,6-difluoro- IIb.16 Br 3-F O 369 4.44 A 3-methylquinoxalinyl IIb.17 Br 3-F O 3-methylquinoxalinyl 333 4.11 A ,6-difluoro- IIb.18 Br 3-Cl O 385 4.82 A 3-methylquinoxalinyl Example logP Method 1 a a U (X ) L M+H logP IIb.19 Br 4-CNF O 5,6-difluoroquinoxalinyl 380 3.81 A ,6-difluoro- IIb.20 Br 5-CN O 376 4.03 A 3-methylquinoxalinyl IIb.21 Br 6-CNF O 5,6-difluoroquinoxalinyl 380 3.72 A ,6-difluoro- IIb.22 Br 3-CN O 376 3.83 A 3-methylquinoxalinyl ,6-difluoro- IIb.23 Br 3-OCF O 435 5.08 A 3-methylquinoxalinyl Note : Me : methyl Table 4 illustrates in a non-limiting manner examples of compounds of formula (IVa), as well as their acceptable salts : (IVa) In table 4, M+H (ApcI+) and logP are defined as for table 1.
In table 4, the point of attachment of the (X ) residue to the phenyl ring is based on the above numbering of the phenyl ring.
Table 4: (X ) L M+H logP IVa.01 - NH quinolinyl 236 1.28 A IVa.02 3-F O 2-methylquinolinyl 269 2.15 A IVa.03 - O 7,8-difluoroquinolinyl 273 2.71 A Example Example logP Method logP Method (X ) L M+H logP IVa.04 3-F O 7,8-difluoroquinolinyl 291 3.02 A 7,8-difluoro- IVa.05 - O 287 2.99 A 2-methylquinolinyl 7,8-difluoro- IVa.06 3-F O 305 3.27 A 2-methylquinolinyl IVa.07 - O 2-methylquinolinyl 251 1.66 A Table 5 illustrates in a non-limiting manner examples of compounds of formula (Va), as well as their acceptable salts : (Va) In table 5, M+H (ApcI+) and logP are defined as for table 1.
In table 5, the point of attachment of the (X)n residue to the phenyl ring is based on the above numbering of the phenyl ring.
Table 5: (X) L M+H logP Va.01 3-F O 7,8-difluoroquinolinyl 321 3.35 A 7,8-difluoro- Va.02 3-F O 335 3.64 A 2-methylquinolinyl Va.03 - O 7,8-difluoroquinolinyl 303 3.06 A 7,8-difluoro- Va.04 - O 317 3.42 A 2-methylquinolinyl Example Example logP logP Method Method (X)n L M+H logP Va.05 3-F O quinolinyl 285 3.13 A Va.06 3-F O 2-methylquinolinyl 299 3.15 A Va.07 - O quinolinyl 267 1.62 A Va.08 - O 2-methylquinolinyl 281 2.64 A Table 6 illustrates in a non-limiting manner examples of compounds of formula (IXa) : (IXa) In table 6, M+H (ApcI+) and logP are defined as for table 1.
Table 6: b b 3a X L R M+H logP IXa.01 3-F O isopropyl 169 4.27 A IXa.02 - O isopropyl 151 4.25 A IXa.03 - O isobutyl 151 4.67 A IXa.04 - O ethyl 180 3.90 B IXa.05 - O cyclohexyl 151 5.25 A IXa.06 - O benzyl 242 5.14 A (1) 3a Note : Mass M - R by GC-mass Note : Mass M by GC-mass Table 7 illustrates in a non-limiting manner examples of compounds of formula (XIa) : Example Example logP Method logP Method (XIa) In table 7, M+H (ApcI+) and logP are defined as for table 1.
Table 7: b 4 3a X U R M+H logP XIa.01 - Br 6-chloropyridinyl 324 4.51 A XIa.02 - I phenyl 225 6.82 A XIa.03 - Br phenyl 5.46 A XIa.04 - Br 2-thienyl 295 5.19 A XIa.05 - Br 4-phenoxyphenyl 381 6.43 A XIa.06 - Br 4-chlorophenyl 323 5.94 A XIa.07 - Br benzyl 238 5.59 A XIa.08 - Br biphenylyl 365 6.53 A XIa.09 - Br 4-benzylphenyl 314 6.50 A Note : Mass M - CH3 by GC-mass (2) 4 Note : Mass M - U by GC-mass Table 8 illustrates in a non-limiting manner examples of compounds of formula (XIIa) : (XIIa) In table 8, M+H (ApcI+) and logP are defined as for table 1.
Example logP Method In table 8, the point of attachment of the (X)n residue to the phenyl ring is based on the above numbering of the phenyl ring.
Table 8: 2 1a 2a 3a W (X)n R R R M+H logP 4,4,5,5-tetramethyl- - XIIa.01 Me Me Me - 5.68 A 1,3,2-dioxaborolanyl Note : Me : methyl Note : no ionization Table 9 illustrates in a non-limiting manner examples of compounds of formula (VIIa) : (VIIa) In table 9, M+H (ApcI+) and logP are defined as for table 1.
In table 9, the point of attachment of the (X)n residue to the phenyl ring is based on the above numbering of the phenyl ring.
Table 9: (X )n L M+H logP VIIa.01 - O 2-chloroquinolinyl 274 3.99 A VIIa.02 - O 2-ethoxyquinolinyl 284 4.74 A 2-(methylsulfanyl) VIIa.03 - O 286 4.92 A quinolinyl VIIa.04 - O 2-methylquinolinyl 254 2.96 A VIIa.05 - O quinolinyl 240 3.21 A Example Example logP Method logP Method (X ) L M+H logP VIIa.06 - O 1-oxidoquinolinyl 256 2.14 A Table 10 illustrates in a non-limiting manner examples of compounds of formula (XIV) : (XIV) In table 10, M+H (ApcI+) and logP are defined as for table 1.
In table 10, the point of attachment of the (X)n residue to the phenyl ring is based on the above numbering of the phenyl ring.
Table 10: 1a 2a 3a Z (X)n R R R M+H logP XIV.01 CH3 - Me Me Me 222 1.39 A Note : Me : methyl Note : Mass M by GC-mass Table 11 illustrates other preferred compounds of formula (II), (VII) and (IX).
In table 11, M+H (ApcI+) and logP are defined as for table 1.
Table 11: Structure M+H logP Example Example Example logP Method logP logP Method Method Structure M+H logP II.01A 376 3.29 A II.02A 378 2.59 A II.03A 358 2.14 A II.04A Br 413 4.13 B II.05A 462 4.56 B II.06A 395 4.04 A II.07A II.08A 376 3.99 A II.01B 365 3.48 A Example logP Method Structure M+H logP VII.01A 254 1.54 A VII.02A 252 2.73 A VII.03A 289 3.68 A VII.04A 2.10 272 A VII.05A 2.68 288 A IX.01A 208 4.72 A IX.02A 226 4.69 A Note : Mass M (minor) by GC-mass together with M - Et, M - 2Et and M - 3Et.
Table 12 provides the NMR data ( H) of a selected number of compounds from table 1, table 2, table 3, table 4, table 5, table 6, table 7, table 8, table 9, table 10 and table 11.
The H-NMR data of selected examples are stated in the form of H-NMR peak lists. For each signal peak, the λ value in ppm and the signal intensity in brackets are listed.
Intensity of sharp signals correlates with the height of the signals in a printed example of a NMR spectrum in cm and shows the real relations of signal intensities. From broad signals several peaks or the middle of Example logP Method the signal and their relative intensity in comparison to the most intensive signal in the spectrum can be shown.
The H-NMR peak lists are similar to classical H-NMR prints and contain therefore usually all peaks, which are listed at classical NMR-interpretation. Additionally they can show like classical H-NMR prints signals of solvents, stereoisomers of the target compounds, which are also object of the invention, and/or peaks of impurities. To show compound signals in the delta-range of solvents and/or water the usual peaks of solvents, for example peaks of DMSO in d6-DMSO and the peak of water are shown in our H- NMR peak lists and have usually on average a high intensity.
The peaks of stereoisomers of the target compounds and/or peaks of impurities have usually on average a lower intensity than the peaks of target compounds (for example with a purity >90%). Such stereoisomers and/or impurities can be typical for the specific preparation process. Therefore their peaks can help to recognize the reproduction of our preparation process via "side-products-fingerprints".
An expert, who calculates the peaks of the target compounds with known methods (MestreC, ACD- simulation, but also with empirically evaluated expectation values), can isolate the peaks of the target compounds as needed optionally using additional intensity filters. This isolation would be similar to relevant peak picking at classical H-NMR interpretation.
Further details of NMR-data description with peak lists can be found in the publication "Citation of NMR Peaklist Data within Patent Applications" of the Research Disclosure Database Number 564025.
Table 12 : NMR peak lists H-NMR [CDCl3 at 300 Mhz] 8.794 (0.71); 8.784 (0.72); 8.115 (0.34); 8.088 (0.38); 7.658 (0.44); 7.63 (0.37); 7.625 (0.4); 7.602 (0.33); 7.586 (0.36); 7.58 (0.37); 7.562 (0.41); 7.556 (0.42); 7.541 (0.34); 7.537 (0.33); I.001 7.514 (0.42); 7.5 (0.55); 7.491 (0.69); 7.378 (0.33); 7.372 (0.32); 7.259 (1.34); 7.232 (0.32); 7.229 (0.32); 7.208 (0.51); 7.204 (0.49); 6.917 (0.47); 6.915 (0.45); 6.89 (0.42); 1.656 (0.42); 0.302 (0.58); 0.291 (16); 0.28 (0.78); 0 (0.96) 8.831 (0.95); 8.822 (0.95); 8.159 (0.5); 8.132 (0.56); 7.737 (0.46); 7.719 (0.64); 7.713 (1.1); 7.709 (1.01); 7.704 (0.49); 7.695 (0.65); 7.689 (0.7); 7.685 (0.68); 7.68 (0.63); 7.675 (0.33); 7.657 (0.48); 7.652 (0.37); 7.6 (0.81); 7.592 (1.2); 7.59 (1.09); 7.566 (0.6); 7.562 (0.38); 7.44 I.002 (0.49); 7.437 (0.47); 7.434 (0.49); 7.431 (0.4); 7.412 (0.45); 7.406 (0.41); 7.299 (6.28); 7.293 (0.72); 7.29 (0.59); 7.269 (0.78); 7.266 (0.73); 7.245 (0.33); 6.935 (0.71); 6.908 (0.64); 2.239 (0.61); 1.608 (3.75); 0.482 (0.68); 0.471 (16); 0.459 (0.73); 0.039 (6.19) 8.814 (2.06); 8.805 (2.11); 8.174 (1); 8.146 (1.13); 7.775 (0.91); 7.748 (1.32); 7.742 (0.8); 7.736 (0.69); 7.718 (1.07); 7.713 (1.19); 7.708 (0.62); 7.69 (0.95); 7.685 (0.76); 7.665 (1.63); 7.657 (1.56); 7.622 (0.91); 7.618 (0.92); 7.595 (1.21); 7.591 (0.75); 7.572 (0.53); 7.568 (0.49); 7.399 (0.59); 7.376 (0.73); 7.372 (1.31); 7.349 (1.34); 7.344 (0.84); 7.322 (0.8); 7.3 (16.11); 6.937 I.003 (0.88); 6.935 (0.85); 6.908 (1.53); 6.881 (0.78); 6.879 (0.72); 6.685 (1.63); 6.658 (1.5); 5.339 (1.16); 2.679 (1); 2.672 (0.95); 1.604 (15.76); 0.547 (0.88); 0.535 (16); 0.53 (15.95); 0.518 (0.69); 0.501 (0.5); 0.495 (0.46); 0.418 (0.46); 0.412 (0.44); 0.103 (0.7); 0.049 (0.44); 0.038 (10.86); 0.028 (0.42) 8.848 (1.07); 8.838 (1.11); 8.16 (0.55); 8.132 (0.64); 7.736 (0.48); 7.709 (1.02); 7.685 (0.57); 7.68 (0.61); 7.676 (0.34); 7.658 (0.48); 7.652 (0.37); 7.594 (0.48); 7.59 (0.5); 7.567 (0.66); I.004 7.563 (0.48); 7.555 (0.9); 7.545 (1.06); 7.478 (0.55); 7.453 (1.06); 7.427 (0.7); 7.3 (2.82); 7.136 (0.76); 7.135 (0.76); 7.111 (0.66); 7.11 (0.66); 6.89 (0.75); 6.888 (0.75); 6.863 (0.7); 5.234 (3.08); 1.678 (0.33); 1.293 (0.44); 0.357 (0.54); 0.345 (16); 0.333 (0.8); 0.109 (0.33); 0.038 Example H-NMR [CDCl3 at 300 Mhz] (1.27) 8.757 (2.02); 8.751 (2.01); 8.12 (1.38); 8.099 (1.44); 7.706 (1.24); 7.685 (1.58); 7.664 (0.75); 7.66 (0.73); 7.646 (1.14); 7.643 (1.39); 7.626 (0.92); 7.622 (0.79); 7.553 (1.08); 7.551 (1.09); 7.533 (1.54); 7.517 (2.4); 7.512 (2.38); 7.329 (0.62); 7.312 (0.89); 7.309 (1.38); 7.292 (1.41); I.005 7.289 (0.95); 7.272 (0.8); 7.259 (4.9); 6.871 (0.97); 6.849 (1.8); 6.829 (0.88); 6.673 (1.93); 6.653 (1.8); 1.602 (1.08); 1.256 (0.94); 0.982 (1.6); 0.962 (5.06); 0.953 (0.84); 0.944 (3.19); 0.869 (1.19); 0.85 (2.14); 0.831 (1.66); 0.811 (0.41); 0.472 (1.04); 0.338 (16); 0.333 (15.8); 0 (3.76) 8.783 (1.92); 8.774 (1.98); 8.16 (1.13); 8.132 (1.28); 7.744 (1.02); 7.717 (1.49); 7.711 (0.86); 7.706 (0.71); 7.687 (1.03); 7.682 (1.22); 7.678 (0.68); 7.659 (0.88); 7.654 (0.74); 7.597 (0.94); 7.594 (1.06); 7.57 (1.29); 7.544 (2.26); 7.535 (1.79); 7.391 (0.57); 7.369 (0.66); 7.364 (1.32); 7.342 (1.29); 7.337 (0.89); 7.314 (0.72); 7.298 (3.01); 6.924 (0.92); 6.896 (1.66); 6.868 (0.81); I.006 6.721 (1.77); 6.694 (1.62); 6.471 (0.49); 6.467 (0.56); 6.423 (0.63); 6.418 (0.67); 6.404 (0.62); 6.399 (0.66); 6.355 (0.75); 6.351 (0.82); 5.993 (1.31); 5.982 (1.53); 5.945 (1.12); 5.933 (1.18); .789 (1.47); 5.778 (1.28); 5.722 (1.17); 5.71 (1.07); 1.292 (1.48); 0.568 (0.52); 0.493 (0.62); 0.482 (15.28); 0.475 (16); 0.037 (3) 8.813 (1.82); 8.804 (1.83); 8.186 (1.04); 8.158 (1.16); 7.774 (1.01); 7.747 (1.46); 7.738 (0.76); 7.733 (0.71); 7.714 (1.08); 7.71 (1.25); 7.705 (0.67); 7.686 (0.91); 7.682 (0.73); 7.651 (1.8); 7.642 (1.8); 7.621 (1.02); 7.617 (1.02); 7.594 (1.3); 7.57 (0.52); 7.567 (0.49); 7.408 (0.6); 7.386 I.007 (0.75); 7.381 (1.34); 7.359 (1.36); 7.354 (0.9); 7.331 (0.76); 7.297 (3.6); 6.929 (0.93); 6.9 (1.71); 6.872 (0.87); 6.694 (1.8); 6.667 (1.66); 3.258 (0.38); 3.194 (5.53); 3.191 (5.52); 1.469 (0.33); 1.323 (0.73); 1.291 (4.98); 0.916 (0.62); 0.892 (0.48); 0.878 (0.33); 0.863 (0.59); 0.69 (1.18); 0.552 (0.67); 0.54 (15.94); 0.535 (16); 0.109 (4.46); 0.036 (2.86) 8.796 (2.24); 8.788 (3.9); 8.781 (3.33); 8.154 (2.41); 8.127 (2.34); 7.738 (2.31); 7.71 (3.17); 7.687 (1.55); 7.675 (2.43); 7.659 (1.32); 7.652 (1.55); 7.588 (2.14); 7.564 (3.28); 7.553 (3.32); 7.545 (4.89); 7.538 (4.26); 7.439 (0.67); 7.431 (1.02); 7.404 (2.16); 7.389 (1.53); 7.382 (2.07); 7.362 (0.85); 7.354 (0.9); 7.301 (2.39); 7.294 (2.79); 7.208 (1.06); 6.952 (1.77); 6.931 (2.01); 6.925 (2.75); 6.905 (1.07); 6.898 (1.29); 6.784 (0.61); 6.771 (2.08); 6.764 (3.01); 6.744 (1.9); 6.737 (2.5); 2.668 (0.61); 2.268 (0.35); 2.253 (0.59); 2.242 (0.76); 2.234 (1.04); 2.219 (1.09); 2.213 (1.25); 2.2 (1.4); 2.192 (1.56); 2.18 (1.33); 2.171 (1.3); 2.164 (1.55); 2.158 (1.61); 2.146 I.008 (1.1); 2.139 (1.51); 2.132 (1.65); 2.115 (1.07); 2.107 (1.21); 2.1 (1.13); 2.091 (0.94); 2.084 (0.75); 2.076 (0.63); 2.066 (0.61); 1.709 (1.18); 1.701 (1.2); 1.642 (0.47); 1.491 (1.3); 1.466 (2.35); 1.46 (2.35); 1.449 (2.38); 1.442 (2.59); 1.416 (2.73); 1.384 (1.49); 1.289 (3); 1.261 (2.29); 1.25 (2.42); 1.239 (2.94); 1.231 (2.98); 1.218 (3.02); 1.211 (3.31); 1.192 (2.11); 1.168 (1.35); 1.16 (1.13); 0.89 (0.77); 0.581 (3.28); 0.568 (11.28); 0.561 (16); 0.305 (0.64); 0.298 (0.97); 0.234 (0.45); 0.216 (0.41); 0.208 (0.42); 0.191 (0.57); 0.175 (0.61); 0.167 (0.8); 0.115 (0.95); 0.108 (1.12); 0.054 (0.45); 0.041 (1.44); 0.034 (1.86) 8.69 (1.13); 8.681 (1.15); 8.023 (0.44); 8.018 (0.47); 7.993 (0.53); 7.849 (0.63); 7.763 (0.91); 7.754 (0.88); 7.669 (0.45); 7.664 (0.39); 7.66 (0.32); 7.644 (0.67); 7.637 (0.62); 7.552 (0.34); 7.535 (0.68); 7.529 (0.65); 7.525 (0.48); 7.515 (1.23); 7.511 (1.2); 7.502 (0.73); 7.49 (1.38); I.009 7.463 (1.06); 7.46 (1.05); 7.45 (0.63); 7.445 (0.56); 7.427 (0.6); 7.422 (0.61); 7.3 (4.89); 7.12 (0.42); 7.115 (0.43); 7.096 (0.62); 7.092 (0.66); 7.072 (0.43); 7.068 (0.43); 1.295 (0.54); 0.692 (1.88); 0.506 (0.71); 0.495 (16); 0.484 (0.73); 0.111 (0.72); 0.04 (2.59) 8.739 (1.02); 8.73 (1.04); 8.072 (0.51); 8.045 (0.55); 7.681 (0.41); 7.677 (0.4); 7.655 (0.6); 7.65 (0.63); 7.613 (0.83); 7.603 (1.03); 7.598 (0.39); 7.58 (0.55); 7.575 (0.5); 7.553 (0.54); 7.547 I.010 (0.43); 7.538 (0.53); 7.533 (0.58); 7.511 (0.5); 7.508 (0.43); 7.453 (0.46); 7.427 (1.01); 7.402 (0.66); 7.3 (4.04); 7.227 (0.78); 7.201 (0.61); 7.032 (0.7); 7.007 (0.62); 5.711 (0.53); 5.214 (2.95); 1.658 (1.42); 0.442 (0.55); 0.43 (16); 0.419 (0.59); 0.039 (2.64) 8.655 (0.73); 8.646 (0.75); 8.045 (0.34); 8.019 (0.38); 7.613 (0.38); 7.607 (0.7); 7.6 (0.5); 7.589 I.011 (0.41); 7.584 (0.43); 7.527 (0.4); 7.521 (0.33); 7.5 (0.68); 7.493 (0.71); 7.469 (0.42); 7.444 Example H-NMR [CDCl3 at 300 Mhz] (0.44); 7.439 (0.33); 7.423 (0.7); 7.416 (0.95); 7.392 (0.61); 7.298 (1.11); 7.226 (0.43); 7.222 (0.42); 5.792 (0.39); 0.375 (0.65); 0.365 (16); 0.354 (0.74); 0.041 (1.18) 8.817 (0.63); 8.81 (0.65); 8.142 (0.39); 8.114 (0.45); 7.756 (0.91); 7.73 (0.71); 7.711 (0.36); 7.706 (0.4); 7.648 (0.35); 7.626 (0.46); 7.619 (0.41); 7.569 (0.33); 7.546 (0.46); 7.348 (0.35); I.012 7.342 (0.39); 7.326 (0.67); 7.32 (0.61); 7.303 (0.44); 7.297 (1.51); 7.071 (0.38); 7.065 (0.41); 7.042 (0.33); 4.377 (1.9); 0.381 (0.68); 0.371 (16); 0.36 (0.85); 0.039 (1.08) 8.558 (0.94); 8.551 (0.91); 8.103 (0.64); 8.075 (0.75); 7.724 (0.55); 7.718 (0.47); 7.714 (0.44); 7.71 (0.45); 7.705 (0.56); 7.701 (0.76); 7.694 (0.67); 7.688 (0.53); 7.682 (0.74); 7.677 (0.39); 7.66 (0.75); 7.655 (0.54); 7.637 (0.86); 7.553 (0.77); 7.545 (1.45); 7.54 (0.9); 7.534 (1.3); 7.529 I.013 (0.7); 7.521 (1.5); 7.514 (0.55); 7.484 (0.95); 7.481 (0.91); 7.385 (0.59); 7.379 (0.62); 7.362 (1.28); 7.357 (1.33); 7.349 (2.34); 7.342 (2.71); 7.333 (1.48); 7.327 (1.13); 7.315 (0.47); 7.303 (1.23); 7.068 (0.61); 7.062 (0.62); 7.039 (0.51); 4.163 (3.02); 0.646 (0.8); 0.635 (16); 0.624 (0.62); 0.051 (0.9) 8.594 (1.07); 8.587 (1.08); 8.107 (0.62); 8.079 (0.73); 7.718 (0.35); 7.712 (0.39); 7.699 (0.62); 7.695 (0.94); 7.69 (0.85); 7.684 (0.44); 7.677 (0.73); 7.67 (0.74); 7.662 (0.81); 7.632 (0.84); 7.555 (0.59); 7.551 (0.53); 7.532 (0.52); 7.528 (0.68); 7.524 (0.36); 7.46 (0.9); 7.456 (0.88); I.014 7.433 (0.46); 7.427 (1.74); 7.42 (0.61); 7.408 (0.89); 7.399 (2.3); 7.393 (0.47); 7.385 (0.71); 7.378 (0.92); 7.371 (0.62); 7.352 (0.64); 7.348 (0.57); 7.304 (1.26); 7.281 (2.36); 7.275 (0.66); 7.259 (0.64); 7.254 (1.5); 7.099 (0.63); 7.095 (0.63); 7.073 (0.54); 7.071 (0.53); 4.142 (2.9); 1.791 (1.56); 0.624 (0.69); 0.614 (16); 0.603 (0.66); 0.048 (1.14) 8.618 (1.04); 8.61 (1.05); 8.111 (0.64); 8.083 (0.62); 7.717 (0.32); 7.713 (0.44); 7.704 (0.59); 7.697 (1.06); 7.69 (1.24); 7.681 (0.79); 7.674 (0.79); 7.671 (0.8); 7.666 (1.51); 7.628 (0.91); 7.626 (0.84); 7.613 (0.97); 7.61 (0.87); 7.564 (0.88); 7.56 (0.89); 7.554 (0.81); 7.55 (0.57); I.015 7.531 (0.45); 7.525 (0.73); 7.388 (0.58); 7.382 (0.6); 7.364 (0.64); 7.357 (0.94); 7.351 (0.62); 7.332 (0.6); 7.328 (0.57); 7.31 (1.09); 7.304 (2.38); 7.299 (1.21); 7.297 (1); 7.183 (0.82); 7.172 (0.79); 7.168 (0.82); 7.156 (0.66); 7.078 (0.6); 7.074 (0.63); 7.05 (0.53); 4.257 (2.91); 1.716 (1.83); 0.702 (0.64); 0.691 (16); 0.68 (0.63); 0.047 (1.89) 8.586 (1.13); 8.578 (1.12); 8.115 (0.64); 8.087 (0.78); 7.717 (0.93); 7.712 (0.53); 7.694 (1.48); 7.688 (1.55); 7.666 (0.69); 7.659 (0.93); 7.556 (0.59); 7.553 (0.54); 7.534 (0.58); 7.53 (0.69); 7.525 (0.5); 7.514 (0.98); 7.51 (1.04); 7.508 (1.02); 7.497 (0.35); 7.49 (1.96); 7.483 (0.65); 7.468 (0.76); 7.461 (2.03); 7.454 (0.33); 7.384 (0.7); 7.378 (1.27); 7.369 (0.41); 7.361 (1.29); I.016 7.352 (1.9); 7.338 (0.71); 7.333 (0.74); 7.33 (0.66); 7.324 (1.12); 7.315 (0.36); 7.304 (4); 7.173 (0.37); 7.17 (0.57); 7.145 (0.85); 7.12 (0.37); 7.073 (0.63); 7.067 (0.66); 7.044 (0.55); 7.016 (1.34); 7.013 (1.54); 7.006 (0.38); 6.991 (0.86); 6.987 (1.32); 6.984 (1.01); 6.97 (0.33); 6.962 (2.16); 6.956 (0.66); 6.94 (0.71); 6.934 (1.81); 4.187 (3.01); 1.664 (4.76); 0.635 (0.8); 0.625 (16); 0.614 (0.67); 0.046 (3.58) 9.445 (1.37); 9.438 (1.4); 8.577 (1.33); 8.571 (1.32); 8.255 (0.83); 8.227 (1.06); 7.964 (0.83); 7.946 (0.63); 7.94 (1.09); 7.937 (1.14); 7.923 (0.77); 7.919 (0.83); 7.895 (0.54); 7.891 (0.44); I.017 7.71 (0.63); 7.686 (0.97); 7.662 (0.43); 7.517 (0.35); 7.499 (0.39); 7.491 (0.67); 7.472 (0.66); 7.465 (0.56); 7.446 (0.51); 7.305 (1.8); 7.261 (0.63); 7.232 (1.01); 7.206 (1.65); 7.182 (1.09); 1.295 (0.41); 0.308 (0.38); 0.297 (15.16); 0.291 (16); 0.166 (0.79); 0.04 (1.36) 8.925 (1.19); 8.916 (1.23); 7.801 (0.62); 7.797 (0.69); 7.776 (0.76); 7.772 (0.8); 7.65 (0.55); 7.646 (0.59); 7.623 (0.83); 7.619 (0.78); 7.519 (1.23); 7.51 (1.38); 7.481 (0.92); 7.454 (0.5); I.018 7.416 (0.66); 7.406 (0.66); 7.39 (0.61); 7.379 (0.63); 7.297 (3.58); 7.14 (0.37); 7.137 (0.46); 7.13 (0.36); 7.126 (0.43); 7.111 (0.41); 7.101 (0.37); 6.963 (0.67); 6.95 (0.69); 6.934 (0.51); 6.92 (0.5); 2.123 (0.65); 1.616 (3.17); 0.435 (0.59); 0.424 (16); 0.412 (0.62); 0.035 (3.15) 8.922 (0.78); 8.913 (0.78); 7.79 (0.44); 7.786 (0.45); 7.765 (0.51); 7.761 (0.52); 7.64 (0.36); I.019 7.636 (0.37); 7.612 (0.53); 7.608 (0.49); 7.498 (0.55); 7.473 (0.61); 7.461 (0.79); 7.452 (0.79); 7.446 (0.38); 7.298 (7.2); 7.282 (0.43); 7.265 (0.37); 7.254 (0.4); 7.112 (0.32); 7.076 (0.38); Example H-NMR [CDCl3 at 300 Mhz] 6.97 (0.45); 6.956 (0.57); 6.94 (0.36); 6.927 (0.43); 4.743 (0.65); 2.046 (0.33); 1.591 (8.01); 0.341 (7.36); 0.33 (1.15); 0.305 (0.58); 0.294 (16); 0.283 (0.63); 0.276 (0.32); 0.036 (7.02) 8.895 (0.62); 8.886 (0.62); 7.638 (0.35); 7.632 (0.37); 7.613 (0.41); 7.608 (0.42); 7.509 (0.48); 7.504 (0.53); 7.5 (0.54); 7.496 (0.46); 7.466 (0.76); 7.46 (0.66); 7.455 (0.49); 7.44 (1.42); 7.425 I.020 (0.38); 7.415 (0.32); 7.302 (1.74); 7.277 (0.53); 7.274 (0.51); 6.959 (0.51); 6.932 (0.46); 1.624 (1.12); 1.296 (0.49); 0.325 (0.68); 0.314 (16); 0.303 (0.65); 0.112 (5.48); 0.04 (1.32) 8.864 (1.17); 8.855 (1.2); 7.525 (0.89); 7.52 (0.96); 7.516 (1); 7.512 (0.87); 7.487 (1.63); 7.475 (0.76); 7.464 (1.7); 7.444 (0.68); 7.412 (0.45); 7.389 (0.46); 7.384 (0.88); 7.362 (0.88); 7.357 I.021 (0.54); 7.335 (0.48); 7.301 (2.28); 6.954 (0.55); 6.952 (0.55); 6.925 (0.98); 6.898 (0.5); 6.896 (0.47); 6.729 (1.05); 6.702 (0.98); 1.631 (1.95); 0.392 (0.64); 0.381 (16); 0.375 (15.93); 0.363 (0.67); 0.123 (0.64); 0.111 (16.17); 0.099 (0.59); 0.039 (2.07) 8.823 (2.03); 8.814 (1.98); 7.609 (1.56); 7.604 (1.78); 7.602 (1.75); 7.491 (0.51); 7.477 (2.37); 7.457 (2.07); 7.446 (1.18); 7.425 (1.25); 7.394 (1.61); 7.371 (1.45); 7.344 (0.69); 7.302 (0.6); I.022 6.953 (1); 6.925 (1.81); 6.897 (0.89); 6.698 (1.98); 6.67 (1.75); 3.077 (0.98); 1.285 (0.62); 0.509 (16); 0.505 (15.33); 0.476 (0.88); 0.47 (0.81); 0.441 (0.46); 0.436 (0.45); 0.209 (0.72); 0.172 (0.84); 0.169 (0.87); 0.132 (0.45); 0.111 (3.35); 0.07 (1.08); 0.026 (0.45) 7.742 (0.67); 7.737 (0.64); 7.718 (0.76); 7.712 (0.69); 7.552 (0.9); 7.547 (0.96); 7.544 (0.96); 7.539 (0.72); 7.468 (0.44); 7.462 (0.38); 7.437 (2.31); 7.422 (0.94); 7.416 (1.57); 7.41 (1.18); 7.391 (0.58); 7.301 (0.48); 7.296 (0.62); 7.293 (0.54); 7.271 (1); 7.269 (0.84); 7.247 (0.43); I.023 7.244 (0.36); 6.93 (0.95); 6.903 (0.86); 3.174 (0.7); 1.293 (1.21); 0.93 (0.41); 0.908 (1.13); 0.885 (0.45); 0.448 (0.91); 0.436 (16); 0.425 (0.69); 0.26 (0.4); 0.252 (0.38); 0.149 (0.34); 0.118 (1.78); 8.829 (1.15); 8.82 (1.12) 7.641 (0.34); 7.635 (0.37); 7.616 (0.39); 7.611 (0.42); 7.432 (0.32); 7.426 (0.33); 7.368 (0.45); 7.363 (0.46); 7.358 (0.6); 7.34 (0.94); 7.326 (0.98); 7.321 (0.76); 7.3 (1.8); 7.29 (0.34); 7.287 I.024 (0.34); 7.266 (0.5); 7.262 (0.5); 6.886 (0.47); 6.861 (0.43); 2.865 (4.23); 1.615 (1.09); 0.328 (0.6); 0.317 (16); 0.306 (0.62); 0.039 (1.81) 7.447 (2.44); 7.402 (0.37); 7.391 (0.44); 7.388 (0.41); 7.382 (1.15); 7.373 (1.78); 7.36 (0.86); 7.354 (1.03); 7.348 (0.79); 7.342 (1.02); 7.334 (1.01); 7.331 (1.41); 7.323 (0.49); 7.318 (1.42); I.025 7.315 (0.89); 7.301 (0.72); 7.261 (2.63); 6.895 (0.93); 6.878 (1.75); 6.861 (0.91); 6.532 (1.86); 6.516 (1.82); 2.763 (12.8); 2.54 (1.78); 2.535 (1.68); 1.601 (1.87); 0.485 (16); 0.483 (15.55); 0.457 (0.4); 0.454 (0.37); 0 (2.55) 7.744 (0.52); 7.738 (0.57); 7.719 (0.6); 7.714 (0.61); 7.454 (0.48); 7.451 (0.47); 7.448 (0.5); 7.427 (0.45); 7.421 (0.44); 7.406 (1.12); 7.401 (1.11); 7.387 (1.11); 7.383 (0.71); 7.376 (0.61); I.026 7.363 (1.61); 7.345 (0.51); 7.312 (0.54); 7.309 (0.56); 7.3 (4.96); 7.288 (0.8); 7.285 (0.78); 7.263 (0.33); 7.261 (0.32); 6.861 (0.74); 6.834 (0.68); 2.846 (6.46); 2.013 (1.74); 1.604 (3.87); 0.466 (0.53); 0.454 (16); 0.443 (0.62); 0.039 (5.04) 7.4 (0.33); 7.393 (1.9); 7.381 (0.9); 7.369 (2.3); 7.364 (1.32); 7.357 (0.51); 7.347 (1.68); 7.342 (2.27); 7.337 (0.81); 7.314 (0.52); 7.3 (3); 6.936 (0.55); 6.934 (0.55); 6.907 (0.99); 6.88 (0.5); I.027 6.878 (0.47); 6.628 (1.05); 6.602 (0.98); 2.832 (8.27); 1.623 (3.11); 1.191 (2.86); 1.152 (2.86); 0.397 (0.66); 0.386 (16); 0.38 (15.97); 0.368 (0.74); 0.038 (2.65) 7.469 (1.99); 7.462 (1.9); 7.456 (1.58); 7.45 (2.65); 7.445 (2.18); 7.348 (0.67); 7.328 (1.53); 7.311 (1.95); 7.288 (1.35); 7.27 (1.37); 7.258 (22.84); 7.246 (1.06); 7.204 (0.86); 7.2 (0.89); 7.192 (0.93); 7.187 (0.94); 7.182 (0.66); 7.177 (0.63); 7.169 (0.57); 7.164 (0.67); 7.151 (0.76); I.028 7.147 (0.63); 7.139 (2.58); 7.132 (1.73); 7.125 (4.35); 7.121 (4.26); 6.916 (3.14); 6.891 (2.05); 6.87 (1); 6.516 (2.17); 6.496 (2.07); 2.543 (14.72); 1.536 (13.75); 0.659 (15.74); 0.653 (16); 0.008 (1.01); 0 (22.32) I.029 7.383 (1.89); 7.379 (1.53); 7.357 (1.36); 7.35 (0.45); 7.33 (0.36); 7.301 (0.77); 6.598 (0.49); Example H-NMR [CDCl3 at 300 Mhz] 6.591 (0.49); 6.571 (0.46); 6.564 (0.46); 6.162 (0.88); 6.155 (0.84); 3.823 (0.35); 2.843 (4.65); 1.297 (0.32); 0.268 (0.61); 0.258 (16); 0.247 (0.85); 0.113 (4.59); 0.039 (0.54) 7.449 (1.75); 7.446 (1.72); 7.433 (1.88); 7.43 (1.84); 7.407 (0.73); 7.385 (1.17); 7.38 (1.53); 7.358 (1.78); 7.353 (1.72); 7.332 (1.51); 7.322 (1.03); 7.309 (1.42); 7.3 (19.81); 7.291 (1.62); 7.288 (1.41); 7.281 (2.05); 7.278 (2.02); 7.27 (1.99); 7.267 (1.79); 7.257 (0.4); 7.119 (2.29); I.030 7.115 (2.3); 7.023 (1.67); 7.012 (1.66); 7.008 (1.66); 6.996 (1.43); 6.958 (0.95); 6.956 (0.92); 6.929 (1.67); 6.902 (0.85); 6.899 (0.78); 6.574 (1.77); 6.547 (1.66); 2.679 (13.51); 1.591 (11.36); 0.769 (0.74); 0.758 (16); 0.75 (15.89); 0.738 (0.72); 0.05 (0.75); 0.039 (20.83); 0.028 (0.77) 8.056 (0.44); 8.05 (0.44); 8.03 (0.54); 8.023 (0.54); 7.785 (0.95); 7.758 (0.8); 7.563 (0.9); 7.557 I.031 (0.86); 7.491 (0.93); 7.487 (0.87); 7.45 (0.99); 7.431 (0.77); 7.42 (0.4); 7.4 (0.37); 7.302 (0.46); 2.825 (4.68); 0.422 (0.73); 0.411 (16); 0.4 (0.71); 0.112 (3.57) 7.481 (0.7); 7.459 (0.83); 7.454 (1.54); 7.439 (0.37); 7.432 (1.72); 7.426 (1.11); 7.409 (6.92); 7.394 (1.6); 7.389 (2.01); 7.382 (1.57); 7.363 (1.22); 7.332 (0.34); 7.301 (5.85); 6.983 (1.12); I.032 6.955 (2.09); 6.928 (1.01); 6.677 (2.19); 6.649 (2.04); 2.817 (16); 2.807 (0.92); 1.626 (1.47); 0.632 (0.36); 0.62 (10.09); 0.614 (10.13); 0.595 (10.12); 0.589 (10.08); 0.577 (0.47); 0.527 (0.64); 0.522 (0.64); 0.038 (5.95) 7.404 (1.08); 7.397 (1.91); 7.39 (2.46); 7.376 (2.46); 7.366 (1.52); 7.349 (1.17); 7.345 (0.77); I.033 7.301 (2.1); 6.804 (1.26); 6.776 (1.15); 6.474 (1.29); 6.446 (1.22); 3.958 (9.47); 3.526 (1.28); 2.818 (8.49); 1.682 (0.71); 0.435 (0.78); 0.424 (16); 0.412 (0.85); 0.037 (1.54) 7.43 (1.42); 7.422 (2.08); 7.406 (0.73); 7.4 (0.88); 7.394 (0.63); 7.375 (0.54); 7.35 (0.51); 7.323 (1.34); 7.302 (1.85); 7.297 (1.2); 7.27 (1.1); 7.267 (1.16); 7.244 (0.54); 7.24 (0.43); 6.713 I.034 (0.81); 6.71 (0.78); 6.687 (0.76); 6.683 (0.71); 2.933 (0.97); 2.81 (6.81); 2.084 (0.37); 1.655 (0.67); 0.569 (0.67); 0.558 (16); 0.546 (0.64); 0.038 (1.39) 7.715 (0.57); 7.691 (0.68); 7.688 (0.7); 7.664 (0.6); 7.51 (1.1); 7.506 (1.09); 7.439 (1.01); 7.418 (0.94); 7.406 (0.52); 7.386 (0.48); 7.302 (1.95); 7.005 (0.34); 6.998 (0.35); 6.978 (0.66); 6.97 I.035 (0.67); 6.95 (0.33); 6.943 (0.32); 6.52 (0.59); 6.513 (0.58); 6.486 (0.6); 6.479 (0.57); 2.814 (6.33); 2.11 (0.47); 1.648 (0.45); 0.479 (0.58); 0.468 (16); 0.456 (0.62); 0.039 (1.55) 7.524 (1.29); 7.52 (1.21); 7.447 (1.16); 7.443 (1.11); 7.426 (1); 7.414 (1.93); 7.394 (0.58); 7.386 (0.89); 7.302 (3.6); 7.149 (0.49); 7.145 (0.5); 7.121 (0.41); 7.118 (0.41); 6.701 (1.01); 6.673 I.036 (0.93); 2.808 (6.85); 2.602 (0.82); 1.616 (1.93); 0.545 (0.7); 0.533 (16); 0.521 (0.66); 0.039 (2.88) 7.434 (0.59); 7.423 (0.63); 7.407 (0.63); 7.396 (0.64); 7.378 (0.8); 7.374 (0.82); 7.369 (0.91); 7.351 (1.59); 7.337 (0.55); 7.318 (1.26); 7.314 (1.21); 7.301 (1.11); 7.138 (0.43); 7.134 (0.46); I.037 7.127 (0.41); 7.124 (0.42); 7.108 (0.41); 7.098 (0.37); 6.889 (0.64); 6.876 (0.67); 6.86 (0.53); 6.846 (0.51); 2.844 (6.65); 2.08 (0.43); 1.294 (0.36); 0.437 (0.71); 0.426 (16); 0.414 (0.65); 0.112 (2.23); 0.036 (0.83) 7.388 (0.4); 7.361 (0.85); 7.35 (0.43); 7.344 (0.44); 7.339 (0.62); 7.334 (0.58); 7.322 (0.86); 7.308 (0.36); 7.297 (3.89); 7.222 (0.66); 7.218 (0.67); 6.773 (0.53); 6.746 (0.48); 6.495 (0.52); I.038 6.47 (0.5); 3.891 (4.62); 2.845 (3.99); 1.606 (3.21); 0.311 (0.54); 0.3 (16); 0.288 (0.51); 0.036 (3.62) 7.571 (1.18); 7.556 (1.46); 7.438 (0.86); 7.422 (1.48); 7.406 (0.78); 7.365 (1.45); 7.353 (2.07); I.039 7.344 (0.72); 7.28 (2.2); 7.261 (5.45); 6.98 (1.36); 6.964 (1.26); 2.788 (8.96); 1.559 (7.06); 1.256 (0.46); 0.984 (0.48); 0.976 (3.88); 0.971 (7.17); 0.958 (0.66); 0.465 (16); 0 (5.16) 7.646 (0.37); 7.514 (0.63); 7.384 (0.37); 7.367 (0.46); 7.36 (0.8); 7.349 (1); 7.337 (0.68); 7.331 I.040 (0.66); 7.304 (1.22); 6.966 (0.32); 4.293 (1.68); 2.776 (4.18); 1.668 (2.25); 0.334 (0.59); 0.323 Example H-NMR [CDCl3 at 300 Mhz] (16); 0.312 (0.62); 0.115 (0.47); 0.043 (0.88) 8.173 (0.74); 8.164 (0.75); 7.536 (0.54); 7.53 (0.58); 7.512 (0.62); 7.506 (0.64); 7.354 (0.33); 7.335 (0.49); 7.333 (0.49); 7.33 (0.51); 7.327 (0.43); 7.308 (0.47); 7.302 (0.55); 7.298 (1.48); 7.166 (0.48); 7.163 (0.49); 7.142 (0.79); 7.139 (0.78); 7.118 (0.35); 7.115 (0.33); 7.013 (0.77); 7.004 (0.75); 6.804 (0.75); 6.803 (0.74); 6.777 (0.68); 2.964 (0.53); 2.943 (1.12); 2.922 (0.65); 2.793 (0.55); 2.772 (0.99); 2.751 (0.52); 1.958 (0.39); 1.941 (0.57); 1.927 (0.51); 1.921 (0.56); I.041 1.851 (0.59); 1.844 (0.55); 1.83 (0.57); 1.824 (0.46); 1.814 (0.4); 1.478 (0.34); 1.466 (0.39); 1.426 (0.34); 1.414 (0.35); 1.304 (0.88); 1.293 (1.89); 1.282 (0.64); 1.016 (0.51); 1.011 (0.81); 1.007 (0.56); 0.983 (2.68); 0.971 (0.35); 0.959 (1.56); 0.862 (0.66); 0.857 (0.58); 0.836 (1.3); 0.831 (0.54); 0.811 (0.79); 0.809 (0.83); 0.32 (0.81); 0.311 (0.73); 0.301 (16); 0.29 (0.73); 0.037 (0.59) 8.601 (2.65); 8.176 (0.7); 8.172 (0.78); 8.145 (0.84); 8.075 (0.71); 8.071 (0.71); 8.048 (0.85); 8.043 (0.85); 7.769 (0.34); 7.764 (0.4); 7.746 (0.65); 7.742 (0.83); 7.737 (0.39); 7.719 (0.6); 7.714 (0.56); 7.691 (0.6); 7.686 (0.66); 7.668 (0.4); 7.663 (0.8); 7.659 (0.6); 7.64 (0.32); 7.305 I.042 (1.47); 7.243 (0.39); 7.22 (0.45); 7.215 (0.88); 7.193 (0.87); 7.188 (0.56); 7.166 (0.47); 6.806 (0.63); 6.778 (1.13); 6.75 (0.55); 6.307 (1.22); 6.28 (1.15); 2.634 (9.67); 1.747 (0.62); 1.302 (0.46); 0.504 (0.62); 0.493 (15.63); 0.487 (16); 0.475 (0.69); 0.132 (0.35); 0.12 (8.56); 0.107 (0.32); 0.046 (1.1) 7.562 (1.18); 7.547 (1.47); 7.431 (0.92); 7.415 (1.52); 7.399 (0.85); 7.383 (0.96); 7.377 (0.96); 7.291 (2.09); 7.261 (5.57); 6.972 (1.38); 6.956 (1.28); 2.78 (9.04); 1.563 (8.23); 1.256 (5.47); I.043 1.218 (0.49); 0.994 (0.51); 0.985 (3.75); 0.979 (7.64); 0.963 (3.8); 0.948 (2.47); 0.894 (0.44); 0.882 (1.19); 0.868 (1.9); 0.852 (1.44); 0.836 (0.49); 0.469 (15.53); 0.4 (0.33); 0.357 (16); 0 (5.14) 8.146 (0.88); 8.118 (0.82); 7.692 (0.53); 7.687 (0.59); 7.665 (1.34); 7.641 (1.72); 7.528 (0.74); 7.525 (0.7); 7.506 (0.61); 7.5 (0.98); 7.478 (0.4); 7.475 (0.36); 7.448 (2.29); 7.392 (0.68); 7.356 (0.9); 7.334 (1.38); 7.304 (2.8); 7.298 (1.02); 7.282 (0.5); 6.909 (0.67); 6.88 (1.15); 6.853 I.044 (0.58); 6.773 (0.97); 6.767 (0.97); 6.716 (0.81); 6.709 (0.78); 6.615 (1.2); 6.587 (1.11); 5.727 (0.92); 5.72 (0.87); 5.691 (0.87); 5.684 (0.86); 1.666 (0.76); 1.301 (1.09); 0.41 (16); 0.404 (15.43); 0.118 (1.12); 0.046 (1.47) 8.238 (0.9); 8.21 (1); 8.008 (1.3); 8.001 (1.18); 7.981 (1.48); 7.976 (1.26); 7.735 (1.21); 7.71 (2.11); 7.681 (0.64); 7.606 (2.5); 7.582 (0.76); 7.557 (0.99); 7.532 (0.59); 7.524 (0.46); 7.518 I.045 (0.38); 7.506 (1.61); 7.484 (2.56); 7.468 (0.5); 7.36 (0.38); 7.333 (0.88); 7.305 (3.87); 7.283 (0.46); 6.881 (0.68); 6.852 (1.23); 6.824 (0.63); 6.727 (1.32); 6.7 (1.21); 1.677 (0.34); 1.301 (1.45); 0.907 (0.4); 0.887 (0.42); 0.281 (16); 0.275 (15.35); 0.118 (0.7); 0.046 (2.92) 8.088 (0.8); 8.058 (0.77); 7.675 (1.44); 7.649 (1.7); 7.645 (1.09); 7.627 (0.64); 7.622 (0.38); 7.522 (0.62); 7.519 (0.61); 7.5 (0.47); 7.495 (0.84); 7.472 (0.34); 7.469 (0.33); 7.402 (2.07); I.046 7.36 (0.39); 7.338 (0.47); 7.333 (0.87); 7.311 (0.88); 7.306 (0.6); 7.3 (1.25); 7.284 (0.47); 6.905 (0.58); 6.903 (0.57); 6.876 (1.07); 6.849 (0.52); 6.847 (0.5); 6.613 (1.12); 6.586 (1.04); 2.781 (8.7); 0.418 (0.68); 0.407 (15.93); 0.401 (16); 0.39 (0.81); 0.115 (0.72); 0.04 (1.02) 8.08 (0.38); 8.05 (0.36); 7.647 (0.34); 7.642 (0.34); 7.631 (0.82); 7.625 (0.57); 7.621 (0.55); 7.615 (0.54); 7.607 (0.75); 7.601 (0.5); 7.476 (0.41); 7.401 (0.33); 7.38 (1.24); 7.374 (0.39); 7.3 I.047 (5.19); 7.258 (0.33); 7.236 (0.49); 7.233 (0.49); 6.874 (0.46); 6.847 (0.42); 5.339 (1.25); 2.81 (4.26); 1.609 (5.62); 0.348 (0.58); 0.337 (16); 0.326 (0.62); 0.039 (4.98) 7.639 (0.75); 7.629 (0.57); 7.522 (0.51); 7.518 (0.48); 7.5 (0.44); 7.494 (0.67); 7.464 (1.57); 7.452 (0.34); 7.427 (0.48); 7.425 (0.47); 7.422 (0.5); 7.4 (0.47); 7.394 (0.46); 7.302 (6.77); 7.282 (0.53); 7.279 (0.56); 7.258 (0.8); 7.255 (0.78); 7.234 (0.55); 6.842 (0.76); 6.814 (0.68); I.048 2.791 (6.68); 2.554 (0.8); 2.142 (0.88); 1.623 (5.43); 1.306 (0.63); 1.027 (0.92); 0.989 (0.93); 0.922 (0.75); 0.489 (0.53); 0.478 (16); 0.466 (0.63); 0.295 (0.33); 0.276 (0.57); 0.177 (0.34); 0.04 (6.77); 8.089 (0.6); 8.06 (0.58); 7.73 (0.54); 7.724 (0.58); 7.706 (0.61); 7.7 (0.63); 7.676 Example H-NMR [CDCl3 at 300 Mhz] (0.48); 7.672 (0.53); 7.666 (0.48); 7.659 (0.35); 7.654 (0.84); 7.644 (0.81) 8.104 (1.19); 8.076 (1.18); 7.717 (2.16); 7.692 (3.29); 7.666 (0.92); 7.661 (0.6); 7.555 (4); 7.529 (1.24); 7.505 (0.57); 7.374 (0.58); 7.346 (1.29); 7.323 (1.37); 7.319 (0.89); 7.304 (11.28); 7.296 (0.94); 6.918 (0.95); 6.889 (1.66); 6.862 (0.84); 6.555 (1.79); 6.527 (1.69); 2.775 (0.42); 2.767 I.049 (0.39); 2.75 (12.65); 2.694 (1.87); 2.684 (1.73); 1.625 (16); 1.31 (1.35); 0.946 (0.48); 0.924 (1.42); 0.902 (0.55); 0.55 (15.81); 0.545 (15.06); 0.515 (0.51); 0.51 (0.48); 0.476 (0.35); 0.471 (0.33); 0.297 (0.95); 0.278 (0.97); 0.234 (0.62); 0.216 (0.54); 0.179 (1); 0.098 (0.75); 0.053 (0.38); 0.042 (10.19); 0.032 (0.37) 8.107 (0.78); 8.079 (0.78); 7.724 (1.4); 7.698 (2.07); 7.673 (0.58); 7.574 (2.02); 7.56 (0.7); 7.534 (0.81); 7.51 (0.37); 7.405 (0.63); 7.378 (1.39); 7.35 (0.81); 7.303 (1.63); 7.115 (0.62); I.050 7.112 (0.61); 7.088 (0.51); 7.084 (0.5); 6.677 (1.14); 6.649 (1.05); 2.8 (1.15); 2.748 (7.56); 1.697 (0.66); 0.553 (16); 0.041 (1.24) 8.095 (0.61); 8.066 (0.59); 7.703 (1.13); 7.698 (0.44); 7.679 (0.96); 7.676 (1.12); 7.671 (0.71); 7.655 (0.51); 7.546 (0.45); 7.542 (0.46); 7.524 (0.35); 7.518 (0.65); 7.491 (1.8); 7.312 (0.47); I.051 7.302 (1.33); 7.286 (1.29); 7.259 (1.07); 7.234 (1.02); 7.23 (1.14); 7.208 (0.51); 7.204 (0.41); 6.687 (0.75); 6.683 (0.75); 6.66 (0.7); 6.657 (0.69); 2.75 (6.72); 2.084 (0.54); 1.298 (0.41); 0.593 (0.55); 0.581 (16); 0.569 (0.62); 0.113 (3.79); 0.039 (0.94) 8.086 (1.2); 8.057 (1.17); 7.674 (2.21); 7.668 (0.89); 7.65 (1.86); 7.646 (2.2); 7.642 (1.39); 7.626 (1); 7.621 (0.55); 7.521 (0.9); 7.517 (0.91); 7.499 (0.69); 7.493 (1.27); 7.471 (0.52); 7.468 (0.49); 7.404 (3.14); 7.353 (0.61); 7.331 (0.71); 7.326 (1.36); 7.304 (1.45); 7.298 (3.8); 7.277 (0.74); 6.898 (0.86); 6.896 (0.88); 6.869 (1.61); 6.842 (0.78); 6.84 (0.78); 6.599 (1.68); 6.572 I.052 (1.57); 2.773 (13.4); 1.72 (0.37); 1.292 (0.74); 1.043 (0.49); 1.035 (1.03); 1.03 (0.74); 1.019 (0.77); 1.008 (4.38); 0.985 (2.82); 0.93 (0.77); 0.926 (1.01); 0.921 (0.72); 0.903 (1.72); 0.893 (0.56); 0.878 (1.32); 0.868 (0.38); 0.393 (0.58); 0.382 (15.78); 0.376 (16); 0.365 (0.79); 0.128 (0.57); 0.036 (2.76) 8.09 (1.51); 8.06 (1.45); 7.673 (2.26); 7.666 (1.14); 7.651 (2.16); 7.644 (2.66); 7.639 (1.69); 7.626 (1.27); 7.621 (0.63); 7.523 (1.18); 7.52 (1.11); 7.501 (0.91); 7.496 (1.6); 7.473 (0.65); 7.47 (0.59); 7.421 (0.72); 7.398 (0.94); 7.394 (1.61); 7.371 (2.17); 7.365 (4.5); 7.344 (0.89); I.053 7.304 (4.49); 6.952 (1.13); 6.925 (2.08); 6.898 (1); 6.692 (2.17); 6.665 (2.02); 4.605 (0.77); 4.592 (1.27); 4.58 (1.28); 4.567 (0.79); 2.785 (16); 2.752 (0.42); 1.336 (0.36); 1.298 (2.94); 0.922 (0.38); 0.905 (0.43); 0.899 (0.44); 0.884 (0.43); 0.551 (0.49); 0.546 (0.47); 0.436 (11.65); 0.432 (11.04); 0.423 (11.84); 0.419 (10.72); 0.115 (0.32); 0.042 (3.31) 7.95 (0.44); 7.929 (0.47); 7.578 (0.41); 7.574 (0.44); 7.56 (0.46); 7.556 (0.47); 7.533 (0.39); I.054 7.513 (0.51); 7.469 (0.38); 7.466 (0.48); 7.449 (0.33); 7.396 (1.67); 7.383 (0.41); 7.379 (0.61); 7.377 (0.57); 7.282 (0.63); 7.257 (2.25); 7.179 (0.54); 7.177 (0.52); 5.598 (0.43); 2.724 (4.45); 0.32 (1.05); 0.313 (16); 0.305 (0.94); 0 (1.84) 7.998 (0.34); 7.97 (0.38); 7.527 (0.6); 7.503 (0.37); 7.498 (0.34); 7.441 (0.33); 7.437 (0.35); 7.414 (0.37); 7.312 (0.45); 7.302 (1.81); 7.293 (0.34); 7.283 (0.51); 7.274 (0.46); 7.264 (0.4); I.055 7.188 (1.02); 5.479 (0.4); 2.771 (3.98); 1.298 (0.62); 0.495 (0.4); 0.327 (0.61); 0.316 (16); 0.306 (0.68); 0.042 (1.16) 7.983 (0.39); 7.956 (0.44); 7.682 (0.72); 7.676 (0.51); 7.657 (0.87); 7.652 (0.78); 7.564 (0.36); 7.56 (0.44); 7.484 (0.33); 7.48 (0.33); 7.457 (0.47); 7.442 (1.09); 7.331 (0.39); 7.325 (0.38); I.056 7.301 (1.51); 7.251 (0.34); 7.247 (0.35); 7.226 (0.51); 7.223 (0.49); 6.975 (0.48); 6.972 (0.47); 6.949 (0.42); 6.946 (0.4); 3.77 (0.93); 3.746 (0.95); 2.447 (4.5); 1.309 (1.25); 1.286 (2.36); 1.262 (1.03); 0.33 (0.68); 0.319 (16); 0.308 (0.72); 0.042 (1.33) 7.62 (1.07); 7.6 (1.02); 7.592 (0.51); 7.574 (0.44); 7.398 (0.59); 7.376 (0.76); 7.371 (1.32); I.057 7.349 (1.38); 7.344 (0.83); 7.322 (0.72); 7.304 (3.43); 7.072 (2.78); 6.948 (0.95); 6.919 (1.72); 6.892 (0.85); 6.666 (1.82); 6.639 (1.7); 2.788 (10.53); 1.294 (1.88); 1.033 (0.58); 1.027 (1.19); Example H-NMR [CDCl3 at 300 Mhz] 0.999 (4.43); 0.976 (2.93); 0.919 (0.38); 0.906 (1.14); 0.882 (1.92); 0.857 (1.42); 0.379 (0.72); 0.368 (16); 0.362 (15.77); 0.112 (0.69); 0.04 (2.95); 8.782 (1.18); 8.753 (1.29); 7.734 (0.52); 7.729 (0.59); 7.706 (1.98); 7.679 (2.92); 7.623 (1.12) 8.718 (0.38); 8.69 (0.43); 7.629 (0.38); 7.624 (0.41); 7.604 (0.7); 7.599 (0.8); 7.573 (1.06); 7.547 (0.47); 7.534 (0.47); 7.528 (0.48); 7.504 (0.33); 7.446 (0.41); 7.441 (0.39); 7.301 (1.12); I.058 7.272 (0.33); 7.25 (0.52); 7.247 (0.54); 7.222 (0.79); 7.195 (0.47); 7.081 (1.05); 5.625 (0.5); 2.797 (4.17); 0.353 (0.78); 0.343 (16); 0.332 (0.82); 0.039 (1.13) 12.096 (0.48); 7.484 (0.76); 7.48 (0.75); 7.467 (1.03); 7.458 (1.05); 7.454 (1.03); 7.443 (0.93); 7.411 (1.19); 7.386 (0.82); 7.364 (0.52); 7.359 (0.84); 7.337 (0.86); 7.332 (0.55); 7.304 (3.38); I.059 7.277 (0.6); 7.273 (0.54); 7.25 (0.85); 7.228 (0.4); 7.224 (0.35); 7.182 (2.57); 6.927 (0.59); 6.898 (1.07); 6.87 (0.53); 6.803 (1.18); 6.776 (1.09); 1.673 (0.92); 1.299 (1.14); 0.44 (16); 0.434 (15.53); 0.043 (2.55) 7.892 (0.75); 7.89 (0.75); 7.864 (0.95); 7.641 (0.73); 7.623 (0.67); 7.618 (1.08); 7.614 (1); 7.6 (0.83); 7.596 (0.74); 7.591 (0.39); 7.572 (0.55); 7.567 (0.38); 7.438 (2.35); 7.429 (0.76); 7.425 (0.63); 7.405 (0.8); 7.403 (0.88); 7.379 (0.43); 7.375 (0.35); 7.33 (0.39); 7.304 (1.79); 7.28 I.060 (0.91); 7.275 (0.53); 7.253 (0.48); 6.874 (0.63); 6.872 (0.52); 6.845 (1.06); 6.818 (0.56); 6.815 (0.45); 6.654 (1.18); 6.626 (1.13); 4.655 (0.73); 4.631 (2.31); 4.608 (2.34); 4.584 (0.75); 1.635 (0.52); 1.444 (2.4); 1.421 (4.9); 1.397 (2.33); 0.497 (1.44); 0.427 (0.78); 0.416 (16); 0.41 (14.91); 0.399 (0.61); 0.05 (1.02) 7.999 (0.7); 7.972 (0.85); 7.646 (0.69); 7.634 (0.53); 7.629 (0.5); 7.62 (1); 7.61 (0.84); 7.606 (0.74); 7.601 (0.42); 7.583 (0.57); 7.578 (0.43); 7.468 (0.6); 7.464 (0.61); 7.442 (0.87); 7.438 (0.54); 7.418 (0.37); 7.414 (0.36); 7.389 (2.15); 7.36 (0.4); 7.338 (0.46); 7.333 (0.88); 7.311 (0.93); 7.305 (1.97); 7.284 (0.48); 6.894 (0.57); 6.892 (0.56); 6.865 (1.04); 6.838 (0.52); 6.835 I.061 (0.49); 6.641 (1.1); 6.614 (1.03); 2.62 (0.34); 2.609 (0.37); 2.593 (0.72); 2.576 (0.4); 2.565 (0.38); 1.388 (0.34); 1.375 (0.99); 1.365 (1.21); 1.359 (1.11); 1.354 (0.78); 1.349 (1.11); 1.338 (0.44); 1.305 (0.62); 1.116 (0.37); 1.105 (1.1); 1.095 (0.97); 1.089 (0.55); 1.078 (1.07); 1.068 (0.95); 0.448 (0.63); 0.437 (16); 0.431 (15.91); 0.419 (0.69); 0.049 (1.4) .098 (3.96); 5.089 (2.9); 5.081 (0.99); 1.576 (10.29); 1.256 (1.43); 0.746 (14.93); 0.738 (16); 0.694 (0.38); 0.687 (0.33); 0.073 (0.71); 0 (6.18); 8.003 (4.72); 7.986 (5.18); 7.664 (0.4); 7.647 (1.92); 7.642 (2.08); 7.635 (2.33); 7.63 (3.97); 7.626 (2.16); 7.618 (2.2); 7.614 (2.32); 7.559 (0.38); 7.545 (4.84); 7.538 (7.32); 7.531 (6.78); 7.526 (5.43); 7.504 (1.61); 7.49 (10.93); 7.488 I.062 (10.37); 7.478 (4.86); 7.462 (1.27); 7.393 (1.81); 7.376 (4.07); 7.363 (4.23); 7.347 (2.1); 7.256 (8.03); 7.181 (0.45); 7.17 (2.54); 7.164 (8.83); 7.163 (8.66); 7.156 (13.45); 7.152 (12.4); 7.134 (12.55); 6.953 (3.07); 6.936 (5.9); 6.92 (3.02); 6.653 (6.11); 6.636 (5.94); 5.115 (0.81); 5.106 (2.78) 8.048 (0.86); 8.03 (0.87); 7.679 (1.04); 7.666 (1.18); 7.662 (1.3); 7.651 (0.64); 7.553 (0.66); I.063 7.536 (0.89); 7.522 (0.43); 7.506 (2.23); 7.33 (0.32); 7.316 (0.61); 7.314 (0.71); 7.3 (0.81); 7.284 (0.36); 7.259 (2.43); 6.886 (0.58); 6.869 (1.07); 6.852 (0.54); 6.604 (1.13); 6.588 (1.08); 1.55 (1.25); 0.377 (16); 0.374 (13.09); 0 (2.44) 8.045 (0.81); 8.018 (0.72); 8.016 (0.78); 7.652 (0.37); 7.647 (0.57); 7.639 (0.68); 7.633 (0.7); 7.629 (0.54); 7.624 (1.11); 7.618 (0.44); 7.612 (0.95); 7.607 (1); 7.6 (0.78); 7.468 (0.63); 7.464 (0.6); 7.446 (0.53); 7.44 (0.92); 7.418 (0.38); 7.414 (0.35); 7.364 (0.39); 7.342 (0.48); 7.336 I.064 (0.87); 7.314 (0.91); 7.309 (0.68); 7.304 (2.43); 7.287 (0.48); 7.253 (2.2); 6.914 (0.58); 6.912 (0.54); 6.885 (1.03); 6.858 (0.53); 6.855 (0.47); 6.692 (1.11); 6.664 (1.03); 2.75 (10.67); 1.598 (1.62); 0.46 (0.49); 0.44 (0.64); 0.429 (16); 0.423 (15.64); 0.412 (0.62); 0.047 (2.31) 8.245 (0.7); 8.217 (0.83); 7.769 (0.36); 7.764 (0.43); 7.741 (1.35); 7.714 (1.74); 7.65 (0.68); 7.629 (0.63); 7.621 (0.34); 7.547 (1.81); 7.405 (0.39); 7.382 (0.48); 7.377 (0.87); 7.355 (0.89); I.065 7.35 (0.54); 7.328 (0.48); 7.304 (4.92); 7.252 (0.76); 7.072 (1.56); 6.958 (0.59); 6.956 (0.58); 6.93 (1.07); 6.902 (0.54); 6.9 (0.53); 6.892 (0.81); 6.71 (1.12); 6.683 (1.05); 1.604 (3.79); 0.411 Example H-NMR [CDCl3 at 300 Mhz] (0.69); 0.4 (16); 0.394 (15.83); 0.382 (0.7); 0.044 (5.04) 8.044 (0.63); 8.018 (0.72); 7.631 (0.46); 7.614 (2.23); 7.607 (1.06); 7.6 (1.17); 7.58 (1.01); 7.574 (0.51); 7.569 (0.35); 7.555 (1.51); 7.55 (1.12); 7.532 (0.5); 7.526 (0.5); 7.421 (0.34); 7.394 (0.8); 7.372 (0.84); 7.367 (0.54); 7.345 (0.48); 7.304 (9.55); 7.183 (1.2); 7.156 (0.96); I.066 7.129 (0.7); 6.947 (1.44); 6.916 (0.59); 6.886 (1.01); 6.858 (0.52); 6.766 (0.71); 6.395 (0.55); 1.597 (11.08); 0.412 (0.66); 0.401 (16); 0.394 (15.88); 0.383 (0.67); 0.054 (0.33); 0.044 (9.62); 0.032 (0.34) 8.289 (0.91); 8.285 (1.04); 8.279 (1.04); 8.275 (1.03); 8.182 (0.79); 8.154 (0.82); 8.098 (0.97); 8.094 (0.98); 8.081 (1.07); 8.077 (1.04); 7.706 (0.4); 7.702 (0.53); 7.684 (1.07); 7.679 (1.77); 7.653 (2.07); 7.541 (0.65); 7.538 (0.68); 7.519 (0.61); 7.514 (0.9); 7.494 (2.43); 7.447 (0.93); I.067 7.437 (0.98); 7.43 (0.96); 7.42 (0.9); 7.381 (0.39); 7.358 (0.46); 7.354 (0.88); 7.331 (0.87); 7.326 (0.57); 7.305 (3.79); 6.933 (0.6); 6.906 (1.1); 6.877 (0.53); 6.718 (1.17); 6.691 (1.08); 1.301 (1.01); 0.908 (0.35); 0.901 (0.34); 0.887 (0.39); 0.38 (0.54); 0.369 (15.51); 0.363 (16); 0.118 (1.75); 0.046 (2.9) 8.662 (1.36); 8.063 (0.4); 8.057 (0.35); 7.795 (0.35); 7.776 (0.32); 7.773 (0.38); 7.769 (0.44); 7.669 (0.39); 7.663 (0.35); 7.642 (0.56); 7.635 (0.55); 7.614 (0.36); 7.609 (0.37); 7.602 (0.36); I.068 7.597 (0.38); 7.578 (0.4); 7.572 (0.42); 7.464 (0.32); 7.462 (0.32); 7.438 (0.32); 7.31 (0.33); 7.289 (0.49); 7.285 (0.51); 7.258 (1.33); 7.247 (0.53); 7.244 (0.48); 7.219 (0.4); 7.217 (0.37); 1.255 (0.49); 0.256 (0.6); 0.244 (16); 0.233 (0.75); 0 (0.82) 8.689 (2.64); 8.135 (0.59); 8.13 (0.49); 8.127 (0.43); 8.109 (0.78); 8.102 (0.66); 7.835 (0.46); 7.83 (0.66); 7.811 (0.61); 7.808 (0.71); 7.804 (0.85); 7.739 (0.38); 7.722 (0.77); 7.716 (0.68); 7.696 (1.32); 7.689 (1.18); 7.673 (0.38); 7.669 (0.65); 7.664 (0.63); 7.476 (0.39); 7.454 (0.45); I.069 7.449 (0.88); 7.427 (0.88); 7.422 (0.54); 7.399 (0.47); 7.3 (3.24); 7.036 (0.95); 7.034 (1.04); 7.01 (1.27); 6.984 (0.94); 6.956 (0.49); 6.954 (0.44); 1.616 (4.92); 0.347 (0.7); 0.335 (16); 0.33 (15.83); 0.318 (0.74); 0.039 (2.67) 8.732 (2.12); 8.134 (0.47); 8.129 (0.38); 8.125 (0.32); 8.108 (0.62); 8.101 (0.53); 7.828 (0.37); 7.821 (0.52); 7.803 (0.48); 7.8 (0.57); 7.796 (0.7); 7.74 (0.66); 7.735 (0.72); 7.716 (1.19); 7.71 (1.12); 7.693 (0.78); 7.691 (0.68); 7.686 (0.74); 7.667 (0.52); 7.661 (0.51); 7.542 (0.5); 7.539 I.070 (0.49); 7.536 (0.5); 7.534 (0.41); 7.515 (0.46); 7.509 (0.42); 7.39 (0.49); 7.387 (0.48); 7.366 (0.79); 7.363 (0.75); 7.342 (0.34); 7.301 (4.81); 7.271 (0.79); 7.244 (0.65); 2.206 (1.55); 1.614 (4.15); 1.323 (0.36); 1.307 (1.19); 0.944 (0.43); 0.922 (1.35); 0.899 (0.5); 0.436 (0.55); 0.425 (16); 0.413 (0.61); 0.04 (5.01) 8.71 (4.25); 8.134 (0.93); 8.129 (0.76); 8.108 (1.2); 8.102 (1.06); 7.828 (0.71); 7.821 (0.94); 7.802 (0.95); 7.799 (1.1); 7.795 (1.39); 7.75 (0.48); 7.744 (0.58); 7.727 (1.22); 7.721 (1.05); 7.703 (1.58); 7.696 (1.46); 7.677 (0.98); 7.671 (0.96); 7.654 (0.43); 7.648 (0.35); 7.519 (0.56); I.071 7.496 (0.7); 7.492 (1.1); 7.469 (1.28); 7.464 (0.8); 7.442 (0.69); 7.301 (3.7); 7.049 (3.19); 7.021 (3.34); 6.992 (0.87); 2.527 (0.49); 1.649 (1.8); 1.306 (0.77); 0.922 (0.86); 0.899 (0.33); 0.471 (0.59); 0.46 (16); 0.454 (15.75); 0.442 (0.77); 0.291 (1.39); 0.273 (1.42); 0.192 (1.03); 0.174 (1.47); 0.151 (0.56); 0.04 (3.69); -0.026 (1.46) 8.68 (1.77); 8.127 (0.43); 8.122 (0.38); 8.101 (0.56); 8.095 (0.5); 7.848 (0.43); 7.843 (0.46); 7.823 (0.44); 7.82 (0.5); 7.816 (0.59); 7.71 (0.49); 7.704 (0.46); 7.681 (0.62); 7.674 (0.59); 7.654 (0.45); 7.648 (0.46); 7.638 (0.42); 7.632 (0.59); 7.614 (0.46); 7.608 (0.57); 7.497 (0.42); I.072 7.491 (0.46); 7.471 (0.39); 7.465 (0.35); 7.34 (0.37); 7.338 (0.44); 7.313 (1.22); 7.302 (1.35); 7.292 (0.32); 7.288 (0.41); 7.284 (0.6); 1.642 (0.76); 0.96 (16); 0.37 (0.89); 0.283 (0.62); 0.274 (11.93); 0.043 (1.07) 8.653 (3.62); 7.892 (0.77); 7.887 (0.86); 7.878 (0.34); 7.868 (1.08); 7.549 (0.75); 7.543 (0.69); I.073 7.531 (1.25); 7.527 (1.17); 7.515 (1.94); 7.512 (2.01); 7.508 (1.52); 7.502 (0.84); 7.498 (1.19); 7.493 (1); 7.488 (0.6); 7.482 (0.44); 7.477 (0.37); 7.374 (0.85); 7.37 (0.97); 7.356 (0.98); 7.352 (1.07); 7.333 (0.5); 7.329 (0.47); 7.313 (0.94); 7.31 (0.88); 7.295 (0.71); 7.29 (0.59); 7.135 Example H-NMR [CDCl3 at 300 Mhz] (0.83); 7.117 (1.5); 7.11 (1.61); 7.101 (0.67); 7.099 (0.69); 7.09 (1.2); 3.351 (0.39); 3.341 (0.57); 3.218 (400.25); 3.163 (0.44); 2.309 (12.66); 2.305 (16); 2.301 (11.68); 1.436 (0.58); 1.42 (0.75); 1.403 (0.61); 0.651 (0.98); 0.635 (0.93); 0.503 (10.94); 0.486 (10.49); 0.454 (3.11); 0.437 (2.95); 0.031 (1.87); 0 (19.76) 9.338 (0.57); 8.847 (5.15); 8.094 (1.09); 8.089 (1.22); 8.079 (0.47); 8.069 (1.49); 7.769 (0.38); 7.765 (0.44); 7.751 (1.25); 7.743 (0.8); 7.732 (1.73); 7.728 (1.62); 7.723 (1.04); 7.718 (1.9); 7.707 (2.22); 7.704 (2.99); 7.701 (2.45); 7.687 (1.28); 7.681 (0.85); 7.552 (1.15); 7.548 (1.48); I.074 7.534 (1.85); 7.53 (1.83); 7.519 (1.52); 7.515 (1.15); 7.499 (1.06); 7.495 (0.8); 7.343 (1.17); 7.325 (1.96); 7.314 (2.18); 7.294 (1.69); 6.746 (0.38); 3.569 (0.33); 3.556 (0.41); 3.551 (0.53); 3.421 (561.36); 3.383 (0.78); 3.369 (0.41); 2.512 (16.49); 2.508 (21.21); 2.503 (15.55); 0.911 (0.87); 0.89 (2.65); 0.873 (1.8); 0.847 (5.15); 0.826 (16); 0.818 (2.3); 0.808 (9.79); 0.78 (1.42); 0.759 (1.03); 0.727 (3.33); 0.724 (3.3); 0.708 (8.05); 0.688 (5.7); 0.67 (1.33); 0.666 (1.28) 8.708 (3.95); 7.956 (0.87); 7.951 (0.97); 7.941 (0.38); 7.931 (1.25); 7.63 (0.33); 7.615 (0.82); 7.608 (0.77); 7.597 (1.44); 7.593 (1.35); 7.582 (2.21); 7.579 (2.28); 7.575 (1.73); 7.57 (0.96); 7.565 (1.32); 7.56 (1.11); 7.556 (0.66); 7.549 (0.5); 7.544 (0.4); 7.43 (0.98); 7.426 (1.12); 7.412 I.075 (1.15); 7.408 (1.31); 7.401 (0.69); 7.397 (0.56); 7.381 (1.1); 7.362 (0.81); 7.358 (0.66); 7.203 (0.92); 7.185 (1.54); 7.17 (1.97); 7.151 (1.35); 3.411 (0.39); 3.285 (400.84); 2.376 (12.72); 2.372 (16); 2.367 (11.76); 0.863 (0.48); 0.845 (0.66); 0.832 (0.43); 0.826 (0.72); 0.809 (0.5); 0.766 (1.31); 0.748 (1.24); 0.726 (10.32); 0.708 (6.79); 0.044 (2.64); 0 (22.55) 9.216 (0.43); 8.708 (4.28); 7.942 (0.92); 7.937 (1.06); 7.928 (0.42); 7.917 (1.35); 7.614 (0.35); 7.599 (0.87); 7.593 (0.82); 7.581 (1.54); 7.577 (1.47); 7.567 (2.37); 7.564 (2.47); 7.56 (1.88); 7.554 (1.02); 7.55 (1.42); 7.545 (1.21); 7.54 (0.72); 7.534 (0.53); 7.529 (0.44); 7.416 (1.03); I.076 7.412 (1.23); 7.398 (1.23); 7.394 (1.44); 7.387 (0.78); 7.383 (0.62); 7.367 (1.18); 7.364 (1.06); 7.348 (0.88); 7.344 (0.73); 7.188 (1.01); 7.17 (1.66); 7.152 (2.39); 7.132 (1.45); 3.327 (1.57); 3.269 (403.6); 3.215 (0.53); 2.36 (12.5); 2.356 (16); 2.351 (11.82); 0.732 (0.73); 0.714 (0.51); 0.688 (1.92); 0.668 (5.14); 0.649 (3.02); 0.588 (0.37); 0.518 (1); 0.5 (2.56); 0.48 (2.02); 0.461 (0.46); 0.459 (0.46); 0.049 (3.73); 0 (25.64) 8.755 (2.01); 7.636 (0.58); 7.63 (0.63); 7.612 (0.72); 7.606 (0.78); 7.594 (0.83); 7.591 (0.88); 7.585 (0.88); 7.582 (0.78); 7.568 (1.69); 7.551 (0.56); 7.532 (0.33); 7.507 (0.59); 7.505 (0.58); 7.502 (0.57); 7.481 (0.52); 7.475 (0.45); 7.367 (0.54); 7.364 (0.54); 7.343 (0.84); 7.34 (0.82); I.077 7.319 (0.37); 7.316 (0.35); 7.3 (1.83); 7.251 (0.88); 7.224 (0.72); 1.296 (1.23); 0.961 (0.89); 0.934 (2.71); 0.92 (0.41); 0.91 (1.7); 0.783 (0.55); 0.779 (0.52); 0.758 (1.4); 0.731 (1.03); 0.253 (0.87); 0.242 (16); 0.232 (0.83); 0.04 (1.75) 8.747 (2.13); 7.608 (0.76); 7.592 (1.85); 7.578 (0.98); 7.576 (1.07); 7.571 (0.89); 7.565 (0.82); 7.487 (0.42); 7.465 (0.47); 7.459 (0.89); 7.437 (0.81); 7.432 (0.59); 7.41 (0.49); 7.3 (5.67); I.078 7.034 (0.5); 7.031 (0.61); 7.006 (1.91); 7.004 (1.89); 6.978 (1.36); 1.589 (2.42); 0.36 (0.48); 0.351 (0.33); 0.344 (0.38); 0.328 (0.95); 0.317 (16); 0.311 (15.98); 0.3 (0.87); 0.198 (0.56); 0.105 (0.4); 0.039 (6) 8.76 (1.23); 7.646 (0.35); 7.64 (0.37); 7.622 (0.41); 7.616 (0.44); 7.596 (0.49); 7.593 (0.52); 7.588 (0.47); 7.583 (0.42); 7.57 (1.11); 7.553 (0.34); 7.511 (0.33); 7.368 (0.33); 7.347 (0.5); I.079 7.344 (0.49); 7.3 (2.96); 7.254 (0.5); 7.252 (0.48); 7.227 (0.41); 1.589 (2.17); 0.278 (0.57); 0.267 (16); 0.256 (0.61); 0.039 (3.17) 8.762 (1.91); 7.609 (0.56); 7.603 (0.61); 7.59 (0.75); 7.582 (1.15); 7.577 (1.67); 7.561 (1.33); 7.557 (0.77); 7.547 (0.58); 7.526 (0.33); 7.502 (0.54); 7.499 (0.53); 7.496 (0.5); 7.493 (0.45); 7.475 (0.51); 7.469 (0.44); 7.361 (0.5); 7.358 (0.53); 7.337 (0.8); 7.333 (0.8); 7.312 (0.36); I.080 7.309 (0.37); 7.3 (1.93); 7.24 (0.8); 7.238 (0.77); 7.213 (0.66); 7.211 (0.62); 1.656 (1.31); 1.619 (1.34); 1.604 (1.39); 1.108 (0.49); 1.071 (0.79); 1.053 (0.51); 1.027 (0.56); 1.022 (0.57); 0.229 (0.8); 0.219 (16); 0.208 (0.79); 0.04 (1.96) I.081 8.778 (1.87); 7.741 (0.5); 7.736 (0.56); 7.717 (0.6); 7.711 (0.64); 7.594 (0.52); 7.579 (1.36); Example H-NMR [CDCl3 at 300 Mhz] 7.569 (0.43); 7.564 (1); 7.558 (0.71); 7.551 (1.11); 7.544 (0.56); 7.523 (0.48); 7.518 (0.46); 7.405 (0.47); 7.402 (0.49); 7.38 (0.76); 7.378 (0.76); 7.356 (0.33); 7.301 (1.42); 7.253 (0.78); 7.252 (0.76); 7.226 (0.66); 1.655 (0.55); 0.416 (0.54); 0.404 (16); 0.393 (0.6); 0.188 (0.52); 0.04 (1.43) 8.765 (3.81); 7.611 (1.01); 7.59 (3.05); 7.58 (1.15); 7.571 (1.42); 7.567 (2.3); 7.559 (0.4); 7.536 (0.64); 7.513 (0.72); 7.508 (1.29); 7.486 (1.26); 7.481 (0.83); 7.459 (0.71); 7.302 (6.25); 7.07 I.082 (0.9); 7.041 (1.76); 7.035 (2.03); 7.013 (0.99); 7.008 (1.73); 5.34 (1.31); 1.626 (1.8); 1.34 (0.58); 1.324 (0.48); 1.306 (0.7); 1.293 (1.09); 0.919 (0.33); 0.449 (0.54); 0.438 (15.7); 0.433 (16); 0.421 (0.77); 0.271 (0.35); 0.264 (0.35); 0.039 (4.72) 8.77 (7.19); 8.763 (2.72); 7.621 (0.53); 7.605 (0.68); 7.588 (3.15); 7.574 (1.05); 7.565 (5.76); 7.561 (5.3); 7.543 (5.59); 7.538 (3.34); 7.533 (2.65); 7.51 (1.67); 7.504 (0.96); 7.482 (0.77); 7.477 (0.6); 7.454 (0.52); 7.297 (6.87); 7.091 (4.05); 7.064 (3.9); 7.057 (3.32); 7.032 (2.29); I.083 7.03 (2.32); 7.006 (1.32); 1.618 (1.15); 1.29 (0.32); 1.244 (1.02); 1.212 (0.56); 0.545 (0.37); 0.533 (14.98); 0.527 (15.89); 0.507 (15.25); 0.501 (16); 0.49 (0.96); 0.448 (0.37); 0.436 (9.86); 0.43 (10.63); 0.419 (0.66); 0.108 (1.69); 0.035 (6.98); 0.024 (0.34) 8.392 (1.37); 7.651 (0.86); 7.625 (1.07); 7.622 (1.09); 7.539 (0.41); 7.522 (1.22); 7.505 (1.04); I.084 7.499 (0.99); 7.365 (0.37); 7.362 (0.35); 7.34 (0.56); 7.3 (1.22); 1.294 (0.56); 0.371 (16); 0.111 (0.39); 0.039 (1.05) 7.531 (0.66); 7.504 (2.6); 7.497 (1.5); 7.492 (1.95); 7.481 (1.77); 7.476 (3.48); 7.461 (1.08); 7.454 (0.83); 7.302 (14.43); 7.066 (0.85); 7.064 (0.82); 7.036 (1.55); 7.009 (0.79); 7.007 (0.73); 6.97 (1.7); 6.942 (1.53); 2.907 (13.52); 2.14 (1.99); 2.131 (2.01); 1.595 (8.15); 1.373 (0.43); I.085 1.35 (0.43); 0.421 (16); 0.416 (16); 0.404 (0.73); 0.262 (0.49); 0.257 (0.37); 0.247 (0.58); 0.237 (0.38); 0.15 (0.51); 0.139 (0.67); 0.092 (0.35); 0.051 (0.56); 0.04 (14.56); 0.029 (0.59); -0.042 (0.49); -0.072 (0.34) 7.649 (0.33); 7.643 (0.36); 7.624 (0.4); 7.619 (0.42); 7.509 (0.4); 7.506 (0.45); 7.503 (0.43); 7.501 (0.35); 7.492 (1.21); 7.482 (0.4); 7.475 (0.86); 7.464 (0.39); 7.443 (0.34); 7.367 (0.34); I.086 7.364 (0.34); 7.342 (0.53); 7.339 (0.51); 7.3 (1.25); 7.188 (0.5); 7.186 (0.48); 7.16 (0.43); 7.158 (0.41); 2.931 (4.44); 2.916 (0.33); 1.613 (1.58); 0.268 (0.66); 0.257 (16); 0.246 (0.64); 0.04 (1.08) 7.74 (0.53); 7.734 (0.57); 7.716 (0.62); 7.71 (0.65); 7.553 (0.53); 7.551 (0.49); 7.547 (0.51); 7.526 (0.47); 7.52 (0.44); 7.49 (1.18); 7.485 (0.7); 7.476 (0.59); 7.466 (1.54); 7.445 (0.5); 7.403 I.087 (0.5); 7.4 (0.49); 7.379 (0.81); 7.376 (0.75); 7.355 (0.35); 7.301 (4.64); 7.211 (0.81); 7.184 (0.68); 5.341 (0.4); 2.932 (6.98); 1.925 (1.44); 1.604 (4.7); 0.408 (0.57); 0.397 (16); 0.385 (0.77); 0.04 (3.9) 7.504 (1.25); 7.498 (0.89); 7.491 (0.74); 7.48 (2.39); 7.46 (0.67); 7.456 (0.53); 7.451 (0.89); 7.429 (0.99); 7.424 (0.55); 7.401 (0.48); 7.301 (5.09); 7.029 (0.54); 7.027 (0.54); 7 (0.97); 6.973 I.088 (0.49); 6.97 (0.47); 6.911 (1.05); 6.884 (0.96); 2.909 (8.71); 1.597 (3.26); 0.306 (0.64); 0.294 (16); 0.288 (15.98); 0.277 (0.65); 0.04 (4.69) 7.473 (0.72); 7.468 (1.14); 7.463 (1.26); 7.461 (1.17); 7.446 (1.87); 7.438 (0.88); 7.43 (0.61); 7.375 (0.34); 7.363 (0.59); 7.348 (0.56); 7.339 (0.41); 7.324 (0.39); 7.314 (0.52); 7.308 (0.52); I.089 7.297 (0.74); 7.28 (0.62); 7.274 (0.51); 5.331 (0.73); 2.936 (7.17); 2.218 (0.73); 0.398 (0.66); 0.386 (16); 0.375 (0.71); 0.034 (0.59) 7.488 (0.64); 7.481 (0.7); 7.476 (0.98); 7.46 (1.36); 7.454 (0.74); 7.445 (0.54); 7.427 (1.3); 7.4 (1.05); 7.369 (0.96); 7.365 (1.12); 7.342 (0.52); 7.339 (0.45); 7.297 (0.81); 7.027 (0.79); 7.023 I.090 (0.82); 7 (0.71); 6.997 (0.71); 2.89 (6.85); 2.485 (1.34); 0.453 (0.57); 0.441 (16); 0.429 (0.65); 0.034 (0.58) I.091 7.506 (1.43); 7.501 (1.05); 7.494 (1.31); 7.482 (3.89); 7.466 (1.68); 7.463 (1.43); 7.453 (1.81); Example H-NMR [CDCl3 at 300 Mhz] 7.431 (1.1); 7.426 (0.88); 7.403 (0.49); 7.304 (22.43); 7.049 (0.51); 7.032 (0.67); 7.02 (0.87); 7.002 (1.03); 6.992 (0.47); 6.975 (0.64); 6.933 (0.92); 6.912 (1.22); 6.886 (1.03); 6.275 (0.32); 6.227 (0.42); 6.208 (0.39); 6.159 (0.5); 6.156 (0.44); 5.796 (0.74); 5.785 (0.85); 5.748 (0.6); .736 (0.65); 5.594 (0.77); 5.582 (0.68); 5.526 (0.63); 5.514 (0.57); 2.911 (8.82); 2.876 (7.1); 1.599 (31.81); 1.52 (1.51); 0.382 (8.32); 0.375 (8.23); 0.308 (0.64); 0.296 (16); 0.291 (15.73); 0.053 (0.7); 0.042 (21.33); 0.032 (0.83); 0.016 (1.03); 0.004 (0.34) 7.592 (0.74); 7.568 (0.99); 7.564 (1.54); 7.542 (1.63); 7.537 (1); 7.514 (0.91); 7.49 (1.62); 7.483 (1.88); 7.478 (2.58); 7.462 (3.39); 7.447 (1.26); 7.304 (9.4); 7.083 (1.05); 7.061 (2.72); 7.035 I.092 (2.14); 7.027 (1); 3.476 (1.33); 3.456 (3.6); 3.438 (1.36); 2.896 (16); 1.682 (1.33); 1.672 (2.01); 1.662 (3.94); 1.653 (2.17); 1.642 (1.65); 1.621 (2.68); 1.523 (0.32); 1.475 (0.59); 0.526 (0.36); 0.514 (9.54); 0.508 (9.49); 0.489 (9.61); 0.482 (9.54); 0.042 (8.82); 0.031 (0.36) 7.865 (1.01); 7.84 (1.27); 7.654 (1.09); 7.65 (1.02); 7.629 (0.74); 7.625 (0.71); 7.538 (1.74); I.093 7.518 (1.39); 7.508 (0.68); 7.494 (1.31); 7.304 (2.51); 2.927 (6.98); 2.918 (1.39); 2.073 (0.37); 2.05 (1.68); 1.635 (0.69); 0.425 (0.63); 0.414 (16); 0.402 (0.61); 0.041 (2.36) 7.504 (1.8); 7.498 (0.82); 7.485 (1.13); 7.47 (1.47); 7.453 (0.59); 7.443 (0.87); 7.304 (22.25); 6.894 (1.02); 6.866 (0.97); 6.772 (1.11); 6.744 (1.01); 3.967 (7.43); 3.253 (2.06); 2.909 (0.4); 2.896 (7.08); 1.595 (26.8); 1.309 (1.77); 1.102 (0.35); 1.064 (0.32); 0.946 (0.62); 0.924 (1.85); I.094 0.902 (0.73); 0.387 (0.55); 0.339 (0.61); 0.327 (16); 0.298 (0.78); 0.292 (0.53); 0.278 (1.34); 0.268 (0.66); 0.256 (0.39); 0.249 (0.63); 0.238 (0.46); 0.198 (0.73); 0.185 (0.55); 0.179 (0.81); 0.155 (0.4); 0.128 (0.56); 0.112 (1.76); 0.104 (0.49); 0.053 (0.74); 0.042 (21.02); 0.031 (0.69); - 0.066 (0.4) 7.57 (0.6); 7.543 (1.43); 7.515 (1.47); 7.506 (1.11); 7.501 (1.3); 7.485 (1.74); 7.47 (0.61); 7.304 (12.01); 7.269 (0.58); 7.266 (0.55); 7.244 (0.53); 7.106 (1.21); 7.079 (1.1); 2.913 (7.51); 2.109 (2.18); 1.596 (15.64); 0.468 (0.58); 0.451 (1.13); 0.432 (16); 0.42 (1.08); 0.216 (0.55); 0.202 I.095 (0.44); 0.191 (0.34); 0.173 (0.44); 0.163 (0.39); 0.148 (0.63); 0.14 (0.68); 0.13 (0.78); 0.12 (1.31); 0.112 (1.26); 0.082 (0.54); 0.076 (0.6); 0.053 (0.63); 0.042 (11.6); 0.031 (0.74); 0.028 (0.72); 0.018 (1.45); 0.005 (0.4); -0.008 (0.74); -0.151 (0.62); -0.166 (1.55) 7.612 (1.07); 7.587 (1.23); 7.507 (1.09); 7.491 (0.69); 7.487 (0.76); 7.482 (0.6); 7.473 (0.6); 7.45 (0.58); 7.304 (3.38); 7.209 (0.72); 7.184 (0.65); 7 (1.27); 2.921 (7.42); 2.438 (5.71); 2.427 I.096 (0.73); 1.96 (1.52); 1.632 (6.29); 0.385 (0.9); 0.374 (16); 0.366 (1.66); 0.336 (0.57); 0.273 (0.54); 0.266 (0.85); 0.259 (1.22); 0.25 (0.78); 0.243 (0.64); 0.218 (0.33); 0.178 (0.5); 0.169 (1.28); 0.162 (0.41); 0.152 (0.59); 0.135 (0.39); 0.114 (0.77); 0.043 (2.39); -0.026 (0.99) 7.5 (1.58); 7.48 (1.11); 7.47 (0.6); 7.447 (0.55); 7.41 (0.55); 7.384 (1.05); 7.358 (0.73); 7.304 (1.96); 7.168 (0.87); 7.143 (0.71); 6.931 (0.8); 6.904 (0.72); 2.909 (7.57); 2.652 (0.57); 2.632 I.097 (5.79); 2.042 (1.61); 1.65 (2.68); 0.432 (0.61); 0.421 (16); 0.41 (0.73); 0.401 (1.54); 0.274 (0.64); 0.266 (1.02); 0.258 (1.85); 0.244 (0.58); 0.188 (0.46); 0.178 (0.69); 0.167 (1.24); 0.162 (0.52); 0.153 (0.49); 0.146 (0.56); 0.136 (0.52); 0.044 (2.7) 7.649 (0.35); 7.502 (0.76); 7.489 (1.34); 7.474 (1.39); 7.46 (0.68); 7.405 (0.47); 7.395 (0.58); 7.378 (0.48); 7.368 (0.61); 7.303 (67.28); 7.22 (0.61); 7.211 (0.61); 7.191 (1.19); 7.176 (0.93); 7.16 (0.39); 6.952 (0.38); 5.344 (0.7); 2.922 (7.25); 2.912 (1.24); 1.892 (2.03); 1.588 (62.91); I.098 0.397 (0.63); 0.386 (16); 0.37 (0.91); 0.34 (2.26); 0.273 (1.56); 0.264 (1.86); 0.256 (1.23); 0.248 (1.66); 0.218 (0.67); 0.208 (0.69); 0.198 (2.48); 0.185 (0.52); 0.172 (0.56); 0.159 (0.77); 0.152 (0.67); 0.123 (0.46); 0.111 (0.87); 0.09 (2.24); 0.053 (2.16); 0.042 (64.21); 0.031 (2.36); 0.013 (0.89) 7.506 (1.02); 7.501 (1.05); 7.492 (1.84); 7.474 (1.19); 7.464 (0.58); 7.442 (0.51); 7.361 (0.45); 7.356 (0.42); 7.334 (0.57); 7.328 (0.54); 7.303 (10.52); 7.102 (1.13); 7.074 (0.91); 2.922 (7); I.099 2.466 (5.28); 1.895 (1.63); 1.594 (7.73); 0.394 (0.63); 0.383 (16); 0.372 (0.61); 0.273 (1.1); 0.264 (1.16); 0.259 (0.86); 0.256 (0.79); 0.248 (0.79); 0.246 (0.77); 0.242 (0.71); 0.238 (0.67); 0.171 (0.39); 0.159 (0.43); 0.053 (0.41); 0.042 (10.76); 0.031 (0.38) Example H-NMR [CDCl3 at 300 Mhz] 7.499 (0.53); 7.494 (0.48); 7.489 (0.46); 7.476 (1.15); 7.458 (0.34); 7.303 (6.66); 7.296 (0.44); I.100 7.286 (0.39); 7.179 (0.4); 7.17 (0.37); 7.157 (0.61); 7.144 (0.64); 5.343 (0.96); 2.922 (4.68); 1.595 (5.01); 0.26 (0.52); 0.249 (16); 0.238 (0.66); 0.042 (5.65) 7.546 (0.74); 7.537 (0.9); 7.509 (0.47); 7.503 (0.5); 7.498 (0.62); 7.481 (1.01); 7.47 (0.62); 7.466 (0.47); 7.462 (0.46); 7.441 (0.6); 7.433 (0.51); 7.303 (13.77); 7.136 (0.89); 7.107 (0.72); I.101 .343 (1.23); 2.92 (4.6); 1.593 (15.41); 0.268 (0.65); 0.257 (16); 0.246 (0.59); 0.053 (0.41); 0.042 (11.29); 0.031 (0.38) 7.656 (1.29); 7.512 (0.89); 7.503 (0.83); 7.495 (1.36); 7.483 (1.09); 7.479 (1.28); 7.475 (1.45); I.102 7.467 (0.65); 7.305 (4.54); 7.168 (1.32); 7.14 (1.12); 2.919 (6.99); 1.957 (1.46); 1.615 (7.36); 0.402 (0.57); 0.391 (16); 0.38 (0.66); 0.113 (0.66); 0.043 (4.13); 7.665 (1.16) 7.636 (1.55); 7.631 (1.67); 7.612 (1.84); 7.606 (2.03); 7.596 (1.83); 7.59 (1.45); 7.569 (2.36); 7.564 (1.59); 7.481 (1.2); 7.465 (3.39); 7.451 (1.92); 7.448 (2.02); 7.443 (1.84); 7.438 (1.51); I.103 7.378 (1.96); 7.354 (2.41); 7.328 (1.34); 7.304 (6.64); 2.96 (16); 2.092 (1.53); 1.635 (9.77); 1.308 (0.51); 0.923 (0.54); 0.384 (13.68); 0.112 (1.04); 0.041 (4.38) 7.562 (0.99); 7.557 (1.1); 7.538 (1.25); 7.533 (1.31); 7.464 (1.36); 7.455 (1.7); 7.451 (2.72); 7.435 (3.04); 7.431 (2.34); 7.422 (1.84); 7.404 (1.55); 7.39 (0.34); 7.348 (1.88); 7.324 (2.41); 7.304 (6.08); 2.95 (16); 2.087 (0.47); 2.067 (12.15); 2.009 (0.56); 1.886 (1.37); 1.642 (9.21); I.104 1.35 (0.55); 1.309 (3.52); 1.278 (0.37); 0.946 (1.25); 0.924 (3.9); 0.901 (1.47); 0.382 (0.33); 0.344 (15.2); 0.286 (0.54); 0.273 (2.52); 0.263 (1.96); 0.256 (1.38); 0.246 (1.68); 0.238 (1.14); 0.229 (0.37); 0.217 (0.64); 0.206 (0.42); 0.179 (0.52); 0.167 (0.44); 0.157 (1.05); 0.152 (0.55); 0.144 (0.52); 0.138 (0.38); 0.126 (0.67); 0.124 (0.8); 0.114 (1.21); 0.043 (4.26) 7.715 (0.55); 7.691 (0.67); 7.687 (0.68); 7.663 (0.61); 7.526 (1.28); 7.512 (0.57); 7.503 (1.23); 7.481 (0.5); 7.304 (6.93); 7.132 (0.34); 7.125 (0.37); 7.105 (0.64); 7.097 (0.69); 7.069 (0.33); 7 I.105 (0.64); 6.992 (0.56); 6.967 (0.65); 6.96 (0.56); 2.924 (6.88); 1.904 (0.98); 1.613 (14.91); 0.401 (0.62); 0.39 (16); 0.379 (0.61); 0.112 (1.08); 0.042 (5.44) 7.552 (0.32); 7.539 (0.32); 7.533 (0.36); 7.526 (0.45); 7.514 (0.45); 7.469 (0.39); 7.452 (0.59); I.106 7.344 (0.35); 7.319 (0.54); 7.304 (5.13); 2.955 (2.82); 1.613 (16); 0.232 (0.4); 0.221 (10.04); 0.21 (0.36); 0.042 (3.12) 7.487 (1.01); 7.482 (1.14); 7.467 (3.11); 7.462 (2.8); 7.456 (2.22); 7.443 (4); 7.424 (1.14); 7.387 (0.75); 7.385 (0.78); 7.381 (0.84); 7.362 (1.63); 7.36 (1.65); 7.356 (1.39); 7.32 (2.02); 7.304 I.107 (6.53); 7.296 (2.38); 7.272 (0.8); 2.949 (16); 2.033 (12.63); 1.627 (14.05); 0.19 (2.26); 0.179 (57.05); 0.168 (2.13); 0.043 (4.16) 7.604 (0.38); 7.58 (0.49); 7.577 (0.47); 7.553 (0.43); 7.531 (1.17); 7.513 (0.76); 7.503 (0.38); I.108 7.481 (0.34); 7.305 (4.27); 7.074 (0.43); 7.066 (0.46); 6.97 (0.44); 6.962 (0.38); 6.936 (0.44); 6.929 (0.37); 2.926 (4.62); 1.596 (3.09); 0.265 (0.65); 0.254 (16); 0.243 (0.63); 0.043 (4.36) 8.04 (0.88); 8.029 (0.74); 8.023 (0.67); 8.015 (0.61); 8.007 (1.02); 7.746 (0.73); 7.736 (0.57); 7.73 (0.6); 7.724 (0.98); 7.713 (1.29); 7.655 (0.44); 7.651 (0.38); 7.642 (2.49); 7.632 (1.33); 7.628 (1.52); 7.622 (1.5); 7.618 (1.05); 7.609 (2.06); 7.511 (0.58); 7.488 (0.72); 7.484 (1.31); I.109 7.461 (1.35); 7.457 (0.84); 7.434 (0.75); 7.298 (10.36); 7.043 (0.81); 7.041 (0.84); 7.013 (1.49); 6.986 (0.75); 6.984 (0.76); 6.97 (1.7); 6.942 (1.49); 2.856 (14.43); 2.34 (0.83); 1.608 (6.51); 0.465 (0.64); 0.458 (0.72); 0.449 (0.85); 0.438 (16); 0.433 (15.98); 0.421 (0.64); 0.122 (0.51); 0.048 (0.37); 0.037 (10.34); 0.026 (0.37); -0.087 (1.53) 8.068 (0.37); 8.057 (0.36); 8.036 (0.43); 7.784 (0.34); 7.762 (0.42); 7.751 (0.51); 7.673 (0.43); 7.667 (0.46); 7.648 (0.58); 7.643 (0.66); 7.632 (1.1); 7.622 (0.63); 7.619 (0.62); 7.613 (0.64); I.110 7.609 (0.49); 7.6 (0.88); 7.521 (0.42); 7.519 (0.42); 7.516 (0.41); 7.495 (0.38); 7.489 (0.33); 7.369 (0.43); 7.366 (0.42); 7.344 (0.68); 7.341 (0.67); 7.32 (0.35); 7.249 (0.65); 7.222 (0.54); Example H-NMR [CDCl3 at 300 Mhz] 2.916 (5.48); 1.224 (1.68); 1.186 (1.66); 0.318 (0.95); 0.308 (16); 0.296 (0.92) 8.053 (0.62); 8.041 (0.62); 8.035 (0.48); 8.029 (0.45); 8.02 (0.71); 7.766 (0.54); 7.756 (0.45); 7.752 (0.47); 7.745 (0.75); 7.734 (0.85); 7.65 (0.35); 7.647 (0.33); 7.637 (1.83); 7.626 (1.11); 7.624 (1.13); 7.617 (1.11); 7.604 (1.44); 7.467 (0.4); 7.445 (0.53); 7.44 (0.89); 7.418 (0.93); I.111 7.413 (0.6); 7.39 (0.53); 7.3 (0.37); 7.013 (0.58); 7.011 (0.6); 6.984 (1.06); 6.956 (0.58); 6.954 (0.59); 6.944 (1.17); 6.917 (1.02); 2.872 (9.18); 1.204 (1.12); 1.166 (1.09); 0.327 (16); 0.321 (15.3) 8.038 (0.44); 8.028 (0.34); 8.022 (0.38); 8.006 (0.53); 7.742 (0.87); 7.735 (0.7); 7.726 (0.4); 7.717 (0.72); 7.71 (1.18); 7.629 (1.15); 7.62 (0.65); 7.614 (0.77); 7.61 (0.77); 7.604 (0.52); 7.596 (1.02); 7.544 (0.49); 7.541 (0.48); 7.538 (0.49); 7.536 (0.42); 7.517 (0.46); 7.511 (0.42); I.112 7.388 (0.48); 7.385 (0.49); 7.364 (0.78); 7.361 (0.75); 7.34 (0.34); 7.301 (5.52); 7.221 (0.77); 7.194 (0.65); 2.885 (7.41); 2.12 (1.7); 1.611 (5.06); 0.426 (0.58); 0.415 (16); 0.403 (0.63); 0.175 (0.32); 0.041 (5.67) 7.99 (0.95); 7.978 (1.06); 7.971 (0.72); 7.967 (0.67); 7.958 (1.13); 7.698 (0.7); 7.686 (0.71); 7.677 (1.08); 7.665 (1.56); 7.653 (0.45); 7.629 (0.68); 7.618 (3.16); 7.606 (2.23); 7.597 (1.9); 7.585 (2.07); 7.511 (0.62); 7.489 (0.78); 7.484 (1.39); 7.462 (1.41); 7.457 (0.89); 7.434 (0.75); I.113 7.402 (1.71); 7.4 (1.65); 7.387 (1.81); 7.385 (1.71); 7.302 (3.36); 7.14 (1.68); 7.137 (1.64); 7.128 (1.87); 7.126 (1.72); 7.051 (0.92); 7.049 (0.91); 7.021 (1.7); 6.994 (0.84); 6.992 (0.8); 6.926 (1.85); 6.914 (1.63); 6.898 (3.22); 6.887 (1.38); 2.608 (15.2); 1.299 (0.55); 0.674 (0.87); 0.662 (16); 0.654 (15.81); 0.643 (0.76); 0.044 (1.65) 7.96 (0.82); 7.95 (0.54); 7.946 (0.63); 7.939 (0.99); 7.928 (0.95); 7.663 (0.47); 7.65 (0.64); 7.645 (0.59); 7.638 (0.74); 7.63 (1.56); 7.621 (0.49); 7.614 (0.65); 7.61 (0.58); 7.601 (2.88); 7.591 (1.5); 7.588 (1.21); 7.579 (1.41); 7.568 (1.86); 7.497 (0.64); 7.475 (0.82); 7.47 (1.38); 7.448 (1.4); 7.443 (0.86); 7.42 (0.73); 7.325 (0.51); 7.318 (3.22); 7.311 (1.29); 7.302 (11.66); I.114 7.297 (1.58); 7.289 (3.44); 7.281 (0.53); 7.046 (0.81); 7.044 (0.84); 7.017 (1.48); 6.99 (0.74); 6.987 (0.71); 6.904 (1.58); 6.877 (1.44); 6.57 (0.46); 6.563 (3.46); 6.556 (1.15); 6.54 (1.08); 6.534 (3.2); 6.526 (0.4); 3.557 (16); 2.542 (14.31); 1.608 (4.11); 1.524 (0.63); 1.478 (0.59); 1.13 (0.58); 1.085 (0.57); 0.613 (0.65); 0.601 (14.44); 0.594 (14.53); 0.582 (0.72); 0.111 (0.37); 0.052 (0.35); 0.041 (10.26); 0.03 (0.38) 7.958 (0.88); 7.948 (0.64); 7.944 (0.68); 7.937 (1.05); 7.926 (1.04); 7.68 (0.61); 7.668 (0.83); 7.661 (0.65); 7.656 (0.74); 7.647 (1.67); 7.637 (0.4); 7.619 (0.55); 7.616 (0.53); 7.607 (3.09); 7.596 (1.7); 7.584 (1.55); 7.574 (2.02); 7.508 (0.63); 7.485 (0.77); 7.48 (1.39); 7.458 (1.42); 7.453 (0.88); 7.431 (0.84); 7.416 (1.59); 7.41 (2.05); 7.401 (1.29); 7.395 (1.61); 7.385 (1.96); I.115 7.301 (14.84); 7.097 (0.43); 7.091 (0.71); 7.081 (3.46); 7.076 (3.66); 7.067 (1.32); 7.063 (1.65); 7.061 (1.71); 7.058 (1.98); 7.052 (1.28); 7.049 (1.13); 7.041 (0.58); 7.023 (1.64); 6.996 (0.83); 6.993 (0.75); 6.918 (1.74); 6.891 (1.59); 2.469 (15.17); 1.605 (3.41); 1.473 (0.35); 1.295 (0.88); 0.618 (0.66); 0.607 (16); 0.599 (15.91); 0.588 (0.74); 0.128 (1.14); 0.123 (1.72); 0.111 (41.11); 0.098 (1.68); 0.086 (0.7); 0.051 (0.58); 0.041 (15); 0.03 (0.59) 8.951 (0.75); 8.945 (0.79); 8.937 (0.79); 8.931 (0.8); 8.891 (1.42); 8.882 (1.44); 8.444 (0.54); 8.442 (0.61); 8.439 (0.61); 8.437 (0.51); 8.416 (0.58); 8.414 (0.66); 8.411 (0.64); 8.409 (0.54); 7.699 (1); 7.697 (0.97); 7.69 (1.02); 7.609 (0.94); 7.595 (0.93); 7.581 (0.89); 7.566 (0.87); 7.419 I.116 (0.4); 7.397 (0.46); 7.392 (0.87); 7.37 (0.87); 7.365 (0.54); 7.343 (0.48); 7.302 (0.65); 6.964 (0.57); 6.961 (0.56); 6.935 (0.98); 6.907 (0.51); 6.905 (0.48); 6.824 (1.05); 6.797 (0.96); 0.372 (0.65); 0.361 (16); 0.355 (15.7); 0.344 (0.71); 0.108 (3.85); 0.028 (0.41) 8.538 (1.18); 7.825 (1.27); 7.735 (1.1); 7.717 (1.42); 7.683 (0.33); 7.665 (0.43); 7.645 (0.34); 7.637 (0.34); 7.589 (1.33); 7.57 (1.05); 7.558 (0.4); 7.367 (0.41); 7.34 (0.95); 7.317 (1.05); I.117 7.304 (2.02); 7.289 (0.52); 6.898 (0.77); 6.87 (1.43); 6.842 (0.7); 6.606 (1.43); 6.579 (1.34); 0.556 (0.33); 0.544 (16); 0.539 (15.97); 0.528 (0.94); 0.438 (2.38); 0.432 (2.38); 0.114 (7.2); 0.101 (0.36); 0.039 (1.37) Example H-NMR [CDCl3 at 300 Mhz] 8.542 (1.58); 8.533 (1.6); 7.766 (1.22); 7.765 (1.19); 7.758 (1.22); 7.702 (1.27); 7.683 (1.71); 7.584 (1.36); 7.566 (1); 7.564 (0.92); 7.348 (0.35); 7.325 (0.52); 7.321 (0.79); 7.304 (0.73); I.118 7.298 (0.87); 7.294 (0.5); 7.271 (0.42); 6.881 (0.59); 6.852 (1.07); 6.825 (0.53); 6.642 (1.17); 6.615 (1.09); 0.42 (0.71); 0.409 (16); 0.403 (15.21); 0.392 (0.65); 0.12 (2.39); 0.041 (0.33) 8.453 (1.86); 8.444 (1.83); 7.728 (2.19); 7.72 (2.08); 7.661 (1.84); 7.641 (2.03); 7.357 (0.53); 7.334 (0.8); 7.33 (1.21); 7.307 (1.79); 7.304 (2.27); 7.28 (0.65); 7.252 (2.35); 7.232 (2.17); I.119 6.889 (0.9); 6.86 (1.6); 6.833 (0.82); 6.59 (1.74); 6.563 (1.63); 1.297 (0.45); 0.557 (0.68); 0.546 (16); 0.54 (14.81); 0.529 (0.66); 0.445 (0.98); 0.439 (0.92); 0.115 (5.95); 0.04 (1.14) 8.441 (1.47); 8.432 (1.51); 7.661 (1.7); 7.653 (1.69); 7.638 (1.51); 7.618 (1.64); 7.339 (0.4); 7.316 (0.49); 7.312 (0.91); 7.304 (0.63); 7.29 (0.91); 7.285 (0.57); 7.262 (0.48); 7.241 (1.83); I.120 7.222 (1.66); 6.872 (0.66); 6.844 (1.19); 6.816 (0.59); 6.624 (1.28); 6.597 (1.19); 0.425 (0.69); 0.415 (16); 0.409 (15.87); 0.398 (0.77); 0.123 (3.56) 8.522 (0.99); 8.516 (1.21); 8.458 (2.14); 8.449 (1.69); 8.16 (2.1); 8.152 (2.13); 7.403 (0.56); 7.38 (0.7); 7.376 (1.24); 7.353 (1.28); 7.348 (0.79); 7.326 (0.69); 7.301 (4.11); 6.934 (0.88); I.121 6.932 (0.84); 6.906 (1.57); 6.878 (0.8); 6.876 (0.74); 6.803 (1.53); 6.801 (1.5); 6.795 (1.56); 6.793 (1.41); 6.654 (1.64); 6.626 (1.53); 2.724 (0.79); 1.659 (0.82); 0.567 (0.71); 0.555 (16); 0.55 (15.65); 0.538 (0.67); 0.477 (0.33); 0.037 (3) 8.445 (4.75); 8.142 (1.47); 8.134 (1.48); 7.37 (0.39); 7.348 (0.47); 7.343 (0.86); 7.321 (0.88); 7.316 (0.53); 7.301 (1.45); 7.294 (0.5); 6.906 (0.6); 6.877 (1.08); 6.85 (0.54); 6.79 (1.18); 6.782 I.122 (1.15); 6.657 (1.14); 6.63 (1.06); 2.082 (0.87); 2.045 (5.79); 1.708 (0.38); 1.296 (0.49); 0.432 (0.66); 0.421 (16); 0.415 (15.64); 0.404 (0.75); 0.108 (1.77); 0.035 (1.08) 8.476 (0.53); 8.468 (0.75); 8.432 (0.52); 8.425 (0.4); 8.13 (0.57); 8.123 (0.58); 7.594 (0.34); 7.589 (0.38); 7.57 (0.4); 7.564 (0.42); 7.399 (0.33); 7.393 (0.33); 7.301 (0.7); 7.249 (0.33); I.123 7.225 (0.53); 7.222 (0.5); 6.884 (0.52); 6.856 (0.47); 6.79 (0.48); 6.783 (0.48); 0.372 (0.61); 0.37 (0.45); 0.361 (16); 0.352 (0.54); 0.35 (0.62); 0.039 (0.43) 8.369 (0.39); 8.363 (0.37); 8.347 (0.41); 8.341 (0.38); 7.557 (0.37); 7.539 (0.37); 7.533 (0.42); 7.403 (0.34); 7.38 (0.33); 7.301 (1.01); 7.259 (0.62); 7.247 (0.4); 7.234 (0.41); 7.232 (0.41); I.124 7.223 (0.57); 7.22 (0.46); 6.938 (0.39); 6.931 (1.36); 6.925 (0.42); 6.916 (0.35); 0.335 (0.6); 0.333 (0.45); 0.324 (16); 0.313 (0.61); 0.037 (0.76) 8.46 (3.25); 8.113 (1.19); 8.104 (1.2); 7.688 (0.53); 7.682 (0.56); 7.664 (0.61); 7.658 (0.61); 7.415 (0.51); 7.413 (0.49); 7.41 (0.51); 7.407 (0.41); 7.388 (0.45); 7.382 (0.41); 7.301 (1); 7.262 (0.51); 7.26 (0.48); 7.238 (0.84); 7.236 (0.76); 7.214 (0.36); 7.211 (0.32); 6.868 (0.79); 6.841 I.125 (0.72); 6.765 (0.86); 6.757 (0.85); 4.186 (0.48); 4.162 (1.47); 4.139 (1.5); 4.115 (0.51); 2.076 (6.73); 2.039 (2.67); 1.313 (1.82); 1.289 (3.63); 1.265 (1.75); 0.496 (0.59); 0.484 (16); 0.473 (0.63); 0.031 (0.7) 7.431 (0.48); 7.428 (0.51); 7.426 (0.43); 7.407 (0.45); 7.401 (0.42); 7.297 (0.73); 7.282 (0.49); 7.279 (0.5); 7.258 (0.8); 7.255 (0.79); 7.233 (0.35); 7.231 (0.33); 6.885 (0.78); 6.858 (0.71); I.126 0.485 (0.64); 0.474 (16); 0.462 (0.69); 0.031 (0.39); 8.431 (1.07); 8.423 (1.17); 8.267 (0.79); 8.263 (0.86); 8.259 (0.8); 8.255 (0.73); 7.982 (1.14); 7.97 (1.14); 7.691 (0.54); 7.685 (0.58); 7.667 (0.62); 7.661 (0.64); 7.434 (0.49) 8.952 (0.55); 8.419 (1.94); 8.411 (2.28); 8.324 (1.6); 8.32 (1.74); 8.316 (1.59); 8.312 (1.44); 8.025 (2.09); 8.014 (2.11); 7.419 (0.55); 7.396 (0.73); 7.391 (1.27); 7.369 (1.29); 7.364 (0.86); I.127 7.341 (0.7); 7.297 (3); 6.948 (0.93); 6.92 (1.7); 6.892 (0.83); 6.664 (1.8); 6.637 (1.68); 2.64 (0.55); 1.67 (1.28); 0.539 (15.76); 0.534 (16); 0.46 (0.37); 0.453 (0.36); 0.032 (1.59) 8.409 (1.27); 8.401 (1.43); 8.25 (0.91); 8.246 (1.06); 8.242 (1); 8.238 (0.94); 8.009 (1.37); 7.997 I.128 (1.38); 7.386 (0.38); 7.364 (0.43); 7.359 (0.86); 7.337 (0.85); 7.332 (0.55); 7.31 (0.47); 7.298 Example H-NMR [CDCl3 at 300 Mhz] (1.11); 6.923 (0.52); 6.921 (0.57); 6.893 (1.01); 6.867 (0.48); 6.865 (0.51); 6.667 (1.05); 6.64 (0.96); 0.421 (0.61); 0.41 (15.5); 0.404 (16); 0.392 (0.75); 0.107 (4.21); 0.033 (0.82); -0.02 (0.86) 8.438 (0.72); 8.43 (0.77); 8.231 (0.52); 8.228 (0.56); 8.223 (0.53); 8.22 (0.47); 7.991 (0.73); 7.979 (0.73); 7.596 (0.36); 7.59 (0.39); 7.572 (0.42); 7.566 (0.44); 7.41 (0.34); 7.408 (0.32); I.129 7.404 (0.34); 7.297 (0.64); 7.264 (0.33); 7.261 (0.33); 7.24 (0.54); 7.237 (0.51); 6.892 (0.52); 6.864 (0.47); 0.357 (0.61); 0.346 (16); 0.335 (0.74); 0.034 (0.4) 8.857 (15.86); 8.85 (16); 8.155 (7.5); 8.133 (8.31); 7.733 (6.71); 7.712 (9.11); 7.708 (5.64); 7.704 (4.73); 7.69 (7.03); 7.687 (8.77); 7.683 (4.5); 7.669 (6.06); 7.666 (4.98); 7.588 (5.87); 7.585 (6.24); 7.57 (5.13); 7.568 (8.92); 7.565 (5.62); 7.55 (3.62); 7.547 (3.63); 7.517 (11.38); IIa.01 7.51 (11.17); 7.372 (4.33); 7.356 (4.69); 7.351 (9.41); 7.336 (9.46); 7.331 (5.5); 7.315 (5.15); 7.286 (8.11); 6.993 (5.14); 6.99 (5.62); 6.975 (5.92); 6.972 (9.43); 6.97 (6.33); 6.954 (4.76); 6.951 (4.96); 6.803 (5.81); 6.8 (10.37); 6.797 (6.24); 6.782 (5.53); 6.779 (9.68); 6.777 (5.75); 2.069 (0.61); 1.88 (1.76); 1.338 (0.85); 1.321 (1.94); 1.303 (2.51); 1.298 (2.52); 1.281 (9.73); 1.263 (1.64); 0.918 (4.82); 0.901 (15.32); 0.883 (6.33); 0.866 (0.35); 0.021 (7.33) 8.862 (16); 8.855 (15.96); 8.143 (7.47); 8.123 (8.2); 8.122 (8.15); 7.966 (9.4); 7.962 (9.74); 7.946 (9.88); 7.942 (10.02); 7.703 (6); 7.7 (6.7); 7.68 (9.75); 7.678 (9.42); 7.674 (5.12); 7.66 (7.68); 7.656 (9.24); 7.652 (4.68); 7.639 (6.53); 7.635 (5.2); 7.56 (6.32); 7.558 (6.42); 7.543 IIa.02 (5.58); 7.54 (9.22); 7.537 (5.45); 7.523 (3.77); 7.52 (3.64); 7.423 (11.45); 7.416 (15.4); 7.412 (6.05); 7.397 (6.79); 7.395 (7.56); 7.393 (7.46); 7.391 (6.69); 7.377 (6.2); 7.373 (6.08); 7.284 (8.06); 7.063 (9.27); 7.06 (11.07); 7.043 (8.61); 7.039 (9.69); 7.026 (6.46); 7.022 (5.53); 7.007 (8.35); 7.006 (8.35); 7.003 (7.7); 6.987 (5.5); 6.984 (4.93); 2.017 (0.87); 1.798 (13.25); 1.282 (0.69); 0.026 (6.82) 8.846 (15.65); 8.84 (16); 8.823 (0.92); 8.816 (0.63); 8.121 (10.46); 8.1 (11.28); 7.72 (8.59); 7.717 (9.63); 7.7 (9.24); 7.697 (10.31); 7.682 (9.51); 7.661 (13.02); 7.637 (9.4); 7.619 (5.98); 7.617 (5.8); 7.57 (0.44); 7.54 (8.43); 7.522 (10.63); 7.503 (4.73); 7.486 (0.46); 7.478 (0.44); IIa.03 7.416 (0.5); 7.39 (13.54); 7.384 (13.8); 7.375 (5.56); 7.358 (9.17); 7.356 (9.52); 7.339 (6.02); 7.336 (6.09); 7.319 (0.52); 7.295 (0.39); 7.284 (0.37); 7.259 (52.44); 7.228 (0.47); 7.208 (0.51); 7.188 (0.34); 7.175 (0.57); 7.169 (0.65); 7.16 (5.08); 7.157 (6.29); 7.138 (10.57); 7.122 (4.74); 7.118 (6); 7.112 (11.34); 7.11 (10.65); 7.092 (9.06); 7.089 (8.92); 1.825 (0.34); 1.723 (1.36); 1.255 (0.47); -0.001 (54.77) 8.942 (15.92); 8.933 (15.8); 8.919 (1.08); 8.901 (0.6); 8.892 (0.59); 8.054 (0.53); 8.05 (0.51); 8.028 (0.58); 8.023 (0.51); 7.879 (10.62); 7.874 (10.34); 7.852 (11.84); 7.848 (10.85); 7.787 (9.6); 7.761 (12.68); 7.719 (11.58); 7.714 (13.59); 7.711 (13.03); 7.706 (10.25); 7.671 (0.76); 7.666 (0.8); 7.63 (3.85); 7.613 (5.01); 7.604 (8.96); 7.587 (8.95); 7.578 (6.87); 7.568 (6.52); IIa.04 7.562 (9.25); 7.56 (9.84); 7.556 (10.24); 7.551 (9.56); 7.543 (10.94); 7.54 (11.64); 7.538 (10.8); 7.53 (5.7); 7.516 (16); 7.493 (5.06); 7.402 (12.35); 7.397 (13.09); 7.374 (9.56); 7.37 (8.85); 7.341 (7.75); 7.336 (6.38); 7.316 (10.52); 7.314 (10.85); 7.311 (9.68); 7.29 (5.79); 7.285 (4.84); 7.256 (0.89); 7.23 (0.68); 7.174 (0.36); 7.148 (0.55); 7.123 (0.4); 5.789 (1.09); 3.366 (16.77); 3.342 (0.41); 2.676 (1.45); 2.539 (9.09); 2.533 (11.41); 2.527 (8.18); 2.47 (0.52); 0.022 (4.96) 7.875 (1.88); 7.87 (1.8); 7.849 (2.07); 7.844 (1.89); 7.7 (1.27); 7.696 (1.04); 7.69 (0.85); 7.677 (1.6); 7.669 (1.57); 7.566 (0.96); 7.561 (0.91); 7.542 (1.65); 7.539 (1.85); 7.536 (1.78); 7.534 IIa.05 (1.73); 7.514 (2.3); 7.509 (2.58); 7.495 (4.67); 7.489 (5.56); 7.463 (1.86); 7.461 (1.87); 7.454 (1.53); 7.435 (0.59); 7.428 (0.41); 7.37 (2.07); 7.365 (2.36); 7.342 (1.8); 7.337 (2.1); 7.335 (1.87); 7.329 (1.13); 7.31 (1.79); 7.308 (1.83); 7.305 (1.52); 7.283 (1.04); 7.278 (0.83); 3.367 (12.9); 2.754 (16); 2.538 (0.99); 2.532 (1.14); 2.526 (0.79) 8.954 (9.73); 8.945 (9.78); 7.773 (6.63); 7.768 (6.86); 7.746 (7.32); 7.741 (7.46); 7.498 (0.63); 7.488 (0.5); 7.467 (7.94); 7.461 (8.77); 7.457 (13.7); 7.44 (16); 7.432 (8.43); 7.431 (8.49); 7.427 IIa.06 (11.88); 7.406 (5.16); 7.401 (4.91); 7.372 (7.78); 7.367 (8.52); 7.363 (8.42); 7.358 (7.29); 7.301 (16.65); 7.244 (4.25); 7.239 (5.07); 7.218 (5.82); 7.213 (7.09); 7.192 (4.28); 7.187 (12.17); Example H-NMR [CDCl3 at 300 Mhz] 7.182 (7.08); 7.16 (6.99); 7.155 (5.8); 1.629 (6.36); 0.122 (0.96); 0.11 (21.08); 0.098 (0.84); 0.049 (0.72); 0.038 (17.4); 0.027 (0.68) 7.77 (1.56); 7.765 (1.55); 7.744 (1.72); 7.738 (1.68); 7.455 (0.76); 7.45 (0.74); 7.43 (1.5); 7.425 (1.44); 7.403 (1.2); 7.398 (1.12); 7.37 (1.8); 7.364 (1.98); 7.359 (2.61); 7.342 (3.53); 7.329 IIa.07 (1.35); 7.299 (5.45); 7.235 (1.03); 7.23 (1.11); 7.209 (1.46); 7.204 (1.56); 7.183 (0.82); 7.178 (0.84); 7.162 (3.01); 7.158 (2.86); 7.147 (2.05); 7.142 (1.69); 7.12 (1.63); 7.115 (1.42); 5.338 (0.61); 2.892 (16); 1.62 (4.22); 0.038 (4.56) 8.082 (1.52); 8.052 (1.42); 7.757 (1.54); 7.752 (1.56); 7.73 (1.7); 7.725 (1.7); 7.66 (0.72); 7.656 (0.97); 7.638 (2.1); 7.633 (2.16); 7.628 (0.86); 7.616 (1.75); 7.611 (2.54); 7.501 (1.17); 7.498 (1.14); 7.479 (0.99); 7.473 (1.68); 7.451 (0.67); 7.448 (0.62); 7.413 (0.73); 7.408 (0.73); 7.387 IIa.08 (1.41); 7.383 (1.4); 7.362 (1.12); 7.356 (1.04); 7.3 (1.26); 7.243 (3.87); 7.19 (0.98); 7.185 (1.09); 7.164 (1.43); 7.16 (1.53); 7.139 (0.77); 7.134 (0.78); 7.095 (1.87); 7.09 (1.66); 7.068 (1.56); 7.063 (1.4); 5.33 (3.52); 2.832 (16); 0.117 (0.4); 0.04 (1.3) 7.571 (0.77); 7.563 (1.07); 7.559 (0.94); 7.547 (0.85); 7.54 (1.53); 7.534 (0.99); 7.36 (1.34); 7.347 (3.47); 7.33 (2.62); 7.325 (2.11); 7.319 (2.15); 7.302 (2.91); 7.298 (1.84); 7.291 (1.39); IIa.09 7.283 (1.49); 7.268 (1.66); 7.262 (2.21); 7.239 (1.14); 7.23 (0.43); 6.999 (2.88); 2.975 (16); 2.085 (1.11); 1.673 (0.63); 1.298 (0.69); 0.038 (2.32) 7.72 (1.51); 7.7 (1.55); 7.69 (1.65); 7.671 (1.61); 7.441 (0.32); 7.423 (0.5); 7.41 (4.13); 7.393 (2.5); 7.382 (1.43); 7.362 (1.27); 7.332 (0.36); 7.301 (2.13); 7.298 (2.97); 7.293 (2.72); 6.968 IIa.10 (0.84); 6.959 (0.96); 6.943 (1); 6.939 (0.92); 6.933 (1.14); 6.929 (0.99); 6.913 (0.78); 6.904 (0.87); 6.83 (1.66); 6.82 (1.43); 6.8 (1.66); 6.79 (1.41); 2.861 (0.46); 2.847 (16); 0.113 (2.6); 0.032 (0.93) 8.987 (15.81); 8.977 (16); 7.822 (0.32); 7.799 (9.03); 7.795 (9.47); 7.774 (10.69); 7.77 (10.86); 7.716 (0.75); 7.706 (0.68); 7.69 (0.73); 7.681 (0.87); 7.66 (0.33); 7.643 (1.41); 7.636 (7.02); 7.632 (7.3); 7.609 (10.74); 7.605 (10.05); 7.52 (5.69); 7.518 (6.1); 7.512 (6); 7.51 (6.47); 7.502 (11.72); 7.493 (7.05); 7.485 (7.05); 7.477 (11.92); 7.45 (6.62); 7.355 (0.4); 7.332 (15.98); 7.323 (15.67); 7.298 (146.91); 7.221 (1.81); 7.203 (2.64); 7.193 (10.97); 7.191 (10.53); 7.186 (9.67); IIa.11 7.177 (10.06); 7.175 (11.85); 7.162 (8.51); 7.153 (7.46); 7.148 (1.86); 7.137 (1.03); 7.132 (1.72); 7.123 (1.98); 7.107 (0.37); 7.09 (0.43); 7.052 (0.33); 6.947 (0.76); 5.337 (2.74); 2.046 (0.36); 1.658 (0.43); 1.592 (181.38); 1.463 (0.59); 1.34 (0.71); 1.321 (0.88); 1.291 (1.59); 1.219 (3.23); 1.14 (1.67); 0.917 (0.53); 0.231 (0.58); 0.047 (4.51); 0.036 (138.67); 0.025 (4.76); -0.163 (0.48) 7.521 (1.11); 7.518 (1.09); 7.514 (1.19); 7.511 (0.94); 7.496 (0.99); 7.491 (1.39); 7.485 (0.89); 7.374 (1.44); 7.361 (3.36); 7.345 (2.61); 7.339 (1.82); 7.334 (1.7); 7.301 (4.16); 7.182 (1.82); IIa.12 7.176 (3.24); 7.175 (3.24); 7.159 (3.04); 7.153 (3.28); 7.144 (0.39); 7.09 (3.1); 7.086 (2.89); 7.017 (0.55); 6.998 (0.38); 6.995 (0.37); 5.339 (0.4); 2.897 (16); 2.839 (1.05); 1.652 (1.95); 1.221 (0.43); 0.037 (3.75) 8.076 (1.66); 8.049 (1.75); 7.655 (0.83); 7.651 (0.97); 7.628 (3.23); 7.603 (3.74); 7.498 (2.68); IIa.13 7.478 (2.43); 7.473 (2.92); 7.45 (0.74); 7.302 (0.83); 7.17 (0.42); 7.153 (4.47); 7.14 (1.75); 7.131 (2); 7.126 (2.54); 7.116 (1.89); 7.108 (3.6); 7.097 (0.5); 2.84 (16); 0.039 (0.52) 8.093 (0.7); 8.089 (0.72); 8.065 (0.76); 8.06 (0.77); 7.588 (0.32); 7.578 (0.33); 7.571 (0.34); 7.565 (0.45); 7.558 (0.46); 7.548 (0.42); 7.541 (0.43); 7.427 (0.46); 7.404 (0.51); 7.396 (1.82); 7.369 (3.72); 7.356 (1.63); 7.351 (1.72); 7.342 (3.45); 7.328 (3.27); 7.314 (1.19); 7.302 (2.41); IIa.14 7.188 (2.41); 7.184 (2.46); 6.886 (1.43); 6.882 (1.58); 6.858 (1.32); 6.854 (1.37); 6.757 (1.65); 6.753 (1.64); 6.73 (1.53); 6.726 (1.45); 4.007 (16); 2.88 (14.38); 2.831 (8.68); 1.746 (2.78); 0.034 (1.93) 8.948 (7.36); 8.939 (7.42); 7.526 (0.35); 7.519 (0.51); 7.495 (6.95); 7.493 (7.18); 7.488 (6.17); IIa.15 7.484 (5.96); 7.469 (16); 7.461 (7.39); 7.457 (7.88); 7.453 (8.82); 7.421 (2.94); 7.401 (2.87); Example H-NMR [CDCl3 at 300 Mhz] 7.393 (5.84); 7.373 (5.88); 7.365 (3.8); 7.345 (3.51); 7.3 (35.3); 7.139 (3.36); 7.134 (3.56); 7.111 (4.76); 7.108 (5.24); 7.084 (2.86); 7.08 (2.85); 6.946 (3.7); 6.942 (6.46); 6.937 (3.48); 6.918 (3.27); 6.914 (5.67); 6.91 (3.08); 1.6 (35.18); 0.049 (1.32); 0.038 (34.78); 0.027 (1.3) 7.652 (0.45); 7.414 (0.83); 7.4 (2.84); 7.395 (2.07); 7.386 (2.27); 7.376 (4.09); 7.366 (1.85); 7.358 (2.28); 7.338 (1); 7.3 (7.59); 7.274 (2.7); 7.27 (2.72); 7.127 (0.93); 7.123 (1.02); 7.1 IIa.16 (1.44); 7.096 (1.57); 7.073 (0.79); 7.068 (0.8); 6.889 (1.01); 6.885 (1.81); 6.881 (1.04); 6.862 (0.91); 6.857 (1.62); 6.853 (0.91); 3.107 (2.2); 2.863 (16); 2.047 (1.06); 1.607 (3.56); 0.038 (7.28) 8.667 (1.28); 8.193 (1.27); 8.165 (1.44); 8.082 (1.23); 8.054 (1.42); 7.796 (0.6); 7.791 (0.69); 7.773 (1.1); 7.768 (1.44); 7.745 (0.96); 7.741 (0.9); 7.702 (1.23); 7.678 (1.46); 7.651 (0.68); 7.305 (6.67); 7.215 (0.73); 7.195 (0.78); 7.188 (1.68); 7.167 (1.69); 7.16 (1.06); 7.139 (0.98); IIa.17 6.961 (0.98); 6.957 (1.09); 6.934 (1.59); 6.93 (1.75); 6.907 (0.84); 6.903 (0.87); 6.439 (1.01); 6.435 (1.85); 6.43 (1.15); 6.411 (0.95); 6.407 (1.72); 2.629 (16); 1.659 (5.22); 1.531 (0.87); 1.318 (0.36); 1.298 (1.55); 1.288 (0.84); 1.279 (0.47); 1.255 (0.35); 0.126 (1.36); 0.114 (32.76); 0.102 (1.25); 0.043 (4.69) 8.094 (1.44); 8.064 (1.41); 7.696 (0.62); 7.691 (1.36); 7.688 (1.4); 7.682 (1.15); 7.674 (0.78); 7.669 (2.05); 7.66 (2.1); 7.655 (1.75); 7.644 (1.33); 7.64 (0.64); 7.536 (1.1); 7.532 (1.14); 7.513 (0.84); 7.508 (1.54); 7.486 (0.6); 7.482 (0.59); 7.371 (1.12); 7.364 (3.73); 7.351 (0.85); 7.344 IIa.18 (1.62); 7.323 (1.62); 7.316 (1.04); 7.302 (4.09); 7.295 (1.1); 7.088 (0.92); 7.083 (0.99); 7.06 (1.47); 7.056 (1.57); 7.033 (0.78); 7.029 (0.79); 6.831 (1); 6.826 (1.77); 6.822 (1.01); 6.803 (0.91); 6.799 (1.6); 6.795 (0.9); 2.798 (16); 2.745 (0.34); 0.124 (0.34); 0.112 (8.71); 0.1 (0.34); 0.04 (3.93) 8.253 (6.5); 8.225 (7.63); 8.188 (0.38); 8.16 (0.41); 8.092 (0.83); 7.849 (0.41); 7.844 (0.42); 7.82 (0.49); 7.773 (3.45); 7.768 (3.92); 7.75 (5.18); 7.745 (7.76); 7.739 (6.03); 7.735 (5.84); 7.731 (5.37); 7.723 (3.72); 7.718 (6.34); 7.707 (9.76); 7.682 (0.54); 7.668 (1.94); 7.655 (6.53); 7.629 (5.59); 7.605 (2.38); 7.462 (0.47); 7.441 (6.13); 7.434 (16); 7.421 (3.82); 7.414 (7.76); 7.393 (7.22); 7.386 (4.88); 7.366 (4.32); 7.344 (6.5); 7.303 (10.28); 7.254 (0.65); 7.236 (0.46); IIa.19 7.164 (13.77); 7.158 (5.23); 7.154 (4.65); 7.13 (7.14); 7.127 (7.01); 7.104 (3.78); 7.099 (3.52); 7.074 (1.26); 7.055 (0.83); 7.019 (0.5); 7.006 (5.47); 7.002 (8.24); 6.998 (4.41); 6.985 (7.59); 6.979 (5.25); 6.974 (7.43); 6.97 (4.11); 6.964 (0.94); 6.956 (0.41); 6.953 (0.36); 6.936 (0.5); 6.921 (0.61); 6.913 (0.52); 6.894 (0.81); 6.889 (0.46); 6.88 (0.68); 6.874 (0.65); 2.653 (4.35); 1.671 (12.51); 1.237 (1.05); 1.226 (7.18); 1.147 (3.7); 1.134 (0.43); 0.118 (0.92); 0.053 (0.37); 0.042 (9.69) 7.442 (1.15); 7.436 (1.3); 7.415 (2.68); 7.409 (2.46); 7.399 (0.33); 7.393 (0.69); 7.386 (3.51); 7.374 (3.61); 7.363 (2.96); 7.347 (3.62); 7.342 (1.54); 7.32 (1.41); 7.312 (0.35); 7.302 (1.29); IIa.20 7.222 (2.75); 7.217 (2.66); 7.011 (1.91); 7.006 (1.92); 6.984 (1.65); 6.979 (1.61); 2.861 (16); 2.079 (0.9); 1.774 (0.39); 1.293 (0.5); 0.032 (1.11) 8.089 (1.44); 8.073 (0.33); 8.06 (1.39); 7.689 (0.67); 7.684 (1.2); 7.679 (1.26); 7.674 (1.1); 7.661 (1.9); 7.652 (1.89); 7.647 (1.68); 7.637 (1.28); 7.632 (0.54); 7.53 (1.1); 7.527 (1.07); 7.508 (0.85); 7.502 (1.54); 7.48 (0.6); 7.477 (0.56); 7.412 (1.04); 7.407 (1.17); 7.385 (2.12); IIa.21 7.38 (2.06); 7.372 (0.41); 7.366 (0.34); 7.354 (0.33); 7.336 (2.01); 7.329 (0.86); 7.315 (3.54); 7.309 (3.58); 7.302 (4.86); 7.282 (1.24); 6.949 (1.65); 6.944 (1.67); 6.922 (1.43); 6.917 (1.44); 4.197 (0.41); 4.173 (1.24); 4.149 (1.26); 4.126 (0.43); 2.804 (16); 2.086 (5.69); 1.69 (2.33); 1.323 (1.52); 1.299 (3.05); 1.275 (1.48); 0.039 (3.45) 8.119 (8.17); 8.098 (2.93); 8.075 (0.61); 7.819 (0.34); 7.767 (2.35); 7.742 (3.12); 7.738 (3.28); 7.718 (1.26); 7.713 (1.43); 7.695 (2.6); 7.69 (2.52); 7.668 (2.51); 7.662 (1.88); 7.648 (2.6); 7.644 (2.61); 7.621 (2.67); 7.597 (0.96); 7.474 (0.5); 7.464 (0.7); 7.454 (0.61); 7.304 (40.56); IIa.22 7.289 (1.25); 7.282 (2.61); 7.262 (2.54); 7.254 (1.89); 7.234 (1.91); 7.193 (3.94); 7.165 (2.53); 7.135 (2.48); 7.124 (0.35); 7.111 (0.49); 7.104 (0.34); 7.097 (0.59); 7.076 (0.6); 7.07 (0.35); 6.954 (6.51); 6.864 (1.82); 6.859 (1.68); 6.837 (3.44); 6.832 (3.07); 6.81 (1.7); 6.805 (1.49); Example H-NMR [CDCl3 at 300 Mhz] 6.773 (2.55); 6.593 (0.66); 6.578 (0.49); 6.566 (0.65); 6.55 (0.79); 6.522 (0.41); 5.344 (16); 4.258 (0.34); 2.053 (0.44); 1.594 (42.05); 0.113 (0.52); 0.054 (1.39); 0.043 (40.32); 0.032 (1.52) 8.988 (15.67); 8.979 (16); 7.796 (8.56); 7.792 (9.47); 7.772 (10.17); 7.767 (10.99); 7.643 (0.68); 7.634 (7.23); 7.63 (7.97); 7.607 (11.12); 7.603 (10.85); 7.5 (11.2); 7.475 (11.84); 7.448 (6.61); 7.358 (7.94); 7.349 (8.81); 7.33 (20.09); 7.321 (21.54); 7.297 (54.56); 7.237 (5.63); 7.22 (6.1); IIa.23 7.207 (10.63); 7.19 (10.42); 7.145 (6.24); 7.135 (5.78); 7.12 (6.44); 7.115 (4.45); 7.11 (6.18); 7.105 (3.83); 7.09 (3.42); 7.08 (3.17); 2.392 (0.43); 1.597 (58.65); 1.29 (0.43); 1.218 (4.08); 1.14 (2.06); 0.046 (1.82); 0.035 (53.12); 0.024 (2.09) 7.463 (1.34); 7.435 (3.42); 7.416 (0.62); 7.407 (5.62); 7.393 (1.47); 7.384 (2.29); 7.381 (1.77); 7.362 (1.26); 7.331 (0.33); 7.302 (2.35); 7.298 (1.44); 7.293 (1.77); 7.284 (3.19); 7.28 (2.88); IIa.24 7.27 (0.94); 7.266 (1.12); 7.261 (0.77); 7.026 (1.93); 7.022 (1.9); 6.999 (1.73); 6.994 (1.65); 2.859 (16); 1.292 (0.35); 0.113 (5.64); 0.036 (1.67) 8.337 (0.44); 8.111 (1.54); 8.082 (1.49); 7.702 (0.66); 7.697 (1.31); 7.693 (1.39); 7.688 (1.17); 7.675 (1.96); 7.666 (2.04); 7.661 (1.73); 7.65 (1.27); 7.646 (0.6); 7.54 (1.13); 7.537 (1.11); IIa.25 7.518 (0.88); 7.512 (1.6); 7.49 (0.64); 7.487 (0.6); 7.415 (1.2); 7.387 (3.08); 7.377 (3.86); 7.36 (1.92); 7.302 (1.18); 7.259 (0.98); 7.254 (1.41); 7.25 (1.03); 7.231 (0.71); 7.226 (0.97); 7.222 (0.68); 6.964 (1.75); 6.96 (1.71); 6.936 (1.56); 6.932 (1.49); 2.8 (16); 0.119 (3.21); 0.039 (0.77) 8.874 (13.84); 7.751 (6.89); 7.746 (7.31); 7.724 (7.71); 7.719 (8.05); 7.617 (1.65); 7.596 (0.66); 7.585 (6.07); 7.564 (8); 7.56 (10.36); 7.554 (7.12); 7.538 (16); 7.527 (2.3); 7.509 (1.4); 7.503 (3.24); 7.498 (3.25); 7.478 (5.1); 7.476 (6.24); 7.474 (5.75); 7.471 (5.72); 7.452 (5.98); 7.447 IIb.01 (5.72); 7.37 (8.36); 7.364 (9.85); 7.342 (5.9); 7.337 (5.85); 7.3 (16.95); 7.288 (5.37); 7.283 (4.83); 7.264 (5.87); 7.262 (6.43); 7.258 (5.88); 7.257 (5.58); 7.237 (3.78); 7.232 (3.46); 3.32 (0.33); 2.084 (0.59); 1.614 (9.15); 1.322 (0.35); 1.293 (1.18); 0.11 (1.35); 0.049 (0.44); 0.038 (13.12); 0.027 (0.52) 7.737 (1.44); 7.732 (1.5); 7.71 (1.61); 7.705 (1.65); 7.503 (0.69); 7.498 (0.68); 7.48 (2.39); 7.476 (2.94); 7.471 (2.8); 7.467 (1.86); 7.453 (4.64); 7.447 (1.68); 7.437 (1.24); 7.392 (1.86); IIb.02 7.386 (2.11); 7.365 (1.19); 7.36 (1.1); 7.298 (2.23); 7.275 (1.07); 7.269 (0.98); 7.25 (1.21); 7.248 (1.3); 7.245 (1.21); 7.243 (1.12); 7.224 (0.79); 7.218 (0.72); 2.96 (16); 1.63 (2.84); 0.111 (1.48); 0.037 (2.01) 7.559 (1.18); 7.556 (1.17); 7.533 (1.35); 7.53 (1.34); 7.478 (1.49); 7.47 (1.78); 7.466 (2.54); IIb.03 7.449 (3.2); 7.435 (1.21); 7.332 (1.14); 7.33 (1.09); 7.304 (8.43); 7.185 (1.62); 7.159 (2.41); 7.133 (1.04); 2.981 (16); 2.262 (12.4); 1.609 (11.61); 0.113 (0.76); 0.042 (6.55) 7.535 (0.79); 7.53 (0.94); 7.522 (1.19); 7.515 (0.82); 7.506 (0.99); 7.502 (1.23); 7.498 (2.17); 7.489 (1.74); 7.484 (2.93); 7.469 (2.77); 7.464 (1.6); 7.455 (1.27); 7.302 (5.27); 7.294 (0.45); IIb.04 7.274 (1.85); 7.271 (1.87); 7.266 (1.43); 7.248 (4.38); 7.236 (1.38); 7.228 (1.34); 2.984 (16); 1.603 (5.63); 0.112 (0.61); 0.04 (4.75) 7.594 (1.55); 7.566 (1.7); 7.509 (0.33); 7.496 (2.58); 7.478 (1.63); 7.469 (0.84); 7.447 (0.76); 7.304 (8.62); 7.183 (1.24); 7.178 (1.35); 7.078 (0.75); 7.073 (0.71); 7.051 (0.67); 7.046 (0.61); IIb.06 .455 (0.63); 5.343 (0.85); 2.95 (10.32); 2.436 (7.9); 2.325 (1.3); 1.604 (16); 0.112 (0.82); 0.042 (7.6) 7.705 (1.4); 7.685 (1.39); 7.675 (1.5); 7.656 (1.47); 7.521 (1.65); 7.516 (1.81); 7.511 (2.01); 7.508 (1.6); 7.494 (3.58); 7.478 (1.15); 7.304 (18); 7.215 (1.38); 7.205 (1.51); 7.186 (1.37); IIb.07 7.176 (1.49); 7.053 (0.87); 7.044 (0.77); 7.027 (1.1); 7.024 (0.94); 7.018 (0.99); 7.014 (0.79); 6.998 (0.78); 6.988 (0.68); 2.959 (16); 1.598 (27.82); 0.112 (1.74); 0.053 (0.65); 0.042 (16.84); 0.031 (0.57) 7.664 (1.56); 7.636 (1.79); 7.522 (1.32); 7.516 (0.92); 7.51 (0.81); 7.498 (2.26); 7.479 (0.66); IIb.08 7.434 (0.77); 7.424 (1.6); 7.416 (1.74); 7.406 (0.85); 7.304 (10.23); 7.269 (0.98); 7.261 (0.92); Example H-NMR [CDCl3 at 300 Mhz] 7.241 (0.86); 7.233 (0.81); 7.086 (0.74); 7.078 (0.79); 6.876 (0.42); 6.869 (0.38); 6.848 (0.38); 6.84 (0.37); 5.613 (1.14); 5.344 (1.87); 2.952 (9.26); 1.6 (16); 0.112 (1); 0.053 (0.33); 0.042 (9.27); 0.032 (0.32) 7.539 (2.4); 7.496 (0.46); 7.487 (2.89); 7.473 (1.3); 7.464 (2.78); 7.441 (1.17); 7.305 (11.01); IIb.09 7.29 (0.34); 7.261 (2.59); 7.255 (6.17); 7.228 (0.33); 5.345 (0.91); 2.955 (16); 2.453 (13.05); 1.598 (11.44); 0.055 (0.37); 0.044 (10.89); 0.034 (0.41) 7.503 (0.91); 7.488 (3.47); 7.478 (1.45); 7.472 (1.55); 7.469 (1.56); 7.464 (2.12); 7.453 (1.24); 7.373 (0.91); 7.356 (0.92); 7.343 (1.36); 7.326 (1.38); 7.303 (25.85); 7.231 (0.8); 7.221 (0.7); IIb.10 7.205 (0.9); 7.201 (0.65); 7.195 (0.82); 7.191 (0.54); 7.175 (0.54); 7.166 (0.48); 5.343 (16); 2.956 (12.46); 2.052 (2.33); 1.591 (33.58); 0.112 (1.97); 0.053 (0.87); 0.042 (23.64); 0.031 (0.85) 7.737 (2.82); 7.729 (2.95); 7.51 (1.25); 7.494 (3.49); 7.476 (3.17); 7.472 (2.38); 7.468 (2.79); IIb.11 7.447 (2.14); 7.439 (2.05); 7.338 (3.64); 7.304 (27.4); 5.344 (2.06); 2.954 (16); 2.053 (0.77); 1.595 (43.11); 1.579 (0.36); 0.112 (0.38); 0.054 (0.93); 0.043 (24.76); 0.032 (0.93) 7.65 (0.33); 7.492 (0.53); 7.483 (2.91); 7.469 (1.25); 7.46 (2.9); 7.438 (1.21); 7.393 (1.04); 7.367 (2.55); 7.341 (1.99); 7.304 (55.38); 7.267 (1.56); 7.243 (0.93); 7.212 (1.5); 7.185 (1.09); IIb.12 6.953 (0.33); 5.63 (0.36); 5.344 (8.62); 2.968 (16); 2.531 (12.83); 2.443 (0.83); 2.053 (2.85); 1.596 (95.82); 0.112 (7.27); 0.054 (1.45); 0.043 (46.71); 0.032 (1.84) 7.48 (1.48); 7.474 (0.96); 7.466 (1); 7.462 (1.09); 7.455 (2.34); 7.435 (2.28); 7.407 (1.08); 7.304 IIb.13 (7.09); 7.024 (1.17); 7.02 (1.08); 6.997 (1.05); 6.992 (0.92); 6.943 (1.07); 6.939 (0.86); 6.915 (0.96); 6.911 (0.76); 4.009 (9.84); 3.934 (0.59); 2.964 (9.22); 1.607 (16); 0.042 (5.72) 8.829 (16); 8.159 (0.38); 8.148 (3.46); 8.142 (2.54); 8.136 (2.13); 8.124 (3.95); 8.116 (3.9); 8.102 (0.46); 7.787 (2.1); 7.779 (2.93); 7.765 (2.76); 7.759 (3.87); 7.754 (5.88); 7.743 (1.03); 7.735 (1.61); 7.728 (2.44); 7.712 (5.67); 7.705 (5.04); 7.7 (5.68); 7.689 (7.85); 7.678 (3.87); IIb.14 7.674 (4.31); 7.667 (3.81); 7.651 (1.48); 7.645 (1.02); 7.474 (2.07); 7.453 (2.24); 7.446 (4.98); 7.426 (5.02); 7.418 (3.22); 7.398 (3.06); 7.3 (4.83); 7.213 (3.09); 7.209 (5.7); 7.204 (3.88); 7.186 (3.05); 7.181 (8.03); 7.177 (5.24); 7.154 (5.44); 7.15 (4.61); 7.127 (2.57); 7.122 (2.28); 1.672 (4.31); 1.304 (0.45); 1.298 (0.45); 0.921 (0.47); 0.116 (7.82); 0.04 (4.97) 8.886 (16); 7.631 (1.52); 7.608 (1.09); 7.599 (4.82); 7.576 (4.89); 7.567 (5.13); 7.563 (6.25); 7.559 (5.13); 7.546 (7.3); 7.544 (9.06); 7.532 (1.39); 7.528 (1.88); 7.511 (1.45); 7.485 (2.55); 7.465 (2.85); 7.458 (5.09); 7.438 (6.1); 7.43 (3.91); 7.41 (3.66); 7.298 (11.19); 7.2 (2.79); 7.196 IIb.15 (5.65); 7.192 (4.16); 7.187 (8.55); 7.182 (3.24); 7.173 (7); 7.168 (6.89); 7.16 (7.14); 7.156 (2.98); 7.145 (3.55); 7.141 (2.62); 1.607 (14.27); 0.12 (0.77); 0.108 (16.99); 0.096 (0.66); 0.046 (0.41); 0.036 (9.57); 0.025 (0.37) 7.496 (1.26); 7.488 (1.07); 7.481 (3.53); 7.467 (2.17); 7.463 (2.39); 7.46 (2.77); 7.453 (1.69); 7.44 (1.68); 7.433 (1.14); 7.413 (1); 7.298 (2.83); 7.217 (0.97); 7.212 (1.81); 7.208 (1.33); 7.19 IIb.16 (1.94); 7.185 (2.26); 7.181 (1.08); 7.163 (1.68); 7.158 (1.44); 7.136 (0.83); 7.131 (0.75); 2.961 (16); 1.618 (2.91); 1.296 (0.37); 0.11 (1.13); 0.036 (2.58) 8.048 (0.97); 8.04 (0.73); 8.035 (0.77); 8.023 (0.72); 8.016 (1.14); 7.723 (0.75); 7.716 (0.6); 7.706 (0.93); 7.7 (0.86); 7.691 (1.5); 7.653 (0.5); 7.638 (1.85); 7.633 (1.91); 7.63 (1.51); 7.62 (2.5); 7.609 (1.13); 7.605 (1.42); 7.602 (1.19); 7.477 (0.59); 7.457 (0.65); 7.45 (1.43); 7.429 IIb.17 (1.44); 7.422 (0.94); 7.402 (0.89); 7.298 (2); 7.242 (0.94); 7.238 (1.73); 7.234 (1.06); 7.215 (0.77); 7.21 (1.35); 7.206 (0.79); 7.172 (0.91); 7.168 (0.81); 7.145 (1.49); 7.141 (1.38); 7.118 (0.73); 7.113 (0.68); 2.914 (16); 1.656 (1.69); 0.113 (2.02); 0.039 (2.09) 7.51 (0.97); 7.503 (1.51); 7.501 (1.44); 7.485 (4.18); 7.478 (2.4); 7.47 (2.62); 7.465 (1.68); IIb.18 7.458 (1.5); 7.448 (1.82); 7.421 (2.87); 7.394 (1.25); 7.302 (6.27); 7.301 (6.11); 7.294 (1.92); Example H-NMR [CDCl3 at 300 Mhz] 7.273 (1.26); 7.267 (1.21); 2.962 (16); 1.599 (5.86); 0.112 (0.83); 0.041 (5.46) .183 (0.63); 8.922 (16); 8.022 (9.45); 8 (9.45); 7.706 (1.61); 7.681 (1.56); 7.674 (4.52); 7.65 (4.77); 7.642 (3.59); 7.62 (7.75); 7.615 (4.4); 7.603 (5.34); 7.598 (4.17); 7.589 (1.67); 7.583 IIb.19 (1.89); 7.571 (1.32); 7.567 (1.58); 7.41 (9.77); 7.38 (9.69); 7.304 (28.2); 5.343 (3.36); 1.598 (29.49); 1.306 (0.62); 0.923 (0.6); 0.111 (1.51); 0.052 (1.03); 0.041 (27.89); 0.03 (1.06) 7.881 (0.53); 7.853 (0.62); 7.727 (0.55); 7.721 (0.58); 7.557 (0.39); 7.55 (0.39); 7.529 (0.34); IIb.20 7.523 (0.41); 7.51 (0.48); 7.492 (0.81); 7.304 (6.36); 2.968 (3.21); 1.603 (16); 0.111 (1.34); 0.041 (4.53) .185 (0.63); 9.013 (0.44); 8.995 (16); 7.982 (5.15); 7.963 (5.33); 7.952 (5.67); 7.933 (5.49); 7.68 (1.64); 7.654 (1.68); 7.648 (4.74); 7.623 (4.57); 7.616 (3.53); 7.592 (3.85); 7.583 (4.14); 7.577 (3.89); 7.566 (4.48); 7.561 (3.92); 7.551 (1.82); 7.545 (2.07); 7.534 (1.4); 7.529 (1.77); IIb.21 7.304 (67.59); 7.244 (5.64); 7.218 (6.51); 7.214 (5.72); 7.188 (5.15); 6.953 (0.42); 5.344 (1.09); 1.595 (103.18); 1.303 (0.76); 0.924 (0.79); 0.112 (5.84); 0.053 (2.57); 0.042 (64.52); 0.032 (2.37) 7.718 (0.66); 7.708 (0.78); 7.696 (0.91); 7.686 (1.25); 7.639 (0.43); 7.621 (2.7); 7.618 (2.37); IIb.22 7.612 (1.41); 7.596 (1.23); 7.525 (0.67); 7.502 (0.67); 7.493 (0.64); 7.487 (0.85); 7.483 (0.69); 7.472 (0.93); 7.468 (1.26); 7.304 (7.77); 2.974 (9.1); 1.604 (16); 0.041 (6.69) 7.548 (1.15); 7.522 (1.63); 7.519 (1.72); 7.508 (1.21); 7.493 (3.23); 7.49 (4.29); 7.478 (1.39); IIb.23 7.471 (1.74); 7.466 (2.34); 7.372 (4.02); 7.347 (2.38); 7.344 (2.47); 7.304 (12.58); 2.972 (16); 1.592 (9.63); 0.053 (0.42); 0.043 (13.16); 0.032 (0.46) 8.679 (15.79); 8.67 (15.95); 8.039 (5.85); 8.034 (6.54); 8.009 (7.34); 7.622 (5.59); 7.617 (4.95); 7.614 (4.31); 7.597 (8.96); 7.59 (8.62); 7.567 (0.4); 7.532 (2.6); 7.526 (3.52); 7.509 (8.03); 7.503 (6.38); 7.499 (3.36); 7.484 (16); 7.477 (14.19); 7.457 (5.96); 7.453 (6.46); 7.434 (2.54); 7.43 (2.02); 7.3 (16.48); 7.232 (6.86); 7.228 (7.61); 7.206 (7.83); 7.202 (8.81); 7.181 (3.9); IVa.01 7.176 (3.6); 7.156 (18.92); 7.149 (16.01); 7.13 (5.71); 7.125 (4.98); 6.928 (8.64); 6.924 (10.31); 6.901 (7.53); 6.897 (8.08); 6.883 (6.19); 6.878 (5.12); 6.858 (9.07); 6.853 (7.98); 6.832 (4.27); 6.828 (3.84); 6.754 (11.03); 5.565 (6.67); 3.852 (5.68); 3.447 (0.44); 2.039 (1.99); 1.768 (0.55); 1.297 (0.64); 0.054 (0.54); 0.043 (17.12); 0.032 (0.6) 8.072 (1.37); 8.044 (1.31); 7.658 (2.56); 7.632 (3.96); 7.607 (1.13); 7.602 (0.7); 7.507 (1.06); 7.503 (1.1); 7.48 (1.35); 7.457 (0.59); 7.453 (0.58); 7.36 (3.64); 7.298 (2.07); 6.991 (0.62); IVa.02 6.984 (0.67); 6.967 (0.73); 6.959 (1.09); 6.943 (0.74); 6.94 (0.64); 6.925 (0.77); 6.76 (0.41); 6.732 (1.34); 6.716 (1.85); 6.711 (2.89); 6.703 (1.68); 6.697 (2.8); 6.683 (0.44); 3.896 (1.71); 2.816 (16); 0.113 (0.48); 0.038 (2.07) 8.97 (8.18); 8.961 (8.3); 7.473 (0.41); 7.464 (0.46); 7.442 (6.8); 7.438 (7.14); 7.434 (7.21); 7.431 (7.12); 7.415 (16); 7.407 (8.46); 7.402 (9.63); 7.37 (0.89); 7.3 (9.85); 7.169 (2.39); 7.164 (2.59); 7.143 (4.88); 7.139 (5.12); 7.118 (3.62); 7.114 (3.85); 7.019 (4.57); 7.015 (4.68); 6.992 IVa.03 (6.52); 6.988 (6.06); 6.957 (6.19); 6.952 (7.06); 6.93 (5.03); 6.925 (5.23); 6.861 (4.19); 6.856 (3.9); 6.836 (4.8); 6.834 (4.85); 6.831 (4.87); 6.81 (2.66); 6.804 (2.48); 3.87 (7.01); 1.659 (6.91); 0.11 (3.07); 0.048 (0.41); 0.037 (10.16); 0.026 (0.36) 8.962 (8.04); 8.953 (8.1); 7.492 (0.66); 7.467 (10.51); 7.461 (12.07); 7.456 (12.24); 7.452 (8.77); 7.447 (8.07); 7.442 (16); 7.425 (4.87); 7.395 (0.98); 7.3 (12.27); 7.028 (2.22); 7.02 IVa.04 (2.26); 7.003 (2.96); 6.995 (4.25); 6.988 (2.55); 6.967 (3.07); 6.962 (3); 6.817 (1.73); 6.812 (2.11); 6.789 (8.4); 6.781 (10.35); 6.764 (5.17); 6.756 (4.48); 6.737 (4.94); 6.729 (1.44); 6.71 (1.73); 3.91 (6.16); 1.641 (7.48); 0.109 (4.86); 0.047 (0.48); 0.036 (13.07); 0.025 (0.48) 7.356 (0.5); 7.35 (2.95); 7.346 (1.8); 7.337 (1.44); 7.325 (3.63); 7.307 (1.29); 7.3 (1.71); 7.254 IVa.05 (2.72); 7.249 (2.72); 7.164 (0.63); 7.159 (0.68); 7.137 (1.29); 7.134 (1.3); 7.113 (0.95); 7.108 (1.04); 6.962 (2.84); 6.957 (2.09); 6.94 (2.04); 6.935 (3.06); 6.931 (1.72); 6.86 (1.16); 6.855 Example H-NMR [CDCl3 at 300 Mhz] (1.08); 6.835 (1.25); 6.83 (1.29); 6.809 (0.64); 6.804 (0.61); 3.84 (2.27); 2.89 (16); 1.736 (0.59); 0.037 (1.48) 7.386 (3.57); 7.372 (1.48); 7.362 (2.83); 7.341 (1.26); 7.311 (3.62); 7.3 (25.35); 7.023 (0.63); 7.016 (0.66); 6.998 (0.76); 6.99 (1.13); 6.975 (0.75); 6.971 (0.64); 6.957 (0.76); 6.789 (0.44); IVa.06 6.761 (1.37); 6.744 (1.95); 6.738 (3.22); 6.726 (3.03); 6.711 (0.47); 3.872 (2.36); 2.88 (16); 1.592 (32.97); 0.049 (0.58); 0.038 (15.66); 0.028 (0.62) 8.064 (1.47); 8.034 (1.39); 7.627 (2.63); 7.622 (1.11); 7.604 (2.41); 7.6 (2.74); 7.596 (1.73); 7.58 (1.25); 7.575 (0.69); 7.481 (1.14); 7.477 (1.13); 7.459 (0.88); 7.453 (1.56); 7.431 (0.63); 7.427 (0.59); 7.304 (3.83); 7.137 (0.66); 7.132 (0.69); 7.11 (1.33); 7.107 (1.34); 7.086 (0.99); IVa.07 7.081 (1.07); 6.948 (3.01); 6.944 (3.08); 6.922 (3.16); 6.917 (3.28); 6.84 (1.21); 6.835 (1.09); 6.815 (1.3); 6.813 (1.27); 6.81 (1.27); 6.789 (0.63); 6.784 (0.61); 3.862 (1.75); 2.839 (16); 0.12 (1.7); 0.042 (0.91) 7.421 (0.49); 7.415 (0.54); 7.397 (0.55); 7.391 (0.59); 7.308 (0.33); 7.3 (0.81); 7.283 (0.55); 7.277 (0.52); 7.256 (0.42); 7.251 (0.37); 6.998 (0.47); 6.995 (0.45); 6.974 (0.8); 6.971 (0.76); 6.949 (0.36); 6.947 (0.34); 6.729 (0.79); 6.703 (0.72); 4.826 (2.25); 1.665 (1.22); 1.038 (0.35); IXa.04 1.031 (0.68); 1.027 (0.47); 1.012 (0.57); 1.004 (2.42); 0.981 (1.47); 0.899 (0.56); 0.894 (0.51); 0.874 (1.28); 0.869 (0.45); 0.864 (0.36); 0.848 (0.72); 0.846 (0.76); 0.346 (0.61); 0.335 (16); 0.324 (0.61); 0.182 (0.53); 0.049 (0.65) 8.897 (14.04); 8.889 (14.22); 7.771 (10.43); 7.766 (11.48); 7.762 (11.51); 7.758 (9.94); 7.591 (2.65); 7.574 (3.27); 7.569 (2.94); 7.557 (10.36); 7.546 (11.49); 7.538 (8.76); 7.534 (6.74); 7.525 (16); 7.516 (8.73); 7.505 (10.41); 7.496 (11.11); 7.485 (2.76); 7.477 (5.7); 7.463 (2.75); Va.01 7.298 (6.03); 7.183 (6.14); 7.18 (6.22); 7.154 (10.96); 7.151 (10.92); 7.125 (5.3); 7.122 (5.16); 6.894 (10.22); 6.869 (6.43); 6.865 (9.36); 2.07 (0.61); 1.71 (6.24); 1.285 (0.37); 0.104 (6.74); 0.024 (5.73) 7.655 (2.75); 7.651 (2.68); 7.523 (1.18); 7.504 (1.28); 7.495 (2.24); 7.488 (1.58); 7.475 (3.99); 7.469 (1.63); 7.467 (1.48); 7.454 (1.14); 7.446 (1.6); 7.444 (1.61); 7.423 (1.21); 7.414 (0.38); Va.02 7.392 (0.43); 7.3 (5.44); 7.163 (1.05); 7.16 (1.06); 7.134 (1.82); 7.131 (1.8); 7.105 (0.89); 7.102 (0.87); 6.77 (1.11); 6.766 (1.68); 6.762 (1.07); 6.742 (1.04); 6.738 (1.54); 6.734 (0.97); 5.338 (1.03); 2.772 (16); 1.618 (6.84); 0.036 (3.77) 8.931 (10.31); 8.922 (10.43); 8.121 (6.58); 8.116 (6.86); 8.094 (7.2); 8.088 (7.35); 7.713 (3.71); 7.708 (3.77); 7.688 (5.47); 7.686 (5.8); 7.683 (5.96); 7.68 (5.22); 7.661 (5.08); 7.655 (4.86); 7.586 (8.19); 7.581 (8.41); 7.577 (8.88); 7.572 (7.58); 7.532 (1.02); 7.513 (2.27); 7.504 (16); Va.03 7.491 (6.93); 7.481 (12.42); 7.46 (6.44); 7.453 (5.34); 7.449 (5.59); 7.428 (6.51); 7.426 (7.27); 7.424 (7.06); 7.422 (6.21); 7.401 (3.95); 7.397 (3.97); 7.298 (10.79); 7.228 (8.18); 7.224 (8.01); 7.2 (7.26); 7.196 (7.05); 2.077 (0.32); 1.653 (9.38); 0.106 (2.37); 0.042 (0.44); 0.031 (10.9); 0.02 (0.37) 8.144 (1.47); 8.138 (1.51); 8.116 (1.61); 8.111 (1.61); 7.709 (0.79); 7.704 (0.79); 7.684 (1.27); 7.682 (1.35); 7.679 (1.37); 7.657 (1.09); 7.651 (1.04); 7.446 (1.12); 7.442 (1.17); 7.413 (3.37); Va.04 7.407 (2.11); 7.402 (1.86); 7.387 (5.99); 7.381 (3.41); 7.372 (1.59); 7.341 (0.34); 7.3 (12.83); 7.163 (1.8); 7.16 (1.76); 7.136 (1.65); 7.132 (1.57); 2.849 (16); 1.602 (8.26); 0.048 (0.39); 0.038 (8.79); 0.027 (0.42) 8.85 (11.05); 8.84 (11.18); 8.193 (5.64); 8.164 (6.43); 7.818 (5.29); 7.797 (12.25); 7.791 (16); 7.78 (4.45); 7.761 (5.91); 7.757 (6.85); 7.752 (3.54); 7.733 (4.88); 7.728 (3.96); 7.655 (4.91); 7.651 (5.06); 7.628 (6.89); 7.624 (4.38); 7.605 (2.68); 7.601 (2.62); 7.503 (3.3); 7.483 (3.54); Va.05 7.475 (7.39); 7.455 (7.4); 7.446 (4.35); 7.426 (4.12); 7.3 (8.33); 7.136 (4.36); 7.133 (4.54); 7.107 (7.39); 7.104 (7.51); 7.078 (3.81); 7.075 (3.76); 6.858 (4.67); 6.854 (7.03); 6.85 (4.67); 6.83 (4.32); 6.826 (6.44); 6.822 (4.23); 1.731 (6.41); 0.111 (3.2); 0.036 (8.64); 0.025 (0.38) Va.06 8.104 (1.27); 8.076 (1.57); 8.074 (1.48); 7.757 (1.31); 7.747 (1.08); 7.742 (0.87); 7.731 (2); Example H-NMR [CDCl3 at 300 Mhz] 7.724 (1.84); 7.719 (1.38); 7.714 (0.84); 7.696 (4.74); 7.578 (1.09); 7.575 (1.06); 7.552 (1.55); 7.528 (0.66); 7.524 (0.61); 7.469 (0.78); 7.449 (0.84); 7.44 (1.72); 7.42 (1.75); 7.412 (1); 7.392 (0.96); 7.3 (1.19); 7.105 (1.04); 7.102 (1.03); 7.076 (1.75); 7.073 (1.69); 7.047 (0.91); 7.044 (0.86); 6.725 (1.11); 6.721 (1.63); 6.717 (1.03); 6.696 (1.04); 6.692 (1.51); 6.688 (0.94); 2.704 (16); 1.862 (1.26); 0.032 (1.11) 8.875 (13.29); 8.865 (13.52); 8.182 (6.53); 8.153 (7.51); 8.102 (7.08); 8.097 (7.46); 8.075 (7.7); 8.07 (7.97); 7.769 (6); 7.748 (8.44); 7.743 (12.23); 7.725 (7.35); 7.72 (7.33); 7.715 (3.93); 7.697 (5.84); 7.692 (4.41); 7.665 (4.02); 7.659 (4.19); 7.64 (16); 7.631 (15.87); 7.623 (7.01); 7.619 Va.07 (6.75); 7.612 (6.04); 7.606 (5.77); 7.596 (8.05); 7.592 (5.09); 7.572 (3.09); 7.569 (3.01); 7.398 (5.17); 7.394 (5.57); 7.37 (7.76); 7.367 (6.69); 7.346 (4.17); 7.342 (4.22); 7.3 (13.25); 7.186 (8.74); 7.182 (8.7); 7.158 (7.75); 7.154 (7.66); 5.335 (0.56); 2.041 (0.37); 1.709 (10.32); 0.11 (3.34); 0.047 (0.49); 0.036 (13.62); 0.026 (0.47) 8.114 (1.46); 8.109 (1.64); 8.102 (1.56); 8.087 (1.74); 8.082 (1.79); 8.074 (1.3); 8.072 (1.41); 7.711 (0.71); 7.706 (1.03); 7.695 (1.19); 7.689 (1.76); 7.683 (2.06); 7.678 (0.81); 7.668 (1.68); 7.663 (2.17); 7.659 (1.84); 7.654 (1.26); 7.649 (0.93); 7.629 (1.2); 7.627 (1.27); 7.624 (1.29); Va.08 7.621 (1.09); 7.602 (1.09); 7.596 (1.04); 7.543 (1.08); 7.54 (1.09); 7.521 (0.87); 7.515 (1.59); 7.493 (0.64); 7.49 (0.63); 7.472 (3.58); 7.384 (1.06); 7.38 (1.11); 7.359 (1.24); 7.357 (1.53); 7.356 (1.47); 7.353 (1.27); 7.332 (0.89); 7.328 (0.85); 7.3 (3.64); 7.107 (1.71); 7.103 (1.67); 7.079 (1.55); 7.075 (1.49); 2.782 (16); 1.7 (4.88); 0.037 (2.79) 8.479 (1); 8.477 (1.03); 8.473 (1.06); 7.752 (0.74); 7.745 (0.76); 7.725 (0.84); 7.718 (0.86); 7.538 (0.71); 7.515 (0.94); 7.499 (1.6); 7.494 (1.44); 7.477 (0.79); 7.382 (0.51); 7.374 (0.42); XIa.01 7.359 (1.58); 7.333 (1.09); 7.304 (2.17); 4.507 (0.53); 4.436 (5.02); 1.629 (1.81); 0.746 (0.8); 0.735 (16); 0.723 (2.08); 0.042 (1.92) 7.551 (0.73); 7.544 (1); 7.536 (0.67); 7.528 (0.96); 7.519 (1.28); 7.512 (1.18); 7.508 (1.09); 7.482 (1.62); 7.422 (0.73); 7.417 (0.66); 7.409 (1.83); 7.405 (1.81); 7.398 (1.32); 7.391 (1.14); XIa.02 7.386 (0.99); 7.373 (0.48); 7.368 (0.55); 7.298 (4.52); 7.275 (0.72); 7.271 (0.63); 4.433 (4.84); 1.583 (5.72); 0.704 (0.59); 0.694 (16); 0.683 (0.68); 0.039 (4.03) 7.528 (0.62); 7.527 (0.62); 7.506 (1.47); 7.501 (1.72); 7.492 (0.74); 7.491 (0.73); 7.484 (1.11); 7.476 (1.34); 7.466 (0.47); 7.461 (0.49); 7.44 (0.99); 7.436 (0.99); 7.423 (0.54); 7.419 (0.53); 7.399 (0.8); 7.395 (0.73); 7.378 (0.53); 7.375 (0.57); 7.362 (2.18); 7.353 (0.95); 7.343 (0.99); XIa.03 7.339 (1.1); 7.322 (0.33); 7.31 (0.66); 7.305 (0.53); 7.286 (0.72); 7.281 (0.69); 7.243 (0.47); 6.809 (0.38); 6.808 (0.34); 4.41 (5.08); 1.523 (0.59); 1.265 (0.6); 0.881 (0.58); 0.654 (16); 0.643 (0.91); 0 (0.6) 7.7 (0.79); 7.698 (0.85); 7.685 (0.86); 7.683 (0.91); 7.58 (0.54); 7.558 (0.64); 7.555 (0.67); 7.522 (0.36); 7.5 (0.84); 7.496 (0.87); 7.482 (0.47); 7.478 (0.47); 7.458 (0.64); 7.454 (0.61); XIa.04 7.362 (0.46); 7.357 (0.46); 7.344 (0.79); 7.342 (0.9); 7.333 (1.56); 7.305 (1.51); 7.261 (0.81); 7.25 (0.7); 7.246 (0.82); 7.235 (0.6); 4.544 (4.77); 1.597 (2.99); 0.777 (0.56); 0.766 (16); 0.755 (0.66); 0.05 (1.23) 7.583 (0.48); 7.58 (0.5); 7.559 (0.6); 7.555 (0.64); 7.516 (0.41); 7.504 (1.77); 7.497 (1.18); 7.491 (0.95); 7.482 (0.72); 7.476 (2.36); 7.452 (0.67); 7.447 (0.61); 7.426 (0.37); 7.418 (0.71); 7.41 (0.33); 7.393 (1.18); 7.39 (1.14); 7.371 (0.42); 7.365 (1.52); 7.36 (0.61); 7.34 (0.65); 7.335 XIa.05 (0.62); 7.304 (2.68); 7.19 (0.49); 7.166 (0.78); 7.141 (0.34); 7.097 (1.1); 7.093 (1.37); 7.086 (0.38); 7.071 (0.69); 7.067 (1.12); 7.065 (0.97); 7.05 (0.32); 7.042 (1.99); 7.036 (0.65); 7.02 (0.57); 7.014 (1.71); 4.484 (4.69); 1.59 (3.56); 0.704 (0.59); 0.694 (16); 0.683 (0.66); 0.048 (2.55) 7.559 (0.52); 7.535 (0.64); 7.532 (0.65); 7.498 (0.85); 7.492 (0.94); 7.486 (0.82); 7.48 (1.45); 7.474 (0.53); 7.463 (0.84); 7.459 (1.25); 7.452 (2.34); 7.446 (0.48); 7.438 (0.32); 7.391 (2.43); XIa.06 7.385 (0.64); 7.37 (0.97); 7.364 (1.58); 7.346 (0.61); 7.34 (0.56); 7.304 (0.81); 4.438 (4.76); 1.595 (1.21); 0.707 (0.67); 0.696 (16); 0.685 (0.62); 0.052 (0.75) Example H-NMR [CDCl3 at 300 Mhz] 2.503 (40.74); 8.849 (0.52); 8.162 (16); 8.015 (11.05); 7.992 (12.55); 7.809 (3.07); 7.806 (2.98); 7.792 (4.47); 7.788 (5); 7.77 (2.92); 7.767 (3.15); 7.684 (3.95); 7.682 (3.85); 7.664 (5.19); 7.646 VIIa.01 (2.41); 7.644 (2.64); 7.511 (2.32); 7.491 (5.2); 7.473 (5.22); 7.453 (2.56); 7.13 (2.55); 7.124 (5.07); 7.118 (3.45); 7.099 (6.69); 7.093 (4.6); 7.079 (4.83); 7.074 (3.37); 7.058 (2.32); 7.054 (1.69); 7.009 (0.35); 6.99 (4.59); 6.984 (4.16); 6.969 (4.15); 6.964 (3.75); 3.486 (0.41); 3.415 (1.88); 3.359 (563.3); 2.677 (0.36); 2.512 (43.27); 2.508 (55.8) 4.595 (5.17); 4.172 (2.77); 1.632 (0.35); 1.612 (7.11); 1.447 (16.57); 1.423 (33.47); 1.4 (16); 1.302 (0.61); 0.125 (0.78); 0.121 (1.05); 0.058 (0.43); 0.047 (12.42); 0.036 (0.42); 7.901 (4.46); 7.873 (5.48); 7.672 (4.45); 7.65 (7.37); 7.645 (8.3); 7.626 (4.67); 7.622 (4.98); 7.617 (2.66); 7.599 (3.36); 7.594 (2.65); 7.566 (14.03); 7.546 (0.64); 7.456 (0.33); 7.448 (3.71); 7.444 (3.75); VIIa.02 7.434 (0.53); 7.421 (5.56); 7.418 (3.57); 7.398 (2.53); 7.394 (2.52); 7.377 (2.19); 7.366 (0.35); 7.355 (2.56); 7.349 (4.87); 7.327 (4.97); 7.322 (3.11); 7.304 (12.88); 7.3 (3.55); 6.917 (1.63); 6.914 (1.87); 6.909 (1.98); 6.906 (2.19); 6.887 (3.83); 6.879 (7.26); 6.87 (4.46); 6.862 (1.87); 6.859 (2.06); 6.851 (4.56); 6.843 (3.93); 6.829 (0.42); 6.821 (3.35); 6.813 (4.65); 6.806 (1.97); 6.796 (0.39); 6.788 (3.21); 6.78 (4.82); 6.772 (2.12); 4.666 (4.98); 4.642 (15.74); 4.619 (15.97) 8.057 (1.23); 8.03 (1.2); 7.679 (2.4); 7.654 (3.36); 7.629 (0.92); 7.624 (0.55); 7.492 (0.96); 7.489 (0.89); 7.466 (1.27); 7.442 (0.62); 7.439 (0.56); 7.419 (3.45); 7.392 (0.63); 7.387 (1.13); 7.364 (1.06); 7.359 (0.71); 7.337 (0.64); 7.304 (1.95); 6.96 (0.43); 6.958 (0.45); 6.952 (0.52); VIIa.03 6.95 (0.5); 6.931 (1.89); 6.923 (2.19); 6.903 (1.24); 6.895 (1.82); 6.874 (0.76); 6.866 (1.06); 6.858 (0.45); 6.841 (0.72); 6.833 (1.07); 6.825 (0.48); 3.002 (0.33); 2.744 (16); 1.616 (1.81); 0.048 (1.76) 8.096 (0.33); 8.069 (0.39); 7.717 (0.34); 7.692 (0.5); 7.682 (0.45); 7.677 (0.38); 7.564 (0.95); VIIa.04 7.522 (0.4); 7.384 (0.36); 7.362 (0.4); 7.3 (7.66); 6.853 (0.33); 6.826 (0.32); 6.807 (0.35); 6.774 (0.38); 2.739 (4.27); 1.61 (16); 0.039 (5.49) 8.804 (16); 8.797 (15.96); 8.138 (9.46); 8.117 (10.23); 7.739 (8.32); 7.719 (10.35); 7.69 (5.26); 7.687 (5.12); 7.673 (7.98); 7.669 (10.22); 7.666 (5.46); 7.652 (7.23); 7.648 (6.89); 7.64 (14.18); 7.634 (13.75); 7.577 (7.23); 7.574 (7.05); 7.557 (10.29); 7.539 (4.39); 7.537 (4.09); 7.377 (4.19); 7.361 (5.34); 7.357 (9.21); 7.34 (9.38); 7.336 (5.83); 7.32 (4.9); 7.258 (22.46); 7.25 VIIa.05 (5.82); 7.19 (1.06); 7.186 (0.72); 7.169 (2.35); 7.151 (3.08); 7.132 (1.48); 6.924 (3.65); 6.922 (3.9); 6.918 (4.22); 6.916 (4.16); 6.903 (6.74); 6.901 (7.25); 6.897 (7.77); 6.895 (7.67); 6.882 (10.03); 6.876 (11.51); 6.861 (6.2); 6.856 (7.67); 6.833 (6.2); 6.827 (8.97); 6.821 (4.32); 6.808 (5.93); 6.802 (9.03); 6.796 (4.31); 6.659 (2.6); 6.654 (2.95); 6.653 (2.93); 6.636 (4.08); 6.632 (3.9); 6.613 (6.22); 6.61 (5.49); 6.59 (4.25); 6.585 (3.21); 6.579 (1.16); 1.649 (8.11); 1.183 (2.5); 1.11 (0.74); 1.104 (3.72); 0.008 (1.21); 0 (20.49); -0.008 (1.03) 8.693 (8.3); 8.671 (8.31); 8.471 (16); 8.466 (15.73); 8.042 (0.54); 7.951 (0.39); 7.932 (0.4); 7.75 (6.74); 7.732 (9.16); 7.729 (9.5); 7.702 (3.61); 7.698 (4); 7.685 (7.28); 7.681 (7.9); 7.677 (4.2); 7.663 (7.08); 7.659 (5.81); 7.645 (7.2); 7.642 (7.52); 7.625 (7.85); 7.608 (2.94); 7.605 (2.69); VIIa.06 (1) 7.493 (0.37); 7.407 (3.63); 7.39 (4.67); 7.386 (7.97); 7.37 (8.13); 7.366 (5.19); 7.349 (4.25); 7.341 (0.48); 7.263 (21.57); 7.244 (13.08); 7.239 (12.7); 6.971 (3.57); 6.965 (3.77); 6.95 (6.48); 6.944 (6.76); 6.93 (3.45); 6.924 (3.93); 6.916 (6.5); 6.911 (7.29); 6.895 (5.59); 6.89 (6.86); 6.867 (5.4); 6.861 (7.87); 6.856 (3.86); 6.843 (5.15); 6.837 (7.87); 6.832 (3.81); 5.298 (1.27); 1.717 (0.34); 1.677 (0.35); 1.64 (0.45); 1.256 (0.51); 0 (3.31) .257 (11.41); 10.255 (10.28); 10.106 (16); 10.105 (14.12); 8.979 (0.81); 8.974 (0.88); 8.965 (0.87); 8.959 (0.84); 8.907 (7.07); 8.898 (7.19); 8.28 (0.66); 8.253 (0.72); 8.192 (4.03); 8.164 (4.89); 7.91 (0.73); 7.883 (0.91); 7.823 (4.26); 7.818 (4.46); 7.807 (0.78); 7.798 (5.22); 7.792 II.01A (5.27); 7.784 (1.22); 7.755 (3.67); 7.743 (2.5); 7.738 (2.35); 7.728 (5.28); 7.72 (4.62); 7.715 (3.3); 7.71 (2); 7.692 (3.16); 7.687 (2.24); 7.649 (0.86); 7.646 (0.91); 7.624 (3.96); 7.621 (3.93); 7.598 (4.36); 7.574 (1.64); 7.57 (1.55); 7.539 (3.03); 7.537 (2.75); 7.513 (6.31); 7.501 (9.33); 7.494 (10.41); 7.487 (4.83); 7.476 (7.47); 7.47 (7.45); 7.393 (3.73); 7.367 (7.98); 7.342 (4.71); Example H-NMR [CDCl3 at 300 Mhz] 7.328 (0.35); 7.313 (5.4); 7.308 (5.79); 7.3 (19.08); 7.296 (9.66); 7.287 (4.48); 7.281 (4.35); 7.275 (4.7); 7.27 (4); 7.108 (1.17); 5.335 (0.7); 2.443 (2.24); 2.085 (0.71); 1.724 (1.95); 1.304 (0.43); 1.297 (0.66); 1.281 (0.4); 0.917 (0.32); 0.046 (0.43); 0.036 (13.14); 0.025 (0.45) .065 (0.81); 10.458 (14.23); 8.942 (3.46); 7.976 (4.12); 7.963 (3.89); 7.958 (4.32); 7.945 (5.22); 7.93 (0.98); 7.646 (1.78); 7.639 (2.06); 7.613 (9.32); 7.608 (12.38); 7.595 (16); 7.582 (4.78); 7.575 (3.45); 7.55 (5.59); 7.533 (3.7); 7.519 (1.7); 7.5 (1.24); 7.368 (1.16); 7.3 (332.81); II.01B 7.258 (1.04); 7.237 (1.2); 6.949 (1.95); 4.172 (0.87); 3.483 (0.83); 2.998 (1.75); 2.924 (1.73); 2.085 (2.85); 1.653 (1.61); 1.586 (433.23); 1.52 (1.42); 1.322 (0.91); 1.299 (2.47); 1.274 (0.89); 1.254 (0.95); 0.235 (1.91); 0.107 (1.5); 0.049 (13.71); 0.038 (331.49); 0.028 (13.11); -0.027 (1.08); -0.159 (1.61); -0.285 (0.87); -1.452 (0.9) 8.969 (1.19); 8.963 (1.22); 8.955 (1.26); 8.949 (1.24); 8.872 (6.7); 8.863 (6.73); 8.748 (0.34); 8.25 (0.98); 8.246 (0.96); 8.222 (1.04); 8.181 (1.32); 8.166 (3.26); 8.155 (1.63); 8.139 (3.69); 7.893 (1.02); 7.867 (1.38); 7.802 (0.75); 7.797 (0.72); 7.779 (1.1); 7.774 (1.5); 7.769 (0.72); 7.75 (1.1); 7.745 (0.93); 7.724 (2.92); 7.708 (2.6); 7.702 (4.43); 7.698 (4.57); 7.684 (4.01); 7.68 (3.39); 7.674 (1.95); 7.657 (3.1); 7.651 (2.2); 7.634 (1.1); 7.63 (1.05); 7.607 (1.65); 7.604 (1.09); 7.593 (3.13); 7.588 (3.17); 7.581 (0.93); 7.566 (3.74); 7.562 (2.36); 7.542 (1.57); 7.539 II.02A (1.44); 7.488 (1.44); 7.474 (1.45); 7.466 (1.41); 7.46 (1.7); 7.446 (6.4); 7.44 (10.96); 7.429 (5.72); 7.419 (16); 7.404 (1.25); 7.3 (34.16); 7.287 (0.72); 7.278 (8.31); 7.252 (6.2); 7.081 (4.87); 7.078 (5.03); 7.076 (5.32); 7.056 (4.04); 7.053 (3.96); 7.051 (4.04); 7.037 (0.72); 7.022 (3.58); 7.012 (3.76); 6.998 (6.97); 6.993 (6.68); 6.971 (4.83); 6.966 (4.25); 6.104 (1.39); 5.051 (0.6); 4.847 (5.32); 4.838 (5.33); 4.732 (7.51); 4.722 (7.46); 4.172 (0.48); 4.149 (0.52); 2.442 (2.86); 2.373 (1.2); 2.31 (1.44); 2.154 (1.89); 2.085 (2.34); 1.671 (10.92); 1.47 (11.75); 1.322 (0.71); 1.298 (1.69); 1.274 (1.05); 0.049 (1.21); 0.038 (30.44); 0.027 (1.08) .339 (0.98); 4.036 (0.71); 4.014 (1.84); 3.994 (1.92); 3.973 (0.81); 3.21 (1.35); 3.188 (2.65); 3.166 (1.23); 2.832 (9.37); 2.085 (1.34); 2.048 (2.15); 1.606 (16); 1.533 (0.81); 1.514 (1.67); 1.494 (0.78); 1.322 (0.51); 1.299 (1.23); 1.275 (0.4); 0.92 (0.68); 0.049 (0.59); 0.038 (16.51); 0.028 (0.68); 8.08 (0.85); 8.05 (0.81); 7.664 (0.41); 7.659 (0.65); 7.651 (0.73); 7.646 (0.84); II.03A 7.642 (0.61); 7.636 (1.2); 7.63 (0.54); 7.625 (1.06); 7.619 (1.12); 7.612 (0.89); 7.508 (0.64); 7.504 (0.65); 7.486 (0.53); 7.48 (0.92); 7.458 (0.36); 7.362 (0.69); 7.336 (1.57); 7.309 (1.52); 7.3 (16.6); 7.253 (2.26); 7.242 (1.19); 7.222 (0.73); 7.216 (0.61); 6.983 (1.03); 6.978 (1); 6.957 (0.88); 6.951 (0.86) 17.544 (0.47); 9.388 (0.48); 8.833 (15.69); 8.824 (16); 8.1 (7.66); 8.073 (8.39); 7.842 (11.64); 7.833 (11.7); 7.739 (6.34); 7.717 (8.4); 7.712 (8.64); 7.653 (3.73); 7.648 (4.52); 7.63 (7.1); 7.625 (7.93); 7.62 (3.91); 7.603 (6.8); 7.598 (5.37); 7.572 (6.7); 7.568 (7.16); 7.545 (8.2); 7.522 (3.3); 7.518 (2.96); 7.481 (0.45); 7.366 (0.75); 7.327 (2.37); 7.312 (33.18); 7.3 (266.57); 7.293 (25.11); 7.266 (2.8); 7.227 (1.24); 7.213 (7.88); 7.202 (5.28); 7.194 (6.05); 7.183 (4.28); 7.17 (0.67); 6.949 (1.36); 6.392 (10.27); 6.004 (0.45); 4.938 (10.33); 4.894 (14.32); 4.873 (5.77); II.04A 4.861 (10.08); 4.85 (6.03); 4.688 (14.61); 4.644 (10.79); 4.05 (0.48); 4.037 (1.98); 4.027 (2.77); 4.01 (2.33); 3.999 (5.11); 3.99 (3.15); 3.972 (2.19); 3.961 (3.32); 3.673 (2.32); 3.654 (4.38); 3.639 (3.02); 3.617 (3.3); 3.603 (2.06); 3.562 (0.48); 3.458 (0.48); 2.016 (0.92); 1.972 (2.58); 1.947 (2.64); 1.92 (1.5); 1.888 (2.77); 1.878 (1.5); 1.857 (3.52); 1.846 (5.69); 1.835 (3.52); 1.804 (5.88); 1.789 (4.25); 1.746 (2.02); 1.733 (1.78); 1.717 (2.45); 1.703 (2.83); 1.687 (3.29); 1.666 (5.8); 1.653 (7.31); 1.64 (10.01); 1.624 (7.13); 1.599 (313.86); 0.233 (0.81); 0.117 (0.49); 0.105 (0.56); 0.049 (7.56); 0.038 (221.58); 0.027 (7.18); -0.029 (0.52); -0.161 (0.68) 8.889 (0.36); 8.88 (0.36); 7.432 (0.84); 7.424 (0.47); 7.417 (0.34); 7.41 (0.42); 7.3 (8.95); 5.004 (0.66); 4.994 (1.05); 4.987 (0.73); 4.978 (0.72); 4.885 (0.44); 4.863 (0.43); 4.855 (0.5); 4.847 (0.45); 4.654 (0.35); 4.609 (0.39); 4.603 (0.36); 3.956 (0.4); 3.946 (0.42); 3.932 (0.34); 3.919 (0.68); 3.908 (0.49); 3.897 (0.4); 3.884 (0.49); 3.62 (0.38); 3.594 (0.49); 3.582 (0.53); 3.576 II.05A (0.74); 3.564 (0.45); 3.558 (0.58); 3.544 (0.34); 3.538 (0.43); 3.534 (0.4); 1.943 (0.34); 1.925 (0.5); 1.912 (0.57); 1.899 (0.59); 1.888 (0.66); 1.875 (0.47); 1.866 (0.5); 1.854 (0.4); 1.844 (0.48); 1.834 (0.75); 1.824 (0.56); 1.804 (0.79); 1.792 (0.93); 1.783 (0.75); 1.766 (0.75); 1.734 (0.39); 1.724 (0.33); 1.703 (0.41); 1.695 (0.52); 1.67 (0.93); 1.658 (1.11); 1.653 (1.03); 1.641 Example H-NMR [CDCl3 at 300 Mhz] (1.06); 1.627 (1.42); 1.612 (16); 1.603 (2.38); 1.602 (2.4); 1.6 (2.4); 1.584 (2.14); 1.571 (1.29); 1.566 (1.14); 1.559 (0.73); 1.546 (0.48); 1.47 (0.49); 0.037 (7.23) 8.163 (1.72); 8.157 (0.66); 8.149 (0.85); 8.143 (3.4); 8.11 (1.67); 8.105 (3.03); 8.095 (2.92); 8.091 (5.57); 7.793 (3.52); 7.726 (0.58); 7.724 (0.58); 7.712 (0.69); 7.706 (1.2); 7.696 (1.07); II.06A 7.695 (1.07); 7.68 (0.85); 7.666 (0.86); 7.66 (1.06); 7.646 (0.97); 7.641 (0.58); 7.627 (0.46); .753 (0.54); 3.309 (1.51); 3.026 (1.58); 2.742 (16); 2.508 (1.59); 2.505 (2.15); 2.502 (1.61); 1.228 (0.43); 0 (1.31) 9.38 (11.61); 9.375 (11.9); 8.514 (9.06); 8.51 (9.21); 8.222 (6.09); 8.205 (6.8); 7.935 (6.02); 7.918 (6.97); 7.911 (4.35); 7.908 (3.9); 7.897 (5.06); 7.894 (7.23); 7.891 (3.85); 7.88 (4.23); II.07A 7.877 (3.74); 7.754 (4.3); 7.752 (7.93); 7.74 (2.82); 7.736 (8.53); 7.673 (4.31); 7.67 (4.38); 7.656 (7.43); 7.642 (3.52); 7.64 (3.44); 7.544 (2.35); 7.542 (2.45); 7.532 (3.01); 7.527 (9.02); 7.515 (6.96); 7.513 (6.57); 7.494 (0.61); 7.485 (16); 7.47 (11.58); 7.468 (8.04); 7.456 (3.3); 7.452 (2.62); 7.288 (27.45); 5.325 (0.57); 1.6 (11.08); 1.217 (0.9) 8.082 (1.11); 8.053 (1.02); 7.67 (0.56); 7.665 (0.83); 7.656 (0.92); 7.65 (1.04); 7.642 (1.58); 7.636 (0.67); 7.629 (1.33); 7.624 (1.51); 7.617 (1.21); 7.512 (0.84); 7.508 (0.85); 7.49 (0.69); 7.484 (1.19); 7.462 (0.47); 7.459 (0.44); 7.373 (0.92); 7.347 (1.98); 7.321 (1.64); 7.3 (15.12); II.08A 7.257 (2.76); 7.24 (1.3); 7.235 (1.39); 7.214 (0.89); 7.209 (0.84); 7 (1.25); 6.995 (1.21); 6.974 (1.1); 6.968 (1.06); 5.339 (0.53); 3.878 (1.77); 3.854 (3.97); 3.83 (2.16); 3.385 (1.79); 3.361 (3.21); 3.337 (1.47); 2.827 (12.09); 1.609 (16); 0.05 (0.6); 0.039 (15.3); 0.028 (0.58) 8.904 (14.15); 8.899 (14.16); 8.311 (11.78); 8.306 (11.6); 7.998 (14.31); 7.977 (16); 7.747 (4.37); 7.744 (4.43); 7.73 (6.34); 7.726 (8.11); 7.723 (4.8); 7.709 (4.56); 7.705 (4.7); 7.618 (5.53); 7.615 (5.5); 7.598 (8.33); 7.595 (6.33); 7.578 (3.92); 7.409 (2.82); 7.389 (6.58); 7.374 VII.01A (6.05); 7.37 (5.72); 7.354 (3.96); 7.325 (5.5); 7.321 (4.93); 7.301 (14.2); 7.298 (14.48); 7.28 (6.32); 7.093 (3.18); 7.088 (2.96); 7.072 (5.44); 7.068 (5.8); 7.05 (2.65); 7.046 (2.4); 6.36 (13.98); 6.349 (14.52); 6.018 (9.73); 6.009 (9.04); 3.322 (35.48); 2.508 (13.38); 2.504 (17.32); 2.499 (12.66); 1.991 (0.54); 0 (17.65); -0.008 (0.82) 9.845 (0.57); 9.225 (16); 9.219 (15.97); 8.788 (13.87); 8.783 (13.07); 8.223 (8.43); 8.204 (9.04); 8.154 (8.55); 8.133 (10.35); 7.974 (5.19); 7.97 (5.39); 7.957 (6.82); 7.953 (9.39); 7.95 (5.22); 7.936 (4.97); 7.932 (4.7); 7.761 (5.94); 7.758 (6.19); 7.741 (9.87); 7.723 (5.46); 7.721 (5.96); VII.02A 7.715 (4.29); 7.711 (3.81); 7.699 (15.85); 7.696 (13.86); 7.689 (12.87); 7.682 (13.67); 7.668 (9.34); 7.664 (7.81); 7.661 (7.58); 7.651 (3.55); 7.631 (3.71); 7.625 (4.84); 7.618 (2.86); 7.608 (5.9); 7.605 (5.61); 7.602 (4.89); 7.589 (2.57); 7.585 (2.85); 7.579 (1.9); 7.565 (1); 7.53 (0.33); 7.525 (0.39); 7.51 (0.4); 7.237 (0.32); 3.319 (41.41); 2.508 (14.62); 2.504 (18.84); 2.5 (13.81); 1.236 (0.88); 0 (9.85); -0.008 (0.48) 8.075 (15.43); 8.052 (4.15); 7.737 (2.95); 7.732 (2.61); 7.711 (4.93); 7.705 (4.75); 7.666 (1.37); 7.66 (1.84); 7.643 (4.08); 7.637 (3.22); 7.617 (7.9); 7.61 (6.77); 7.587 (3.37); 7.568 (1.14); 7.563 (0.96); 7.39 (1.78); 7.38 (0.43); 7.367 (2.28); 7.362 (3.9); 7.348 (0.78); 7.34 (4.24); 7.334 (2.61); 7.313 (2.64); 7.304 (14.74); 7.119 (4.13); 7.004 (6.73); 6.996 (4.39); 6.988 (3.74); 6.984 VII.03A (3.68); 6.981 (3.73); 6.968 (2.77); 6.96 (4.11); 6.953 (2.09); 6.938 (8.39); 6.838 (1.68); 6.835 (1.71); 6.83 (1.66); 6.827 (1.53); 6.81 (3.3); 6.807 (3.26); 6.802 (3.11); 6.782 (1.61); 6.78 (1.58); 6.774 (1.54); 6.756 (4.2); 6.502 (2.58); 1.616 (16); 0.117 (0.48); 0.056 (0.47); 0.045 (14.74); 0.034 (0.5) Note : in CDCl3 at 400 Mhz Note : in CDCl3 at 500 Mhz Note : in d6-DMSO at 400 Mhz : in d -DMSO at 300 Mhz Note 6 Note : in d -DMSO at 500 Mhz Example The following examples illustrate in a non-limiting manner the preparation and efficacy of the compounds of formula (I) according to the invention.
Preparation example 1 : preparation of 3-[2-(trimethylsilyl)phenoxy]quinoline (compound I.001) In a 5 mL microwave vial, 145 mg (0.68 mmol) of 3-bromoquinoline and 136 mg of 2-(trimethylsilyl)- phenol were dissolved in 4 mL of toluene. 300 mg (1.37 mmol) of potassium phosphate dihydrate were added, followed by 3 mg (0.014 mmol) of palladium (II) acetate and 9 mg (0.021 mol) of 2-di-tert-butyl- phosphino-2',4',6'-triisopropylbiphenyl. The mixture was heated under microwave [Biotage Initiator™] at 120 °C for 3 hours. The cooled reaction mixture was filtered off and the filtrate was diluted by ethyl acetate, washed by water and dried over magnesium sulfate. The organic phase was concentrated under vacuum to give 199 mg of the crude product as an orange oil. This residue was purified by preparative HPLC (gradient acetonitrile / water + 0.1% HCO2H) to yield 74 mg (37 % yield) of 3-[2- (trimethylsilyl)phenoxy]quinoline as a pale orange oil. LogP = 5.17 [Method A]. Mass (M+H) = 294.
Preparation example 2 : preparation of {2-[(7,8-difluoromethylquinolinyl)oxy]phenyl}(dimethyl)silanol (compound I.026) Step 1 : preparation of 7,8-difluoromethyl(2-nitrophenoxy)quinoline (compound Va.04) Under argon, 1 g (5.12 mmol) of 7,8-difluoromethylquinolinol and 723 mg (5.12 mmol) of 1-fluoro nitrobenzene were dissolved in 10 mL of DMF [N,N-dimethylformamide]. 1.10 g (5.63 mmol) of cesium carbonate was added and the reaction mixture was stirred at room temperature for 5 days. The reaction mixture was diluted by 500 mL of water. After 4 hours, the precipitate was filtered off and dried at 40 °C under vacuum to yield 1.33 g (82 %) of pure 7,8-difluoromethyl(2-nitrophenoxy)quinoline used as such in the next step. LogP = 3.37 [Method A]. Mass (M+H) = 317.
Step 2 : preparation of 2-[(7,8-difluoromethylquinolinyl)oxy]aniline (compound IVa.05) A 0.05 molar solution of 1.25 g (3.95 mmol) of 7,8-difluoromethyl(2-nitrophenoxy)quinoline in ethyl acetate was reduced in a H-Cube™ [Continuous-flow Hydrogenation Reactor] over a cartridge of 10% Pd/C at a speed of 1 mL / min. Solvent evaporation has given 1.13 g (95 %) of 2-[(7,8-difluoro methylquinolinyl)oxy]aniline as a solid of 95 % purity used as such in the next step. LogP = 2.99 [Method A]. Mass (M+H) = 287.
Step 3 : preparation of 3-(2-bromophenoxy)-7,8-difluoromethylquinoline (compound IIa.07) To a suspension of 630 mg (4.40 mmol) of copper (I) bromide, 955 mg (11 mmol) of lithium bromide and 0.630 mL (4.76 mmol) of tert-butyl nitrite in 20 mL of dry acetonitrile gently warmed at 60 °C, was added dropwise over a period of 10 minutes, a solution of 1.05 g (3.66 mmol) of 2-[(7,8-difluoro methylquinolinyl)oxy]aniline in 20 mL of dry acetonitrile. After addition, the reaction mixture was stirred for further 30 minutes. The cooled reaction mixture was diluted by ethyl acetate and filtered over a cake of diatomaceous earth. The organic phase was concentrated under vacuum and the residue was purified by 40 column chromatography on silica gel (gradient n-heptane/ethyl acetate) to yield 0.90 g (70 %) of 3-(2- bromophenoxy)-7,8-difluoromethylquinoline as a viscous oil which solidified. LogP = 4.25 [Method A].
Mass (M+H) = 350.
Step 4 : preparation of {2-[(7,8-difluoromethylquinolinyl)oxy]phenyl}(dimethyl)silanol (compound I.026) In a dried Radleys vial under argon, a mixture of 250 mg (0.71 mmol) of 3-(2-bromophenoxy)-7,8- difluoromethylquinoline, 21 mg (0.071 mmol) of biphenylyl(di-tert-butyl)phosphine [Johnphos], 6.3 mg (0.036 mmol) of palladium (II) chloride and 0.37 mL (2.14 mmol) of N,N-diisopropylethylamine in 1.5 mL of dry NMP [N-methylpyrrolidone], was heated at 80 °C for 10 minutes. After further addition of 295 mg (1.42 mmol) of 1,2-diethoxy-1,1,2,2-tetramethyldisilane, the tube was sealed and stirred at 80 °C for 20 hours. To the cooled reaction mixture, were then added 1 mL of acetonitrile and 2 mL of an aqueous 1M acetic acid solution. The reaction mixture was vigorously stirred at room temperature for 2 hours. The reaction mixture was extracted by ethyl acetate (3 x 50 mL), and the organic extracts were washed by water then brine and dried over sodium sulfate. The organic phase was concentrated under vacuum and the residue was purified by column chromatography on silica gel (gradient n-heptane/ethyl acetate) to yield 101 mg (41 %) of {2-[(7,8-difluoromethylquinolinyl)oxy]phenyl}(dimethyl)silanol as a solid. LogP = 3.51 [Method A]. Mass (M+H) = 346.
Preparation example 3 : preparation of N-(1,1-dimethyl-1,3-dihydro-2,1-benzoxasilolyl)quinolin amine (compound I.010) Step 1 : preparation of 2-[(2-bromoiodobenzyl)oxy]tetrahydro-2H-pyran To a solution of 3.15 g (10 mmol) of (2-bromoiodophenyl)methanol and 1.5 g (15 mmol) of 3,4-dihydro- 2H-pyran in 15 mL of a 2:1 mixture of dichloromethane : tetrahydrofuran, were added 25 mg (0.1 mmol) of pyridinium p-toluenesulfonate. The reaction mixture was stirred at room temperature for 3 days.
Solvents were removed under vacuum and the residue was dissolved in 200 mL of dichloromethane. The organic phase was washed by an aqueous saturated solution of NaHCO3, dried and concentrated under vacuum to give 4.35 g (87 %) of 2-[(2-bromoiodobenzyl)oxy]tetrahydro-2H-pyran as a viscous oil of 80 % purity used as such in the next step. GC-mass analysis : (M) = 396.
Step 2 : preparation of N-{2-bromo[(tetrahydro-2H-pyranyloxy)methyl]phenyl}quinolinamine (compound II.04A) In a dried Radleys vial sealed under argon, a mixture of 300 mg (2.03 mmol) of quinolinamine, 962 mg (1.93 mmol) of 2-[(2-bromoiodobenzyl)oxy]tetrahydro-2H-pyran, 127 mg (0.105 mmol) of 4,5- bis(diphenylphosphino)-9,9-dimethylxanthene [Xantphos] and 93 mg (0.102 mmol) of tris(dibenzylidene- acetone)dipalladium(0), were heated at 90 °C for 6 hours. The cooled reaction mixture was diluted by ethyl acetate and filtered over a cake of diatomaceous earth. The organic phase was concentrated under vacuum and the residue was purified by column chromatography on silica gel (gradient n-heptane/ethyl acetate) to yield 556 mg (66 %) of N-{2-bromo[(tetrahydro-2H-pyranyloxy)-methyl]phenyl}quinolin amine as a solid. LogP = 4.13 [Method B]. Mass (M+H) = 413. 40 Step 3 : preparation of N-(1,1-dimethyl-1,3-dihydro-2,1-benzoxasilolyl)quinolinamine (compound I.010) In a dried Radleys vial under argon, a mixture of 250 mg (0.60 mmol) of N-{2-bromo[(tetrahydro-2H- pyranyloxy)methyl]phenyl}quinolinamine, 18 mg (0.06 mmol) of biphenylyl(di-tert-butyl)- phosphine, 5.3 mg (0.03 mmol) of palladium (II) chloride and 0.42 mL (2.42 mmol) of N,N-diisopropyl- ethylamine in 1.5 mL of dry NMP, was heated at 80 °C for 10 minutes. After further addition of 374 mg (1.81 mmol) of 1,2-diethoxy-1,1,2,2-tetramethyldisilane, the tube was sealed and stirred at 80 °C for 36 hours. To the cooled reaction mixture, were then added 1 mL of acetonitrile and 2 mL of an aqueous 1M acetic acid solution. The reaction mixture was vigorously stirred at room temperature for 2 hours. The reaction mixture was extracted by ethyl acetate (3 x 50 mL), and the organic extracts were washed by water then brine and dried over sodium sulfate. The organic phase was concentrated under vacuum and the residue was purified by column chromatography on silica gel (gradient n-heptane/ethyl acetate) to give 150 mg of a viscous oil. This oily residue was dissolved in 40 mL of methanol and 230 mg (1.21 mmol) of 4-toluenesulfonic acid monohydrate were added. The reaction mixture was further stirred at room temperature for 4 days. The solvent was removed under vacuum and the residue was diluted by dichloromethane. The organic phase was washed by an aqueous saturated solution of NaHCO , dried and concentrated under vacuum to give 16 mg of a viscous oil. Purification by preparative HPLC (gradient acetonitrile / water + 0.1% HCO2H) yields 4 mg (2 % yield) of N-(1,1-dimethyl-1,3-dihydro-2,1- benzoxasilolyl)-quinolinamine as a viscous oil. LogP = 3.15 [Method B]. Mass (M+H) = 307.
Preparation example 4 : preparation of 3-[3-fluoro(1-methylsiletanyl)phenoxy]quinoline (compound I.008) To a solution of 100 mg (0.39 mmol) of 3-(3-fluorophenoxy)quinoline in 4 mL of tetrahydrofuran [THF] were added 122 mg (0.99 mmol) of 1-chloromethylsiletane in solution in 4 mL of THF. The reaction mixture was cooled to -78 °C and 0.218 mL of a 2M solution of lithium diisopropylamine [LDA] in THF was slowly added. The reaction mixture was further stirred at -78 °C for 4 hours. The reaction mixture was brought up to room temperature, diluted by water and extracted by ethyl acetate. The organic phase was washed by water, dried over magnesium sulfate and concentrated under vacuum to give 170 mg of the crude product as an orange oil. This residue was purified by preparative HPLC (gradient acetonitrile / water + 0.1% HCO H) to yield 30 mg (23 % yield) of 3-[3-fluoro(1-methylsiletanyl)phenoxy]- quinoline as an orange oil. LogP = 5.39 [Method A]. Mass (M+H) = 324.
Preparation example 5 : preparation of 3-{2-[(4-chlorophenyl)(dimethyl)silyl]benzyl}quinoline (compound I.014) Step 1 : preparation of [2-(bromomethyl)phenyl](4-chlorophenyl)dimethylsilane (compound XIa.06) To a mixture of 390 mg (1.40 mmol) of {2-[(4-chlorophenyl)(dimethyl)silyl]phenyl}methanol and 156 mg (1.55 mmol) of triethylamine in 10 mL of dichloromethane, were added 313 mg (1.4 mmol) of methanesulfonyl bromide. The reaction mixture was stirred for 4 hours at room temperature. Solvents were removed under vacuum, the residue was dissolved in a minimum amount of dichloromethane and purified by column chromatography on silica gel (n-heptane/ethyl acetate 95/5) to yield 399 mg (79 %) of 40 [2-(bromomethyl)-phenyl](4-chlorophenyl)dimethylsilane as a solid. LogP = 5.94 [Method A]. GC-mass analysis : (M-CH ) = 323.
Step 2 : preparation of 3-{2-[(4-chlorophenyl)(dimethyl)silyl]benzyl}quinoline (compound I.014) In a 5 mL microwave vial, 100 mg (0.57 mmol) of 3-quinolylboronic acid were dissolved together with 196 mg (0.57 mmol) of [2-(bromomethyl)phenyl](4-chlorophenyl)dimethylsilane in 3 mL of 1dioxane. 239 mg (1.73 mmol) of potassium carbonate in solution in 1 mL of water were added, and the reaction mixture been degassed with argon for a few minutes. 33 mg (0.029 mmole) of tetrakis(triphenyl- phosphine)palladium(0) were further added and the mixture was heated under microwave at 80 °C for 10 min. The cooled reaction mixture was filtered over a ChemElut™ cartridge (3 g) and the cartridge was further washed with 1dioxane. The organic extracts were concentrated under vacuum and the residue was purified by column chromatography on silica gel (n-heptane/ethyl acetate 90/10) to yield 161 mg (68 %) of 3-{2-[(4-chlorophenyl)(dimethyl)silyl]benzyl}quinoline. LogP = 4.74 [Method A]. Mass (M+H) = 388.
Preparation example 6 : preparation of 7,8-difluoro{3-fluoro[fluoro(dimethyl)silyl]phenoxy}methyl- quinoline (compound I.032) To a solution of 200 mg (0.519 mmol) of {2-[(7,8-difluoromethylquinolinyl)oxy]fluorophenyl}- (dimethyl)silanol in 2 mL in dry THF, was added in one portion, 0.066 mL (0.519 mmol) of boron trifluoride diethyl etherate. The reaction mixture was stirred for 30 minutes and allowed to stand overnight at room temperature. The reaction mixture was diluted by a saturated aqueous solution of sodium bicarbonate and extracted by dichloromethane. The organic extracts were dried over sodium sulfate and the organic phase was concentrated under vacuum to give 275 mg of a viscous oil. This residue was purified by preparative HPLC (gradient acetonitrile / water + 0.1% HCO H). Fractions were added to a saturated aqueous solution of sodium bicarbonate and extracted by dichloromethane. The combined organic extracts were dried over sodium sulfate and concentrated under vacuum to give 96 mg (45 %) of 7,8- difluoro{3-fluoro[fluoro(dimethyl)silyl]phenoxy}methylquinoline as an oil of 90 % purity. LogP = 4.75 [Method A]. Mass (M+H) = 366.
Preparation example 7 : preparation of 2-chloro{3-fluoro[methyl(phenyl)silyl]phenoxy}quinoline (compound I.062) Step 1 : preparation of 3-(3-fluorophenoxy)quinoline (compound VIIa.05) In a 10 mL microwave vial, 1 g (4.71 mmol) of 3-bromoquinoline, 0.566 g (4.94 mmol) of 3-fluorophenol and 174 mg (0.94 mmol) of dipivaloylmethane were dissolved in 5 mL of N,N-dimethylacetamide. 1 g (5.18 mmol) of copper(I) iodide and 1.697 g (5.18 mmol) of cesium carbonate were further added and the mixture was heated under microwave at 200 °C for 1 hour. The experiment was repeated three times.
The combined reaction mixtures were diluted by ethyl acetate and filtered over a cake of diatomaceous earth. The organic phases were washed by water, dried over magnesium sulfate and concentrated under vacuum to give 6.76 g of a dark brown oil. This residue was purified by column chromatography on silica gel (n-heptane/ethyl acetate 95/5 to 85/15) to yield 3.03 g (64 %) of 3-(3-fluorophenoxy)quinoline as an 40 orange oil. LogP = 3.21 [Method A]. Mass (M+H) = 240.
Step 2 : preparation of 3-(3-fluorophenoxy)quinoline 1-oxide (compound VIIa.06) To a solution of 1.5 g (6.27 mmol) of 3-(3-fluorophenoxy)quinoline in 30 mL of chloroform, was slowly added at 0 °C, a solution of 1.80 g (6.27 mmol) of meta-chloroperoxybenzoic acid [60 % purity] in 30 mL of chloroform. The reaction mixture was stirred at room temperature for 90 minutes. The reaction mixture was poured over 100 mL of a 1M aqueous solution of sodium thiosulfate. The organic phase was separated, washed by water and dried over magnesium sulfate. Concentration under vacuum gave 2.40 g of an orange oil as a residue. This residue was purified by column chromatography on silica gel (n- heptane/ethyl acetate 65/35 to 50/50) to yield 1.30 g (78 %) of 3-(3-fluorophenoxy)quinoline 1-oxide as an orange oil which crystallizes. LogP = 2.14 [Method A]. Mass (M+H) = 256.
Step 3 : preparation of 2-chloro(3-fluorophenoxy)quinoline (compound VIIa.01) To a solution of 1.27 g (4.98 mmol) of 3-(3-fluorophenoxy)quinoline 1-oxide in 50 mL of dichloromethane, were added 182 mg (2.49 mmol) of DMF. The reaction mixture was cooled down to 0°C and 917 mg (5.98 mmol) of phosphorous oxychloride were slowly added at 0°C. The reaction mixture was further stirred at room temperature for 8 hours. The reaction mixture was poured over 150 mL of a saturated aqueous solution of sodium bicarbonate and extracted by dichloromethane. The organic extracts were combined and dried over magnesium sulfate. Concentration under vacuum gave 1.40 g of an orange oil.
This residue was purified by column chromatography on silica gel (n-heptane/ethyl acetate 80/20) to yield 1.27 g (93 %) of 2-chloro(3-fluorophenoxy)quinoline as an pale orange oil. LogP = 3.99 [Method A].
Mass (M+H) = 274.
Step 4 : preparation of 2-chloro{3-fluoro[methyl(phenyl)silyl]phenoxy}quinoline (compound I.062) To a solution of 100 mg (0.36 mmol) of 2-chloro(3-fluorophenoxy)quinoline in 4 mL of THF were added 153 mg (0.91 mmol) of chloro(methyl)phenylsilane in solution in 4 mL of THF. The reaction mixture was cooled to -78 °C and 0.365 mL of a 2M solution of LDA in THF was slowly added. The reaction mixture was further stirred at -78 °C for 7 hours. The reaction mixture was brought up to room temperature, diluted by water and extracted by ethyl acetate. The organic phase was washed by water, dried over magnesium sulfate and concentrated under vacuum to give 243 mg of a yellow oil. This residue was purified by column chromatography on silica gel (n-heptane/ethyl acetate 96/4) to yield 58 mg (38 %) of 2-chloro{3-fluoro[methyl(phenyl)silyl]phenoxy}quinoline as an pale orange oil. LogP = 5.78 [Method A]. Mass (M+H) = 394. Further purification of a second fraction yielded 17 mg (11%) of 2- chloro(3-fluorophenoxy)[methyl(phenyl)silyl]quinoline and 20 mg (13 %) of 6-chlorofluoro methylphenyl-12H-[1,4]benz-oxasilino[2,3-c]quinoline. LogP = 5.90 and 5.94 respectively [Method A].
Preparation example 8 : preparation of 2-methyl[2-(trimethylsilyl)phenoxy]quinoline (compound I.047) Step 1 : preparation of 1-[2-(trimethylsilyl)phenoxy]acetone (compound XIV.01) To a solution of 1 g (6 mmol) of 2-trimethylsilylphenol in 50 mL of acetone, were added 1.2 g (11.6 mmol) of chloroacetone [of 90 % purity] together with 100 mg (0.6 mmol) of potassium iodide and 1 g (7.21 mmol) of potassium carbonate. The reaction mixture was stirred at 50 °C for 7 hours. The cooled 40 reaction was filtered over a sintered glass, washed by ethyl acetate and the solvents further removed under vacuum. The orange oily residue of 1.29 g was purified by column chromatography on silica gel (n- heptane/dichloromethane 75/25) to yield 924 mg (66 %) of 1-[2-(trimethylsilyl)phenoxy]acetone as an orange oil. LogP = 1.39 [Method A]. GC-mass analysis : mass (M) = 322.
Step 2 : preparation of 2-methyl[2-(trimethylsilyl)phenoxy]quinoline (compound I.047) In a 5 mL microwave vial, 100 mg (0.45 mmol) of 1-[2-(trimethylsilyl)phenoxy]acetone were mixed together with 56 mg (0.45 mmol) of 2-aminobenzaldehyde in 5 mL of acetic acid. The mixture was heated under microwave at 120 °C for 8 hours. The cooled reaction mixture was poured over 100 mL of an aqueous solution of 7 g of potassium bicarbonate and extracted by ethyl acetate. The organic extracts were concentrated under vacuum to leave 198 mg of a brownish residue. This residue was purified by column chromatography on silica gel (n-heptane/ethyl acetate 97/3 to 90/10) to yield 40 mg (21 %) of 2- methyl[2-(trimethylsilyl)phenoxy]quinoline as an orange oil. LogP = 4.85 [Method A]. Mass (M+H) = 308.
In the following: CMP1 designates 7,8-difluoromethyl{2-[(trimethylsilyl)methyl]phenoxy}quinoline (prepared in accordance with the teaching of JP2014/166991).
CMP2 designates 8-chloro[4-fluoro(trimethylsilyl)phenoxy]quinoline (prepared in accordance with the teaching of EP 0326330).
CMP3 designates 7,8-difluoro[3-fluoro(trimethylsilyl)phenoxy]methylquinoline (prepared in accordance with the teaching of EP 0326330).
CMP4 designates 4-[3-fluoro(trimethylsilyl)-phenoxy]-1,5-naphthyridine (prepared in accordance with the teaching of EP 0410762).
Example A : in vitro cell test on Pyricularia oryzae Solvent: dimethyl sulfoxide Culture medium: 14.6 g anhydrous D-glucose (VWR), 7.1 g mycological peptone (Oxoid), 1.4 g granulated yeast extract (Merck), QSP 1liter Inoculum: spore suspension The tested compounds were solubilized in dimethyl sulfoxide and the solution used to prepare the required range of concentrations. The final concentration of dimethyl sulfoxide used in the assay was ≤ 1 %.
A spore suspension of Pyricularia oryzae was prepared and diluted to the desired spore density.
The compounds were evaluated for their ability to inhibit spore germination and mycelium growth in liquid culture assay. The compounds were added in the desired concentration to the culture medium with spores. After 5 days incubation, fungi-toxicity of compounds was determined by spectrometric measurement of mycelium growth. Inhibition of fungal growth was determined by comparing the absorbance values in wells containing the fungicides with the absorbance in control wells without 40 fungicides.
In this test the following compounds according to the invention showed efficacy between 70 % and 79 % at a concentration of 20 ppm of active ingredient: I.125.
In this test the following compounds according to the invention showed efficacy between 80 % and 89 % at a concentration of 20 ppm of active ingredient: I.010; I.042; I.099; I.118; I.121; I.122.
In this test the following compounds according to the invention showed efficacy between 90 % and 100 % at a concentration of 20 ppm of active ingredient: I.001; I.002; I.003; I.004; I.005; I.006; I.007; I.008; I.009; I.011; I.012; I.013; I.017; I.018; I.019; I.020; I.021; I.022; I.023; I.024; I.025; I.026; I.027; I.028; I.029; I.030; I.031; I.032; I.033; I.034; I.035; I.036; I.037; I.038; I.039; I.041; I.044; I.045; I.046; I.047; I.049; I.050; I.051; I.052; I.053; I.054; I.056; I.057; I.059; I.062; I.063; I.065; I.066; I.067; I.069; I.070; I.071; I.072; I.073; I.074; I.075; I.076; I.077; I.078; I.081; I.082; I.084; I.085; I.086; I.087; I.088; I.089; I.090; I.091; I.093; I.094; I.095; I.096; I.097; I.098; I.100; I.109; I.110; I.111; I.112; I.113; I.114; I.115; I.116; I.120; I.123; I.124; I.127; I.129.
In this test the following compound according to the invention showed efficacy between 90% and 100% at a concentration of 4 ppm of active ingredient: I.119.
In this test, compound I.024 showed efficacy of at least 80% when tested at a dose of 0.25 ppm or 0.06 ppm whereas CMP1 (structurally close compound, not according to the invention) showed much lower efficacy at the same doses as shown in table A1.
Table A1: Compound dose (ppm) Efficacy I.024 0.25 96 I.024 0.06 89 CMP1 0.25 56 CMP1 0.06 1 In this test, compounds I.019, I.027 and I.116 showed efficacy of at least 90% when tested at a dose of ppm or 4 ppm whereas the structurally close compounds CMP2, CMP3 and CMP4 (not according to the invention) showed much lower efficacy at a dose of 4 ppm, as shown in table A2.
Table A2: Efficacy Example 20 ppm 4 ppm 1 ppm I.019 97 98 45 CMP2 93 46 0 I.027 100 94 85 CMP3 96 25 0 I.116 100 100 90 CMP4 44 11 0 Example B : in vivo preventive test on Botrytis cinerea (grey mould) Solvent: 5 % by volume of dimethyl sulfoxide % by volume of acetone Emulsifier: 1 µL of Tween® 80 per mg of active ingredient The tested compounds were made soluble and homogenized in a mixture of dimethyl sulfoxide/acetone/ /Tween® 80 and then diluted in water to the desired concentration.
The young plants of gherkin were treated by spraying the tested compounds prepared as described above. Control plants were treated only with an aqueous solution of acetone/dimethyl sulfoxide/Tween® 80.
After 24 hours, the plants were contaminated by spraying the leaves with an aqueous suspension of Botrytis cinerea spores. The contaminated gherkin plants were incubated for 4 to 5 days at 17 °C and at 90 % relative humidity.
The test was evaluated 4 to 5 days after the inoculation. 0 % means an efficacy which corresponds to that of the control plants while an efficacy of 100 % means that no disease is observed.
In this test the following compounds according to the invention showed efficacy between 70 % and 79 % at a concentration of 500 ppm of active ingredient: I.013; I.033; I.096; I.116.
In this test the following compounds according to the invention showed efficacy between 80 % and 89 % at a concentration of 500 ppm of active ingredient: I.005; I.053; I.056; I.069; I.089.
In this test the following compounds according to the invention showed efficacy between 90 % and 100 % at a concentration of 500 ppm of active ingredient: I.006; I.020; I.021; I.022; I.023; I.024; I.025; I.026; I.027; I.028; I.029; I.030; I.031; I.032; I.037; I.040; I.046; I.047; I.049; I.054; I.055; I.071; I.078; I.079; I.080; I.081; I.082; I.084; I.085; I.086; I.087; I.088; I.090; I.094; I.095; I.097; I.098; I.099; I.100.
In this test, compounds I.027 and I.116 showed efficacy of at least 70% when tested at a dose of 500 ppm whereas the structurally close compounds CMP3 and CMP4 (not according to the invention) showed no efficacy at a dose of 500 ppm, as shown in table B.
Table B: Example dose (ppm) Efficacy I.027 500 92 CMP3 500 0 I.116 500 73 CMP4 500 0 Example C : in vivo preventive test on Leptosphaeria nodorum (wheat) Solvent: 49 parts by weight of N,N-dimethylacetamide Emulsifier: 1 part by weight of alkylaryl polyglycol ether To produce a suitable preparation of active compound, 1 part by weight of active compound was mixed with the stated amounts of solvent and emulsifier, and the concentrate was diluted with water to the desired concentration.
To test for preventive activity, young plants were sprayed with the preparation of active compound at the stated rate of application.
After the spray coating has been dried, the plants were sprayed with a spore suspension of Leptosphaeria nodorum. The plants remained for 48 hours in an incubation cabinet at approximately °C and a relative atmospheric humidity of approximately 100 %.
The plants were placed in the greenhouse at a temperature of approximately 25 °C and a relative atmospheric humidity of approximately 80 %.
The test was evaluated 8 days after the inoculation. 0 % means an efficacy which corresponds to that of the untreated control, while an efficacy of 100 % means that no disease is observed.
In this test the following compounds according to the invention showed efficacy between 90 % and 100 % at a concentration of 500 ppm of active ingredient: I.025; I.026; I.085.
Example D : in vivo preventive test on Septoria tritici (leaf spot on wheat) Solvent: 5 % by volume of dimethyl sulfoxide % by volume of acetone Emulsifier: 1 µL of Tween® 80 per mg of active ingredient The active compounds were made soluble and homogenized in a mixture of dimethyl sulfoxide/acetone/ /Tween® 80 and then diluted in water to the desired concentration.
The young plants of wheat were treated by spraying the active compound prepared as described above.
Control plants were treated only with an aqueous solution of acetone/dimethyl sulfoxide/Tween® 80.
After 24 hours, the plants were contaminated by spraying the leaves with an aqueous suspension of Septoria tritici spores. The contaminated wheat plants were incubated for 72 hours at 18 °C and at 100 % relative humidity and then for 21 days at 20 °C and at 90 % relative humidity.
The test was evaluated 24 days after the inoculation. 0 % means an efficacy which corresponds to that of the control plants while an efficacy of 100 % means that no disease is observed.
In this test the following compounds according to the invention showed efficacy between 70 % and 79 % at a concentration of 500 ppm of active ingredient: I.048; I.109; I.112; I.116.
In this test the following compounds according to the invention showed efficacy between 80 % and 89 % at a concentration of 500 ppm of active ingredient: I.024; I.033; I.051.
In this test the following compounds according to the invention showed efficacy between 90 % and 100 % at a concentration of 500 ppm of active ingredient: I.025; I.026; I.030; I.032; I.034; I.049; I.081; I.082; I.085; I.087; I.090; I.091; I.094; I.095; I.097; I.117.
Under the same conditions, high (at least 80%) protection was observed at a dose of 500 ppm of compound I.024, whereas no protection was observed with compound CMP1, as shown in table D : Table D: Compound dose (ppm) Efficacy I.024 500 81 CMP1 500 0 Example E : in vivo preventive test on Venturia test (apples) Solvent: 24.5 parts by weight of acetone 24.5 parts by weight of N,N-dimethylacetamide Emulsifier: 1 part by weight of alkylaryl polyglycol ether To produce a suitable preparation of active compound, 1 part by weight of active compound was mixed with the stated amounts of solvent and emulsifier, and the concentrate was diluted with water to the desired concentration.
To test for preventive activity, young plants were sprayed with the preparation of active compound at the stated rate of application. After the spray coating has dried on, the plants were inoculated with an aqueous conidia suspension of the causal agent of apple scab (Venturia inaequalis) and then remained for 1 day in an incubation cabinet at approximately 20 °C and a relative atmospheric humidity of 100 %.
The plants were then placed in a greenhouse at approximately 21 °C and a relative atmospheric humidity of approximately 90 %.
The test was evaluated 10 days after the inoculation. 0 % means an efficacy which corresponds to that of the untreated control, while an efficacy of 100 % means that no disease is observed.
In this test the following compounds according to the invention showed efficacy between 80 % and 89 % at a concentration of 250 ppm of active ingredient: I.031; I.032.
In this test the following compounds according to the invention showed efficacy between 90 % and 100 % at a concentration of 250 ppm of active ingredient: I.020; I.021; I.022; I.023; I.025; I.026; I.037; I.046; I.047; I.049; I.054; I.071; I.079; I.082; I.085; I.086; I.087; I.088; I.090.
Claims (17)
1. A compound of formula (I) 5 (I) wherein • A represents a partially saturated or unsaturated fused bicyclic 9-, 10- or 11-membered heterocyclyl ring comprising at least 1 nitrogen atom and from 0 to 4 more heteroatoms independently selected in the list consisting of N, O and S ; 10 • Z is selected from the group consisting of hydrogen atom, halogen atom, unsubstituted or substituted C -C -alkyl, C -C -halogenoalkyl comprising up to 9 halogen atoms that can be the 1 8 1 8 same or different, unsubstituted or substituted C2-C8-alkenyl, C2-C8-halogenoalkenyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C2-C8- alkynyl, C2-C8-halogenoalkynyl comprising up to 9 halogen atoms that can be the same or 15 different, unsubstituted or substituted C -C -cycloalkyl, unsubstituted or substituted C -C - 3 7 4 7 cycloalkenyl, hydroxyl, unsubstituted or substituted C -C -alkoxy, C -C -halogenoalkoxy 1 8 1 8 comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted aryl, unsubstituted or substituted heterocyclyl, formyl, unsubstituted or substituted C1-C8- alkylcarbonyl, unsubstituted or substituted (hydroxyimino)C1-C8-alkyl, unsubstituted or substituted 20 (C -C -alkoxyimino)C -C -alkyl, carboxyl, unsubstituted or substituted C -C -alkoxycarbonyl, 1 8 1 8 1 8 carbamoyl, unsubstituted or substituted C -C -alkylcarbamoyl, unsubstituted or substituted di-C - 1 8 1 C8-alkylcarbamoyl, amino, unsubstituted or substituted C1-C8-alkylamino, unsubstituted or substituted di-C1-C8-alkylamino, sulfanyl, unsubstituted or substituted C1-C8-alkylsulfanyl, unsubstituted or substituted C -C -alkylsulfinyl, unsubstituted or substituted C -C -alkylsulfonyl, 1 8 1 8 25 unsubstituted or substituted C -C -trialkylsilyl, cyano and nitro ; • n represents 0, 1, 2, 3 or 4 ; • p represents 0, 1, 2, 3, 4 or 5 ; 4 5 6 • L represents O, S, SO, SO2, CR R or NR wherein o R and R are independently selected from the group consisting of hydrogen atom, 30 halogen atom, hydroxyl, unsubstituted or substituted C1-C8-alkoxy and unsubstituted or substituted C -C alkyl, or they may form together with the carbon atom to which they are linked a carbonyl group ; o R is selected from the group consisting of hydrogen atom, substituted or non- substituted C1-C8-alkyl, C1-C8-halogenoalkyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C -C -alkenyl, C -C - 2 8 2 8 halogenoalkenyl comprising up to 9 halogen atoms that can be the same or different, 5 unsubstituted or substituted C -C -alkynyl, C -C -halogenoalkynyl comprising up to 9 3 8 3 8 halogen atoms that can be the same or different, unsubstituted or substituted C3-C7- cycloalkyl, C3-C7-halogenocycloalkyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C -C -cycloalkyl-C -C -alkyl, 3 7 1 8 formyl, unsubstituted or substituted C -C -alkylcarbonyl, C -C -halogenoalkylcarbonyl 1 8 1 8 10 comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C1-C8-alkoxycarbonyl, C1-C8-halogenoalkoxycarbonyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C1-C8- alkylsulfonyl, C -C -halogenoalkylsulfonyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted aryl-C -C -alkyl and 15 unsubstituted or substituted phenylsulfonyl ; • X is independently selected from the group consisting of halogen atom, unsubstituted or substituted C -C -alkyl, C -C -halogenoalkyl comprising up to 9 halogen atoms that can be the 1 8 1 8 same or different, unsubstituted or substituted C2-C8-alkenyl, C2-C8-halogenoalkenyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C2-C8- 20 alkynyl, C2-C8-halogenoalkynyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C -C -cycloalkyl, unsubstituted or substituted C -C - 3 7 4 7 cycloalkenyl, hydroxyl, unsubstituted or substituted C -C -alkoxy, C -C -halogenoalkoxy 1 8 1 8 comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted aryl, unsubstituted or substituted heterocyclyl, formyl, unsubstituted or substituted C1-C8- 25 alkylcarbonyl, unsubstituted or substituted (hydroxyimino)C1-C8-alkyl, unsubstituted or substituted (C -C -alkoxyimino)C -C -alkyl, carboxyl, unsubstituted or substituted C -C -alkoxycarbonyl, 1 8 1 8 1 8 carbamoyl, unsubstituted or substituted C -C -alkylcarbamoyl, unsubstituted or substituted di-C - 1 8 1 C8-alkylcarbamoyl, amino, unsubstituted or substituted C1-C8-alkylamino, unsubstituted or substituted di-C1-C8-alkylamino, sulfanyl, unsubstituted or substituted C1-C8-alkylsulfanyl, 30 unsubstituted or substituted C -C -alkylsulfinyl, unsubstituted or substituted C -C -alkylsulfonyl, 1 8 1 8 unsubstituted or substituted C -C -trialkylsilyl, cyano, nitro, hydroxymethyl and (tetrahydro-2H- pyranyloxy)methyl ; • Y is independently selected from the group consisting of halogen atom, unsubstituted or substituted C -C -alkyl, C -C -halogenoalkyl comprising up to 9 halogen atoms that can be the 1 8 1 8 35 same or different, unsubstituted or substituted C -C -alkenyl, C -C -halogenoalkenyl comprising 2 8 2 8 up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C2-C8- alkynyl, C2-C8-halogenoalkynyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C3-C7-cycloalkyl, unsubstituted or substituted C4-C7- cycloalkenyl, hydroxyl, unsubstituted or substituted C -C -alkoxy, C -C -halogenoalkoxy 1 8 1 8 40 comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted aryl, unsubstituted or substituted heterocyclyl, formyl, unsubstituted or substituted C1-C8- alkylcarbonyl, unsubstituted or substituted (hydroxyimino)C1-C8-alkyl, unsubstituted or substituted (C1-C8-alkoxyimino)C1-C8-alkyl, carboxyl, unsubstituted or substituted C1-C8-alkoxycarbonyl, carbamoyl, unsubstituted or substituted C -C -alkylcarbamoyl, unsubstituted or substituted di-C - 1 8 1 C -alkylcarbamoyl, amino, unsubstituted or substituted C -C -alkylamino, unsubstituted or 8 1 8 5 substituted di-C -C -alkylamino, sulfanyl, unsubstituted or substituted C -C -alkylsulfanyl, 1 8 1 8 unsubstituted or substituted C1-C8-alkylsulfinyl, unsubstituted or substituted C1-C8-alkylsulfonyl, unsubstituted or substituted C1-C6-trialkylsilyl, cyano and nitro ; • R is selected from the group consisting of unsubstituted or substituted C -C -alkyl, unsubstituted or substituted C2-C8-alkenyl, unsubstituted or substituted C2-C8-alkynyl, unsubstituted or 10 substituted C3-C7-cycloalkyl, unsubstituted or substituted C4-C7-cycloalkenyl, unsubstituted or substituted aryl and unsubstituted or substituted heterocyclyl ; • R is selected from the group consisting of hydroxyl, unsubstituted or substituted C -C -alkoxy, unsubstituted or substituted C1-C8-alkyl, unsubstituted or substituted C2-C8-alkenyl, unsubstituted or substituted C2-C8-alkynyl, unsubstituted or substituted C3-C7-cycloalkyl, unsubstituted or 15 substituted C -C -cycloalkenyl, unsubstituted or substituted aryl and unsubstituted or substituted heterocyclyl ; • When R and R represent an unsubstituted or substituted C1-C8 alkyl or an unsubstituted or substituted C2-C8 alkenyl, they can form, together with the silicon atom to which they are linked, an unsubstituted or substituted C -C -silacycloalkyl ring or an unsubstituted or substituted C -C - 3 8 4 8 20 silacycloalkenyl ring ; • R is selected from the group consisting of hydrogen atom, halogen atom, unsubstituted or substituted C -C -alkyl, C -C -halogenoalkyl comprising up to 9 halogen atoms that can be the 1 8 1 8 same or different, unsubstituted or substituted C -C -alkenyl, unsubstituted or substituted C -C - 2 8 2 8 alkynyl, unsubstituted or substituted C3-C7-cycloalkyl, unsubstituted or substituted C4-C7- 25 cycloalkenyl, hydroxyl, unsubstituted or substituted C1-C8-alkoxy, unsubstituted or substituted aryl, unsubstituted or substituted aryl-C1-C8-alkyl, unsubstituted or substituted heterocyclyl, unsubstituted or substituted heterocyclyl-C -C -alkyl, unsubstituted or substituted hydroxy-C -C - 1 8 1 8 alkyl, unsubstituted or substituted C -C -alkoxy-C -C -alkyl, unsubstituted or substituted C -C - 1 8 1 8 1 8 alkylcarbonyloxy-C1-C8-alkyl, unsubstituted or substituted aryloxy-C1-C8-alkyl, unsubstituted or 30 substituted heterocyclyloxy-C1-C8-alkyl, unsubstituted or substituted amino-C1-C8-alkyl, unsubstituted or substituted C -C -alkylamino-C -C -alkyl, unsubstituted or substituted di-C -C - 1 8 1 8 1 8 alkylamino-C -C -alkyl, unsubstituted or substituted arylamino-C -C -alkyl, unsubstituted or 1 8 1 8 substituted di-arylamino-C1-C8-alkyl, unsubstituted or substituted heterocyclylamino-C1-C8-alkyl, unsubstituted or substituted C1-C8-alkylcarbonylamino-C1-C8-alkyl, unsubstituted or substituted 35 C1-C8-alkoxycarbonylamino-C1-C8-alkyl, unsubstituted or substituted C1-C8-alkylsulfanyl-C1-C8- alkyl, unsubstituted or substituted C -C -alkylsulfinyl-C -C -alkyl, unsubstituted or substituted C - 1 8 1 8 1 C -alkylsulfonyl-C -C -alkyl and unsubstituted or substituted cyano-C -C -alkyl ; 8 1 8 1 8 3 1 2 3 • R and X, when said X is vicinal to SiR R R , may form, together with the silicon and carbon atoms to which they are respectively attached, an unsubstituted or substituted 5-, 6- or 7- 40 membered, partially saturated, heterocycle ; • When R represents an unsubstituted or substituted C -C -alkoxy and R represents an unsubstituted or substituted C -C -alkoxy or an unsubstituted or substituted C -C alkyl, they can 1 8 1 8 form, together with the silicon atom to which they are linked an unsubstituted or substituted 5-, 6- or 7-membered heterocycle ; 5 as well as its salts, N-oxides, metal complexes, metalloid complexes and optically active isomers or geometric isomers.
2. The compound according to claim 1 wherein Y is independently selected from the group consisting of halogen atom, substituted or unsubstituted C1-C6-alkyl, C1-C6-halogenoalkyl comprising up 10 to 9 halogen atoms that can be the same or different, unsubstituted or substituted C1-C6-alkoxy, C1-C6- halogenoalkoxy comprising up to 9 halogen atoms that can be the same or different and cyano.
3. The compound according to claim 1 or 2 wherein A is selected in the list consisting of : ( ) 1 2 3 (A ) (A ) (A ) 4 5 6 (A ) (A ) (A ) 7 8 9 (A ) (A ) (A ) 10 11 12 (A ) (A ) (A ) 13 14 15 (A ) (A ) (A ) 16 17 (A ) (A ) wherein : W is CY or N ; Q is O, S or NY with Y being a hydrogen atom or an unsubstituted or substituted C1-C8-alkyl ; 1 2 3 4 5 Y , Y , Y , Y and Y are independently a hydrogen atom or Y as recited in claim 1 or 2 ; 5 Z is as recited in claim 1 ; and m is 1, 2 or 3.
4. The compound according to any one of the preceding claims wherein Z is selected from the group consisting of hydrogen atom, halogen atom, hydroxyl, unsubstituted or substituted C1-C6-alkyl, C1- 10 C -halogenoalkyl comprising up to 9 halogen atoms that can be the same or different, unsubstituted or substituted C -C -alkoxy, C -C -halogenoalkoxy comprising up to 9 halogen atoms that can be the same 1 6 1 6 or different and cyano.
5. The compound according to any one of the preceding claims wherein X is independently a 15 halogen atom or an unsubstituted or substituted C -C -alkyl group.
6. The compound according to any one of the preceding claims wherein L is O or CH2.
7. The compound according to any one of the preceding claims wherein n is 0 or 1.
8. The compound according to any one of the preceding claims wherein : - R is an unsubstituted or substituted C1-C6-alkyl ; and/or - R is an unsubstituted or substituted C1-C6-alkyl ; and/or - R is selected from the group consisting of hydrogen atom, unsubstituted or substituted 25 C -C -alkyl, unsubstituted or substituted C -C -cycloalkyl, unsubstituted or substituted aryl, unsubstituted 1 6 3 7 or substituted aryl-C -C -alkyl, unsubstituted or substituted heterocyclyl, unsubstituted or substituted heterocyclyl-C1-C6-alkyl and hydroxyl.
9. The compound according to any one of the preceding claims wherein A is selected from the list 1 2 3 5 10 12 17 1 consisting of A , A , A , A , A , A and A as recited in claim 3, preferably wherein A is A .
10. The compound according to any one of the preceding claims wherein A represents a heterocycle 5 of formula (A ) as recited in claim 3 wherein : W is CY or N ; Y to Y independently represent a hydrogen atom, a fluorine atom or a methyl group ; and Z represents a hydrogen atom or a methyl group. 10
11. A composition comprising one or more compounds of formula (I) according to any one of claims 1 to 10 and one or more acceptable carriers.
12. A method for controlling unwanted phytopathogenic microorganisms which comprises the step of applying one or more compounds of formula (I) according to any one of claims 1 to 10 or a composition 15 according to claim 11 to the microorganisms and/or in their habitats.
13. A process for preparing a compound of formula (I) according to any one of claims 1 to 10 which comprises the step of : - reacting a halogenoaryl of formula (II) or one of its salts: (II) wherein A, L, n, p, X, Y and Z are as recited in any one claims 1 to 8 and U represents a chlorine atom, a bromine atom, an iodine atom, a mesyl group, a tosyl group or a triflyl group, with a disilyl derivative of formula (IIIa): (IIIa) 1 2 3 wherein R , R and R are as recited in claims 1 or 8 ; or - reacting a compound of formula (VI) or one of its salts: (VI) wherein A, L, n, p, X, Y and Z are as recited in any one claims 1 to 10 and M represents an alkali metal 5 that can be complexed by 1 to 2 ligands or a halogenomagnesium that can be complexed by 1 to 2 ligands, with a silyl derivative of formula (IIIb) or a silyl derivative of formula (IIIc): (IIIb) (IIIc) 1 2 3 2 wherein R , R and R are as recited in claims 1 or 8 and U represents a chlorine atom, a bromine atom, 10 an iodine atom or an unsubstituted or substituted C1-C6-alkoxy ; or - reacting a compound of formula (VIII) or one of its salts with a compound of formula (IX) : 15 (VIII) (IX) (I) wherein L represents O, S or NR ; U represents a chlorine atom, a bromine atom, an iodine atom, a mesyl group, a tosyl group or a triflyl group ; 1a 2a 20 R and R independently represent an unsubstituted or substituted C -C -alkyl, an unsubstituted or substituted C2-C8-alkenyl, an unsubstituted or substituted C3-C7-cycloalkyl, an unsubstituted or substituted aryl or an unsubstituted or substituted heterocyclyl ; and R represents a hydrogen atom, an unsubstituted or substituted C -C -alkyl, a C -C - 1 8 1 8 halogenoalkyl comprising up to 9 halogen atoms that can be the same or different, an unsubstituted or 25 substituted C2-C8-alkenyl, an unsubstituted or substituted C2-C8-alkynyl, an unsubstituted or substituted C3-C7-cycloalkyl, an unsubstituted or substituted C4-C7-cycloalkenyl, an unsubstituted or substituted aryl, an unsubstituted or substituted aryl-C1-C8-alkyl, an unsubstituted or substituted heterocyclyl, an unsubstituted or substituted heterocyclyl-C1-C8-alkyl, an unsubstituted or substituted hydroxy-C1-C8-alkyl, an unsubstituted or substituted C -C -alkoxy-C -C -alkyl, an unsubstituted or substituted C -C - 1 8 1 8 1 8 alkylcarbonyloxy-C -C -alkyl, an unsubstituted or substituted aryloxy-C -C -alkyl, an unsubstituted or 1 8 1 8 5 substituted heterocyclyloxy-C -C -alkyl, an unsubstituted or substituted amino-C -C -alkyl, an 1 8 1 8 unsubstituted or substituted C1-C8-alkylamino-C1-C8-alkyl, an unsubstituted or substituted di-C1-C8- alkylamino-C1-C8-alkyl, an unsubstituted or substituted arylamino-C1-C8-alkyl, an unsubstituted or substituted di-arylamino-C -C -alkyl, an unsubstituted or substituted heterocyclylamino-C -C -alkyl, an 1 8 1 8 unsubstituted or substituted C -C -alkylcarbonylamino-C -C -alkyl, an unsubstituted or substituted C -C - 1 8 1 8 1 8 10 alkoxycarbonylamino-C -C -alkyl, an unsubstituted or substituted C -C -alkylsulfanyl-C -C -alkyl, an 1 8 1 8 1 8 unsubstituted or substituted C1-C8-alkylsulfinyl-C1-C8-alkyl, an unsubstituted or substituted C1-C8- alkylsulfonyl-C1-C8-alkyl, or an unsubstituted or substituted cyano-C1-C8-alkyl ; and A, n, p, X, Y, R and Z are as recited in any one of claims 1 to 10 ; or 15 - reacting a compound of formula (X) or one of its salts with a compound of formula (XI) : (X) (XI) (I) 20 wherein L represents CR R ; R and R independently represent a hydrogen atom or an unsubstituted or substituted C -C alkyl ; U represents a bromine atom, a chlorine atom, an iodine atom, a mesyl group, a tosyl group or a triflyl group ; 25 W represents a boronic acid, a boronic ester or a potassium trifluoroborate; 1a 2a R and R independently represent an unsubstituted or substituted C -C -alkyl, an unsubstituted or substituted C2-C8-alkenyl, an unsubstituted or substituted C3-C7- cycloalkyl, an unsubstituted or substituted aryl or an unsubstituted or substituted heterocyclyl ; 30 R represents a hydrogen atom, an unsubstituted or substituted C -C -alkyl, a C -C - 1 8 1 8 halogenoalkyl comprising up to 9 halogen atoms that can be the same or different, an unsubstituted or substituted C -C -alkenyl, an unsubstituted or substituted C -C -alkynyl, 2 8 2 8 an unsubstituted or substituted C3-C7-cycloalkyl, an unsubstituted or substituted C4-C7- cycloalkenyl, an unsubstituted or substituted aryl, an unsubstituted or substituted aryl-C1- 35 C -alkyl, an unsubstituted or substituted heterocyclyl, an unsubstituted or substituted heterocyclyl-C -C -alkyl, an unsubstituted or substituted hydroxy-C -C -alkyl, an 1 8 1 8 unsubstituted or substituted C1-C8-alkoxy-C1-C8-alkyl, an unsubstituted or substituted C1- C8-alkylcarbonyloxy-C1-C8-alkyl, an unsubstituted or substituted aryloxy-C1-C8-alkyl, an unsubstituted or substituted heterocyclyloxy-C -C -alkyl, an unsubstituted or substituted amino-C -C -alkyl, an unsubstituted or substituted C -C -alkylamino-C -C -alkyl, an 1 8 1 8 1 8 5 unsubstituted or substituted di-C -C -alkylamino-C -C -alkyl, an unsubstituted or 1 8 1 8 substituted arylamino-C1-C8-alkyl, an unsubstituted or substituted di-arylamino-C1-C8- alkyl, an unsubstituted or substituted heterocyclylamino-C1-C8-alkyl, an unsubstituted or substituted C -C -alkylcarbonylamino-C -C -alkyl, an unsubstituted or substituted C -C - 1 8 1 8 1 8 alkoxycarbonylamino-C -C -alkyl, an unsubstituted or substituted C -C -alkylsulfanyl-C - 1 8 1 8 1 10 C -alkyl, an unsubstituted or substituted C -C -alkylsulfinyl-C -C -alkyl, an unsubstituted 8 1 8 1 8 or substituted C1-C8-alkylsulfonyl-C1-C8-alkyl or an unsubstituted or substituted cyano-C1- C8-alkyl ; and A, n, p, X, Y and Z are as recited in any one of claims 1 to 10 ; or 15 - reacting a compound of formula (VIII) or one of its salts with a compound of formula (XII) : (VIII) (XII) (I) 20 wherein L represents CR R ; R and R independently represent a hydrogen atom, an unsubstituted or substituted C -C - alkoxy or an unsubstituted or substituted C1-C8 alkyl ; U represents a bromine atom, a chlorine atom, an iodine atom , a mesyl group, a tosyl group or a triflyl group ; 25 W represents a boronic acid, a boronic ester or a potassium trifluoroborate; 1a 2a R and R independently represent an unsubstituted or substituted C -C -alkyl, an unsubstituted or substituted C2-C8-alkenyl, an unsubstituted or substituted C3-C7-cycloalkyl, an unsubstituted or substituted aryl or an unsubstituted or substituted heterocyclyl ; R represents a hydrogen atom, an unsubstituted or substituted C -C -alkyl, a C -C - 1 8 1 8 30 halogenoalkyl comprising up to 9 halogen atoms that can be the same or different, an unsubstituted or substituted C2-C8-alkenyl, an unsubstituted or substituted C2-C8-alkynyl, an unsubstituted or substituted C3-C7-cycloalkyl, an unsubstituted or substituted C4-C7-cycloalkenyl, an unsubstituted or substituted aryl, an unsubstituted or substituted aryl-C1-C8-alkyl, an unsubstituted or substituted heterocyclyl, an unsubstituted or substituted heterocyclyl-C -C -alkyl, an unsubstituted or substituted hydroxy-C -C -alkyl, 1 8 1 8 35 an unsubstituted or substituted C -C -alkoxy-C -C -alkyl, an unsubstituted or substituted C -C - 1 8 1 8 1 8 alkylcarbonyloxy-C1-C8-alkyl, an unsubstituted or substituted aryloxy-C1-C8-alkyl, an unsubstituted or substituted heterocyclyloxy-C1-C8-alkyl, an unsubstituted or substituted amino-C1-C8-alkyl, an unsubstituted or substituted C1-C8-alkylamino-C1-C8-alkyl, an unsubstituted or substituted di-C1-C8- alkylamino-C -C -alkyl, an unsubstituted or substituted arylamino-C -C -alkyl, an unsubstituted or 1 8 1 8 substituted di-arylamino-C -C -alkyl, an unsubstituted or substituted heterocyclylamino-C -C -alkyl, an 1 8 1 8 5 unsubstituted or substituted C -C -alkylcarbonylamino-C -C -alkyl, an unsubstituted or substituted C -C - 1 8 1 8 1 8 alkoxycarbonylamino-C1-C8-alkyl, an unsubstituted or substituted C1-C8-alkylsulfanyl-C1-C8-alkyl, an unsubstituted or substituted C1-C8-alkylsulfinyl-C1-C8-alkyl, an unsubstituted or substituted C1-C8- alkylsulfonyl-C -C -alkyl or an unsubstituted or substituted cyano-C -C -alkyl ; and 1 8 1 8 A, n, p, X, Y and Z are as recited in any one of claims 1 to 10 ; or - reacting a compound of formula (XIII) or one of its salts with a compound of formula (XIV) : (XIII) (XIV) (I) wherein T represents a hydrogen atom, an unsubstituted or substituted C -C alkyl, an unsubstituted or substituted C -C -cycloalkyl, an unsubstituted or substituted aryl or an unsubstituted or substituted heterocyclyl ; p represents 0, 1, 2, 3 or 4 ; 20 Z represents an unsubstituted or substituted C1-C8-alkyl, an unsubstituted or substituted C3-C7- cycloalkyl, an unsubstituted or substituted aryl or an unsubstituted or substituted heterocyclyl ; 1a 2a R and R independently represent an unsubstituted or substituted C -C -alkyl, an unsubstituted or substituted C2-C8-alkenyl, an unsubstituted or substituted C3-C7-cycloalkyl, an unsubstituted or substituted aryl oran unsubstituted or substituted heterocyclyl ; 25 R represents a hydrogen atom or an unsubstituted or substituted C1-C8-alkyl, a C1-C8- halogenoalkyl comprising up to 9 halogen atoms that can be the same or different, an unsubstituted or substituted C -C -alkenyl, an unsubstituted or substituted C -C -alkynyl, an unsubstituted or substituted 2 8 2 8 C3-C7-cycloalkyl, an unsubstituted or substituted C4-C7-cycloalkenyl, an unsubstituted or substituted aryl, an unsubstituted or substituted aryl-C1-C8-alkyl, an unsubstituted or substituted heterocyclyl, an 30 unsubstituted or substituted heterocyclyl-C -C -alkyl, an unsubstituted or substituted hydroxy-C -C -alkyl, 1 8 1 8 an unsubstituted or substituted C -C -alkoxy-C -C -alkyl, an unsubstituted or substituted C -C - 1 8 1 8 1 8 alkylcarbonyloxy-C -C -alkyl, an unsubstituted or substituted aryloxy-C -C -alkyl, an unsubstituted or 1 8 1 8 substituted heterocyclyloxy-C1-C8-alkyl, an unsubstituted or substituted amino-C1-C8-alkyl, an unsubstituted or substituted C1-C8-alkylamino-C1-C8-alkyl, an unsubstituted or substituted di-C1-C8- 35 alkylamino-C -C -alkyl, an unsubstituted or substituted arylamino-C -C -alkyl, an unsubstituted or 1 8 1 8 substituted di-arylamino-C -C -alkyl, an unsubstituted or substituted heterocyclylamino-C -C -alkyl, an 1 8 1 8 unsubstituted or substituted C1-C8-alkylcarbonylamino-C1-C8-alkyl, an unsubstituted or substituted C1-C8- alkoxycarbonylamino-C1-C8-alkyl, an unsubstituted or substituted C1-C8-alkylsulfanyl-C1-C8-alkyl, an unsubstituted or substituted C -C -alkylsulfinyl-C -C -alkyl, an unsubstituted or substituted C -C - 1 8 1 8 1 8 alkylsulfonyl-C -C -alkyl or an unsubstituted or substituted cyano-C -C -alkyl ; and 1 8 1 8 5 n, X and Y are as recited in claim 1.
14. The compound according to any one of claims 1 to 10, substantially as herein described with reference to any example thereof. 10
15. The composition according to claim 11, substantially as herein described with reference to any example thereof.
16. The method according to claim 12, substantially as herein described with reference to any example thereof.
17. The process according to claim 13, substantially as herein described with reference to any example thereof.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15290278 | 2015-10-29 | ||
EP15290278.9 | 2015-10-29 | ||
PCT/EP2016/076048 WO2017072283A1 (en) | 2015-10-29 | 2016-10-28 | Trisubstitutedsilylphenoxyheterocycles and analogues |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ742971A NZ742971A (en) | 2020-10-30 |
NZ742971B2 true NZ742971B2 (en) | 2021-02-02 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10683311B2 (en) | Trisubstitutedsilylphenoxyheterocycles and analogues | |
US20200008426A1 (en) | Active compound combinations | |
US11219214B2 (en) | Benzosultams and analogues and their use as fungicides | |
CA3046718A1 (en) | Phenylamidines and the use thereof as fungicides | |
EP3580218A1 (en) | Novel triazole derivatives | |
CA3046715A1 (en) | Phenoxyphenylamidines and the use thereof as fungicides | |
NZ742971B2 (en) | Trisubstitutedsilylphenoxyheterocycles and analogues | |
EP3421460A1 (en) | 2-[(4-alkylphenoxy)-pyridinyl]-1-(1,2,4-triazol-1-yl)alkan-2-ol fungicides | |
TW201841902A (en) | Novel triazolethione derivatives | |
WO2019122320A1 (en) | Heterocyclic benzosultams and analogues | |
US20200017467A1 (en) | Novel triazole derivatives | |
WO2018060076A1 (en) | Novel triazole derivatives | |
WO2018060070A1 (en) | Novel triazole derivatives | |
WO2018060071A1 (en) | Novel triazole derivatives |